cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
14622,Decan-3-one,213-183-9,928-80-3,Not Classified,Notified C&L,88.0,Not classified:88
14623,"2-[difluoro(methoxy)methyl]-1,1,1,3,3,3-hexafluoropropane",609-534-4,382-26-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,3.0,H331:1;H301:2;H311:1;H225:1;H330:1;H350:1;H317:1
14625,2-chloro-6-nitrobenzoic acid,226-287-4,5344-49-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,44.0,H302:39;H319:44;H335:6;H315:6
14629,6-(pentylthio)-1H-purine,226-638-1,5443-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
14630,Sodium α-bromo-p-toluenesulphonate,250-898-5,32014-22-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14632,N4-Benzoylcytidine,603-444-9,13089-48-0,Not Classified,REACH registration C&L,2.0,Not classified:2
14636,"3,4-dichlorostyrene",218-023-1,2039-83-0,,Notified C&L,1.0,H335:1;H315:1;H319:1
14637,"Bis(2-ethylhexyl) hydrogen phosphate, triethylammonium salt",925-551-2,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,83.0,H335:83;H318:83;H302:83;H315:83
14638,Diethylstilbestrol,200-278-5,56-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44.0,H360:41;H410:39;H350:39;H315:39;H319:39;H335:39;H400:39;H301:3;H330:3;H351:2
14639,"2,4,6-trihydroxybenzaldehyde",207-663-7,487-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
14643,"2-Naphthalenesulfonic acid, 5-[2-(5-chloro-4-methyl-2-sulfophenyl)diazenyl]-6-hydroxy-, strontium salt (1:1)",606-370-5,197566-87-3,Not Classified,Notified C&L,11.0,Not classified:11
14644,diethyl (1-cyano-3-methylbutyl)malonate,606-069-9,186038-82-4,Eye Irrit. 2B;Aquatic Chronic 2,Notified C&L,29.0,H411:29;H320:29
14650,3-(4-chlorophenoxy)propionic acid,221-932-6,3284-79-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14652,"Pentane-2,3-dione",209-984-8,600-14-6,Flam. Liq. 2;Skin Sens. 1;Eye Dam. 1;STOT RE 2,Notified C&L,1607.0,H317:1423;H318:1422;H225:1606;H373:1474;H332:52;H315:102;H319:101;H335:100;H411:1;H301:1;H314:1;H302:1
14656,"2-[[4-[[4-[[(2,3-dichloro-6-quinoxalinyl)carbonyl]amino]-5-sulpho-1-naphthyl]azo]-7-sulpho-1-naphthyl]azo]benzene-1,4-disulphonic acid, lithium sodium salt",280-398-2,83399-85-3,Skin Sens. 1,Notified C&L,9.0,H317:9
14663,4-amino-2-(trifluoromethyl)benzonitrile,700-293-1,654-70-6,Not Classified,REACH registration C&L,62.0,Not classified:3;H317:43;H302:50;H301:9;H330:7;H311:11;H319:14;H315:14;H335:7;H331:5;H332:2;H312:2
14664,"1,2,4-Trichloro-5-iodobenzene",925-152-3,7145-82-6,,Notified C&L,4.0,H335:4;H315:4;H319:4
14667,Natural gas,232-343-9,8006-14-2,Flam. Gas 1,Notified C&L,115.0,H220:103;H280:63;H224:12;H281:13;H361:9;H412:12;H332:12;H350:7;H340:7;H336:3
14668,Sodium [4-(dimethylamino)-2-methylphenyl]phosphinate,209-391-4,575-75-7,STOT RE 2,Notified C&L,35.0,H373:35
14669,Cytidine 5'-(dihydrogen phosphate),213-849-9,1032-65-1,Not Classified,Notified C&L,2.0,Not classified:1;H332:1;H302:1;H312:1
14670,"Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl-, reaction products with 2,2'-[1,6-hexanediylbis(oxymethylene)]bis[oxirane]",291-131-4,90341-98-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1.0,H318:1;H314:1;H317:1;H412:1;H312:1;H302:1
14671,Tripotassium citrate,212-755-5,866-84-2,Not Classified,REACH registration C&L,446.0,Not classified:424;H335:18;H315:18;H319:18;H302:4;H314:4
14672,"2-bromo-3,4-dihydronaphthalen-1(2H)-one",237-154-5,13672-07-6,Acute Tox. 4;Skin Irrit. 2,Notified C&L,39.0,H302:39;H315:39;H335:1;H319:1
14675,"3,4-dimethylbenzonitrile",245-293-8,22884-95-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,46.0,H302:45;H319:44;H335:4;H315:4;H332:1;H312:1;H412:1
14677,Calcium disulphamate,237-399-8,13770-92-8,Eye Irrit. 2,REACH registration C&L,85.0,H319:85
14678,Chromium copper oxide,234-335-0,11104-65-7,Ox. Sol. 1;STOT SE 3,Notified C&L,10.0,H271:10;H335:10
14679,"Bis[(5-ethyl-2-methyl-1,3,2-dioxaphosphorinan-5-yl)methyl] methyl phosphonate P,P'-dioxide",255-902-9,42595-45-9,Not Classified,Notified C&L,96.0,Not classified:96
14683,"3,4-dimethoxy-N-methylphenethylamine",222-483-9,3490-06-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,130.0,H335:129;H315:130;H319:130
14684,"7-amino-4-hydroxy-3-[[4-[(4-sulphophenyl)azo]phenyl]azo]naphthalene-2-sulphonic acid, compound with 2,2',2''-nitrilotriethanol (1:2)",265-016-4,64683-40-5,Not Classified,REACH registration C&L,91.0,Not classified:91
14687,"2,2-dioctyl-1,3,2-oxathiastannolan-5-one",239-581-2,15535-79-2,Acute Tox. 4;STOT SE 2,Notified C&L,17.0,H371:14;H302:14;H372:2;H413:3;H361:2;H373:1
14690,"3,3'-(oxydimethanediyl)bis(3-ethyloxetane)",444-140-4,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,11.0,H302:11;H412:11
14691,Perfluamine,206-420-2,338-83-0,Acute Tox. 4;Acute Tox. 3;Eye Irrit. 2,REACH registration C&L,2.0,H319:1;H302:1;H311:1;Not classified:1
14692,"3,5,5-trimethylhexyl methacrylate",236-621-0,13453-03-7,,Notified C&L,1.0,H335:1;H315:1;H319:1
14693,"Silane, chlorodimethyloctyl-, hydrolysis products with silica",271-543-0,68584-80-5,Eye Irrit. 2,Notified C&L,39.0,H319:39;H335:1;H315:1
14694,"Ethanol, 1,1'-[2-butyne-1,4-diylbis(oxy)]bis [2,2,2-trichloro- (9CI)",607-754-5,25600-48-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
14697,4-ethylcyclohexanol,224-878-1,4534-74-1,Eye Irrit. 2,Notified C&L,38.0,H319:38
14699,"Kerosine (petroleum), sweetened;Kerosine - unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",294-799-5,91770-15-9,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
14702,"(+/-)-1,2-Diphenylethylenediamine",605-438-1,16635-95-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2;H302:1
14703,"1,2,4-trimethylcyclohexane",218-783-4,2234-75-5,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,40.0,H302:38;H225:40;H319:38;H400:38;H304:1
14704,3-methylcyclopentadec-4-en-1-one,253-015-1,36399-15-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1286.0,H317:1286;H410:1286;H400:1286
14707,C.I. Reactive Yellow 160,603-372-8,129898-77-7,Not Classified,Notified C&L,20.0,Not classified:20
14709,Isopropyl isobutyrate,210-517-5,617-50-5,Not Classified,Notified C&L,131.0,Not classified:90;H225:41
14710,Chlorotripropylsilane,213-624-5,995-25-5,Skin Corr. 1A;STOT SE 3,Notified C&L,42.0,H335:38;H314:42
14713,1-(N-ACETYLSULFANILYL)UREA,608-186-0,2828-63-9,Acute Tox. 4,Notified C&L,38.0,H302:38
14716,C.I. Acid Red 357,612-775-8,61951-36-8,Not Classified,Notified C&L,3.0,Not classified:2;H411:1;H319:1
14719,"Disodium 3-hydroxy-4-nitrosonaphthalene-2,7-disulphonate",208-369-1,525-05-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H332:41;H302:41;H312:41;H335:5;H315:6;H319:6
14720,Amcinonide,256-915-2,51022-69-6,Repr. 2;STOT RE 2,Notified C&L,2.0,H361:2;H373:1
14722,Hexanol,247-346-0,25917-35-5,Acute Tox. 4,Notified C&L,22.0,H302:22
14723,"Pine, Pinus sylvestris, ext.",640-016-0,8023-99-2,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,30.0,H304:30;H410:29;H317:30;H226:29;H400:30;H411:1;H319:1;H315:1
14725,"2,3,5-trimethyl-4-nitropyridine 1-oxide",617-893-3,86604-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14726,"[4-[α-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium acetate",255-288-2,41272-40-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,64.0,H318:47;H410:48;H317:44;H361:46;H302:52;H400:48;Not classified:11;H332:3;H314:3;H412:3;H312:3;H335:3;H315:3;H319:3;H334:1;H411:1
14727,Potassium p-[2-(aminothioxomethyl)hydrazino]benzenesulphonate,268-178-4,68025-19-4,,Notified C&L,1.0,H319:1
14728,2-amino-3-chloro-5-nitrobenzonitrile,243-760-0,20352-84-5,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,38.0,H317:38;H332:38;H312:38;H319:38
14730,"3,4-dimethylbenzylamine",203-034-6,102-48-7,,Notified C&L,6.0,H314:5;H335:1;H315:1;H319:1;H318:1
14736,calcium,231-179-5,7440-70-2,Water-react. 2,Harmonised C&L,0.0,H261:0
14738,Isopropyldinitrophenol,249-592-4,29385-11-3,Acute Tox. 3,Notified C&L,38.0,H301:38
14742,"Oils, Hamamelis virginiana",614-784-2,68916-39-2,Flam. Liq. 3,Notified C&L,88.0,H226:52;Not classified:36
14747,"4-amino-5-thioxo-1,2,4-triazolidin-3-one hydrazone",217-135-8,1750-12-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43;H228:5
14749,D-α-methylbenzylamine,223-423-4,3886-69-9,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,144.0,H314:144;H302:143;H312:139;H318:85;H311:3;H335:1
14750,"Anthracene oil, anthracene paste;Anthracene Oil Fraction;[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.]",292-603-2,90640-81-6,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
14751,"2-phenylpropane-1,3-diyl dicarbamate",247-001-4,25451-15-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,27.0,H317:26;H334:26;Not classified:1
14752,tert-butyl (4-aminophenyl)carbamate,275-132-7,71026-66-9,Acute Tox. 4;Skin Sens. 1,Notified C&L,5.0,H317:3;H302:4;H315:2;H319:2;H332:1;H312:1;H335:1
14754,4-tert-butylcyclohexanol,202-676-4,98-52-2,Eye Irrit. 2,REACH registration C&L,1749.0,H319:1476;Not classified:273
14760,"(2S,3S)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid",615-177-5,70831-56-0,Not Classified,Notified C&L,3.0,Not classified:2;H317:1;H334:1;H302:1
14765,1-[4-(trans-4-Butylcyclohexyl)-1-cyclohexen-1-yl]-4-trifluormethoxybenzene,922-483-5,,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
14766,potassium polysulphides,253-390-1,37199-66-9,Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0.0,H314:0;H400:0
14770,Diboron manganese tetraoxide,254-794-0,40105-04-2,Not Classified,Notified C&L,7.0,Not classified:7
14772,"Formula 1a:Trisodium {1-(2-carboxylato-kO-5-sulfonatophenyl)-5-[3-(2,6-difluoropyrimidin-4-ylamino)-2-olato-kO-5-sulfonatophenyl]-3-phenylformazan-5-ido-k2N1,N5}cuprate(II)Formula 2a:Trisodium {1-(2-carboxylato-kO-5-sulfonatophenyl)-5-[3-(4,6-difluoropyrimidin-2-ylamino)-2-olato-kO-5-sulfonatophenyl]-3-phenylformazan-5-ido-k2N1,N5}cuprate(II)",473-160-6,,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,43.0,H318:43;H302:41
14774,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium sulphate (2:1)",281-436-0,83949-76-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,2.0,H318:2;H302:2
14775,N-benzyl-N-phenylhydrazine,210-377-5,614-31-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
14782,Lorazepam,212-687-6,846-49-1,Repr. 2,Notified C&L,100.0,H361:95;H360:2;H362:4;H302:4;H412:4;H336:2;H373:1;H341:1
14785,Sucrose dilaurate,247-345-5,25915-57-5,Not Classified,Notified C&L,1.0,Not classified:1
14786,3-[(4-formylphenyl)methylamino]propiononitrile,202-315-0,94-21-3,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,131.0,H317:83;H412:83;H302:47;H332:38;H312:38;H319:38;H335:38;H315:38;Not classified:1
14790,"Evernia prunastri, ext., ethanolyzed",305-672-1,94944-94-2,Skin Sens. 1,Notified C&L,124.0,H317:124
14792,"3,3'-[ethylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:6)",278-294-7,75701-36-9,Skin Sens. 1B,Notified C&L,126.0,H317:83;Not classified:43
14793,Sodium 2-stearoyllactate,246-929-7,25383-99-7,Not Classified,REACH registration C&L,154.0,Not classified:154
14796,7-amino-4-hydroxynaphthalene-2-sulphonic acid,201-718-9,87-02-5,Not Classified,REACH registration C&L,193.0,Not classified:62;H332:1;H314:129;H312:1;H319:3;H335:2;H302:1;H341:1
14802,Isopropyl lactate,210-518-0,617-51-6,Not Classified,Notified C&L,5.0,Not classified:5
14805,"1,2-dibromo-4-fluorobenzene",219-131-1,2369-37-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H315:3;H319:3;H335:2;H302:1
14810,4-[(trifluoromethyl)thio]aniline,206-744-4,372-16-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,44.0,H332:43;H302:39;H312:43;H301:4;H319:6;H315:6;H335:1
14813,"Chromate(1-), bis[ethyl [7-hydroxy-8-[[2-hydroxy-5-(methylsulfonyl)phenyl]azo]-1-naphthalenyl]carbamato(2-)]-, hydrogen, (OC-6-11)-",601-926-3,12218-94-9,Not Classified,Notified C&L,1.0,Not classified:1
14816,"N,N-dibutylphenethylamine hydrochloride",238-036-6,14180-18-8,Acute Tox. 4;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H336:1;H302:1;H319:1
14819,α-methyl-1H-imidazole-1-ethanol,253-668-2,37788-55-9,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,63.0,H318:3;H314:63;H360:2;H302:59;H332:59;H312:59;H319:59;H315:59
14823,Dibutyl terephthalate,217-803-9,1962-75-0,Not Classified,REACH registration C&L,15.0,Not classified:14;H412:1;H315:1;H319:1
14824,"1,1,1,2,4,5,5,5-octafluoro-2,4-bis(trifluoromethyl)pentan-3-one",212-384-9,813-44-5,,Notified C&L,7.0,H302:5;H332:5;H315:6;H319:6;H335:6;Not classified:1
14836,6-chloronicotinic acid,226-201-5,5326-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,136.0,H335:135;H315:136;H319:136
14841,Titanium tetraiodide,231-754-0,7720-83-4,Skin Corr. 1B,Notified C&L,65.0,H314:64;H335:4;Not classified:1
14843,9-BROMO-1-NONANOL,611-262-6,55362-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
14844,"2,3,6,7,12,13,16,17-octahydro-9-(trifluoromethyl)-1H,5H,11H,15H-xantheno[2,3,4-ij:5,6,7-i'j']diquinolizin-18-ium perchlorate",264-312-0,63561-42-2,Ox. Sol. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H272:1;H315:1;H319:1
14845,"1-ethoxy-3,7-dimethylocta-2,6-diene",254-867-7,40267-72-9,Not Classified,Notified C&L,88.0,Not classified:88
14847,Ceftazidime,276-715-9,72558-82-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,65.0,H317:63;H334:63;H300:1;H410:1;H400:1;H319:1
14852,methyl quinoline-6-carboxylate,609-595-7,38896-30-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14853,2-chloro-4-fluoroaniline,218-282-0,2106-02-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H302:45;H332:45;H312:41;H319:46;H335:41;H315:46;H373:6;H311:4;H301:1
14854,"β-D-Glucopyranoside, (3β,25R)-26-(β-D-glucopyranosyloxy)furosta-5,20(22)-dien-3-yl O-6-deoxy-α-L-mannopyranosyl-(1.fwdarw.2)-O-[6-deoxy-α-L-mannopyranosyl-(1.fwdarw.4)]-",600-274-7,102115-79-7,Not Classified,Notified C&L,1.0,Not classified:1
14855,Barium isooctanoate,299-090-4,93843-12-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,40.0,H332:40;H302:40
14857,N-[2-(1-piperidinyl)ethyl]ethylenediamine,227-060-2,5625-69-4,Acute Tox. 4;Skin Corr. 1B;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H314:1
14858,Sodium p-hydroxybenzenesulphonate,249-038-1,28469-73-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H302:1;H315:1;H319:1
14859,"2,3,10,11-tetramethoxy-8-methyldibenzo[a,g]quinolizinium chloride",254-239-2,38989-38-7,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,38.0,H301:38;H413:38
14860,Barium periodate,237-279-5,13718-58-6,Ox. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,38.0,H332:38;H272:38;H315:38;H319:38;H302:38
14861,Pyridin-3-ol,203-637-4,109-00-2,Not Classified,REACH registration C&L,54.0,Not classified:2;H335:51;H315:52;H319:52;H302:4;H332:1;H312:1
14862,2-(m-tolyloxy)ethanol,237-091-3,13605-19-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H302:38;H315:38
14863,3-phenyl-2-thioxoimidazolidin-4-one,217-927-3,2010-15-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,40.0,H331:38;H301:40;H311:38;H335:1;H315:1;H319:1
14864,"Oils, tallow",293-410-6,91079-23-1,Not Classified,Notified C&L,1.0,Not classified:1
14867,Oct-1-ene-3-ol,222-226-0,3391-86-4,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,1784.0,H301:54;H332:1737;H317:54;H319:1782;H315:1782;H302:1730;H400:1681;H331:4;H335:4;H312:1;H410:1;H336:1
14869,"2,5-Bis-(4-acryloxybenzoyl)isomannid",609-279-9,366448-52-4,Skin Sens. 1B;Aquatic Chronic 4,Notified C&L,4.0,H317:4;H413:4
14871,"4-chlorophenyl 2,3-epoxypropyl ether",218-655-8,2212-05-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1.0,H332:1;H317:1;H315:1;H412:1;H319:1;H335:1
14872,α-oxo-1H-indole-3-acetyl chloride,245-362-2,22980-09-2,Skin Corr. 1B,Notified C&L,42.0,H314:42
14873,"St.-John's-wort, Hypericum perforatum, ext.",282-026-4,84082-80-4,Not Classified,Notified C&L,240.0,Not classified:192;H302:37;H319:36;H304:9;H410:6;H317:6;H226:11;H315:5;H400:6;H332:1;H411:1
14878,"3,7-dimethylnona-2,6-dienenitrile",263-214-5,61792-11-8,Aquatic Chronic 2,REACH registration C&L,1703.0,H411:1493;Not classified:210
14879,4-(4-nitrophenyl)sulfonylaniline,606-323-9,1948-92-1,Not Classified,Notified C&L,1.0,Not classified:1
14880,Imipramine,200-042-1,50-49-7,Not Classified,REACH registration C&L,8.0,Not classified:6;H400:1;H302:1
14882,sec-butylbenzene,205-227-0,135-98-8,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,83.0,H411:38;H226:61;H315:47;H304:17;Not classified:6;H302:6;H319:9;H335:4
14886,N-(4-Oxocyclohexyl)acetamide,608-106-4,27514-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44.0,H335:43;H315:43;H319:43;Not classified:1
14890,4-(2-aminoethyl)guaiacol hydrochloride,211-437-3,645-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:39;H319:39;H302:1
14893,"Hydrogen [3-[[1-[anilinocarbonyl]-2-oxopropyl]azo]-2-hydroxy-5-nitrobenzene-1-sulphonato(3-)]hydroxychromate(1-) , compound with 3-[(2-ethylhexyl)oxy]propylamine (1:1)",304-519-6,94276-33-2,Not Classified,REACH registration C&L,106.0,Not classified:90;H411:16
14894,"Chromate(2-), [3-hydroxy-4-[(2-hydroxy-1-naphthalenyl)azo]-7-nitro-1-naphthalenesulfonato(3-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-, sodium",290-928-4,90294-44-3,,Notified C&L,447.0,H319:447
14895,"Distillates (petroleum), light catalytic cracked, thermally degraded;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 °C to 340 °C (374 °F to 644 °F). This stream is likely to contain organic sulfur compounds.]",295-991-1,92201-60-0,Carc. 1B,Harmonised C&L,0.0,H350:0
14896,Diethylhydridoaluminium,212-805-6,871-27-2,Pyr. Liq. 1;Skin Corr. 1B,Notified C&L,38.0,H260:38;H314:38;H250:38
14897,Ethyl 3-acetoxyhexanoate,244-263-1,21188-61-4,Not Classified,Notified C&L,88.0,Not classified:88
14898,"2-Propenoic acid, telomer with sodium sulfite (1:1)",613-870-7,66019-18-9,Not Classified,Notified C&L,3.0,Not classified:3
14903,"2-oxo-2-[(4aS,4bS,5aS,6aS,6bS,9aR,10aS,10bS)-4a,6a,8,8-tetramethyl-2-oxo-2,5a,6,6a,9a,10,10a,10b,11,12-decahydronaphtho[2’,1’:4,5]oxireno[5,6]indeno[1,2-d][1,3]dioxol-6b(4aH)-yl]ethyl acetate",607-542-2,25092-32-4,Repr. 2;Aquatic Chronic 3,REACH registration C&L,4.0,H361:3;H412:3;Not classified:1
14909,"Formaldehyde, polymers with sulfonated 1,1'-oxybis[methylbenzene], sodium salts",615-971-1,73378-66-2,Aquatic Chronic 3,Notified C&L,66.0,H412:66
14913,Lidocaine,205-302-8,137-58-6,Acute Tox. 4,REACH registration C&L,220.0,H302:218;H319:10;H361:9;Not classified:2;H332:1;H312:1;H334:1;H317:1;H335:1
14916,o-amino-N-(2-chloro-3-pyridyl)benzamide,213-478-2,956-30-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
14921,1-bromo-4-(trifluoromethoxy)benzene,206-979-2,407-14-7,Skin Irrit. 2,REACH registration C&L,48.0,H315:48;H302:39;H334:39;H319:46;H335:45;H227:1
14922,Trioctylaluminium,213-964-4,1070-00-4,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,REACH registration C&L,145.0,H260:145;H314:145;H250:145;H411:6;H412:3;H252:1
14926,4-methoxypyridine N-oxide,214-367-1,1122-96-9,,Notified C&L,6.0,H335:5;H315:6;H319:6;H302:1;H332:1;H312:1
14931,"Dibenzo(b,f)cycloheptan-1-one",214-912-3,1210-35-1,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,74.0,H315:4;H319:10;Not classified:63;H411:1;H302:1
14932,"2,6-dihydroxyisonicotinic acid",202-731-2,99-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:48;H315:49;H319:49;H412:1
14933,"1,1-dimethoxyethyl(dimethyl)amine",242-641-0,18871-66-4,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,48.0,H302:47;H332:44;H225:44;H312:44;H319:44;H335:43;H315:43;H371:7;H224:4;H314:1;H360:1;H370:1;H372:1;H311:3;H331:3
14940,"Oleylalcohol, ethoxylated, phosphated, ammonium salt",611-755-6,58857-49-1,Skin Irrit. 2;Eye Dam. 1,Notified C&L,15.0,H318:6;H315:10;Not classified:5
14941,"N-Butyl-2-(1-ethylpentyl)-1,3-oxazolidine",425-660-0,,Aquatic Chronic 2,REACH registration C&L,47.0,H411:47
14942,Triethylammonium p-toluenesulphonate,239-421-1,15404-00-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,90.0,H302:89;H314:89;H315:1;H319:1
14943,2-chloro-6-methylpyridin-3-ol,252-675-8,35680-24-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
14944,"O,O,O',O'-tetrapropyl dithiopyrophosphate",221-817-0,3244-90-4,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H312:0;H410:0;H400:0
14947,Decafluorobutane,206-580-3,355-25-9,Press. Gas (Liq.),Notified C&L,41.0,H280:41;H335:1;H315:1;H319:1
14950,"(S)-2-amino-3-(3,4-dimethoxyphenyl)-2-methylpropiononitrile monohydrochloride",219-823-3,2544-13-0,Not Classified,REACH registration C&L,1.0,Not classified:1
14952,Magnesium chromate,236-540-0,13423-61-5,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT SE 3;Muta. 1B;Carc. 1B;Aquatic Chronic 1,Notified C&L,60.0,H301:57;H318:57;H410:60;H330:57;H350:60;H317:60;H312:57;H335:60;H340:60;H315:60;H272:3;H319:3;H400:4
14955,Pentatitanium trisilicide,235-082-9,12067-57-1,,Notified C&L,4.0,H228:4;H335:4;H315:4;H319:4
14957,lead hydrogen arsenate,232-064-2,7784-40-9,Acute Tox. 3;Acute Tox. 3;Carc. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0.0,H360:0;H301:0;H410:0;H373:0;H350:0;H331:0;H400:0
14958,"Rac-[dimethylsilyl-bis(4,5,6,7-tetrahydro-1H-inden-1-yl)]zirconium dichloride",416-990-6,,Not Classified,Notified C&L,33.0,Not classified:33
14962,3-hydroxy-4-[(1-hydroxy-2-naphthyl)azo]-7-nitronaphthalene-1-sulphonic acid,247-237-8,25747-08-4,Aquatic Chronic 3,Notified C&L,4.0,H412:3;Not classified:1;H319:1
14963,Magnesium oxide,215-171-9,1309-48-4,Not Classified,Notified C&L,1739.0,Not classified:1534;H410:73;H335:70;H317:63;H315:78;H319:125;H371:6;H318:3;H302:5;H332:3;H411:1;H334:1;H304:2;H400:2;H373:2;H336:2;H225:2;H361:2
14964,"1,5-Pentanedione, 1-(4-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-",606-164-5,189028-93-1,Not Classified,Notified C&L,1.0,Not classified:1
14965,Reaction mixture of hydrogenated tallow alkyl amines with sebacic acid and lithium hydroxide,433-100-1,,Not Classified,REACH registration C&L,8.0,Not classified:8
14969,(tert-Butoxycarbonylmethylene)triphenylphosphorane,609-052-4,35000-38-5,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43.0,H411:43;H301:43;H373:43;H317:43;H319:43
14974,4-allyl-2-methoxyphenyl formate,233-099-6,10031-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,112.0,H335:112;H315:112;H319:112
14976,"Soaps, stocks, sunflower-oil, acidulated, hydrogenated",296-512-9,92704-76-2,Not Classified,Notified C&L,1.0,Not classified:1
14980,"[R-(R*,R*)]-2-[2-[1-(p-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidinium hydrogen fumarate",239-055-2,14976-57-9,Not Classified,Notified C&L,18.0,Not classified:12;H410:5;H400:4;H331:1;H301:1;H311:1
14981,"1,1,4,4-tetraphenylbuta-1,3-diene",215-914-7,1450-63-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
14983,"Fatty acids, C12-18 and C18-unsatd.",292-776-4,90990-15-1,Eye Irrit. 2,Notified C&L,230.0,H319:183;Not classified:47;H315:3
14984,nickel monoxide,215-215-7,1313-99-1,Skin Sens. 1;STOT RE 1;Aquatic Chronic 4;Carc. 1A,Harmonised C&L,0.0,H372:0;H317:0;H413:0;H350:0
14986,"2-Butenoic acid, 4-oxo-4-(tridecylamino)-, (Z)-, branched",283-219-6,84583-68-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,83.0,H411:83;H317:83;H315:83;H319:83
14987,"Salt of N-acetyl-L-glutamic acid and 1-[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine (1:1), monohydrate",922-576-0,1184182-45-3,Skin Sens. 1A,REACH registration C&L,1.0,H317:1
14989,1-methylpiperidine-2-one,213-231-9,931-20-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
14993,"Poly(oxy-1,2-ethanediyl), α-(isooctylphenyl)-ω-hydroxy-",618-400-4,9004-87-9,Aquatic Chronic 3,Notified C&L,218.0,H412:105;H411:96;H315:92;H319:92;H318:13;H302:13;Not classified:7;H413:1
14996,"(±)-13-ethyl-3-methoxygona-1,3,5(10),8-tetraen-17-one",227-699-7,5941-92-4,Not Classified,REACH registration C&L,1.0,Not classified:1
14999,"2-chloro-N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide",218-932-3,2293-55-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,39.0,H301:38;H318:38;H334:38;H315:38;H335:38;Not classified:1
15005,methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate,413-040-2,149850-30-6,Skin Sens. 1,Harmonised C&L,0.0,H317:0
15006,"2,3,5,6-tetrachlorophenol",213-310-8,935-95-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,42.0,H301:41;H318:41;H413:38;H315:41;H335:41;Not classified:1
15008,"3,3,4,4,5,5-hexafluorodihydro-2H-pyran-2,6(3H)-dione",206-811-8,376-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:38;H315:39;H319:39;H314:6
15013,Magnesium myristate,223-817-6,4086-70-8,Not Classified,Notified C&L,12.0,Not classified:12
15016,4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone,431-490-8,79876-59-8,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
15017,2-bromocinnamaldehyde,226-637-6,5443-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H302:45;H315:45;H319:45
15019,"(5-methoxy-1,5-dimethylhexyl)oxirane",254-924-6,40454-19-1,Not Classified,Notified C&L,1.0,Not classified:1
15023,(5-ethyl-2-trimethylsilyloxypyrimidin-4-yl)oxy-trimethylsilane,608-586-5,31167-05-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2.0,H317:2;H318:2;H302:2
15030,"Distillates (petroleum), chemically neutralized light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-136-7,64742-35-4,Carc. 1A,Harmonised C&L,0.0,H350:0
15033,"Cerium(3+) 2-hydroxypropane-1,2,3-tricarboxylate",208-139-0,512-24-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4.0,H410:3;H400:3;H315:1;H319:1
15034,Tetraethyl ethylenebisphosphonate,213-625-0,995-32-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H315:43;H319:43
15036,"mipafox (ISO);N,N'- di-isopropylphosphorodiamidic fluoride",206-742-3,371-86-8,STOT SE 1,Harmonised C&L,0.0,H370:0
15041,"(R,E)-Methyl 3-[(tert-butyldimethylsilyl)oxy]-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]-5-oxohept-6-enoate",604-566-5,147118-38-5,Aquatic Chronic 4,Notified C&L,1.0,H413:1
15042,Magnesium disulphamate,237-398-2,13770-91-7,Not Classified,Notified C&L,2.0,Not classified:2
15043,β-pilocarpine nitrate,227-800-4,5984-94-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H332:38;H302:38;H312:38
15045,"Cyclohexanemethanamine, 5-amino-1,3,3-trimethyl-, reaction products with glycidyl tolyl ether",291-130-9,90341-97-2,Acute Tox. 4;Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,89.0,H411:2;H302:1;H315:1;H400:1;Not classified:87;H317:1;H314:1
15046,2-methoxyethyl 2-cyanoacrylate,248-670-5,27816-23-5,Not Classified,REACH registration C&L,162.0,Not classified:162
15050,2-(trifluoromethyl)benzylamine,221-258-2,3048-01-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,47.0,H302:40;H314:47;H318:1;H332:1;H312:1
15052,(ethoxymethyl)oxirane,223-671-3,4016-11-9,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,39.0,H411:38;H226:39;H302:38;H319:39;H315:1
15053,"Benzeneethanamine, N,.alpha.-dimethyl-N-2-propynyl-, (R)-",604-507-3,14611-51-9,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,86.0,H411:86;H302:86;H332:1
15057,"4,5-dimethoxy-2-methylbenzaldehyde",231-759-8,7721-62-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
15059,3-Benzyloxyphenylacetonitrile,606-679-5,20967-96-8,,Notified C&L,7.0,H302:6;H312:6;H332:2;H335:1;H315:2;H319:2
15061,"Dibutoxybis(ethyl acetoacetato-O1',O3)titanium",244-010-5,20753-28-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,47.0,H315:47;H319:47
15064,Arsanilic acid,202-674-3,98-50-0,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,44.0,H331:43;H301:43;H410:43;H400:39;H373:4;Not classified:1;H350:1
15067,"2,2'-(2-methylpropylidene)bis[4,6-xylenol]",251-394-8,33145-10-7,Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,19.0,H410:1;H373:1;H413:1;H302:1;H400:1;H412:18
15068,"β-Alanine, N-C8-18-alkyl derivs., monopotassium salts",290-475-2,90170-42-6,Not Classified,REACH registration C&L,3.0,Not classified:3
15071,"ethyl 3-[[]benzyl({[[](3Z)-3-methyl-6-oxo-5-oxa-2-thia-4,7-diazaoct-3-en-7-yl]sulfanyl})amino]propanoate",617-442-0,83130-01-2,Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1,Notified C&L,39.0,H302:39;H330:39;H400:39;H410:1;H319:1
15072,"Quinoline-2,4-diol",201-711-0,86-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,50.0,H335:49;H315:50;H319:50;H341:4
15076,Methyl fluorosulphate,207-004-3,421-20-5,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 1,Notified C&L,1.0,H301:1;H318:1;H330:1;H225:1;H311:1;H315:1
15077,Oxytocin,200-048-4,50-56-6,,Notified C&L,49.0,Not classified:39;H361:7;H300:4;H302:5;H332:4;H312:4;H319:3;H335:2;H315:3;H360:2;H301:2;H334:1;H317:1
15082,Tris[oxalato(2-)]dineodymium,214-692-9,1186-50-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H302:1;H312:1
15086,2-sec-butylthiazole,242-154-3,18277-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,134.0,H335:129;H315:129;H319:129;H226:42;Not classified:1
15092,"Hydrocarbons, C10-C12, n-alkanes, <2% aromatics",926-527-4,,Asp. Tox. 1,REACH registration C&L,2.0,H304:2
15095,"2,4-dimethylthiazole",208-786-9,541-58-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,160.0,H302:115;H315:158;H226:160;H319:158;H335:157
15102,Tetradecafluorohexane,206-585-0,355-42-0,Not Classified,REACH registration C&L,104.0,Not classified:2;H335:74;H315:74;H319:74;H412:35;H225:6
15109,Buten-2-yl (3-methylbutoxy)acetate,276-962-2,72894-11-2,Not Classified,Notified C&L,88.0,Not classified:88
15110,Octylphosphonic acid,225-218-5,4724-48-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,336.0,H318:143;H314:332;H302:199;H373:89;H290:23;H315:4;H319:4
15111,(chloromethyl)triethoxysilane,239-311-3,15267-95-5,Flam. Liq. 3;Skin Sens. 1B,REACH registration C&L,47.0,H317:2;H226:42;H315:6;H319:7;H335:1
15114,7-(diethylamino)-4-(trifluoromethyl)-2-benzopyrone,255-593-0,41934-47-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;Not classified:1
15116,"2,4-dimethyl-2-(4-methylpent-3-enyl)-1,3-dioxolane",269-499-2,68258-95-7,Not Classified,Notified C&L,1.0,Not classified:1
15117,"Trisodium [22-[[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]phenyl]amino]sulphonyl]-29H,31H-phthalocyanine-1,8,15-trisulphonato(5-)-N29,N30,N31,N32]nickelate(3-)",275-295-4,71243-96-4,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,31.0,H317:31;H412:31
15118,4-nitrophenethylamine hydrochloride,249-980-3,29968-78-3,Not Classified,Notified C&L,10.0,Not classified:8;H315:2;H319:2;H341:1;H351:1
15119,"reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate",403-410-1,114565-65-0,Skin Sens. 1,Harmonised C&L,0.0,H317:0
15120,Diammonium tetraoxotellurate,236-622-6,13453-06-0,,Notified C&L,4.0,H302:4
15127,Indan-5-amine,246-241-7,24425-40-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H332:45;H302:45;H312:41;H311:4;H319:2;H315:2
15128,"Amides, castor-oil, N-[3-(dimethylamino)propyl], formates",286-997-5,85408-36-2,Not Classified,Notified C&L,71.0,Not classified:71
15129,"Anthracene oil, anthracene-low;Anthracene Oil Fraction;[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.]",292-604-8,90640-82-7,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
15131,Methyl 2-(hydroxymethyl)acrylate,604-981-1,15484-46-5,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2.0,H318:1;H302:1;H315:2;H311:1;H335:1;H413:1;H319:1
15133,chlorfenson (ISO);4-chlorophenyl 4-chlorobenzenesulfonate,201-270-4,80-33-1,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H315:0;H410:0;H400:0
15134,Lutetium trihydroxide,240-519-1,16469-21-9,Not Classified,Notified C&L,2.0,Not classified:2
15140,Sodium hexafluorophosphate,244-333-1,21324-39-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,49.0,H314:49;H332:47;H302:47;H312:47;H318:2;H362:1;H290:1
15142,"quinclorac (ISO);3,7-dichloroquinoline-8-carboxylic acid",402-780-1,84087-01-4,Skin Sens. 1,Harmonised C&L,0.0,H317:0
15143,3-amino-4-chlorobenzonitrile,258-471-5,53312-79-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H302:39;H317:39;H315:41;H319:41;H335:40;H301:2;H311:1;H331:1
15144,"isoproturon (ISO); 3-(4-isopropylphenyl)-1,1-dimethylurea",251-835-4,34123-59-6,Carc. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H351:0;H373:0
15145,"1,1-dimethyl-3-phenylpropyl isobutyrate",233-092-8,10031-71-7,Not Classified,Notified C&L,89.0,Not classified:89
15147,"1,1,3,3-tetramethoxypropane",203-037-2,102-52-3,Flam. Liq. 3,REACH registration C&L,58.0,H226:58
15152,"2-Phenyl-1,3-propanediol",605-082-7,1570-95-2,Eye Dam. 1,Notified C&L,38.0,H318:38
15158,Dimethyl hydrogen phosphate,212-389-6,813-78-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,40.0,H314:39;H302:38;H312:38;H317:38;Not classified:1
15159,aluminium-magnesium-zinc-carbonate-hydroxide,423-570-6,169314-88-9,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
15162,Sodium toluenesulphonate,235-088-1,12068-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,312.0,H315:198;H319:245;Not classified:42;H318:25;H335:3
15163,"cis-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane-4-ylmethyl benzoate",262-765-9,61397-56-6,Aquatic Chronic 4,REACH registration C&L,2.0,H413:1;H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
15164,Dimethoxymethylphenylsilane,221-192-4,3027-21-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83.0,H335:38;H302:79;H315:39;H319:42;H318:13;Not classified:4;H332:2;H312:2
15166,Triphenylstibine sulphide,223-555-2,3958-19-8,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,38.0,H411:38;H332:38;H302:38
15171,tetracyclohexylstannane,215-910-5,1449-55-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H332:0;H410:0;H312:0;H302:0;H400:0
15173,p-tolyl salicylate,210-144-8,607-88-5,Acute Tox. 4,Notified C&L,260.0,H302:260;H315:1;H319:1
15178,"Fatty acids, animal, distn. residues",274-511-4,70248-27-0,Not Classified,Notified C&L,9.0,Not classified:9
15181,Lead dioxide,215-174-5,1309-60-0,Ox. Sol. 3;Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,153.0,H360:153;H332:153;H272:132;H410:153;H373:121;H302:153;H400:151;H351:34;H372:32;H341:32;Not classified:1
15184,"2,6-dimethoxyhydroquinone",239-282-7,15233-65-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
15186,"demeton-O-methyl (ISO);O-2-ethylthioethyl O,O-dimethyl phosphorothioate",212-758-1,867-27-6,Acute Tox. 3,Harmonised C&L,0.0,H301:0
15188,5-chloro-2-methoxyanilinium chloride,224-272-7,4274-03-7,Acute Tox. 4,REACH registration C&L,83.0,H302:48;Not classified:31;H318:9;H412:9;H301:4;H373:4;H311:4;H319:4;H315:4
15189,"1-DECENE, DIMER",917-709-4,17438-89-0,Asp. Tox. 1;Acute Tox. 4,REACH registration C&L,2.0,H332:2;H304:2
15190,3-bromo-o-xylene,209-398-2,576-23-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,53.0,H335:49;H315:52;H319:53;H332:1;H302:4;H312:1
15194,zirconium powder (pyrophoric),231-176-9,7440-67-7,Pyr. Sol. 1;Water-react. 1,Harmonised C&L,0.0,H260:0;H250:0
15203,"2,2'-p-phenylenedioxydiethanol",203-197-3,104-38-1,Not Classified,REACH registration C&L,120.0,Not classified:17;H315:102;H319:102;H412:1
15208,"Triethylammonium, salt with phosphoric acid",233-010-0,10017-56-8,Not Classified,Notified C&L,176.0,Not classified:97;H335:39;H315:77;H319:54;H318:23;H373:23;H302:6;H317:2
15216,(2H4)urea,215-857-8,1433-11-0,,Notified C&L,38.0,Not classified:38
15218,"Cashew, nutshell liq, polymer with ethylenediamine and formaldehyde",614-464-2,68413-28-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,66.0,H317:58;H334:23;H315:35;H319:54;H335:22;Not classified:8;H314:1;H302:1;H312:1
15220,"Benzonitrile, 5-chloro-2-methoxy-",611-331-0,55877-79-7,,Notified C&L,5.0,H301:5;H332:4;H312:4;H319:4;H335:4;H315:4;H331:1;H311:1
15225,(hydroxymethyl)phosphonic acid,220-047-2,2617-47-2,Skin Corr. 1;Skin Sens. 1;Eye Dam. 1;Carc. 1B,REACH registration C&L,4.0,H317:1;H318:1;H314:4;H350:1;H290:3
15227,"Zeolite, silica rich, crystalline, synthetic, non-fibrous",930-985-0,,Not Classified,REACH registration C&L,109.0,Not classified:109
15229,"Soaps, stocks, shea-fat, acidulated, hydrogenated",296-510-8,92704-74-0,Not Classified,Notified C&L,1.0,Not classified:1
15231,Ethyl dibromoacetate,210-510-7,617-33-4,,Notified C&L,5.0,H335:5;H302:4;H315:5;H319:5;H301:1
15232,"Chelate of Zinc(II)hexacyanocobaltate(III)/Zinc(II)chloride/1,2-demethoxyethane/water",421-730-1,,Repr. 1B,Notified C&L,1.0,H360:1
15234,2-chloro-5-nitrobenzenesulphonyl chloride,224-873-4,4533-95-3,Skin Corr. 1B,Notified C&L,39.0,H314:39
15235,"rac-N-(2,3-Dihydroxypropyl)-5-nitroisophthalamic acid",602-890-1,122731-58-2,Not Classified,Notified C&L,1.0,Not classified:1
15238,Potassium cyclohexanebutyrate,263-666-3,62638-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39;H302:1
15239,2-hydroxypropyl neodecanoate,276-138-2,71880-79-0,Skin Sens. 1,Notified C&L,3.0,H317:3
15240,"1H-Pyrrole-3-carboxylic acid, 5-formyl-2,4-dimethyl-",607-716-8,253870-02-9,Not Classified,Notified C&L,39.0,Not classified:29;H335:8;H302:7;H315:9;H319:9;H332:1;H312:1
15242,"Alcohols, C8-14, γ-ω-perfluoro",269-927-8,68391-08-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,174.0,H332:83;H226:83;H315:83;H312:83;H361:47;H373:47;Not classified:44
15247,(+)-α-methoxy-α-(trifluoromethyl)phenylacetic acid,243-829-5,20445-31-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
15250,"[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino](4-hydroxyphenyl)acetic acid",279-328-3,79868-75-0,Not Classified,Notified C&L,1.0,Not classified:1
15252,"Chromate(2-), [5-(diethylamino)-2-[(2-hydroxy-4-nitrophenyl)azo]phenolato(2-)][5-hydroxy-6-[(2-hydroxy-4-nitrophenyl)azo]-1-naphthalenesulfonato(3-)]-, sodium",290-923-7,90294-39-6,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,66.0,H317:14;H412:57;H411:9
15257,3-(methylthio)propyl acetate,240-679-2,16630-55-0,Not Classified,Notified C&L,116.0,Not classified:114;H335:2;H315:2;H319:2
15258,N-octylpyridin-4-amine,265-019-0,64690-19-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4.0,H302:3;H332:2;H315:3;H319:2;H335:2;H331:1;H301:1;H314:1;H310:1;H318:1;H410:1;H400:1
15261,N-(cyclopent-1-en-1-yl)morpholine,213-316-0,936-52-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H226:40;H315:42;H319:42;H318:1;H304:1;H314:1;H373:1;H361:1
15264,strychnine,200-319-7,57-24-9,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H400:0;H410:0;H310:0;H300:0
15265,"Butyl dihydrogen phosphate, potassium salt",286-763-2,85391-11-3,Eye Irrit. 2,Notified C&L,1.0,H319:1
15266,Pyrvinium embonate,222-596-3,3546-41-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,39.0,H302:39;H332:39;H351:39;H312:39;H319:39;H335:39;H315:39;H317:1;H341:1
15269,"2,4,5-Trifluorophenylacetic acid",606-684-2,209995-38-0,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,47.0,H302:3;H319:9;H335:44;H318:38;H315:44
15270,3-[[4-[(2-chloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile,255-127-6,40880-51-1,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,58.0,H411:3;H317:3;H302:3;Not classified:55
15271,"(11'S,15'S)-15'-methylspiro[1,3-dioxolane-2,5'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-1'(17'),2'(7')-dien-14'-one",611-306-4,5571-36-8,Repr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,4.0,H360:2;H411:1;H373:1;H351:1;H413:1;H302:2;H350:1
15273,"Hydrogen 5-phenyl-2-[2-[[5-phenyl-3-(3-sulphonatopropyl)-3H-benzoxazol-2-ylidene]methyl]but-1-enyl]-3-(3-sulphonatopropyl)benzoxazolium, sodium salt",251-603-2,33628-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
15275,Titanium tetrakis(2-ethylhexanolate),213-969-1,1070-10-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,REACH registration C&L,922.0,H335:132;H315:786;H319:913;H412:83;H226:53;Not classified:5;H317:6;H318:4
15278,Hydroxyprogesterone acetate,206-119-6,302-23-8,Carc. 2;Repr. 1A;Lact.;Aquatic Chronic 4,REACH registration C&L,51.0,H360:11;H362:11;H413:11;H351:50;H361:1
15281,4-chloronaphthylamine,225-138-0,4684-12-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
15282,2-nitrobutane,209-989-5,600-24-8,Acute Tox. 3;Eye Dam. 1,Notified C&L,38.0,H301:38;H318:38
15283,N-((Dimethoxy(methyl)silyl)methyl)-N-phenylamine,457-680-0,,Muta. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,3.0,H341:3;H411:3;H373:3
15286,"2,5-dimethylstyrene",218-028-9,2039-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42
15289,"2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;methazole",243-761-6,20354-26-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0;H312:0;H319:0;H315:0
15292,"Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with triethanolamine",290-652-4,90194-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,4.0,H318:3;H302:3;H315:3;Not classified:1
15296,Tetracaine,202-316-6,94-24-6,Acute Tox. 3;Skin Sens. 1;Carc. 2,Notified C&L,41.0,H301:40;H351:39;H317:39;H334:1;H302:1;H319:2
15298,"7-hydroxy-8-[[4-(phenylazo)phenyl]azo]naphthalene-1,3-disulphonic acid, compound with 2-ethyl-N-(2-ethylhexyl)hexylamine (1:2)",271-461-5,68555-82-8,Not Classified,Notified C&L,1.0,Not classified:1
15302,2-methyl-3-(1-methylethoxy)pyrazine,302-122-2,94089-22-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;Not classified:1
15305,"1-xylene-1H-pyrrole-2,5-dione",601-729-2,1206-49-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40.0,H335:40;H318:39;H315:40;H301:1;H319:1
15307,"4H-Pyrido[1,2-a]pyrimidin-4-one, 3-(2-chloroethyl)-2-methyl-9-(phenylmethoxy)-",604-596-9,147687-17-0,Not Classified,Notified C&L,2.0,Not classified:1;H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
15308,1-isobutyl-4-piperidone,276-712-2,72544-16-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H302:1;H315:1;H319:1
15310,"1-(1,3-dioxolan-2-ylidene)-1H-indene-3-carbonitrile",610-344-9,474024-38-9,Not Classified,REACH registration C&L,4.0,Not classified:4
15313,Amidase,232-736-5,9012-56-0,Skin Sens. 1;Resp. Sens. 1,Notified C&L,41.0,H317:39;H334:41
15315,"Gases (petroleum), C3-4;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately – 51 °C to – 1 °C (– 60 °F to 30 °F.)]",268-629-5,68131-75-9,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
15316,Geranyl formate,203-339-4,105-86-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1700.0,H411:28;H317:1318;H410:30;H400:29;Not classified:353;H318:24;H335:3;H315:4;H319:5
15318,"1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-",600-451-9,103577-40-8,Not Classified,REACH registration C&L,12.0,Not classified:6;H302:2;H317:1;H315:4;H319:4;H412:1;H332:1;H335:2;H413:1
15323,3-(methylthio)butyraldehyde,240-678-7,16630-52-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1487.0,H318:1303;H315:1346;H302:1303;H312:1303;Not classified:114;H335:43;H319:44;H226:26;H332:2;H341:1;H225:1
15324,"D-pentose, oligomeric, C16 and C18 alkyl glycosides",453-180-1,1235552-58-5,Not Classified,Notified C&L,1.0,Not classified:1
15325,"Extracts (petroleum), light paraffinic distillate solvent, acid-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-339-6,91995-76-5,Carc. 1B,Harmonised C&L,0.0,H350:0
15326,3-bromobenzoic acid,209-562-3,585-76-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H335:49;H315:50;H319:51
15331,Methyl thiophen-2-acetate,243-054-2,19432-68-9,Not Classified,REACH registration C&L,1.0,Not classified:1
15338,"Bis(2,2,2-trifluoroethyl)amine",206-978-7,407-01-2,,Notified C&L,7.0,H314:7;H332:7;H302:7;H312:7;H225:2;H226:1
15340,tert-butyl 1H-imidazole-1-carboxylate,256-475-1,49761-82-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
15341,Mercury hydrogen cyclohexanebutyrate,263-665-8,62638-02-2,Acute Tox. 2;Acute Tox. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H410:1;H373:1;H300:1;H310:1;H400:1
15343,Beclometasone,224-585-9,4419-39-0,Repr. 2,REACH registration C&L,15.0,H361:4;H360:11;H317:10;H373:10;H410:1;H372:1
15346,p-vinylphenol,220-103-6,2628-17-3,Acute Tox. 4;Muta. 2;Repr. 2;STOT RE 1,REACH registration C&L,279.0,H341:2;H302:34;H372:2;H361:2;H301:172;H334:111;H330:111;H314:143;H317:143;H311:111;Not classified:58;H335:61;H318:130;H315:65;H310:32;H319:14
15349,Molybdenum,231-107-2,7439-98-7,Not Classified,REACH registration C&L,1231.0,Not classified:585;H228:456;H361:449;H225:176;H252:6;H315:6;H319:11;H250:6;H335:7;H372:5;H413:2
15351,Toluene-p-sulphonic anhydride,223-926-9,4124-41-8,Skin Corr. 1B,Notified C&L,48.0,H314:48;H318:2;H290:1
15354,"Eriodictyon californicum, exts.",273-580-8,68990-14-7,Flam. Liq. 2,Notified C&L,1287.0,H225:1286;Not classified:1
15360,Sodium 2-(p-(dimethylamino)phenylazo)benzoate,212-682-9,845-10-3,,Notified C&L,13.0,H302:8;Not classified:4;H332:3;H312:3;H319:3;H335:3;H315:3;H301:1;H341:1;H410:1;H351:1
15361,1-chloro-2-fluoro-3-nitrobenzene,218-285-7,2106-49-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H302:2;H332:2;H312:2;H319:2;H335:2;H315:2
15363,"Distillates (petroleum), sweetened middle;Gasoil - unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-088-7,64741-86-2,Carc. 1B,Harmonised C&L,0.0,H350:0
15364,"Soaps, stocks, tallow, acidulated, hydrogenated",296-967-3,93165-79-8,Not Classified,Notified C&L,1.0,Not classified:1
15371,"N,N-dimethylphenothiazine-2-sulphonamide",214-128-1,1090-78-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:1;H302:2;H312:1;Not classified:1;H335:1;H315:1;H319:1
15372,"2,2'-[(1,1-dimethylethyl)imino]bisethanol",218-480-7,2160-93-2,Eye Irrit. 2A,REACH registration C&L,275.0,H319:1;Not classified:235;H314:39;H318:1
15385,C.I. Acid Orange 154,603-751-8,133556-24-8,Not Classified,Notified C&L,2.0,Not classified:2
15388,Metaphosphoric acid,233-750-4,10343-62-1,Not Classified,Notified C&L,3.0,Not classified:3
15389,5-fluoro-2-methyl-1H-indene-3-acetic acid,250-891-7,32004-66-3,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,4.0,H332:3;H302:4;H312:3;H319:4;H335:1;H315:1
15394,"2,3-dichlorophenol",209-399-8,576-24-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Aquatic Chronic 2,REACH registration C&L,50.0,H411:8;H302:8;H312:7;H319:48;H315:48;H335:4;Not classified:1;H311:1
15397,p-cyanobenzenesulphonamide,221-492-5,3119-02-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,162.0,H335:161;H302:161;H315:161;H319:161;H331:1;H301:1;H311:1;H332:1;H312:1
15401,Morpholinium toluene-4-sulphonate,237-301-3,13732-62-2,Not Classified,REACH registration C&L,355.0,Not classified:120;H315:217;H319:216;H317:18;H334:18;H318:1
15403,"(1α,2α,4β)-1,2,4-trimethylcyclopentane",225-441-8,4850-28-6,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H302:38;H304:38;H410:38;H225:42;H319:38;H335:38;H315:38;H400:38
15404,ASK (silica),613-187-4,63231-67-4,Not Classified,Notified C&L,528.0,Not classified:446;H312:56;H331:21;H319:22;H373:4
15405,Trimorpholinophosphine oxide,224-662-7,4441-12-7,Not Classified,REACH registration C&L,9.0,Not classified:4;H335:4;H315:5;H319:5;H371:1
15408,"Fuel oil, No 6;Heavy Fuel oil;[A distillate oil having a minimum viscosity of 900 SUS at 37.7 °C (100 °F) to a maximum of 9000 SUS at 37.7 °C (100 °F).]",271-384-7,68553-00-4,Carc. 1B,Harmonised C&L,0.0,H350:0
15411,"Ammonium 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulphonate",269-513-7,68259-10-9,Not Classified,Notified C&L,22.0,Not classified:22
15412,"Copper, [[[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]phenyl]amino]sulfonyl]-29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, aminosulfonyl sulfo derivs., sodium salts",276-012-7,71786-55-5,Skin Sens. 1B,REACH registration C&L,108.0,H317:108;H412:70
15413,"Formaldehyde, polymer with 1,2-ethanediamine and nonylphenol",614-673-9,68631-00-5,Not Classified,Notified C&L,77.0,Not classified:59;H317:14;H314:14;H315:4;H319:4
15415,Nandrolone laurate,247-739-7,26490-31-3,Carc. 1B;Repr. 1A;Aquatic Chronic 3,Notified C&L,90.0,H360:52;H412:51;H350:51;H332:39;H302:39;H312:39;H351:39
15418,N-ethyl-5-nitropyridin-2-amine,266-985-6,67730-09-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
15420,Isopropyl salicylate,210-143-2,607-85-2,Aquatic Chronic 2,Notified C&L,39.0,H411:38;H315:1;H319:1
15423,"L-Phenylalanine, N-(3,3-dimethylbutyl)-L-α-aspartyl-, 2-methyl ester",605-408-8,165450-17-9,Not Classified,Notified C&L,3.0,Not classified:3
15427,Hexamethyldisilane,215-911-0,1450-14-2,Flam. Liq. 2;Eye Irrit. 2A;Resp. Sens. 1;STOT SE 3,REACH registration C&L,82.0,H334:44;H335:53;H225:82;H319:53;H317:37
15428,"Hydrocarbons, C14-C20, n-alkanes,",923-583-1,,Asp. Tox. 1,Notified C&L,88.0,H304:88
15433,"4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane",260-350-7,56706-10-6,Not Classified,REACH registration C&L,81.0,Not classified:78;H302:2;H332:2;H312:2;H319:3;H335:2;H315:3;H412:1;H320:1
15434,p-propylphenyl trans-p-(4-pentylcyclohexyl)benzoate,284-999-0,85005-66-9,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
15436,"N,N,N',N'-tetraethylmethylenediamine",203-038-8,102-53-4,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,42.0,H226:42;H314:42
15437,Disodium hexachloroiridate,241-011-2,16941-25-6,Met. Corr. 1;Acute Tox. 4;Eye Irrit. 2,Notified C&L,1.0,H318:1;H290:1;H302:1;H319:1
15438,3-(4-methoxyphenyl)-2-oxopropanoic acid,843-613-6,28030-16-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
15439,"1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, chloride, reaction products with hectorite",306-493-1,97280-96-1,Not Classified,Notified C&L,3.0,Not classified:3
15440,"Poly(oxy-1,2-ethanediyl), a-[[]2-[[]3,6-bis(diethylamino)xanthylium-9-yl]benzoyl]-[?]-hydroxy-, [[]2,4-dihydro-4-[[]2-[[]2-(hydroxy-[?]O)-5-nitrophenyl]diazenyl-[?]N1]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)-[?]O3][[]2-[[]2-[[]4,5-dihydro-3-methyl-5-(oxo-[?]O)-1-phenyl-1H-pyrazol-4-yl]diazenyl-[?]N1]benzoato(2-)-[?]O]chromate(1-) (1:1)",600-469-7,103671-34-7,Not Classified,Notified C&L,5.0,Not classified:5
15443,Tetramethyl-p-benzoquinone,208-409-8,527-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
15448,"4-methyl-α,α-bis(trifluoromethyl)benzyl alcohol",217-928-9,2010-61-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
15449,"[S-(R*,S*)]-2-amino-6-(1,2-dihydroxypropyl)-1H-pteridin-4-one",244-807-8,22150-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;Not classified:1
15451,2-Aminothiazole-5-carboxylic acid,609-810-4,40283-46-3,Skin Sens. 1,Notified C&L,41.0,H317:39;Not classified:1;H302:1
15455,Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl) oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloride (PQ Polymer),607-843-9,25988-97-0,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,322.0,H302:107;H410:251;H400:239;H319:125;Not classified:35;H332:53;H412:12;H315:2;H318:1;H350:1;H411:1
15458,"1H-Indene-1,3(2H)-dione, 2-(3-hydroxy-2-quinolinyl)-",602-350-5,12223-85-7,,Notified C&L,1.0,Not classified:1
15459,"2-Propenoic acid, gamma-omega-perfluoro-C8-14-alkyl ester, copolymer with 2-Propenoic acid, octadecyl ester, 2-Propenamide, N-(hydroxymethyl)-2-methyl-, 2-Propenoic acid, 2-ethylhexyl ester, 2-Propenoic acid, 2-methyl-, 2-methylpropyl ester, 1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propenyl)amino]-",924-482-5,,Not Classified,Notified C&L,6.0,Not classified:6
15467,Methyl-1H-benzotriazole,249-596-6,29385-43-1,Acute Tox. 4;Repr. 2;Aquatic Chronic 2,REACH registration C&L,3882.0,H411:714;H302:3840;H361:12;H412:2347;H319:2865;H332:59;Not classified:29;H318:14;H335:15;H317:9;H315:11;H312:1
15470,Calcium bis(3-phenylpyruvate),257-455-5,51828-93-4,,Notified C&L,2.0,H335:1;H315:1;H319:1;Not classified:1
15472,Adipoyl dichloride,203-876-4,111-50-2,Skin Corr. 1B,Notified C&L,46.0,H314:46;H332:2;H302:2;H312:2;H318:2;H290:1
15473,"1,2-dihydro-5-nitro-3H-1,2,4-triazol-3-one",213-254-4,932-64-9,Expl. 1.1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,15.0,H335:6;H201:6;H315:6;H319:6;Not classified:9
15475,"Poly(oxy-1,2-ethanediyl), α-sulfo-ω-[(9Z)-9-octadecen-1-yloxy]-, sodium salt (1:1)",608-060-5,27233-34-7,Skin Irrit. 2;Eye Dam. 1,Notified C&L,36.0,H318:36;H315:36
15478,"Benzene-1,3-dithiol",210-925-3,626-04-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,44.0,H335:39;H318:42;H315:44;H302:5;H332:5;H312:5;H319:2
15479,Bis(2-hydroxyethyl) sulphone,219-948-3,2580-77-0,Not Classified,REACH registration C&L,42.0,Not classified:3;H334:39
15489,sodium perchlorate,231-511-9,7601-89-0,Ox. Sol. 1;Acute Tox. 4,Harmonised C&L,0.0,H271:0;H302:0
15490,α-toluenesulphonyl fluoride,206-350-2,329-98-6,Acute Tox. 3;Skin Corr. 1B,Notified C&L,99.0,H301:98;H314:98;H318:1;H290:1;H311:1;H330:1;H302:1
15493,"2,6-dichlorostyrene",249-039-7,28469-92-3,,Notified C&L,5.0,H335:5;H315:5;H319:5
15494,Disodium selenide,215-212-0,1313-85-5,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Chronic 1,Notified C&L,212.0,H301:208;H410:212;H373:212;H331:212;H400:212;H300:4
15496,4-octylaniline,240-358-7,16245-79-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,43.0,H335:38;H315:39;H319:39;H400:38;H302:5;H312:5;H332:1
15499,5-Chloro-1-indanone,610-016-5,42348-86-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H302:39;H332:39;H312:39;H319:47;H335:46;H315:47
15500,1-(2-chloroethyl)-4-fluorobenzene,206-364-9,332-43-4,,Notified C&L,6.0,H315:6;H319:6;H335:1
15501,9-methylcarbazole,216-054-5,1484-12-4,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,39.0,H318:38;H302:38;H400:38;H341:1
15505,2-carbamoyloxypropyltrimethylammonium chloride,209-686-8,590-63-6,Acute Tox. 4,Notified C&L,43.0,H302:43;H319:2;H335:1;H315:1
15508,"2,5-Cyclohexadiene-1,4-dione, 2,5-dichloro-3,6-bis[(1-ethyl-2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]-",609-937-5,415933-85-6,Not Classified,Notified C&L,31.0,Not classified:31
15510,Ethyl cinnamate,203-104-6,103-36-6,Not Classified,REACH registration C&L,1621.0,Not classified:1621
15511,"3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile",609-091-7,35202-54-1,,REACH registration C&L,3.0,H302:2;H332:1;H312:1;H319:1;H315:1;Not classified:1
15512,bis(2-methoxyethyl) phthalate,204-212-6,117-82-8,Repr. 1B,Harmonised C&L,0.0,H360:0
15514,"Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts",270-115-0,68411-30-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1212.0,H318:1204;H302:1201;H315:1206;H412:366;H330:6;Not classified:6;H319:3;H301:1
15515,"2,4-dihydroxybenzoic acid",201-946-9,89-86-1,Eye Dam. 1,REACH registration C&L,54.0,H318:4;H317:2;H335:48;H315:49;H319:50
15516,Ethoxycarbonylmethyl ethyl phthalate,201-555-3,84-72-0,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,3.0,H317:2;H412:2;H315:1
15518,"2,4,5-trimethoxybenzaldehyde",224-713-3,4460-86-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H302:3;H315:3;H319:3;H335:2;H332:1;H312:1
15520,"2,9-dimethyl-1,10-phenanthroline",230-732-8,7296-20-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H335:3;H315:4;H319:4
15522,Oxeladin,207-412-1,468-61-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,1.0,H331:1;H301:1;H311:1
15525,4-tert-butyltoluene,202-675-9,98-51-1,Acute Tox. 4;Eye Irrit. 2A;Acute Tox. 2;Repr. 2;STOT SE 1;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,248.0,H411:157;H330:205;H370:112;H372:2;H401:2;H319:238;H302:248;H361:112;H226:229;H312:77;H335:125;H315:118;H332:40;H360:1;H336:1
15527,2-nitro-p-phenetidine,210-497-8,616-86-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H312:38;H319:38;H335:38;H315:38
15529,"3,4-dihydroxybenzohydrazide",254-550-3,39635-11-5,,Notified C&L,5.0,H335:5;H315:5;H319:5
15533,2-chloropropionamide,248-671-0,27816-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
15535,[No public or meaningful name is available],462-520-8,,Not Classified,Notified C&L,1.0,Not classified:1
15538,Cyanoacetic acid,206-743-9,372-09-8,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,203.0,H318:124;H332:173;H302:200;H314:200;H331:10;H412:16;H312:6;Not classified:5;H290:3;H335:1
15540,Cytidine 3'-(dihydrogen phosphate),200-556-6,63-37-6,Not Classified,REACH registration C&L,17.0,Not classified:17
15542,Disodium 5-[[4-[[[[2-methoxy-4-[(3-sulphonatophenyl)azo]phenyl]amino]carbonyl]amino]phenyl]azo]salicylate,230-657-0,7248-45-5,Not Classified,Notified C&L,1.0,Not classified:1
15543,"3,7-bis(dimethylamino)phenothiazin-5-ium chloride, compound with zinc chloride",228-905-8,6372-69-6,Eye Irrit. 2,Notified C&L,5.0,H319:3;Not classified:2
15546,"N,N,N-trimethyl-3-nitroanilinium chloride",252-279-5,34907-26-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 2;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H301:1;H410:1;H350:1;H311:1;H331:1;H341:1;H400:1
15551,1-[(3-aminophenyl)amino]-3-phenoxypropan-2-ol,253-899-9,38353-82-1,Not Classified,Notified C&L,22.0,Not classified:22
15552,5-methylisoxazole-3-carbonyl chloride,254-475-6,39499-34-8,,Notified C&L,5.0,H314:5
15557,"Rubber, silicone",613-211-3,63394-02-5,Not Classified,Notified C&L,5.0,Not classified:5
15558,"Hexa-1,3,5-triene, mixed isomers",218-789-7,2235-12-3,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Eye Irrit. 2,Notified C&L,42.0,H226:42;H302:42;H319:39;H304:39
15561,4'-methylformanilide,221-400-3,3085-54-9,,Notified C&L,4.0,H332:4;H302:4;H312:4
15564,"1,3-di-o-tolyl-2-thiourea",205-309-6,137-97-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H301:38;H410:38;H315:38;H319:38;H335:38;H400:38;H317:1
15568,"Phosphinic acid, P,P-diethyl-, aluminum salt (3:1)",607-114-5,225789-38-8,Not Classified,Notified C&L,119.0,Not classified:119
15570,"Ethanol, 2,2',2''-nitrilotris-, compd. with α-[2,4,6-tris(1-phenylethyl)phenyl]-ω-hydroxypoly(oxy-1,2-ethanediyl) phosphate",600-650-0,105362-40-1,Not Classified,Notified C&L,28.0,Not classified:23;H315:4;H319:5
15572,"Trisodium 5-[[4-chloro-6-[(o-tolyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",300-504-3,93941-05-0,Not Classified,REACH registration C&L,6.0,Not classified:4;H317:2
15580,N-[4-(4-Fluorophenyl)-5-formyl-6-isopropyl-2-pyrimidinyl]-N-methylmethanesulfonamide,604-564-4,147118-37-4,Aquatic Chronic 4,Notified C&L,3.0,H413:1;H335:2;H315:2;H319:2
15581,5-vinylnorborn-2-ene,221-259-8,3048-64-4,Flam. Liq. 2;Asp. Tox. 1;Skin Sens. 1B;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,95.0,H411:39;H332:39;H304:39;H373:39;H317:39;H225:37;H226:55;H315:54;H319:52;Not classified:3
15585,"Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-O2,O3)copper",304-146-9,94246-73-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
15586,"Phosphoric acid, 2-ethylhexyl ester",235-741-0,12645-31-7,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,634.0,H318:175;H314:575;H315:32;H319:20;H226:8;H302:9;Not classified:5;H312:1;H290:2
15590,Ethyl 2-cyanohexanoate,230-978-6,7391-39-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H315:38
15591,"1-(2,3-Dichlorophenyl)piperazine hydrochloride",601-621-5,119532-26-2,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,66.0,H302:7;H410:7;H400:6;H335:57;H315:58;H319:58;Not classified:1
15592,β-chloropropiophenone,213-317-6,936-59-4,Acute Tox. 4,REACH registration C&L,13.0,H302:7;H335:3;H315:4;H319:4;H318:1;Not classified:1
15594,di-tert-butyl dicarbonate,246-240-1,24424-99-5,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;STOT SE 3,REACH registration C&L,168.0,H318:29;H330:165;H317:163;H226:109;H335:102;H315:166;H225:49;H319:137;H228:29;Not classified:3;H331:2;H301:1;H311:1;H302:1
15597,2-methylbut-3-en-2-ol,204-068-4,115-18-4,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1701.0,H315:114;H302:1678;H225:1679;H319:1678;Not classified:22;H335:4;H226:1
15599,Tetrabutylammonium acetate,234-101-8,10534-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,54.0,H335:53;H315:54;H319:54;H302:1;H332:1;H312:1
15600,"(1H,3H)-quinazoline-2,4-dione",201-712-6,86-96-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
15601,PATCHOULI OIL,616-944-7,8014-09-3,Asp. Tox. 1,Notified C&L,106.0,H304:73;Not classified:27;H412:6;H411:3
15605,Dioctylphosphinic acid,211-671-6,683-19-2,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H319:1
15607,1-(4-isopropylphenyl)-1-methylethyl hydroperoxide,202-673-8,98-49-7,Org. Perox. F;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1;H242:1
15608,"Benzene, 1,5-dibromo-2,4-dimethoxy-",607-474-3,24988-36-1,,Notified C&L,1.0,H335:1;H315:1;H319:1
15610,4-Chloro-3-fluorophenol,609-036-7,348-60-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:40;H315:41;H319:41;H411:4;H314:4;H302:6;H312:6;H332:2
15614,"Glycerides, C8-18 and C18-unsatd. mono-, di- and tri-",293-185-4,91052-27-6,Not Classified,Notified C&L,45.0,Not classified:45
15615,"1,1,1-trifluoroacetone",207-005-9,421-50-1,Flam. Liq. 1;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,52.0,H314:5;H318:5;H224:52;H412:5;H335:46;H315:47;H319:47
15618,4-amino-3-nitrobenzenesulphonic acid,210-495-7,616-84-2,Not Classified,REACH registration C&L,34.0,Not classified:34
15619,"2-Propyn-1-ol, polymer with propylene oxide",607-800-4,25749-63-7,Not Classified,Notified C&L,1.0,Not classified:1
15621,[2H3]acetic [2H]acid,214-693-4,1186-52-3,Flam. Liq. 3;Skin Corr. 1A,Notified C&L,48.0,H226:48;H314:48;H318:2;H290:2;Not classified:1
15623,2-cyanoguanidine,611-249-5,55295-98-2,Aquatic Chronic 2,Notified C&L,105.0,H411:59;H412:39;H319:38;H317:3;Not classified:5;H302:4;H315:1
15625,Cesium dibromoiodate,242-155-9,18278-82-5,Not Classified,Notified C&L,25.0,Not classified:25
15631,Acid Black 107,601-927-9,12218-96-1,Aquatic Chronic 2,Notified C&L,7.0,H411:6;Not classified:1
15634,1-(3-methoxyphenyl)acetone,221-191-9,3027-13-2,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
15635,Prop-1-enyl propyl disulphide,227-604-9,5905-46-4,Flam. Liq. 3,Notified C&L,1373.0,H226:1296;H315:87
15636,"13-ethyl-11-methylene-gon-4-ene-3,17-dione",620-092-1,54024-17-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1.0,H332:1;H351:1;H312:1;H302:1;H361:1
15639,"2,3,3,3-tetrafluoroprop-1-ene",468-710-7,754-12-1,Press. Gas (Liq.),REACH registration C&L,51.0,H221:11;H280:51;H220:40
15641,Perhydroazepine,203-875-9,111-49-9,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 3;STOT SE 1;Aquatic Chronic 3,REACH registration C&L,174.0,H318:96;H314:174;H225:82;H412:5;H331:45;H335:2;H302:134;H226:92;H300:40;H332:32;H312:36;H317:3
15642,"3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl isobutyrate",266-825-5,67634-20-2,Not Classified,Notified C&L,1578.0,Not classified:1511;H411:36;H319:36;H302:31;H315:31;H412:31
15643,1'(or 2')-(isopropylidene)isonicotinohydrazide,225-381-2,4813-04-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H301:38;H315:38;H319:38
15647,3-benzyloxyaniline,216-056-6,1484-26-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H315:41;H319:41;H302:1
15649,C.I. Solvent Blue 99,615-549-7,71832-15-0,Not Classified,Notified C&L,5.0,Not classified:5
15650,"N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide",413-200-1,129604-78-0,Skin Sens. 1,Harmonised C&L,0.0,H317:0
15652,"Distillates (petroleum), clay-treated paraffinic;Baseoil - unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-137-2,64742-36-5,Carc. 1B,Harmonised C&L,0.0,H350:0
15654,"1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-6-iodohexane",206-586-6,355-43-1,Aquatic Chronic 4,REACH registration C&L,56.0,H413:40;H290:2;H411:6;H335:9;H315:10;H319:10;Not classified:1;H302:1;H332:1;H312:1
15655,"1-[4-(p-Chlorophenyl)-2-[2,6-dichlorophenyl)thio]butyl] imidazole mononitrate",613-721-6,64872-77-1,Acute Tox. 4,Notified C&L,41.0,H302:41;H332:2;H312:1;H319:1
15656,Gold trichloride,236-623-1,13453-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:43;H315:43;H319:43;H314:6;H317:1
15666,"Solvent naphtha (petroleum), hydrodesulfurized medium;Kerosine - unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-884-5,101316-82-9,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
15673,Triethyl phosphonoacetate,212-757-6,867-13-0,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,64.0,H332:3;H302:6;H411:30;H401:2;H319:58;H315:13;H335:6;H318:3;H413:1
15674,4-propylpyridine,214-360-3,1122-81-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H335:38;H318:38;H315:39;H319:1
15675,(methylthio)acetaldehyde,245-587-6,23328-62-3,Not Classified,Notified C&L,91.0,Not classified:90;H226:1
15676,ethiofencarb (ISO);2-(ethylthiomethyl)phenyl N-methylcarbamate,249-981-9,29973-13-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H400:0
15679,"Fatty acids, C12-18, compds. with morpholine",292-923-2,91031-23-1,Not Classified,Notified C&L,5.0,Not classified:4;H335:1;H315:1;H319:1
15680,2-ethyl-2-(3-methoxyphenyl)butan-1-amine,618-921-7,93309-48-9,Not Classified,REACH registration C&L,1.0,Not classified:1
15684,"Creosote oil, acenaphthene fraction;Wash Oil;[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.]",292-605-3,90640-84-9,Carc. 1B,Harmonised C&L,0.0,H350:0
15685,2-methoxyethyl methanesulfonate,605-354-5,16427-44-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
15686,"Toluene diisocyanate, oligomeric reaction products with polyethoxylated and polypropoxylated glycerol",500-138-6,57516-88-8,Not Classified,Notified C&L,63.0,Not classified:60;H334:3;H351:2;H317:2;H319:2;H315:2;H332:1
15687,Lithium hexafluorophosphate(1-),244-334-7,21324-40-3,Acute Tox. 3;Skin Corr. 1A;Eye Dam. 1;STOT RE 1,REACH registration C&L,257.0,H372:173;H301:199;H318:171;H314:257;H302:58;H311:46;H332:2;H312:2;H290:1;H331:1;Not classified:1
15689,4-ethoxybenzaldehyde,233-093-3,10031-82-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1587.0,H315:1587;H319:1587;H335:38
15690,"(3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl butyrate",250-567-5,31316-20-8,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;STOT RE 1;Aquatic Chronic 4,REACH registration C&L,1.0,H330:1;H300:1;H413:1;H311:1;H372:1
15692,"N-methylbenzene-1,2-diamine dihydrochloride",246-655-8,25148-68-9,,Notified C&L,2.0,H331:2;H301:2;H311:2;H319:1;H315:1
15694,(E)-m-chlorocinnamic acid,238-466-4,14473-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
15695,Octyl isovalerate,232-100-7,7786-58-5,Not Classified,Notified C&L,89.0,Not classified:89
15697,R-(+)-1-(1-naphthyl)ethylamine,223-425-5,3886-70-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;STOT SE 3,REACH registration C&L,133.0,H318:85;H302:2;H317:2;H312:2;H335:43;H315:44;H411:83;H301:89;H314:89;H319:42;H311:6;H331:1
15699,"(Z)-α-[[2-(tert-butoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-(tritylamino)thiazol-4-acetic acid",272-056-6,68672-66-2,,Notified C&L,12.0,Not classified:12
15701,"[1R-[1α(R*),2β,5α]]-5-methyl-2-(1-methylethyl)cyclohexyl lactate",261-678-3,59259-38-0,Aquatic Chronic 3,Notified C&L,608.0,H412:470;Not classified:103;H411:31;H315:35;H302:2;H319:3;H336:1;H335:1
15704,4-methoxy-o-toluidine,203-036-7,102-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:40;H315:41;H319:41;H332:4;H302:4;H312:4;H351:5;H331:2;H301:3;H311:3;H330:1;H350:1;H373:1
15707,Iotroxic acid,256-917-3,51022-74-3,Not Classified,REACH registration C&L,2.0,Not classified:2
15711,"6,10-dimethylundeca-3,9-dien-2-one",237-547-1,13835-41-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1286.0,H411:1286;H318:1286;H317:1286;H315:1286;H302:1286
15712,"2,7-naphthalenedisulfonic acid, 3-hydroxy-4-[[2-hydroxy-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-, copper complex",404-270-4,12769-07-2,Skin Sens. 1,Notified C&L,15.0,H317:14;Not classified:1
15714,"Dodecylbenzenesulphonic acid, compound with ethylenediamine (2:1)",235-089-7,12068-06-3,,Notified C&L,1.0,Not classified:1
15715,"1-Chloro-3,5-dimethyladamantane",615-149-2,707-36-8,Not Classified,REACH registration C&L,7.0,Not classified:5;H302:1;H317:1;H315:1;H319:1
15719,Tetrabromothiophene,223-554-7,3958-03-0,,Notified C&L,6.0,H335:5;H315:6;H319:6
15721,N-{2-butyl-3-[4-(3-dibutylaminopropoxy)benzoyl]benzofuran-5-yl} methanesulfonamide,604-240-2,141626-36-0,Aquatic Chronic 1,Notified C&L,5.0,H410:4;H360:2;H400:2;H373:2
15724,Bis(glycinato)copper,236-783-2,13479-54-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,89.0,H302:87;H315:86;H319:86;H400:86;Not classified:2;H410:1;H335:2;H412:1;H317:1
15725,"Glass, oxide, silver- and zinc-contg.",609-747-2,398477-47-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,117.0,H410:115;H400:115;Not classified:2
15726,"Pentane-1,2-diol",226-285-3,5343-92-0,Eye Dam. 1,REACH registration C&L,950.0,H318:354;H304:448;H315:88;H319:91;Not classified:58;H317:1
15728,"1,4-bis[[4-(1,1-dimethylethyl)phenyl]amino]-5,8-dihydroxyanthraquinone",225-443-9,4851-50-7,Not Classified,REACH registration C&L,484.0,Not classified:484
15729,Cobalt diiodide,239-283-2,15238-00-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45.0,H302:40;H332:40;H312:40;H319:40;H335:40;H315:40;H341:5;H317:5
15730,"Chromate(2-), [3-[[[5-[(2-chloro-4-nitrophenyl)azo]-2-hydroxyphenyl]methylene]amino]-4-hydroxybenzenesulfonamidato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-sulfobenzoato(3-)]-, lithium sodium",290-922-1,90294-38-5,,Notified C&L,33.0,Not classified:33
15731,"1-Propanamine, 3-(trimethoxysilyl)-, reaction products with trimethoxymethylsilane and 2-[[3-(trimethoxysilyl)propoxy]methyl]oxirane",602-917-7,123127-06-0,Eye Irrit. 2,Notified C&L,36.0,H319:36
15737,α-methylpyridine-4-methanol,245-630-9,23389-75-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
15739,2-bromo-m-xylene,209-397-7,576-22-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:46;H315:47;H319:47;H225:1
15741,"Boric acid, ester with 2,2',2''-nitrilotris[ethanol]",268-339-9,68071-04-5,Not Classified,Notified C&L,32.0,Not classified:32
15742,Aluminium silicate,235-253-8,12141-46-7,Not Classified,Notified C&L,224.0,Not classified:184;H318:38;H335:2;H315:2;H319:2
15744,"Trisodium (R)-2,5-dihydro-5-((R)-2-(hexadecanoyloxy)-1-hydro xyethyl)-4-oxido-2-oxo-3-furylphosphate",471-090-0,302345-18-2,Eye Irrit. 2,Notified C&L,1.0,H319:1
15746,2-(decylthio)ethylammonium chloride,405-640-8,36362-09-1,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H373:0;H315:0;H400:0
15749,"2-hydroxy-4-tetradecyl-1,3,2-dioxaborolane",284-222-5,84819-41-0,Skin Sens. 1,Notified C&L,840.0,H317:840
15751,"tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate",432-810-9,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
15753,"Zinc, 2-ethylhexanoate isooctanoate complexes, basic",286-296-4,85204-04-2,Not Classified,Notified C&L,3.0,Not classified:2;H335:1;H315:1;H319:1
15761,ADIPIC ACID/EPOXYPROPYL DIETHYLENETRIAMINE COPOLYMER,607-642-6,25212-19-5,Aquatic Chronic 2,Notified C&L,89.0,H411:64;H315:22;H319:22;H412:3
15762,Antimony(3+) tripropan-2-olate,242-561-6,18770-47-3,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,42.0,H411:42;H332:42;H302:42
15763,3-(2-{}{4-[2-(4-cyanophenyl)vinyl]phenyl}}vinyl)benzonitrile,419-060-8,79026-02-1,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
15764,Natamycin,231-683-5,7681-93-8,Not Classified,Notified C&L,6.0,Not classified:6
15765,Triphenyltin hydride,212-967-8,892-20-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H301:42;H410:42;H311:42;H331:38;H400:42;H330:4
15767,"rac-5-Amino-N-(2,3-diacetoxypropyl)-2,4,6-triiodoisophthalamic acid",602-891-7,122731-59-3,Acute Tox. 3,Notified C&L,1.0,H311:1
15770,"1,1,2,2-Tetramethyldiphosphane 1,2-disulfide",609-289-3,3676-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
15772,Ethyl pyruvate,210-511-2,617-35-6,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,1542.0,H318:35;H226:1541;H314:36;H317:1;H335:1;H315:1;H319:1
15777,bis(fluoromethyl)carbonate,606-636-0,207804-65-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H315:1;H226:1;H319:1;H302:1
15779,Cadmium sulfoselenide red,261-218-1,58339-34-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,149.0,H332:102;H302:102;H312:83;Not classified:47;H335:19;H315:19
15780,"Gases (petroleum), light straight run gasoline fractionation stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.]",272-878-5,68919-05-1,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
15782,Neodecanoic acid,248-093-9,26896-20-8,Not Classified,REACH registration C&L,1121.0,Not classified:482;H318:442;H412:528;H302:93;H319:121;H315:47;H335:23
15784,"Amines, (C14-18 and C16-18-unsatd. alkyl)dimethyl",269-926-2,68391-07-1,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1,Notified C&L,4.0,H318:4;H302:4;H314:4;H400:4
15785,"1,3-dimethyl-1,3-diphenyl-1,3-divinyldisiloxane",220-101-5,2627-97-6,Not Classified,Notified C&L,23.0,Not classified:22;H315:1;H319:1
15791,1-bromo-1-phenylethane,209-560-2,585-71-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46;H227:1
15793,Benzo[ghi]perylene,205-883-8,191-24-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25.0,H410:16;H400:24;H413:8;Not classified:1
15796,"Oils, rosemary",616-767-5,8000-25-7,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Muta. 2;STOT SE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,369.0,H371:245;H304:294;H410:243;H317:247;H226:292;H341:194;H400:242;H335:38;H315:43;H319:41;Not classified:36;H411:4;H228:1;H331:1;H332:1
15797,"[2R-[2α,3α(4E,7E)]]-3-(1-oxonona-4,7-dienyl)oxirane-2-carboxamide",241-424-8,17397-89-6,,Notified C&L,129.0,H302:129;H332:1;H315:1;H319:1;H335:1
15801,"(2,3-dichlorophenyl)oxoacetonitrile",278-747-9,77668-42-9,Acute Tox. 3;Skin Sens. 1A;Eye Irrit. 2A;Aquatic Acute 1,REACH registration C&L,55.0,H301:53;H400:53;H319:54;H317:53;H302:1;H332:1;H312:1;H335:1;H315:1;Not classified:1
15803,"β-D-Xylopyranoside, (3β,12β,16β,23S,24R,25R)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl",607-941-1,264624-38-6,Not Classified,Notified C&L,2.0,Not classified:2
15804,"Ferrate(1-), bis[4-[2-[5-chloro-2-(hydroxy-κO)phenyl]diazenyl-κN1]-3-(hydroxy-κO)-N-phenyl-2-naphthalenecarboxamidato(2-)]-, sodium (1:1)",603-053-3,125304-21-4,Not Classified,Notified C&L,21.0,Not classified:21
15811,Bismuth,231-177-4,7440-69-9,Not Classified,REACH registration C&L,317.0,Not classified:275;H413:19;H228:23
15812,"2-propen-1-aminium,N,N-dimethyl-N-2-propenyl-,chloride, polymer with 2-propenoic acid",611-036-7,53694-17-0,Aquatic Chronic 3,Notified C&L,521.0,H412:486;Not classified:34;H411:1;H335:1
15813,"Starch, hydrogen phosphate",611-338-9,55963-33-2,Not Classified,Notified C&L,56.0,Not classified:56
15814,N-(Cyanomethyl)acetamide,610-412-8,4814-80-6,Acute Tox. 4,Notified C&L,38.0,H302:38
15819,2-[(methylthio)methyl]-2-butenal,255-126-0,40878-72-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1373.0,H315:1363;H319:1363;H226:466;Not classified:10
15825,Sodium 5-(aminosulphonyl)-2-[7-(diethylamino)-2-oxo-2H-1-benzopyran-3-yl]benzoxazolesulphonate,299-370-6,93859-32-6,Aquatic Chronic 3,REACH registration C&L,6.0,H412:3;Not classified:3
15829,Orphenadrine dihydrogen citrate,225-137-5,4682-36-4,Acute Tox. 4;Carc. 2,Notified C&L,40.0,H302:39;H351:39;Not classified:1
15831,Maleimide,208-787-4,541-59-3,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,48.0,H301:48;H314:48;H317:48;H318:3;H332:2;H312:2
15833,Chlormadinone acetate,206-118-0,302-22-7,Carc. 2;Repr. 1B,Notified C&L,72.0,H360:70;H351:51;H373:9;H341:2;H332:1;H361:2;H312:1
15836,Caramel (color),232-435-9,8028-89-5,Not Classified,REACH registration C&L,305.0,Not classified:305
15837,(5-fluoro-2-methoxyphenyl)boronic acid,605-875-8,179897-94-0,,Notified C&L,10.0,H335:8;H315:9;H319:9;H302:3;H332:2;H312:2
15840,Tris[2-(diphenylphosphino)ethyl]phosphine,245-754-3,23582-03-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H302:39;H332:39;H312:39;H319:40;H335:40;H315:40
15841,1-Butyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide,605-742-4,174899-83-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,42.0,H411:40;H301:41;H314:40;H373:40;H311:40;H315:1;H319:1;H412:1
15843,6-nitroveratraldehyde,243-762-1,20357-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2;H302:1
15847,"Cuprate(4-), [μ-[[3,3'-methylenebis[6-[[5-[(2,4-disulfophenyl)azo]-2,4-dihydroxyphenyl]azo]benzoato]](8-)]]di-, sodium",286-689-0,85338-16-5,Not Classified,Notified C&L,157.0,Not classified:157
15848,"Naphtha (petroleum), sweetened;Low boiling point naphtha - unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-089-2,64741-87-3,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H304:0;H350:0
15850,Tetradodecylammonium nitrate,264-548-4,63893-35-6,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H228:38;H335:38;H315:38;H319:38
15851,[(4-hydroxyphenyl)methylene]malononitrile,223-253-0,3785-90-8,Acute Tox. 3,Notified C&L,38.0,H301:38
15856,Tetrahydro-4-methylene-2-(2-methyl-1-propenyl)-2H-pyran,262-475-2,60857-05-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,84.0,H412:84;H315:84;H319:84
15858,"Dichloro[(1,2,5,6-η)-cycloocta-1,5-diene]ruthenium",256-889-2,50982-12-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,158.0,H335:157;H315:157;H319:157;H302:1;H332:1;H413:1
15861,Butyl 4-aminobenzoate,202-317-1,94-25-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:40;H317:40;H315:42;H319:42
15863,1-phenylguanidine,217-898-7,2002-16-6,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,89.0,H411:89;H319:89
15866,"5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-enyl]naphthalene-1,4-dione",610-730-7,517-89-5,Aquatic Chronic 3,Notified C&L,1.0,H412:1
15868,5-fluoro-2-methyl-1-[[4-(methylthio)phenyl]methylene]-1H-indene-3-acetic acid,250-892-2,32004-67-4,Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1;Repr. 2;Lact.;STOT RE 2,REACH registration C&L,40.0,H362:1;H301:1;H334:39;H373:1;H317:40;H361:40;H302:39
15872,"2,2-diethoxyethylamine",211-439-4,645-36-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H335:38;H226:50;H315:38;H319:38;H318:7;H314:12
15875,Chlorbutanol,200-317-6,57-15-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,66.0,H302:62;H315:8;H319:5;H318:3;H335:3;Not classified:1
15876,"(8E,10E)-dodeca-8,10-dienol",251-761-2,33956-49-9,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,146.0,H317:100;H315:146;H410:99;H400:145;H334:54
15880,"5-chloro-10,11-dihydro-5H-dibenzo[a,d]cycloheptene",214-910-2,1210-33-9,,Notified C&L,5.0,H314:4;H315:1;H319:1
15882,carbaryl (ISO);1-naphthyl methylcarbamate,200-555-0,63-25-2,Acute Tox. 4;Acute Tox. 4;Carc. 2;Aquatic Acute 1,Harmonised C&L,0.0,H332:0;H302:0;H351:0;H400:0
15884,3-methylacetophenone,209-561-8,585-74-0,Acute Tox. 4,Notified C&L,44.0,H302:43;Not classified:1
15886,"Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-338-0,91995-75-4,Carc. 1B,Harmonised C&L,0.0,H350:0
15887,"Strychnidin-10-one, 19-oxide",230-656-5,7248-28-4,Acute Tox. 4,Notified C&L,40.0,H302:38;H400:2;H410:2;H330:2;H300:2
15890,"3,3,4,4,5,5,6,6,6-nonafluorohexene",243-053-7,19430-93-4,Flam. Liq. 2,REACH registration C&L,61.0,H225:43;Not classified:17;H226:1
15894,Disodium adipate,231-293-5,7486-38-6,Not Classified,REACH registration C&L,13.0,Not classified:13
15896,"Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, acetate (1:1), (3S,4R)-",615-763-0,72471-80-8,Not Classified,Notified C&L,1.0,Not classified:1
15900,Fluroxene,206-977-1,406-90-6,Flam. Liq. 2;Eye Dam. 1,Notified C&L,43.0,H318:38;H225:43;H341:5
15901,"Hydrogen 9-(2,5-dicarboxylatophenyl)-3,6-bis(diethylamino)xanthylium, sodium salt",278-292-6,75701-30-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
15903,"2,4,6,8-tetramethylcyclotetrasiloxane",219-137-4,2370-88-9,Flam. Liq. 3,REACH registration C&L,2294.0,H226:2239;Not classified:55;H319:31;H260:1
15904,4-chlorochalcone,213-476-1,956-04-7,,Notified C&L,5.0,H335:5;H315:5;H319:5
15910,Ammonium toluene-4-sulphonate,223-927-4,4124-42-9,Not Classified,REACH registration C&L,5.0,Not classified:5
15911,"Salai, ext.",308-366-6,97952-72-2,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,82.0,H304:76;H410:57;H317:76;H226:58;H315:76;H400:56;H411:19;Not classified:6
15912,Methyl 4-(Cyanomethyl)benzoate,616-338-2,76469-88-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H315:1
15915,mercury,231-106-7,7439-97-6,Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H410:0;H330:0;H372:0;H400:0
15917,[2-[(1-oxoallyl)oxy]ethyl] hydrogen maleate,242-874-8,19201-36-6,,Notified C&L,1.0,H315:1;H319:1
15920,"Terpineol, sulfurized, palladium salts",307-618-2,97675-46-2,Flam. Sol. 2,Notified C&L,1.0,H228:1
15925,"Hydrogen tetrakis[2,2-bis[(allyloxy)methyl]butan-1-olato-O1]bis(ditridecyl phosphito -O'')titanate(2-)",264-709-9,64157-14-8,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,92.0,H411:2;H317:2;H227:2;H315:25;Not classified:66;H335:23;H319:23;H318:1;H302:1
15926,"Diisononylnaphthalenedisulphonic acid, compound with 4,4-dimethyloxazolidine (1:2)",264-318-3,63568-32-1,,Notified C&L,1.0,Not classified:1
15928,"Pine, Pinus sylvestris, ext.",281-679-2,84012-35-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1648.0,H411:17;H304:1645;H317:1646;H226:1645;H315:1609;H410:1446;H400:1365;H302:2;H332:3;H312:3;H319:6;Not classified:2
15935,"Cyclohex-2-ene-1,1-dimethanol",218-481-2,2160-94-3,Acute Tox. 4,Notified C&L,38.0,H302:38
15939,"1-(N,N-bis(2-ethylhexyl)aminomethyl)-1,2,4-triazole",618-727-2,91273-04-0,Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,43.0,H411:43;H317:43;H314:43;H318:1
15942,5-chloro-2-fluoroaniline,218-284-1,2106-05-0,Not Classified,REACH registration C&L,48.0,Not classified:2;H335:41;H315:46;H319:46;H332:4;H373:4;H311:4;H302:5
15943,"1-Chloro-3,4-difluorobenzene",614-988-1,696-02-6,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H302:39;H315:44;H226:45;H319:45;H335:44
15945,Copper di-D-gluconate,208-408-2,527-09-3,Acute Tox. 4;Skin Sens. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,203.0,H411:98;H373:104;H317:104;H302:149;H400:158;H410:14;H315:7;H319:7;H332:2;H312:2;Not classified:1
15948,"Methyl 3-α,12-α-dihydroxy-5-β-cholan-24-oate",221-819-1,3245-38-3,Not Classified,Notified C&L,1.0,Not classified:1
15949,"Eucalyptus polybractea, ext.",294-961-5,91771-67-4,Not Classified,Notified C&L,192.0,Not classified:184;H411:8;H304:8;H317:8;H226:8;H319:6;H315:7;H302:1
15951,methyl 2-[(ethoxycarbonothioyl)thio]propanoate,435-690-6,344562-80-7,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,105.0,H318:105;H410:105;H373:105;H317:105;H302:105;H400:105
15953,Holmium(3+) perchlorate,237-839-9,14017-54-0,Ox. Sol. 2,Notified C&L,42.0,H272:42;H335:4;H315:4;H319:4
15963,C.I. Solvent Yellow 89,612-931-5,61969-51-5,Not Classified,Notified C&L,6.0,Not classified:6
15966,4-hydroxy-2-pyridone,210-924-8,626-03-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
15969,"3-methylbutane-1,2-diol",256-597-5,50468-22-9,Not Classified,Notified C&L,4.0,Not classified:3;H335:1;H315:1;H319:1
15970,"Benzenamine, N-phenyl-, reaction products with isobutylene and ,4,4-trimethylpentene",606-029-0,184378-08-3,STOT RE 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,17.0,H413:17;H373:17
15978,Victoria green garnet,271-385-2,68553-01-5,Not Classified,Notified C&L,6.0,Not classified:6
15979,"4,4',4''-trimethoxytrityl chloride",256-474-6,49757-42-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42
15981,Diethyl benzylmalonate,210-142-7,607-81-8,Aquatic Chronic 3,REACH registration C&L,3.0,H412:2;H335:1;H315:1;H319:1
15982,Bis(butanedione dioximato)nickel,236-782-7,13478-93-8,,Notified C&L,4.0,H351:4;H317:4;H315:4;H319:4;H335:4
15983,"Methyl (2S,4R)-4-aminopyrrolidine-2-carboxylate hydrochloride, N1-BOC protected",608-878-2,334999-32-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
15984,Diniobium pentaoxide,215-213-6,1313-96-8,Not Classified,REACH registration C&L,425.0,Not classified:225;H335:200;H315:200;H319:200;H413:20
15985,"1,4-dibutoxybenzene",203-196-8,104-36-9,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H319:38;H400:38
15986,"4,4-dimethylpentan-2-one",209-685-2,590-50-1,Flam. Liq. 2,Notified C&L,43.0,H225:43
15988,Quinoline-8-thiol hydrochloride,251-785-3,34006-16-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
15991,"2-aminoethanol, salt with sulphuric acid",260-298-5,56633-27-3,Not Classified,Notified C&L,5.0,Not classified:5
15993,"1,1,1-trimethyl-2,2,2-triphenyldisilane",215-912-6,1450-18-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
15994,2-amino-2'-chloro-5-nitrobenzophenone,217-929-4,2011-66-7,Not Classified,REACH registration C&L,9.0,Not classified:4;H411:2;H302:2;H341:3;H315:3;H319:3
15995,"2,2'-[6-(4-methoxyphenyl)-1,3,5-triazine-2,4-diyl]bis[5-[(2-ethylhexyl)oxy]phenol",606-111-6,187393-00-6,Not Classified,Notified C&L,40.0,Not classified:39;H413:1
15998,Hexachloroiridic acid,241-012-8,16941-92-7,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,127.0,H318:4;H290:4;H302:89;H314:6;H411:83;H317:83;H315:121;H319:121;H335:38;H332:2;H351:2;H312:2
16000,Hexadecylsuccinic acid,219-781-6,2530-31-6,,Notified C&L,1.0,Not classified:1
16001,"3-aminonaphthalene-2,7-disulphonic acid",202-143-6,92-28-4,Not Classified,Notified C&L,7.0,Not classified:7
16002,"Bis(2-ethylhexyl) cyclohexane-1,2-dicarboxylate",201-554-8,84-71-9,Not Classified,Notified C&L,6.0,Not classified:5;H335:1;H319:1
16005,"Nonene, branched",306-492-6,97280-95-0,Flam. Liq. 2;Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,442.0,H411:1;H304:1;H410:1;H225:1;H400:1;Not classified:441
16007,"Benzenamine, reaction products with aniline hydrochloride and nitrobenzene, hydrochlorides",309-913-1,101357-16-8,Not Classified,REACH registration C&L,71.0,Not classified:69;H373:2;H412:1
16009,"1,1'-(methylenebis(4,1-phenylene))bis(3-cyclohexylurea)",611-759-8,58890-25-8,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,40.0,H317:39;H413:39;H302:1;H312:1
16013,"Octadecanoic acid, mixed esters with palmitic acid and propylene glycol",294-012-5,91672-07-0,Not Classified,Notified C&L,1.0,Not classified:1
16018,2-chloro-5-nitrobenzyl alcohol,279-584-6,80866-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42
16019,(decyloxy)acetaldehyde,276-961-7,72894-07-6,Not Classified,Notified C&L,88.0,Not classified:88
16022,"Coenzyme A, trilithium salt",242-317-9,18439-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16024,(2S)-2-hexyloxirane,610-528-9,50418-68-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H226:39;H315:39;H319:39
16026,Calcium 3-methyl-2-oxobutyrate (1:2),257-456-0,51828-94-5,Not Classified,Notified C&L,1.0,Not classified:1
16028,"6-methyl-1,2,4-triazine-3,5-diol",213-253-9,932-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
16030,"2-(3-(4-amino-9,10-dihydro-3-sulpho-9,10-dioxoanthracen-4-yl)aminobenzenesulphonyl)vinyl) disodium sulphate",219-949-9,2580-78-1,Not Classified,REACH registration C&L,123.0,Not classified:51;H412:47;H319:28;H317:6;H334:5;H315:2;H335:1
16036,"2-[7-[1,3-dihydro-1,1-dimethyl-3-(4-sulphonatobutyl)-2H-benz[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-dimethyl-3-(4-sulphonatobutyl)-1H-benz[e]indolium disodium iodide",264-177-8,63450-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,38.0,H335:38;H360:38;H315:38;H319:38
16038,"Resin acids and Rosin acids, tall-oil, esters with glycerol",287-658-4,85566-48-9,Not Classified,Notified C&L,9.0,Not classified:9
16039,D-threonine,246-488-0,24830-94-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,20.0,H335:19;H302:18;H315:19;H319:19;Not classified:1
16043,Icosyl acrylate,256-350-1,48076-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,205.0,H335:205;H411:205;H315:205;H319:205
16048,Cedar leaf oil,616-907-5,8007-20-3,Acute Tox. 4;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,114.0,H411:63;H317:76;H304:76;H302:114;H226:40;H315:38;H412:13
16049,"Phenol, dodecyl-, sulfurized, calcium salts",272-486-4,68855-45-8,Aquatic Chronic 4,Notified C&L,501.0,H413:473;H361:52;H319:29;H360:26
16051,9-vinylcarbazole,216-055-0,1484-13-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H317:0;H312:0;H341:0;H315:0;H400:0
16052,bis(4-dodecylphenyl)iodonium hexafluoroantimonate,404-420-9,71786-70-4,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H317:0;H412:0
16053,"Anthocyanins, grape",600-954-3,11029-12-2,Not Classified,Notified C&L,36.0,Not classified:36
16054,(6R-trans)-7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid dihydrochloride,266-312-6,66309-69-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,4.0,H317:4;H334:4;H315:3;H319:3
16057,METHOXYPROPYLTRIMETHOXYSILANE,608-893-4,33580-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,24.0,H335:18;H315:18;H319:18;Not classified:5;H332:1;H226:1;H302:1;H312:1
16061,Butyl 3-hydroxybutyrate,258-658-1,53605-94-0,Eye Irrit. 2A,REACH registration C&L,10.0,H319:10;H332:1
16066,"1,1,3,3-tetrabutyl-1,3-bis[(1-oxohexadecyl)oxy]distannoxane",288-248-8,85702-57-4,Muta. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,296.0,H360:274;H410:274;H373:198;H341:274;H400:274;H372:76;Not classified:22
16068,"1,2,4-trihydroxyanthraquinone",201-359-8,81-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,128.0,H335:127;H315:128;H319:128
16069,4-nitro-m-xylene,201-947-4,89-87-2,Acute Tox. 4,Notified C&L,44.0,H302:42;H332:4;H312:4;H330:2;H310:2;H300:2
16073,"(1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0^{2,6}.0^{11,13}]pentadeca-3,8-dien-14-yl tetradecanoate",605-413-5,16561-29-8,Skin Irrit. 2,Notified C&L,46.0,H315:46;H335:4;H319:3;H351:3;H301:1;H318:1;H311:1;H331:1
16075,"Benzenesulfonic acid, C10-13-alkyl derivs., compds. with triethanolamine",270-116-6,68411-31-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,242.0,H318:138;H315:178;Not classified:65;H319:40;H302:37;H412:18;H334:1
16076,Benzyl butyrate,203-105-1,103-37-7,Not Classified,REACH registration C&L,1644.0,Not classified:1631;H302:13
16077,Bis(2-butoxyethyl) phthalate,204-213-1,117-83-9,Aquatic Chronic 4,Notified C&L,94.0,H413:83;Not classified:10;H319:1
16082,"4,4'-sulphonylbis[2,6-dibromophenol]",254-551-9,39635-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16083,"Fatty acids, coco, esters with sucrose",292-993-4,91031-88-8,Eye Irrit. 2,Notified C&L,43.0,H319:36;Not classified:7
16085,"Butyl 4,4-bis(tert-butyldioxy)valerate",213-626-6,995-33-5,Org. Perox. C;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,22.0,H411:4;H242:22;H400:4;H319:13;H413:5;H226:1
16086,"4-amino-3-[[4-[[[4-[(2,4-diaminophenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonic acid, sodium salt",276-529-8,72245-56-8,Not Classified,REACH registration C&L,10.0,Not classified:10
16087,2-fluorobenzylic alcohol,207-170-7,446-51-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H335:2;H315:3;H319:3
16088,"(1R,3aR,4aR,5R,6S,7S,8R,10S,15S)-10-tert-butyl-1,5,7-trihydroxy-15-methyltetrahydro-5H,8H-6,5-(epoxyethano)-8,4a-(epoxymethano)dicyclopenta[b,c]furo[3,2-d]furan-2,12,14-trione",604-876-0,15291-77-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H335:3;H315:3;H319:3
16089,"cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol",267-747-4,67914-85-6,Not Classified,REACH registration C&L,1.0,Not classified:1
16090,"4-(4-chlorophenyl)piperidine-2,6-dione",284-171-9,84803-46-3,,Notified C&L,1.0,H302:1
16092,Cyclohexyldiphenylphosphine,228-904-2,6372-42-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4.0,H315:3;H319:3;H373:1;H317:1;H413:1;H302:2;H335:1
16094,1-(4-methylphenyl)ethan-1-amine,443-160-0,586-70-9,Acute Tox. 4;Skin Corr. 1C;Acute Tox. 3;Aquatic Chronic 2,REACH registration C&L,5.0,H331:3;H411:3;H302:3;H314:5;H318:1;H227:1
16096,perchloric acid ... %,231-512-4,7601-90-3,Ox. Liq. 1;Skin Corr. 1A,Harmonised C&L,0.0,H271:0;H314:0
16099,3-hydroxy-1-azabicyclo[2.2.2]octane-3-carbonitrile,613-020-5,6238-30-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,3.0,H302:3;H332:3;H317:2;H413:2;H312:3;H319:2;H335:2;H315:2
16102,"11β,17,21-trihydroxypregn-4-ene-3,20-dione 17-butyrate",237-093-4,13609-67-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6.0,H315:2;H319:2;H361:1;H332:1;H302:2;H312:1;H373:1;Not classified:1;H341:1
16104,"Rosin, maleated, polymer with formaldehyde, nonylphenol and pentaerythritol",614-318-8,68152-62-5,Not Classified,Notified C&L,71.0,Not classified:71
16106,4-isopropyl-9H-thioxanthen-9-one,281-065-4,83846-86-0,Not Classified,Notified C&L,177.0,Not classified:94;H413:38;H302:51;H317:32
16107,4-(trifluoromethoxy)benzonitrile,206-363-3,332-25-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H302:44;H332:44;H312:44;H319:45;H335:43;H315:45;H301:2;H330:1;H311:1
16114,"2-bromo-1,2-diphenylethan-1-one",216-057-1,1484-50-0,Skin Corr. 1B;STOT SE 3,Notified C&L,43.0,H335:42;H314:43;H318:1;H290:1
16117,"2,2'-thiodiethanol;thiodiglycol",203-874-3,111-48-8,Eye Irrit. 2,Harmonised C&L,0.0,H319:0
16118,"Hexane, branched and linear",295-570-2,92112-69-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,186.0,H317:84;H315:144;H412:84;H411:59;H304:68;H373:48;H336:68;H225:101;H319:39;H361:77;Not classified:1
16119,"3-(D-apio-β-D-furanosyloxy)-1,8-dihydroxy-6-methylanthraquinone",237-953-9,14101-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:38;H315:38;H319:38;H302:2
16124,Tetrakis(hydroxymethyl)phosphonium sulphate(2:1),259-709-0,55566-30-8,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 3;Repr. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,338.0,H411:7;H318:336;H400:297;H317:336;H331:231;H302:180;H361:119;H410:112;H360:134;H301:140;H340:55;H315:22;H373:20;Not classified:2;H413:1;H334:1;H314:1;H335:1;H313:1;H333:1
16125,"Methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide",252-601-4,35511-15-0,Not Classified,REACH registration C&L,4.0,Not classified:3;H302:1
16127,Glucose 6-(disodium phosphate),222-938-1,3671-99-6,Not Classified,Notified C&L,3.0,Not classified:3
16128,5-aminouracil,213-252-3,932-52-5,Acute Tox. 4,Notified C&L,44.0,H302:44
16130,2-ethylhexyl nonanoate,261-819-9,59587-44-9,Not Classified,REACH registration C&L,22.0,Not classified:22
16131,2-fluoroethanol,206-740-2,371-62-0,Flam. Liq. 3;Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,43.0,H226:43;H330:43;H310:43;H300:43
16132,"Lavender, Lavandula angustifolia angustifolia, ext.",283-994-0,84776-65-8,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1443.0,H411:1289;H317:1399;H304:1368;H315:1443;H412:104;H226:30;H319:28;H402:2
16133,"1,6-Hexandiammonium dihydroxide, N,N'-bis-(2-hydroxypropyl)-N,N,N',N'-tetramethyl",442-730-6,35132-93-5,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,REACH registration C&L,35.0,H318:2;H302:35;H314:35;H412:2
16134,Goethite (Fe(OH)O),215-176-6,1310-14-1,,Notified C&L,60.0,Not classified:59;H373:1
16136,1-Butyl-1-methylpyrrolidinium Bis(trifluoromethanesulfonyl)imide,606-989-0,223437-11-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:41;H315:47;H319:47;H301:1
16138,Sodium 1-methyl 2-sulphonatododecanoate,223-673-4,4016-21-1,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,13.0,H318:13;H412:13
16139,N-(4-(4-fluorophenyl)-5-(hydroxymethyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide,604-563-9,147118-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,12.0,H335:9;H315:9;H319:9;Not classified:1;H302:2
16141,nickel bis(sulfamidate); nickel sulfamate,237-396-1,13770-89-3,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0.0,H360:0;H334:0;H410:0;H350:0;H317:0;H372:0;H341:0;H302:0;H400:0
16145,Copper zinc oxide,603-453-8,131064-29-4,Not Classified,Notified C&L,22.0,Not classified:22
16146,"Fatty acids, tall oil, compds. with 2-[(2-hydroxyphenyl)methylene]hydrazinecarboximidamide",269-810-1,68334-11-2,Not Classified,Notified C&L,9.0,Not classified:9
16154,5-amino-2-naphthol,201-713-1,86-97-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:2;H319:2
16155,"Formaldehyde, oligomeric reaction products with phenol and m-phenylenebis(methylamine)",500-137-0,57214-10-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,317.0,H410:239;H400:239;H413:57;Not classified:15;H314:6;H317:6;H412:3;H331:3;H302:3;H318:1
16160,Nerolidol,205-540-2,142-50-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,272.0,H410:234;H400:198;H335:38;H315:38;H319:80;H317:1
16162,"Benzenamine, N,N-dimethyl-, oxidized, molybdatetungstatephosphates",309-916-8,101357-19-1,Self-heat. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,198.0,H318:121;H252:91;H410:158;H317:91;H400:156;Not classified:40;H319:4
16166,"Acetic acid, 2,2',2''-[(octylstannylidyne)tris(thio)]tris-, tri-C12-22-alkyl esters",290-473-1,90170-40-4,Repr. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,1.0,H413:1;H361:1;H373:1
16168,Decyl undecyl phthalate,242-947-4,19295-82-0,Not Classified,Notified C&L,1.0,Not classified:1
16169,Sodium trihydrogen [[(2-hydroxyethyl)imino]bis(methylene)]bisphosphonate,282-459-9,84215-53-2,,Notified C&L,7.0,H319:6;Not classified:1
16170,Clostebol acetate,212-720-4,855-19-6,Aquatic Chronic 4,Notified C&L,41.0,H413:38;H300:2;H332:1;H302:1;H351:1;H373:1
16172,2-pentylpyridine,218-937-0,2294-76-0,Acute Tox. 4,Notified C&L,1592.0,H302:1549;H335:42;H315:43;H319:43
16174,POLYBUTYLENE TEREPHTHALATE,607-857-5,26062-94-2,,Notified C&L,59.0,Not classified:38;H319:21
16177,"Fatty acids, palm-oil, hydrogenated, distn. residues",307-847-8,97765-90-7,Not Classified,Notified C&L,1.0,Not classified:1
16178,forchlorfenuron (ISO);1-(2-chloro-4-pyridyl)-3-phenylurea,614-346-0,68157-60-8,Carc. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H351:0
16180,"3,3-bis(4-hydroxy-5-isopropyl-o-tolyl)phthalide",204-729-7,125-20-2,Not Classified,REACH registration C&L,38.0,Not classified:13;H341:20;H361:20;H350:20;H225:4;H302:1;H400:1
16184,Octadecylphosphonic acid,225-216-4,4724-47-4,,Notified C&L,29.0,H335:27;H315:28;H319:28;H290:1;H314:1
16188,Bis(2-ethylhexyl) isophthalate,205-308-0,137-89-3,Repr. 1B;Aquatic Acute 1,Notified C&L,41.0,H360:38;H400:38;Not classified:3
16189,"Fatty acids, C16-22, reaction products with hexakis(methoxymethyl)melamine",281-285-0,83899-29-0,Not Classified,Notified C&L,28.0,Not classified:28
16195,"trans-tetrahydrothiophene-3,4-diol 1,1-dioxide",238-030-3,14176-47-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
16196,clopidogrel besilate,603-890-4,135046-48-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H315:1;H319:1;H335:1
16197,Cyclohexyl isothiocyanate,214-361-9,1122-82-3,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1,Notified C&L,46.0,H317:40;H318:40;H334:40;H314:45;H331:4;H302:6;H312:5;H332:2;H335:1;H315:1;H319:1
16207,ethyl 1-azabicyclo[2.2.2]octane-3-carboxylate,613-022-6,6238-33-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,2.0,H302:2;H332:2;H312:2;H319:2;H335:2;H315:2
16209,"Fatty acids, vegetable-oil, reaction products with tetraethylenepentamine",273-652-9,68991-84-4,Skin Corr. 1A;Skin Sens. 1;Eye Irrit. 2,Notified C&L,608.0,H317:540;H315:577;H314:599;H319:575;H335:60;Not classified:5;H411:7;H318:7;H290:5;H410:4;H302:2;H360:1;H334:1
16212,"1,5-dihydro-1-phenyl-4H-pyrazolo[3,4-d]pyrimidin-4-one",244-331-0,21314-17-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
16213,"Ethene, homopolymer, chlorinated",613-688-8,64754-90-1,Not Classified,Notified C&L,39.0,Not classified:39
16214,Europium trihydroxide,240-517-0,16469-19-5,Not Classified,Notified C&L,2.0,Not classified:2
16216,Sulfamethoxypyridazine,201-272-5,80-35-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,101.0,H317:52;H334:52;H335:43;H318:44;H315:44;Not classified:5
16217,Cyamemazine,222-594-2,3546-03-0,Acute Tox. 4;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41.0,H410:41;H317:3;H336:2;H302:3;H400:40
16219,"2,2'-ethylenedianiline",251-837-5,34124-14-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H315:1
16221,"3,7-Nonadien-2-one, 4,8-dimethyl-",617-260-1,817-88-9,Not Classified,Notified C&L,41.0,Not classified:41
16224,"1,5-diaminochloro-4,8-dihydroxyanthraquinone",235-401-1,12217-79-7,Not Classified,Notified C&L,33.0,Not classified:33
16225,CALCIUM TRIFLUOROMETHANESULFONATE,415-540-6,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2.0,H318:2;H315:2
16226,"Oxydi-2,1-ethanediyl dioleate",244-269-4,21209-30-3,Not Classified,Notified C&L,1.0,Not classified:1
16229,"Isotridecyl 3,5,5-trimethylhexanoate",261-675-7,59231-37-7,Not Classified,REACH registration C&L,24.0,Not classified:24
16230,Methyl pyruvate,209-987-4,600-22-6,Skin Sens. 1B;Eye Dam. 1;STOT SE 3,REACH registration C&L,49.0,H317:5;H318:5;H335:5;H226:45
16232,o-chlorostyrene,218-026-8,2039-87-4,Flam. Liq. 3;Acute Tox. 4;Carc. 1B,Notified C&L,45.0,H332:38;H226:40;H350:38;H335:5;H315:7;H319:7
16234,Ashes (residues),268-627-4,68131-74-8,Not Classified,Notified C&L,240.0,Not classified:158;H319:81;H331:1;H302:1;H314:1
16235,Isononanoic acid,248-092-3,26896-18-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,149.0,H318:86;H302:87;H315:32;Not classified:33;H319:29;H314:1
16236,"Decanoic acid, compound with 2,2'-iminodiethanol (1:1)",264-959-9,64601-14-5,Not Classified,Notified C&L,1.0,Not classified:1
16239,3-hydroxy-2-naphthohydrazide,226-282-7,5341-58-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
16240,"Gases (petroleum), naphtha unifiner desulfurization stripper off;Petroleum gas;[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]",272-879-0,68919-06-2,Press. Gas;Flam. Gas 1;Muta. 1B;Carc. 1A,Harmonised C&L,0.0,H220:0;H340:0;H350:0;Not classified:0
16242,N-methyldioctadecylamine,223-819-7,4088-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:39;H315:40;H319:40;Not classified:1;H410:1
16243,"5,6-dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one",601-654-5,120014-30-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
16244,"2,2'-trimethylenebisisothiouronium dibromide",226-635-5,5442-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16251,[[p-(2-methoxyethyl)phenoxy]methyl]oxirane,260-353-3,56718-70-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,7.0,H315:6;H319:6;H317:3;H413:3;H335:3;H302:1
16252,α-bromo-3-nitrotoluene,223-557-3,3958-57-4,Skin Corr. 1B;STOT SE 3,Notified C&L,46.0,H335:40;H314:46;H319:1;H318:2;H340:1;H290:1
16259,4-cyclohexylbutyric acid,224-665-3,4441-63-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,132.0,H315:132;H319:132;H335:43
16264,Sodium hydroxymethanesulphonate,212-800-9,870-72-4,Not Classified,REACH registration C&L,56.0,Not classified:49;H335:4;H315:7;H319:4
16268,p-nonylphenol,203-199-4,104-40-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,637.0,H318:104;H410:151;H314:189;H302:188;H400:149;Not classified:447;H361:181;H411:38;H332:1;H312:1;H317:1;H413:1
16269,C.I. Acid Blue 260,612-949-3,62168-86-9,Not Classified,Notified C&L,5.0,Not classified:5
16270,Lanolin,232-348-6,8006-54-0,Not Classified,Notified C&L,721.0,Not classified:721
16271,1-[3-(Hydroxymethyl)pyridin-2-yl)-4-methyl-2-phenylpiperazine,700-296-8,61337-89-1,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,3.0,H318:2;H302:3
16272,1-acetyl-1H-indole,209-396-1,576-15-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16275,1-benzyl-4-(isopropylamino)piperidine-4-carboxamide,213-846-2,1031-36-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H301:38;H315:38;H319:38
16277,"1,1,1-trifluoropropane",207-002-2,421-07-8,Flam. Gas 2;Press. Gas (Comp.),Notified C&L,1.0,H221:1;H280:1
16279,"Horse, ext.",308-902-9,98999-13-4,Flam. Liq. 2,Notified C&L,1.0,H225:1
16280,D-Glucan,232-739-1,9012-72-0,Not Classified,Notified C&L,1.0,Not classified:1
16281,"2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-amine monohydrochloride",604-085-0,138564-60-0,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,5.0,H318:2;H332:3;H302:4;H412:1
16285,Quinidine sulphate,200-046-3,50-54-4,Acute Tox. 4,Notified C&L,42.0,H302:41;H332:1;H317:3
16289,"Propanoic acid, 2,3-dibromo-2-methyl-, methyl ester",609-286-7,3673-79-8,Acute Tox. 2;STOT SE 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157.0,H410:157;H330:157;H341:156;H335:156;H400:156;H371:1;H319:1;H315:1
16290,2-chloroethyltriethoxysilane,242-156-4,18279-67-9,,Notified C&L,1.0,H335:1;H226:1;H315:1;H319:1
16295,"2,2,3,3,4,4,5,5-octafluoropentyl acrylate",206-816-5,376-84-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,44.0,H335:43;H411:39;H315:44;H319:44
16296,"alcohols, C12-20, ethoxylated",614-570-9,68526-94-3,Aquatic Acute 1,Notified C&L,574.0,H400:441;H411:89;H318:89;H302:89;Not classified:44
16297,methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate,414-400-1,32750-89-3,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
16307,"phosphoramidic dichloride, methyl-",609-264-7,36598-86-4,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 2;STOT RE 1,REACH registration C&L,2.0,H372:2;H302:2;H314:2;H330:2
16308,6-chlorohex-1-ene,213-186-5,928-89-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:44;H226:44;H315:44;H319:44
16309,"Benzene, 4-ethoxy-2-methyl-1-nitro-",610-793-0,52177-06-7,Not Classified,Notified C&L,1.0,Not classified:1
16314,4-chloro-2-nitrophenylsulphonyl chloride,224-875-5,4533-96-4,Skin Corr. 1B,Notified C&L,39.0,H314:39
16316,"Tetrasodium [μ-[7-[[3,3'-dihydroxy-4'-[(4-hydroxy-2-sulphobenzo[a]phenazin-3-yl)azo][1,1'-biphenyl]-4-yl]azo]-8-hydroxynaphthalene-1,3,6-trisulphonato(8-)]]dicuprate(4-)",276-136-1,71873-63-7,Aquatic Chronic 3,Notified C&L,48.0,H412:45;Not classified:3
16317,"4-methyl-2-(1-phenylethyl)-1,3-dioxolane",266-828-1,67634-23-5,Not Classified,Notified C&L,1399.0,Not classified:1399
16320,"Trisodium 4-hydroxy-4-(4-anilino-5-sulphonato-1-naphthylazo)naphthalene-2,7-disulphonate",223-378-0,3861-73-2,Not Classified,Notified C&L,103.0,Not classified:63;H319:39;H412:1
16325,Tetrahydro-2-(p-tolyloxy)-2H-pyran,236-784-8,13481-09-9,Not Classified,Notified C&L,88.0,Not classified:88
16326,"2-Bromo-1,10-phenanthroline",607-070-7,22426-14-8,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H301:2;H318:1;H410:1;H315:2;H400:1;H311:1;H331:1;H319:1;H335:1
16328,"2-chloro-N,N-diethylacetamide",219-019-2,2315-36-8,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,43.0,H330:39;H315:43;H311:43;H319:43;H335:42;H302:39;H301:4
16330,RED MOC 127,440-190-6,,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H318:1
16332,S-(5'-deoxy-5'-adenosyl)methionine iodide,222-486-5,3493-13-8,Skin Sens. 1,Notified C&L,38.0,H317:38
16334,Zinc di(toluene-4-sulphonate),236-576-7,13438-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,74.0,H335:73;H315:73;H319:73;Not classified:1
16338,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 2,5-dihydro-3,6-diphenyl-",611-183-7,54660-00-3,Not Classified,Notified C&L,31.0,Not classified:31
16340,"Amines, C12-18-alkyldimethyl, N-oxides",273-281-2,68955-55-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,626.0,H411:543;H319:446;H400:626;H318:180;H315:180;H302:82;H410:19
16341,"Gases (petroleum), acetylene manuf. off",270-745-6,68477-64-5,Flam. Gas 1;Press. Gas (Comp.);Acute Tox. 3;Repr. 1A;STOT RE 1,Notified C&L,84.0,H220:84;H360:84;H372:84;H331:84;H280:84
16344,Pentafluoroarsorane,232-061-6,7784-36-3,Press. Gas (Liq.);Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,111.0,H400:111;H410:111;H330:111;H280:111
16345,4-chloro-4'-methoxybutyrophenone,255-125-5,40877-19-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16352,Trilead dioxide phosphonate,235-252-2,12141-20-7,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,67.0,H360:60;H362:16;H332:61;H410:61;H351:17;H228:30;H372:17;H302:61;H400:54;H373:44;H350:14;Not classified:6;H361:1
16354,"Creosote oil, acenaphthene fraction, acenaphthene-free;Wash Oil Redistillate;[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.]",292-606-9,90640-85-0,Carc. 1B,Harmonised C&L,0.0,H350:0
16355,Chlorotrimethylsilane,200-900-5,75-77-4,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 3,REACH registration C&L,2451.0,H301:2305;H314:2389;H225:2450;H331:2315;H312:2373;H318:38;H351:2120;H332:33;H335:81;H302:28;H315:6;H319:6;H290:1;Not classified:1;H226:1;H371:1;H231:1
16357,6-methoxybenzothiazol-2-ylamine,217-130-0,1747-60-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:41;H302:45;H315:41;H319:41;H301:1;H332:1;H312:1
16360,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium sulphate (2:1)",281-430-8,83949-70-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2.0,H302:2;H319:2
16362,Tetrakis(2-butoxyethyl) orthosilicate,242-560-0,18765-38-3,Skin Irrit. 2;STOT RE 2,REACH registration C&L,108.0,H315:103;H373:3;H335:43;H319:43
16364,2-ethylhexyl dihydrogen phosphate,213-967-0,1070-03-7,Skin Corr. 1C;Eye Dam. 1,Notified C&L,678.0,H318:612;H314:672;H335:27;H332:6;H302:6;H315:3;H319:3;Not classified:3;H312:2
16367,"5-acetyl-10,11-dihydro-3-nitro-5H-dibenz[b,f]azepine",279-251-5,79752-03-7,Aquatic Chronic 3,REACH registration C&L,2.0,H412:2
16369,"Fatty acids, C10-14",292-770-1,90990-09-3,Not Classified,Notified C&L,2.0,Not classified:1;H319:1
16370,1-(3-aminopropyl)azepan-2-one,607-402-0,24566-95-8,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,84.0,H318:83;H314:84;H412:83;H226:83;H302:84
16374,Tricalcium bis(orthophosphate),231-840-8,7758-87-4,Not Classified,REACH registration C&L,536.0,Not classified:481;H335:55;H315:55;H319:55
16375,"chloral hydrate;2,2,2-trichloroethane-1,1-diol",206-117-5,302-17-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0.0,H301:0;H315:0;H319:0
16384,"Glycerides, soya mono-, di- and tri-, hydrogenated",294-672-4,91745-04-9,Not Classified,Notified C&L,1.0,Not classified:1
16388,butyl 4-hydroxybenzoate,202-318-7,94-26-8,Not Classified,Notified C&L,1144.0,Not classified:544;H335:534;H315:560;H319:559;H318:38;H317:4;H413:3
16389,"Castor oil, ethoxylated propoxylated",615-879-1,72986-44-8,Not Classified,Notified C&L,25.0,Not classified:25
16392,"Peach, ext.",281-678-7,84012-34-0,Flam. Liq. 3,Notified C&L,1389.0,H226:1337;Not classified:26;H225:26;H411:13;H304:13;H317:13;H315:13
16394,"Fatty acids, rape-oil, hydrogenated, calcium salts",294-321-5,91697-59-5,Not Classified,Notified C&L,1.0,Not classified:1
16397,[2H4]acetaldehyde,216-641-6,1632-89-9,Flam. Liq. 1;Acute Tox. 4;Eye Dam. 1;STOT SE 3;Carc. 2,Notified C&L,38.0,H318:38;H302:38;H224:38;H351:38;H335:38
16403,N-isopropylhydroxylamine,225-791-1,5080-22-8,STOT RE 2;Aquatic Chronic 2,REACH registration C&L,125.0,H411:55;H373:2;H315:69;H319:69;H312:33;Not classified:1;H335:1;H302:1
16405,3-amino-6-chloromethyl-2-(pyrazin-4-oxide)carbonitrile,254-799-8,40127-89-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H312:38;H319:38;H335:38;H315:38
16408,Butoxypropan-1-ol,249-598-7,29387-86-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,113.0,H315:112;H319:112;Not classified:1
16411,Cobalt(2+) isononanoate,282-603-0,84255-52-7,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 1,Notified C&L,2.0,H332:1;H410:1;H317:2;H302:2;H400:2;H412:1;H361:1;H319:1
16413,methyl (R)-lactate,241-420-6,17392-83-5,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H226:0;H335:0;H319:0
16415,"Zinc, 2-ethylhexanoate neodecanoate complexes, basic",286-299-0,85204-06-4,Not Classified,Notified C&L,1.0,Not classified:1
16416,"1,4-dichloro-2,5-diethoxybenzene",267-282-7,67828-63-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
16420,"(Z)-1-propene-1,2,3-tricarboxylic acid",209-564-4,585-84-2,,Notified C&L,8.0,H335:5;H315:5;H319:5;Not classified:3;H302:1;H332:1
16426,"Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with diethanolamine",290-650-3,90194-40-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,3.0,H318:2;H302:2;H315:2;Not classified:1
16427,"1,6-dibromo-2-naphthol",240-356-6,16239-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
16428,"2,2'-dichloroacetic anhydride",223-924-8,4124-30-5,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4,Notified C&L,39.0,H332:38;H314:39;H311:38;H318:1;H312:1
16429,Yttrium,231-174-8,7440-65-5,Not Classified,REACH registration C&L,169.0,Not classified:75;H228:70;H332:47;H312:47;H250:47;H302:47;H413:19;H371:5
16430,"2,2'-azobis[2,4-dimethylvaleronitrile]",224-583-8,4419-11-8,Self-react. D;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,205.0,H411:177;H317:55;H242:174;H319:47;H315:27;H228:37;H301:2;H311:2;H331:2;H412:1
16432,2-(Methoxymethyl)-pyridine,607-248-4,23579-92-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H302:38;H315:38
16435,α-propylcyclohexanemethanol,224-419-5,4352-42-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H301:38;H315:43;H319:43
16436,"2H-1-Benzopyran-2-carboxylic acid, 6-fluoro-3,4-dihydro-, methyl ester",618-023-5,874649-82-8,Not Classified,Notified C&L,1.0,Not classified:1
16437,FEWCOOP,434-020-1,,Aquatic Chronic 4,Notified C&L,1.0,H413:1
16438,"Sage, Salvia officinalis lavandulifolia, ext.",308-365-0,97952-71-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1372.0,H304:1346;H410:1343;H373:1286;H317:1372;H226:1345;H315:1286;H400:1343;H341:57;H411:28;H371:27;H302:28;H332:2;H412:1;H319:1
16439,ammonium (Z)-α-methoxyimino-2-furylacetate,405-990-1,97148-39-5,Flam. Sol. 2,Harmonised C&L,0.0,H228:0
16442,2-hydroxyphenylalanine,219-134-8,2370-61-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
16443,"Chromate(2-), [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)][2-[(2-hydroxy-5-methoxyphenyl)azo]-4,6-dinitrophenolato(2-)]-, sodium",290-925-8,90294-41-0,Aquatic Chronic 2,Notified C&L,570.0,H411:570
16444,Benzyl isovalerate,203-106-7,103-38-8,Eye Irrit. 2,REACH registration C&L,1611.0,H319:9;Not classified:1602;H315:6
16445,"Disodium 5-[[4'-[[2,4-dihydroxy-3-[(4-sulphonatophenyl)azo]phenyl]azo][1,1'-biphenyl]-4-yl]azo]salicylate",220-768-2,2893-80-3,Carc. 1B,Notified C&L,38.0,H350:38
16447,Choline 2-ethylhexanoate,272-508-2,68856-36-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,22.0,H302:22;H315:22;H319:22
16448,Ammonium diisononylnaphthalenesulphonate,264-315-7,63568-29-6,Eye Irrit. 2;STOT SE 3,Notified C&L,28.0,H335:26;H319:27;Not classified:1;H315:1
16450,"5,6-dimethoxyindan-1-one",218-287-8,2107-69-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,5.0,H332:4;H302:4;H312:4;H319:1;H335:1;H315:1;Not classified:1
16451,"Soaps, stocks, soya, acidulated, hydrogenated",296-965-2,93165-77-6,Not Classified,Notified C&L,1.0,Not classified:1
16454,"Fatty acids, fish-oil, mixed with fish oil, reaction products with N,N-dimethyl-1,3-propanediamine",305-675-8,94944-97-5,Not Classified,Notified C&L,1.0,Not classified:1
16456,3-methoxypyridine,230-730-7,7295-76-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:40;H315:41;H319:41;H332:1;H302:1;H312:1
16459,"Fatty acids, C6-12, mixed esters with C18-unsatd. fatty acid dimers and dipentaerythritol and isononanoic acid",604-540-3,146832-04-4,Not Classified,Notified C&L,22.0,Not classified:22
16461,"1,1'-(4,6-dihydroxy-1,3-phenylene)bisethan-1-one",218-482-8,2161-85-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H302:40;H332:40;H312:40;H319:40;H335:39;H315:40
16470,"(3R)-4,4,4-Trifluorobutane-1,3-diol, tech",603-933-7,135859-36-8,Flam. Liq. 3,Notified C&L,1.0,H226:1
16473,2-sulphobenzoic anhydride,201-322-6,81-08-3,,Notified C&L,9.0,H335:6;H315:8;H319:8;Not classified:1;H318:1;H332:1;H314:1;H312:1;H302:1
16474,p-nitrophenyl β-D-xylopyranoside,217-897-1,2001-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
16476,1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene,412-620-2,121626-74-2,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
16477,N-acetyl-DL-leucine,202-734-9,99-15-0,Not Classified,Notified C&L,4.0,Not classified:3;H318:1
16478,"magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate)",413-360-2,164058-21-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H302:0;H315:0;H317:0
16481,"Ethanol, 2,2'-iminobis-, N-C12-18-alkyl derivs.",276-014-8,71786-60-2,Acute Tox. 4;Skin Corr. 1C;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,353.0,H410:332;H314:319;H361:7;H302:284;H400:324;H318:132;H315:29;H301:20
16483,Methylenecyclopentane,216-203-4,1528-30-9,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,39.0,H304:39;H225:39
16486,"Syrups, hydrolyzed starch",232-436-4,8029-43-4,Not Classified,Notified C&L,304.0,Not classified:304
16487,"4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone",423-860-2,56309-94-5,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H317:0;H412:0
16489,"reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate",434-970-5,160987-57-5,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
16490,"Rubber, butadiene, hydroxy-terminated",613-185-3,63231-65-2,Not Classified,Notified C&L,5.0,Not classified:5
16491,"Androst-4-ene-3,17-dione",200-554-5,63-05-8,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.,REACH registration C&L,47.0,H360:45;H362:45;H302:46;H351:45;H350:1;H341:1
16500,"Acetic acid, oxo-, sodium salt, reaction products with ethylenediamine and phenol, iron sodium salts",283-044-5,84539-55-9,Not Classified,REACH registration C&L,335.0,Not classified:68;H317:267
16501,Sodium 5-chloro-2-(5-hydroxy-3-methyl-4-(4-((4-methylphenyl)sulphonyloxy)phenylazo)pyrazol-1-yl)benzenesulphonate,228-907-9,6372-96-9,Not Classified,Notified C&L,11.0,Not classified:11
16503,"Kieselguhr, soda ash flux-calcined",272-489-0,68855-54-9,Not Classified,REACH registration C&L,2327.0,Not classified:1593;H373:379;H372:226;H351:87;H341:55;H332:80;H302:55;H371:69;H335:41;H319:62;H315:21;H350:10
16508,4-methylcoumarin,210-141-1,607-71-6,Acute Tox. 4,Notified C&L,39.0,H302:39
16509,BEANTREE,440-220-8,,Not Classified,Notified C&L,1.0,Not classified:1
16510,α-bromo-2-nitrotoluene,223-558-9,3958-60-9,Skin Corr. 1B,Notified C&L,44.0,H314:44;H317:4;H318:1;H332:1;H290:1;H312:1;H302:1
16514,(S)-N-2-naphthyl-5-oxopyrrolidine-2-carboxamide,244-809-9,22155-91-5,Aquatic Acute 1,Notified C&L,43.0,H400:39;H302:3;H350:1;H410:1
16516,"1-Propanesulfonic acid, 2-methyl-2-[(1-oxo-2-propen-1-yl)amino]-, homopolymer",608-044-8,27119-07-9,Skin Corr. 1B,Notified C&L,74.0,H314:60;H319:14;H335:1;H315:1
16518,sulphuryl difluoride,220-281-5,2699-79-8,Press. Gas;Acute Tox. 3;STOT RE 2;Aquatic Acute 1,Harmonised C&L,0.0,H331:0;H400:0;H373:0;Not classified:0
16519,Tranexamic acid,214-818-2,1197-18-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,148.0,H335:117;H315:118;H319:118;Not classified:29;H317:4;H302:1
16524,"Solvent naphtha (petroleum), hydrocracked heavy arom.;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-881-9,101316-80-7,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
16527,ethyl-N-(3-hydroxyphenyl)-carbamateethyl 3-hydroxyphenylcarbamate,615-309-1,7159-96-8,Not Classified,REACH registration C&L,1.0,Not classified:1
16532,Tributylchlorosilane,213-627-1,995-45-9,Skin Corr. 1B,Notified C&L,44.0,H314:44;H318:1;H290:1
16533,kresoxim-methyl (ISO);methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate,604-351-6,143390-89-0,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H351:0;H400:0
16538,Vanadium tetrafluoride,233-171-7,10049-16-8,,Notified C&L,6.0,H301:5;H314:5;H330:4;H335:1;H315:1;H319:1;H331:1;H311:1
16539,2-phenylpropyl butyrate,279-587-2,80866-83-7,Not Classified,Notified C&L,88.0,Not classified:88
16540,"1-ol, [[4-[(3-aminophenyl)amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-[(E)-2-ylazo]-, polysulfonate, polynaphthen, sodium salt (1:?), diazotized, reaction products with 2-[(aminophenyl)sulfonyl]ethyl hydrogen sulfate, 1-naphthalenol, 8-amino- (1:1), polysulfonates, sodium salts and 2,4,6-trihalogeno-1,3,5-triazine",,,Eye Dam. 1,Notified C&L,1.0,H318:1
16543,"Fatty acids, C18-unsatd., dimers, hydrogenated, reaction products with fatty acids, C8-10 and propylidenetrimethanol",500-705-8,162353-68-6,Not Classified,Notified C&L,25.0,Not classified:25
16544,Calcium 4-methyl-2-oxovalerate,257-457-6,51828-95-6,Not Classified,Notified C&L,1.0,Not classified:1
16547,4-bromophenylhydrazine hydrochloride,255-590-4,41931-18-4,Skin Corr. 1B,Notified C&L,2.0,H314:2;H318:1
16549,"4,4',5,5'-tetramethyl-2,2'-bisimidazole",273-955-6,69286-06-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16550,Poly(sodium-4-styrenesulfonate),607-780-7,25704-18-1,Not Classified,Notified C&L,101.0,Not classified:98;H335:3;H315:2;H319:2
16553,"Willow, Salix alba, ext.",282-029-0,84082-82-6,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,106.0,H317:5;H319:2;Not classified:100;H226:1
16558,"2-phosphonobutane-1,2,4-tricarboxylic acid",253-733-5,37971-36-1,Met. Corr. 1;Eye Irrit. 2,REACH registration C&L,230.0,H290:112;H319:124;H318:20;H314:26;Not classified:7;H371:1;H373:1;H315:1
16564,Zinc borate oxide (Zn3(BO2)4O),603-063-8,12536-65-1,Not Classified,Notified C&L,1.0,Not classified:1
16565,"(1S,1'R)-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate",431-700-8,,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
16566,Potassium arsonate,233-337-9,10124-50-2,Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,27.0,H331:27;H301:27;H410:27;H400:27
16568,Isopropyl Crotonate,613-088-6,6284-46-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H226:1;H315:1;H319:1
16569,1-methylcyclohexanol,209-688-9,590-67-0,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H302:42;H228:42;H312:38;H319:39;H335:39;H315:40;H332:7;H336:2;H227:1
16571,Amprolium hydrochloride,205-307-5,137-88-2,Not Classified,Notified C&L,2.0,Not classified:2
16575,Pyridinium chlorochromate,247-595-5,26299-14-9,Ox. Sol. 2;Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,55.0,H272:40;H410:55;H350:55;H317:54;H400:44;H271:11;H301:1;H311:1;H331:1
16576,"(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide",432-970-1,217324-98-6,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
16577,"2-propyn-1-ol, polymer with ethylene oxide",607-802-5,25749-64-8,Acute Tox. 4;Eye Dam. 1;Acute Tox. 2;STOT SE 3;STOT RE 2,Notified C&L,94.0,H318:94;H302:94;H330:94;H373:93;H335:94;H361:10
16579,"Fokienia hodginsii, ext.",296-189-4,92347-03-0,Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,59.0,H317:57;H304:56;H410:58;H400:56;H411:1;H319:1
16581,"Cuprate(3-), [3-hydroxy-4-[[2-hydroxy-5-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-2,7-naphthalenedisulfonato(5-)]-, potassium sodium",287-791-8,85585-89-3,Aquatic Chronic 2,REACH registration C&L,2066.0,H411:2;Not classified:2064
16582,Manganese,231-105-1,7439-96-5,Not Classified,REACH registration C&L,2682.0,Not classified:971;H412:369;H411:368;H319:458;H228:360;H373:105;H260:47;H360:16;H372:17;H340:11;H370:11;H335:2;H361:1;H332:1;H302:1;H312:1;H315:1;H341:1
16589,"Benzenesulfonic acid, dodecyl-, branched",270-117-1,68411-32-5,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,95.0,H411:95;H302:95;H314:95
16590,Chloroacetyl isocyanate,224-715-4,4461-30-7,Acute Tox. 3;Skin Corr. 1B;Resp. Sens. 1,Notified C&L,42.0,H301:38;H334:42;H314:42;H330:4
16593,4-(4-methylphenylthio)benzophenone,281-064-9,83846-85-9,Aquatic Chronic 4,REACH registration C&L,118.0,H413:9;H302:107;H315:108;H312:106;H319:109;H335:107
16594,Dioctyl phthalate,204-214-7,117-84-0,Not Classified,Notified C&L,201.0,Not classified:188;H361:12;H317:5;H334:5;H413:1;H319:1
16596,"N,N'-dibenzylidenetoluene-α,α-diamine",202-144-1,92-29-5,Acute Tox. 3,Notified C&L,38.0,H301:38
16598,(ethylamino)acetonitrile,246-243-8,24426-40-2,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,1.0,H301:1;H314:1;H330:1;H311:1;H226:1
16602,Black HM 2482,400-920-6,89857-06-7,Aquatic Chronic 3,Notified C&L,39.0,H412:39
16604,"3-AZA-BICYCLO[3,3,0]OCTANE HYDROCHLORIDE",601-190-3,112626-50-3,,Notified C&L,3.0,H302:2;H332:2;H315:3;H319:3;H335:3
16605,"1S,2R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11R,11aR)-3-(1,1-dimethylethyl)hexahydro-2,4,7b,11-tetrahydroxy-8-methyl-9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione",604-875-5,15291-76-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H335:3;H315:3;H319:3
16607,3-oxa-2-oxobornane-4-carbonyl chloride,254-552-4,39637-74-6,Skin Corr. 1B,Notified C&L,46.0,H314:46;H318:1;H290:1
16608,Methyltrioctylammonium iodide,252-672-1,35675-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,38.0,H335:38;H360:38;H315:38;H319:38
16609,3-hexyldihydrofuran-2(3H)-one,242-316-3,18436-37-8,Not Classified,Notified C&L,127.0,Not classified:89;H319:38
16610,Ethyl 3-(chloroformyl)propionate,238-855-9,14794-31-1,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,50.0,H302:5;H314:50;H318:1;H290:1
16611,"Calcium, acetate tallow fatty acids complexes",290-885-1,90268-80-7,Not Classified,Notified C&L,2.0,Not classified:1;H318:1;H315:1;H319:1
16612,tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-),404-760-8,117342-25-3,Eye Dam. 1;Acute Tox. 3,Harmonised C&L,0.0,H331:0;H318:0
16613,4-tert-butoxystyrene,619-127-3,95418-58-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;H411:1;H317:1
16617,Potassium tri-sec-butylhydroborate,259-241-7,54575-49-4,Water-react. 1;Skin Corr. 1B,Notified C&L,40.0,H314:39;H260:39;H302:1;H225:2;H351:1;H319:1;H335:1
16619,4-fluoromandelic acid,206-899-8,395-33-5,,Notified C&L,6.0,H335:5;H315:6;H319:6
16626,Doxylamine,207-414-2,469-21-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,40.0,H302:40;H315:2;H412:2;H319:2;H335:2
16628,"Glycerides, C16-18 and C18-unsatd. mono- and di-, lactates",293-182-8,91052-24-3,Not Classified,Notified C&L,1.0,Not classified:1
16634,"1-(2,4-dimethylphenylazo)-2-naphthol",221-490-4,3118-97-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,74.0,H317:2;H315:68;H319:68;H335:65;Not classified:5;H351:5;H341:1
16637,Trioctyl phosphite,221-194-5,3028-88-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
16638,3-(propylthio)propene,248-673-1,27817-67-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H226:1;H315:1;H319:1
16641,"2-methyl-2-(1-methylpropyl)propane-1,3-diol",212-387-5,813-60-5,Not Classified,REACH registration C&L,40.0,Not classified:1;H318:39;H334:38
16643,Pancrelipase,258-659-7,53608-75-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,79.0,H334:79;H317:44;H315:79;H319:79;H335:44
16648,"2,2-dichloroacetamide",211-674-2,683-72-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
16650,1-vinylhexahydro-2H-azepin-2-one,218-787-6,2235-00-9,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2A;STOT RE 1,REACH registration C&L,355.0,H317:278;H372:240;H312:167;H319:318;H302:341;H373:38;H335:43;H318:27;Not classified:9;H315:6
16651,Trimethoxy(2-methylpropyl)silane,242-272-5,18395-30-7,Flam. Liq. 3;Skin Irrit. 2;STOT SE 3,REACH registration C&L,217.0,H336:40;H226:184;H315:159;H332:39;H319:68;H335:43;H302:39;Not classified:33
16652,4-(3-Aminophenyl)-2-methyl-3-butyn-2-ol,614-923-7,69088-96-6,Acute Tox. 4;Skin Sens. 1,Notified C&L,2.0,H317:1;H302:1;H315:1;H319:1
16653,"1-(3,5-dimethoxyphenyl)-1-methylethyl carbazate",254-477-7,39508-00-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16657,Isocarboxazid,200-438-4,59-63-2,Acute Tox. 3,Notified C&L,39.0,H301:39;H341:1
16658,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-methylphenyl)-3-oxobutyramide]",228-771-0,6358-37-8,Not Classified,Notified C&L,52.0,Not classified:52
16659,Cyclopentolate,208-136-4,512-15-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2.0,H332:2;H302:2;H312:2
16660,"Octadecanoic acid, reaction products with diethylenetriamine, carboxymethylated",296-587-8,92797-51-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2
16670,"tert-butyl (S)-[1-benzyl-2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl]carbamate",222-939-7,3674-06-4,,Notified C&L,1.0,Not classified:1
16673,Calcium divanadium hexaoxide,237-952-3,14100-64-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Muta. 2;Repr. 2;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,36.0,H411:35;H318:35;H302:3;H332:3;H315:2;H372:2;H341:2;H335:36;H361:2;H301:33;H331:33;H319:1
16674,3-hydroxypyridine-2-carbonitrile,213-251-8,932-35-4,,Notified C&L,3.0,H301:3;H311:3;H331:3;H319:2;H335:2;H315:2
16675,"Jasmine, Jasminum grandiflorum, ext.",283-993-5,84776-64-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1488.0,H411:1370;H317:1484;H315:1485;H226:1345;H302:1347;H319:63;H410:114;H400:77;H312:6;H412:4;H227:1;H401:1;Not classified:1;H318:1;H332:1;H225:1;H314:1
16677,(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine hydrochloride,604-508-9,14611-52-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,5.0,H411:3;H302:4;H332:1;H372:1;H290:1;H315:1
16678,"Formaldehyde, polymer with tetrahydroimidazo[4,5-d]imidazole-2,5(1H,3H)-dione",609-298-2,36833-16-6,Not Classified,Notified C&L,71.0,Not classified:71
16679,"N'-(2-aminoethyl)-N,N-diethylethylenediamine",246-242-2,24426-16-2,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43.0,H318:38;H314:43;H317:4
16680,"Potassium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonate",261-818-3,59587-38-1,Acute Tox. 4;Eye Irrit. 2;STOT RE 2,REACH registration C&L,50.0,H302:3;H319:49;H373:2
16681,"Phosphoric acid, isooctyl ester",235-743-1,12645-53-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,41.0,H318:20;H314:20;H315:21;H319:21
16684,R-(-)-Oxo-3-(tert-butyldimethylsilyloxy)-6-triphenylphosphoranediylhexanoic acid methyl ester,604-562-3,147118-35-2,Not Classified,Notified C&L,2.0,Not classified:1;H410:1;H400:1
16685,"2-[2-(propan-2-yl)-1,3-oxazolidin-3-yl]ethanol",608-245-0,28770-01-6,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,75.0,H317:48;H318:48;H302:47;Not classified:27;H412:1
16686,Triethylaluminium,202-619-3,97-93-8,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1A,REACH registration C&L,313.0,H260:313;H314:313;H250:313;H252:3;H225:4;H318:195
16687,"Menthane, monohydroperoxy derivative",247-987-6,26762-92-5,Org. Perox. F;Skin Corr. 1A;STOT RE 2,REACH registration C&L,45.0,H314:44;H242:44;H373:36;H318:34;H315:1;H226:1;H302:1;H400:1;H332:2;H241:1
16691,Ytterbium trihydroxide,240-518-6,16469-20-8,Not Classified,Notified C&L,2.0,Not classified:2
16694,Sodium propan-2-olate,211-673-7,683-60-3,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1;STOT SE 3;STOT SE 3;STOT SE 3;STOT SE 3;Carc. 2,REACH registration C&L,6.0,H318:2;H314:6;H351:1;H336:1;H225:1;H335:1;H228:5;H251:4
16696,PRASINATE,434-200-8,,Not Classified,Notified C&L,1.0,Not classified:1
16697,3-nitrobenzenesulphonic acid,202-671-7,98-47-5,Skin Corr. 1B,Notified C&L,2.0,H314:2;H318:1
16700,Hex-4-enoic acid,252-427-9,35194-36-6,Skin Corr. 1B,Notified C&L,43.0,H314:43
16701,N-(2-hydroxypropyl)dodecanamide,205-541-8,142-54-1,Eye Irrit. 2,Notified C&L,533.0,H319:502;H318:26;Not classified:5;H315:5;H335:1
16703,"4,7-dichloroquinoline",201-714-7,86-98-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,65.0,H411:8;H317:11;H315:60;H319:55;H335:45;H302:4
16705,"[2-(1,3-dioxoisoindolin-2-yl) ethoxycarbonyl]methyl 3-[2-chloro-4-(4-nitrophenylazo)anilino] propionate",435-990-7,,Not Classified,REACH registration C&L,38.0,Not classified:38
16707,"Hexanedioic acid, polymer with N-(2-aminoethyl)1,2-ethanediamine",607-531-2,25085-20-5,Aquatic Chronic 1,Notified C&L,61.0,H411:33;H319:29;H412:7;H315:7
16708,"Dichlorobis(1,1-dimethylethyl)silane",242-273-0,18395-90-9,Skin Corr. 1B,Notified C&L,43.0,H314:43;H318:1;H290:1
16709,"1,2-Propanediol, 3-[ethyl[3-methyl-4-[2-(5-nitro-2-thiazolyl)diazenyl]phenyl]amino]-",602-282-6,12222-97-8,Not Classified,Notified C&L,1.0,Not classified:1
16710,"4-(morpholinomethyl)-2,5-xylenol hydrochloride",251-600-6,33625-43-3,,Notified C&L,4.0,H335:4;H315:4;H319:4
16711,"(±)-3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate monobenzenesulfonate",601-097-8,111470-99-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,170.0,H302:165;H332:52;H315:122;H319:129;H335:121;H318:40;H410:33;H400:33;H411:10;H361:4;H300:2;H373:3;H301:4
16712,α-methyl-o-(trifluoromethyl)benzyl alcohol,279-252-0,79756-81-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H302:39;H315:42;H319:42
16714,"3-methylcyclopentadecane-1,5-dione",606-859-3,21890-10-8,Flam. Sol. 1,REACH registration C&L,1.0,H228:1
16715,"4,11-diamino-2-(3-methoxypropyl)-1H-naphth[2,3-f]isoindol-1,3,5,10(2H)-tetrone",235-402-7,12217-80-0,Not Classified,REACH registration C&L,200.0,Not classified:105;H410:39;H400:38;H302:35;H412:23;H332:1;H315:1;H319:1
16716,Oxyphenisatine,204-728-1,125-13-3,Acute Tox. 3,Notified C&L,38.0,H301:38
16719,"1-methoxy-N,N,N',N'-tetramethylmethylenediamine",214-695-5,1186-70-5,Flam. Liq. 2,Notified C&L,38.0,H225:38
16721,"Cuprate(4-), [4,5-dihydro-4-[[8-hydroxy-7-[[2-hydroxy-5-methoxy-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-6-sulfo-2-naphthalenyl]azo]-5-oxo-1-(4-sulfophenyl)-1H-pyrazole-3-carboxylato(6-)]-, sodium",287-793-9,85585-91-7,Skin Sens. 1,Notified C&L,2110.0,H317:2104;Not classified:6
16723,"Distillates (petroleum), chemically neutralized heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C",265-135-1,64742-34-3,Carc. 1A,Harmonised C&L,0.0,H350:0
16727,Dipropyl sulphide,203-873-8,111-47-7,Acute Tox. 4,Notified C&L,1424.0,H302:1376;H226:138;H335:43;H315:44;H319:47
16728,2-ethylpiperidine,216-058-7,1484-80-6,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,40.0,H226:40;H314:38;H315:2;H319:2;H335:1
16732,"Octanoic acid, zinc salt, basic",291-793-4,90480-58-3,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,4.0,H411:2;H319:3;H400:2;Not classified:1
16733,4-fluoro-1-iodo-2-methylbenzene,613-917-1,66256-28-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16738,"Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;Kerosine - unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-882-4,101316-81-8,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
16739,Tiletamine,238-031-9,14176-49-9,Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1
16740,"2,3-epoxypropyl isopropyl ether",223-672-9,4016-14-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Repr. 2;Aquatic Chronic 3,REACH registration C&L,42.0,H315:42;H412:3;H331:3;H226:42;H319:42;H302:3;H361:3;H317:38;H335:38;H332:1;H370:1
16741,N-sulphinylaniline,214-362-4,1122-83-4,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,40.0,H335:39;H334:39;H315:40;H319:40
16742,Cyclohexylhydroxylamine,218-650-0,2211-64-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38
16743,"Uridine, 2'-deoxy-5-ethyl-, 3',5'-bis(4-chlorobenzoate)",607-566-3,25137-84-2,Not Classified,REACH registration C&L,4.0,Not classified:3;H335:1;H315:1;H319:1
16747,ethyl 1-azabicyclo[2.2.2]oct-2-ene-3-carboxylate,613-021-0,6238-32-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,2.0,H302:2;H332:2;H312:2;H319:2;H335:2;H315:2
16748,Reserpine,200-047-9,50-55-5,Acute Tox. 4,Notified C&L,173.0,H302:173;H360:6;H351:5;H362:1;H319:1;H332:2;H312:1;H370:1;H372:1;H350:1
16750,5-nitrotoluene-2-sulphonyl chloride,244-332-6,21320-90-1,Skin Corr. 1B;STOT SE 3,Notified C&L,1.0,H335:1;H314:1
16754,4-bromo-m-cresol,238-464-3,14472-14-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45;H302:4;H312:4
16756,"Fatty acids, coco, 2,2-dimethyl-1,3-propanediyl esters",292-990-8,91031-85-5,Not Classified,Notified C&L,29.0,Not classified:29
16759,"Fatty acids, C12-18 and C16-18-unsatd., esters with sucrose",308-119-2,97862-70-9,Not Classified,Notified C&L,40.0,Not classified:40
16761,"1-[4'-trans-Ethyl-[1,1'-bicyclohexyl]-4-trans-yl-]-4-trifluormethoxybenzene",603-929-5,135734-59-7,STOT RE 2;Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1;H373:1
16763,"N2-[(1,1-dimethylethoxy)carbonyl]-N5-[imino[[(4-methylphenyl)sulphonyl]amino]methyl]-L-ornithine",237-549-2,13836-37-8,,Notified C&L,2.0,Not classified:2
16768,C.I. Solvent Blue 45,609-361-4,37229-23-5,Not Classified,Notified C&L,38.0,Not classified:38
16769,dibutyl phthalate;DBP,201-557-4,84-74-2,Aquatic Acute 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H400:0
16773,Hydroxychloroquine sulphate,212-019-3,747-36-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,52.0,H302:49;H319:51;H335:7;H315:9;H334:3;H317:6;H332:1;H312:1;H351:1;H411:1
16775,"Borate(1-), (2-cyanophenyl)trifluoro-, potassium (1:1), (T-4)-",618-885-2,929038-12-0,,Notified C&L,2.0,H335:2;H315:2;H319:2;H301:1;H311:1;H331:1
16777,"1,2,4,5-tetrachloro-3-(methylthio)benzene",272-054-5,68671-90-9,,Notified C&L,41.0,Not classified:41
16780,Hydrazine dihydrochloride,226-283-2,5341-61-7,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,15.0,H301:14;H410:15;H350:15;H317:15;H311:14;H331:14;H400:14;H318:1;H314:1;H330:1;H300:1;H310:1
16782,(Z)-hex-4-en-1-ol,213-187-0,928-91-6,Not Classified,Notified C&L,130.0,Not classified:64;H226:66
16790,Diethyl [(5-bromo-1H-indol-3-yl)methylene]malonate,300-502-2,93941-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38.0,H335:38;H413:38;H315:38;H319:38
16791,ammonium ethyl hydrogen phosphate,614-677-0,68647-23-4,Skin Corr. 1B,Notified C&L,1.0,H314:1
16796,Cerium(3+) perchlorate,237-836-2,14017-47-1,,Notified C&L,4.0,H335:4;H272:4;H315:4;H319:4
16798,Ethyl dithioacetate,212-801-4,870-73-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H226:38;H315:38;H319:38
16803,"Chromate(2-), [3-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulfonato(3-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]-, sodium",290-924-2,90294-40-9,Aquatic Chronic 2,REACH registration C&L,465.0,H411:2;H412:447;Not classified:16
16810,Cadmium zirconium trioxide,235-251-7,12139-23-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H332:38;H410:38;H312:38;H302:38;H400:38
16811,Magnesium distearate,209-150-3,557-04-0,Not Classified,Notified C&L,537.0,Not classified:253;H413:150;H335:114;H315:112;H319:130;H372:2;H373:2;H250:1
16812,"Ethanone, 1-(2-bromo-4-fluorophenyl)-",600-117-2,1006-39-9,,Notified C&L,7.0,H315:6;H319:6;H314:1
16813,Candelilla wax,232-347-0,8006-44-8,Not Classified,Notified C&L,184.0,Not classified:184
16814,"3,5-xylyl isocyanate",258-987-0,54132-75-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,47.0,H302:42;H332:42;H312:42;H319:47;H335:47;H315:47;H301:5;H334:4;H330:4;H331:1
16817,"2,6-dichlorophenoxyacetic acid",209-395-6,575-90-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39.0,H302:39;H319:39
16821,"Carbon Nanotube Single-walled (>55%) below 2nm(diam.), 5-15micro m(length)",608-533-6,308068-56-6,Eye Irrit. 2;STOT SE 3,Notified C&L,77.0,H335:75;H319:76;H315:2;H372:1;H332:1;H361:1
16826,Diflovidazin,605-284-5,162320-67-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,39.0,H302:39;H319:38;H400:39
16827,2-ISOCYANATOETHYLACRYLATE,688-012-8,13641-96-8,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3,Notified C&L,2.0,H301:2;H330:1;H312:1;H319:1;H335:1;H315:1;H411:1;H334:1;H314:1;H317:1
16828,2-bromostyrene,218-027-3,2039-88-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
16829,Guanidinium sulphamate,256-886-6,50979-18-5,Aquatic Chronic 3,Notified C&L,7.0,H412:3;H302:4
16836,"2(1H)-Isoquinolinepropanoic acid, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-, 1,5-pentanediyl ester, [R-(R*,R*)]-",613-515-6,64228-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16837,Tridecafluoro-N-methylhexanesulphonamide,269-516-3,68259-15-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16838,"Lithium 1,1-dimethylpropoxide",485-110-0,,Flam. Sol. 1;Skin Corr. 1B;Acute Tox. 4,REACH registration C&L,1.0,H228:1;H332:1;H314:1
16839,"Fatty acids, C16-22, mixed esters with hydrogenated tallow fatty acids and triethanolamine, acetates (salts)",308-901-3,98999-12-3,Not Classified,Notified C&L,3.0,Not classified:3
16842,"Fatty acids, C12-14",292-771-7,90990-10-6,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,6.0,H318:5;H315:5;Not classified:1
16845,"2-Thiabicyclo[3.1.0]hex-3-ene-6-carboxylic acid, ethyl ester, (1R,5R,6S)-rel-",619-649-1,72554-41-7,Acute Tox. 3;Skin Irrit. 2,Notified C&L,1.0,H315:1;H311:1
16849,"2,4-dimethylcyclohexylmethyl acetate",266-827-6,67634-22-4,Not Classified,Notified C&L,88.0,Not classified:88
16855,"Amines, C16-22-tert-alkyl",273-280-7,68955-54-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,173.0,H410:133;H314:173;H330:84;H317:133;H311:120;H372:55;H302:173;H400:133;H373:65;H331:49
16857,Trimethylthioacetic S-acid,259-708-5,55561-02-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,44.0,H226:42;H314:44;H318:1
16858,Trifluoroarsine,232-060-0,7784-35-2,,Notified C&L,1.0,H331:1;H301:1;H311:1
16861,"Acid D,L-aspart",210-513-3,617-45-8,Not Classified,REACH registration C&L,37.0,Not classified:34;H315:3;H319:3
16862,"[1,1'-Bicyclohexyl]-4-carboxaldehyde, 4'-pentyl-, (trans,trans)-",617-312-3,82241-70-1,Not Classified,Notified C&L,1.0,Not classified:1
16863,Bromotris(triphenylphosphine)rhodium,239-050-5,14973-89-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H332:38;H302:38;H312:38
16864,"Fatty acids, tallow, hydrogenated",263-130-9,61790-38-3,Not Classified,Notified C&L,205.0,Not classified:205
16867,Aphidicolin from Nigrospora sphaerica,609-602-3,38966-21-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
16871,N-acetyl-3-dimethyl-DL-cysteine,239-585-4,15537-71-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16872,"Methyl (2E)-2-[(2,3-dichlorophenyl)methylidene]-3-oxobutanoate",616-044-4,74073-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,7.0,H335:7;H315:7;H319:7
16879,antimony trioxide,215-175-0,1309-64-4,Carc. 2,Harmonised C&L,0.0,H351:0
16881,Bis(2-methylisothiouronium) sulphate,212-759-7,867-44-7,Acute Tox. 4,Notified C&L,50.0,H302:49;H332:1;H312:1
16883,"bis(N-hydroxy-N-ni­trosocyclohexylamina­to-O,O’)copper; bis(N-cyclohexyl-dia­zenium-dioxy)-copper; [Cu-HDO]",239-703-4,15627-09-5,Flam. Sol. 1;Acute Tox. 4;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H373:0;H228:0;H302:0;H400:0
16888,"Distillates (coal tar), heavy oils;Heavy Anthracene Oil;[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 °C to 400 °C (464 °F to 752 °F). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.]",292-607-4,90640-86-1,Carc. 1B,Harmonised C&L,0.0,H350:0
16889,"Fatty acids, C12-18, compds. with ethanolamine",292-921-1,91031-21-9,,Notified C&L,47.0,H318:39;Not classified:8
16891,C.I. Acid Black 83,612-598-6,61901-06-2,Not Classified,Notified C&L,5.0,Not classified:5
16896,"Dodecan-1-ol, ethoxylated, benzoate",500-136-5,56992-68-8,Not Classified,Notified C&L,1.0,Not classified:1
16897,Sulfurized phenols,235-526-1,12262-52-1,Not Classified,Notified C&L,37.0,Not classified:37
16900,zinc powder - zinc dust (pyrophoric);zinc powder - zinc dust (stabilised),231-175-3,7440-66-6,,,0.0,H260:0;H410:0;H400:0;H250:0
16901,Cymarin,208-087-9,508-77-0,Acute Tox. 3;Acute Tox. 3;STOT RE 2,Notified C&L,39.0,H331:39;H301:39;H373:39
16904,Erythro-3-aminoaspartic acid,245-500-1,23220-52-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
16907,"1,3,3-trimethyl-2-[[methyl(p-tolyl)hydrazono]methyl]-3H-indolium acetate",281-431-3,83949-71-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,4.0,H302:3;H319:3;Not classified:1
16911,"Fatty acids, C16-18 and C18-hydroxy",268-174-2,68025-11-6,Not Classified,Notified C&L,1.0,Not classified:1
16912,Ethoxylated Thioether,618-399-0,9004-83-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,233.0,H412:180;H315:177;H319:144;H317:84;H318:84;H410:33;H400:33;Not classified:5;H335:1
16913,Disodium 5-acetamido-2-[2-(4-isothiocyanato-2-sulphonatophenyl)vinyl]benzenesulphonate,256-919-4,51023-76-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38.0,H302:38;H334:38;H315:38;H319:38;H335:38
16914,Tungsten hydroxide oxide phosphate,235-087-6,12067-99-1,Skin Corr. 1B,Notified C&L,46.0,H314:45;H272:4;H318:1;H332:2;H302:2;H315:1;H312:1
16917,Cerium trifluoride,231-841-3,7758-88-5,Not Classified,REACH registration C&L,57.0,Not classified:10;H332:42;H315:47;H312:42;H319:47;H335:47;H302:1;H413:1
16920,"5,7-dihydro-2-methylthieno[3,4-d]pyrimidine",252-940-8,36267-71-7,Acute Tox. 4,Notified C&L,112.0,H302:102;H301:10
16922,"vinclozolin (ISO);N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione",256-599-6,50471-44-8,Skin Sens. 1;Carc. 2;Aquatic Chronic 2;Repr. 1B,Harmonised C&L,0.0,H411:0;H317:0;H360:0;H351:0
16925,"6-diazo-2,4-dinitrocyclohexa-2,4-dien-1-one",225-134-9,4682-03-5,Unst. Expl.,REACH registration C&L,4.0,H200:4
16926,Oxydiethylene di(acetate),211-049-4,628-68-2,Eye Irrit. 2,REACH registration C&L,40.0,H319:40
16928,"(E)-4-methyl-2-(pent-1-enyl)-1,3-dioxolane",302-121-7,94089-21-1,Not Classified,Notified C&L,2.0,Not classified:1;H411:1;H317:1;H311:1;H226:1;H302:1
16940,"2,2'-ethylenedioxydiethyl bis(2-ethylhexanoate)",202-319-2,94-28-0,Not Classified,REACH registration C&L,94.0,Not classified:94
16941,"1,2-diethylhydrazine",216-567-4,1615-80-1,Acute Tox. 3;Carc. 2,Notified C&L,38.0,H301:38;H351:38
16948,"ethyl 2-(ethoxymethylene)-4,4-difluoro-3-oxobutanoate",619-794-0,176969-33-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2.0,H332:2;H302:2;H312:2
16951,1-hydroxybutan-2-one,225-790-6,5077-67-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91.0,H335:91;H226:91;H315:91;H319:91
16954,Bis(2-methoxyethyl)aminosulfur Trifluoride,478-190-3,202289-38-1,Acute Tox. 2;Skin Corr. 1A;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1;H300:1
16958,3-methylpyridazine,216-640-0,1632-76-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,165.0,H335:164;H315:165;H319:165
16959,Valinomycin,217-896-6,2001-95-8,Acute Tox. 2;Acute Tox. 2,Notified C&L,45.0,H310:45;H300:45;H330:1;H319:1
16961,2-Amino-5-ethylphenol HCI,480-270-8,149861-22-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5.0,H335:3;H315:3;H319:3;H410:2;H314:2;H317:2;H302:2;H400:2
16962,Dichromium arsenide,235-499-6,12254-85-2,,Notified C&L,4.0,H331:4;H301:4;H410:4;H373:4
16963,"Phosphoric acid, mono- and di-C16-22-alkyl esters",293-857-7,91648-00-9,Not Classified,Notified C&L,1.0,Not classified:1
16965,methyl (R)-2-(4-hydroxyphenoxy)propionate,411-950-4,96562-58-2,Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H318:0;H412:0
16968,"2,5-dibromoterephthalic acid",237-300-8,13731-82-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:2;H319:2
16972,"1,2-Diacetoxybut-3-ene",605-909-1,18085-02-4,Acute Tox. 4,Notified C&L,39.0,H302:39
16973,[No public or meaningful name is available],467-470-0,,Skin Sens. 1,Notified C&L,1.0,H317:1
16981,"2-Propenoic acid, 3-(3-bromo-4-fluorophenyl)-",605-209-6,160434-49-1,,Notified C&L,5.0,H335:5;H315:5;H319:5
16983,1-bromo-3-nitrobenzene,209-563-9,585-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:44;H315:45;H319:45;H302:8;H332:8;H373:5;H312:7;H351:1;H331:2;H301:2;H311:2
16984,Trichloroacetic anhydride,223-925-3,4124-31-6,Acute Tox. 4;Skin Corr. 1A,Notified C&L,44.0,H302:39;H314:44;H318:1;H290:1
16988,Calcium(2+) 3-(acetylamino)propanesulphonate,278-665-3,77337-73-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:39;H315:40;H319:41;H361:1
16991,"Benzene-1,4-diammonium sulphate",240-357-1,16245-77-5,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,38.0,H301:37;H410:34;H317:36;H319:29;H400:23;H311:26;H331:26;H411:7;H318:1;H334:1;H370:1;H372:1;H315:1;Not classified:2;H413:1;H332:1
16994,1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate,605-586-7,170791-09-0,Not Classified,REACH registration C&L,7.0,Not classified:4;H332:1;H302:1;H362:1;H351:1;H315:1;H319:1;H335:1;H361:1
16995,2-ethoxyethyl methacrylate,219-135-3,2370-63-0,Repr. 1B,REACH registration C&L,44.0,H360:1;H335:41;H315:41;H319:41;H412:2;H361:1;Not classified:1
16996,"Phosphoric acid, C8-10-branched and linear alkyl esters, compds. with triethanolamine",306-957-3,97468-07-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2.0,H318:1;H315:1;H314:1
16999,DL-3-(3-fluorophenyl)alanine,220-104-1,2629-54-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
17001,"chrysoidine monoacetate;4-(phenylazo)benzene-1,3-diamine monoacetate",278-290-5,75660-25-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H315:0;H341:0;H302:0;H400:0
17002,2-chloro-4-fluoro-1-nitrobenzene,218-286-2,2106-50-5,,Notified C&L,8.0,H319:8;H302:6;H315:8;H311:5;H332:2;H312:2;H335:3;H301:1;H331:1
17007,"Phosphonic acid, P-propyl-, diethyl ester",920-290-0,18812-51-6,,Notified C&L,4.0,H315:4;H319:4
17008,"Soaps, stocks, sunflower-oil, acidulated",296-966-8,93165-78-7,Not Classified,Notified C&L,2.0,Not classified:2
17009,"sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate",429-720-7,184246-86-4,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
17010,Coronene,205-881-7,191-07-1,STOT SE 2,Notified C&L,16.0,H371:12;Not classified:3;H332:1;H302:1;H312:1
17011,"3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride",604-388-8,144010-02-6,Not Classified,Notified C&L,2.0,Not classified:1;H332:1;H302:1
17012,"1-methoxycyclohexa-1,3-diene",218-483-3,2161-90-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H332:38;H226:38;H302:38;H312:38
17018,"trans-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol",230-731-2,7295-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:41;H315:42;H319:42
17020,"Copper, [3,7,11,15-tetramethyl-2-hexadecenyl 9-ethenyl-14-ethyl-13-formyl-21-(methoxycarbonyl)-4,8,18-trimethyl-20-oxo-3-phorbinepropanoato(2-)-N23,N24,N25,N26]-, [SP-4-2-[3S-[3α(2E,7S*,11S*),4β,21β]]]-",246-020-5,24111-17-9,Not Classified,Notified C&L,25.0,Not classified:25
17022,"1,3,3-Trimethyl-N-(2-methylpropyl)-5-[(2-methylpropyl)amino]-cyclohexanemethanamine",920-264-9,41094-42-2,Skin Corr. 1A,Notified C&L,1.0,H314:1
17024,Benzoin,204-331-3,119-53-9,Not Classified,Notified C&L,446.0,Not classified:307;H412:137;H301:1;H315:1;H319:1
17025,"1,2-benzisothiazol-3(2H)-one 1,1-dioxide",201-321-0,81-07-2,Not Classified,REACH registration C&L,435.0,Not classified:429;H332:9;H315:10;H311:9;H331:9;H302:9;H400:9;H341:5;H361:5;H351:5;H317:1;H318:1
17026,"3,5-di(undecan-2-yl)heteropolycycle",,,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,4.0,H317:4;H413:4
17027,"1,5-naphthylene diisocyanate",221-641-4,3173-72-6,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H334:0;H332:0;H315:0;H412:0;H319:0;H335:0
17028,Tributylvinylstannane,231-291-4,7486-35-3,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,48.0,H301:48;H410:47;H372:46;H226:40;H312:47;H319:47;H315:47;H400:47;H330:1;H331:1;H311:1
17029,(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-[(triphenylmethyl)carbamoyl]butanoic acid,603-564-1,132327-80-1,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,42.0,H317:40;H413:40;H332:1;H302:1;H312:1;Not classified:1;H315:1;H319:1;H335:1
17035,"cis-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-ylmethyl methanesulphonate",267-749-5,67914-86-7,,Notified C&L,2.0,H302:1;H335:1;H315:1;H319:1
17039,"Butan-2-one O,O',O''-(methylsilylidyne)trioxime",245-366-4,22984-54-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,463.0,H317:453;H315:306;H319:427;H312:117;H318:27;H373:56;H410:14;H400:14;Not classified:7;H336:12;H412:14;H335:8;H302:2;H332:3;H351:1
17042,"Reaction product of 4,4'-methylenediphenyl diisocyanate (MDI) (101-68-8), Hexamethylenediamine (124-09-4) and p-Toluidine (106-49-0)",927-743-1,,Not Classified,Notified C&L,1.0,Not classified:1
17043,"4,4,14,14-tetraethoxy-3,15-dioxa-8,9,10-trithia-4,14-disilaheptadecane",260-351-2,56706-11-7,Not Classified,Notified C&L,30.0,Not classified:29;H412:1;H320:1;H315:1;H319:1
17044,Diethylmethylpropylammonium bromide,273-956-1,69286-10-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17045,Barium bis[2-[(2-hydroxy-1-naphthyl)azo]benzoate],228-906-3,6372-81-2,Not Classified,REACH registration C&L,36.0,Not classified:36
17047,Thiophene-2-sulphonyl chloride,240-677-1,16629-19-9,Skin Corr. 1B,Notified C&L,46.0,H314:46;H318:1;H290:1;H332:1;H302:1;H312:1
17048,Gadolinium(3+) perchlorate,237-837-8,14017-52-8,,Notified C&L,4.0,H335:4;H272:4;H315:4;H319:4
17050,Steatite (Mg(SiO3)),613-181-1,63210-56-0,Not Classified,Notified C&L,9.0,Not classified:9
17051,"3-acetylamino-5-(2-hydroxy-ethylcarbamoyl)-2,4,6-triiodo-benzoate ammonium",926-540-5,,Not Classified,REACH registration C&L,1.0,Not classified:1
17052,Tetrachloro-μ-hydroxy(μ-stearato)dichromium,239-286-9,15242-96-3,Eye Dam. 1,Notified C&L,51.0,H318:51;H302:1
17059,4-Ethyl-4-methoxydiphenylacetylene,613-182-7,63221-88-5,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
17060,(prop-2-ynyloxy)benzene,237-095-5,13610-02-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40.0,H335:39;H318:38;H315:40;H319:2
17061,"(2S)-propane-1,2-diamine dihydrochloride",606-377-3,19777-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,45.0,H335:44;H315:45;H319:45
17062,"3,4-dihydroxycinnamic acid",206-361-2,331-39-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;Repr. 2,Notified C&L,52.0,H351:50;H315:49;H319:49;H335:48;H361:43;H302:1;H332:1;H312:1
17064,2-methylquinolin-4-ol,210-140-6,607-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
17067,"Pyridine, alkyl derivs.;Crude Tar Bases;[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150°C (302°F) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.]",269-929-9,68391-11-7,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
17070,Thiophen-2-acetamide,224-714-9,4461-29-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H335:38;H318:38;H302:38;H315:38;H301:4
17071,4-(dimethylamino)benzonitrile,214-819-8,1197-19-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H302:42;H317:38;H315:43;H319:43;H335:42;H332:4;H312:4;H301:1
17074,"Benzamide, 2,5-dichloro-",611-892-1,5980-26-7,,Notified C&L,4.0,H335:4;H315:4;H319:4
17077,2-trifluoromethylphenothiazine,202-145-7,92-30-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,163.0,H302:163;H410:157;H400:1
17085,"Sodium hydrogen [R-[R*,S*-(Z)]]-7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate",279-694-4,81129-83-1,Eye Irrit. 2,Notified C&L,37.0,H319:37;H335:1;H315:1
17087,"Calcium, carbonate C8-10-branched fatty acids complexes",290-886-7,90268-81-8,Skin Irrit. 2,Notified C&L,75.0,H315:41;Not classified:34;H302:1;H319:1
17089,Calcium (S)-3-methyl-2-oxovalerate,257-458-1,51828-96-7,Not Classified,Notified C&L,1.0,Not classified:1
17092,5-bromo-2-methoxybenzyl alcohol,279-586-7,80866-82-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
17093,Dotriacontan-1-ene,242-315-8,18435-55-7,Not Classified,Notified C&L,11.0,Not classified:11
17100,"Oxirane, 2-ethyl-, homopolymer, ether with 1,4-butanediol (2:1), bis(2-oxiranylmethyl) ether, reaction products with 1,6-diisocyanatohexane",600-580-0,1045809-29-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H315:1;H316:1;H319:1;H335:1
17104,"Propane, 2-bromo-1-chloro-2-methyl-",606-619-8,2074-80-8,,Notified C&L,4.0,H335:4;H226:4;H315:4;H319:4
17105,[(2-methoxyphenyl)amino]methanesulphonic acid,202-220-4,93-13-0,Skin Sens. 1;Carc. 1B,REACH registration C&L,9.0,H317:1;H350:2;Not classified:7
17109,"N,N'-Bis[3-(diethylamino)propyl]-7,14-dioxo-5,7,12,14-tetrahydroquino[2,3-b]acridine-1,2-disulfonamide",605-531-7,168754-51-6,Skin Sens. 1,Notified C&L,227.0,H317:227;H413:51
17111,"1,1'-(dimethoxymethylene)bisbenzene",218-788-1,2235-01-0,Acute Tox. 4,Notified C&L,38.0,H302:38
17114,4-fluorostyrene,206-975-0,405-99-2,Flam. Liq. 3,Notified C&L,57.0,H226:57;H335:5;H315:5;H319:5
17115,"2,5-diphenylfuran",213-474-0,955-83-9,,Notified C&L,1.0,H335:1;H315:1;H319:1;H400:1
17116,"6,7-dimethoxyphthalide",209-311-8,569-31-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17117,Nitryl hexafluorophosphate,242-872-7,19200-21-6,Skin Corr. 1B,Notified C&L,43.0,H314:43;H318:1
17120,"magnesium powder (pyrophoric);magnesium, powder or turnings",231-104-6,7439-95-4,,,0.0,H260:0;H250:0
17124,"Hydrocarbon waxes (petroleum), chemically neutralized",265-134-6,64742-33-2,Not Classified,Notified C&L,6.0,Not classified:6
17128,Tetraethylurea,214-696-0,1187-03-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2
17130,Ferrocene,203-039-3,102-54-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,692.0,H360:27;H332:26;H410:26;H373:26;H412:10;H228:677;H302:678;H361:10;H411:183;H304:13;H225:13;H335:1;H319:1;Not classified:2
17131,"Parsley, ext.",281-677-1,84012-33-9,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1672.0,H304:1671;H410:1300;H317:1671;H226:1670;H400:1300;H315:324;H411:186;H412:1
17132,"Fatty acids, tall-oil, castor-oil alkyl esters",288-016-6,85631-66-9,Not Classified,Notified C&L,1.0,Not classified:1
17133,"1,2,3,3a,4,5,6,8a-octahydro-2-isopropylidene-4,8-dimethylazulen-6-ol",201-949-5,89-88-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1647.0,H317:1646;H315:1647;H319:1647;H411:1;H301:1;H314:1
17134,"1,3-Benzenediol, reaction products with 4-chloro-2,6-dimethylphenol",270-118-7,68411-35-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17135,"3,4,5,6-tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine hydrochloride",245-585-5,23327-57-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,53.0,H331:51;H301:53;H311:51
17140,Heptyl acetoacetate,255-906-0,42598-96-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17141,Di(carbazamidine) sulphate,213-628-7,996-19-0,Skin Sens. 1B;Repr. 1B;Aquatic Chronic 2,REACH registration C&L,4.0,H360:2;H317:2;H411:2;Not classified:2
17142,Triphenylmethanethiol,223-020-3,3695-77-0,Acute Tox. 4,Notified C&L,46.0,H332:41;H335:4;H315:5;H319:6;H302:1;H312:1
17146,1-[10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl]propan-1-one phosphate,238-856-4,14796-43-1,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,24.0,H331:24;H301:24;H411:24;H317:24
17147,"6-hydroxy-3,4-dihydroquinolin-2(1H)-one",611-111-4,54197-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43.0,H335:43;H315:43;H319:43;H302:1;H332:1;H312:1
17152,"9H-1,7a-(Epoxymethano)-1H,6aH-cyclopenta[c]furo[2,3-b]furo[3',2':3,4]cyclopenta[1,2-d]furan-5,9,12(4H)-trione,3-(1,1-dimethylethyl)hexahydro-4,7b-dihydroxy-8-methyl-, (1R,3S,3aS,4R,6aR,7aR,7bR,8S,10aS,11aS)",604-873-4,15291-75-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H335:3;H315:3;H319:3
17156,Acetylcysteine,210-498-3,616-91-1,Not Classified,REACH registration C&L,53.0,Not classified:26;H319:26;H335:16;H315:17;H318:1;H302:1;H332:1
17160,"Rosin, maleated, polymer with glycerol and pentaerythritol",614-319-3,68152-64-7,Not Classified,Notified C&L,6.0,Not classified:5;H317:1;H413:1;H319:1
17161,"Benzene, (1-methylethyl)-, distn. residues",273-050-6,68936-98-1,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,65.0,H317:65;H226:65;H319:65;H400:65
17165,"2,6-dibromopyridine",210-926-9,626-05-1,Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,56.0,H335:50;H315:56;H319:55;H300:54;H332:6;H412:6;H312:5;H302:1
17169,"1,1-dimethylcyclohexane",209-687-3,590-66-9,Flam. Liq. 2,Notified C&L,41.0,H225:41
17173,"[1,1'-Bicyclohexyl]-4-one, 4'-(4-methylphenyl)-, trans-",603-102-9,125962-80-3,Not Classified,Notified C&L,1.0,Not classified:1
17175,Methyl 2-(Bromomethyl)-3-nitrobenzoate,619-354-8,98475-07-1,Skin Corr. 1B;Muta. 1B;Carc. 1B;STOT RE 2,Notified C&L,2.0,H373:1;H340:1;H314:2;H350:1;H318:1;H290:1
17178,"4,4'-carbonimidoylbis[N,N-diethylaniline] monohydrochloride",228-770-5,6358-36-7,Acute Tox. 3;Skin Corr. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,566.0,H301:12;H410:10;H314:12;H319:6;H400:10;H411:556;H318:559
17179,Triethylmethylammonium bromide,220-282-0,2700-16-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17181,2-ethylbutyl acetate,233-095-4,10031-87-5,Flam. Liq. 3,Notified C&L,46.0,H226:46
17182,disodium sulfide,215-211-5,1313-82-2,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Harmonised C&L,0.0,H302:0;H314:0;H311:0;H400:0
17187,Methyl 4-(bromomethyl)-3-methoxybenzoate,615-092-3,70264-94-7,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40.0,H318:38;H410:38;H317:38;H315:40;H400:38;H302:1;H332:1;H312:1;H319:2;H335:2
17190,"Amylase, iso-",232-956-1,9067-73-6,Resp. Sens. 1,Notified C&L,43.0,H334:43
17192,"Benzenesulfonic acid, 4-[[4-[2-(4-hydroxy-2-methylphenyl)diazenyl]phenyl]amino]-3-nitro-, sodium salt (1:1)",612-742-8,61931-26-8,,Notified C&L,1.0,H315:1;H412:1
17195,2-ethoxymethylpyrazine,265-794-5,65504-94-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;Not classified:1
17205,"5,7-dimethoxy-2-benzopyrone",207-646-4,487-06-9,Skin Sens. 1,Notified C&L,40.0,H317:38;Not classified:2
17209,"Guava, Psidium guajava pyrifera, ext.",289-907-2,90045-46-8,Not Classified,Notified C&L,9.0,Not classified:9
17210,3-[bis(2-hydroxyethyl)amino]-2-hydroxypropanesulphonic acid,269-992-2,68399-80-4,Not Classified,Notified C&L,3.0,Not classified:2;H335:1;H315:1;H319:1
17214,N-phenyl-4-(phenylazo)aniline,202-972-3,101-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H335:44;H315:45;H319:45;Not classified:5;H302:6;H317:1;H332:1;H312:1
17216,(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone,226-907-3,5543-57-7,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Chronic 2;Repr. 1A,Harmonised C&L,0.0,H411:0;H360:0;H330:0;H300:0;H372:0;H310:0
17222,"Bis(glycinato-N,O)magnesium",238-852-2,14783-68-7,Not Classified,Notified C&L,1.0,Not classified:1
17223,Citronellyl formate,203-338-9,105-85-1,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,1668.0,H317:1334;H315:1348;Not classified:296;H335:38;H319:38
17224,Sodium hydrogen 5(or 6)-carboxylato-4-hexylcyclohex-2-ene-1-octanoate,268-573-1,68127-35-5,Not Classified,Notified C&L,2.0,Not classified:2
17225,"Adansonia digitata, ext.",294-680-8,91745-12-9,Not Classified,Notified C&L,2.0,Not classified:2
17226,"D-pentose and D-glucose, oligomeric, C12 and C14 alkyl glycosides",483-990-0,,Eye Irrit. 2,REACH registration C&L,2.0,H319:2
17227,Tetrapropylammonium tetrafluoroborate,206-416-0,338-38-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17228,"1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalene",229-723-1,6683-46-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1.0,H332:1;H315:1;H312:1;H319:1;H335:1
17230,(S)-(-)-1-Benzyl-3-pyrrolidinol,600-202-4,101385-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:41;H315:46;H319:46;H302:1;H332:1;H312:1
17235,"Hydrogen 9-amino-7-phenyl-5-(phenylamino)-4,10-disulphonatobenzo[a]phenazinium, disodium salt",276-817-3,72749-80-5,Not Classified,REACH registration C&L,2047.0,Not classified:2047
17236,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with o-cresol and m-phenylenebis(methylamine)",500-651-5,161308-11-8,Not Classified,Notified C&L,22.0,Not classified:22
17238,Octacarbonyldicobalt,233-514-0,10210-68-1,Flam. Sol. 1;Self-heat. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1A;Carc. 1B;Repr. 2;Aquatic Chronic 3,REACH registration C&L,48.0,H302:48;H334:2;H330:46;H351:48;H350:2;H317:48;H412:10;H228:9;H312:2;H319:3;H315:3;H251:40;H361:8;H413:38;H252:5;H335:1;H301:1
17239,"2,4-dimethylbenzonitrile",244-580-5,21789-36-6,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40.0,H335:39;H318:38;H315:40;H302:1;H332:1;H312:1;H319:2
17245,"N,N,N-trimethyl-1-adamantanaminium sulfate (2:1)",600-024-7,1000777-61-6,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,85.0,H302:85;H412:85;H361:83
17247,Copper hydroxide nitrate,439-590-3,12158-75-7,Ox. Sol. 2;Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,13.0,H318:13;H272:13;H410:13;H302:13;H400:13
17248,"Oxirane,hexyl-,(R)-",616-463-2,77495-66-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H226:38;H315:38;H319:38
17249,2-chloroethyl(methyl)ammonium chloride,224-882-3,4535-90-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17253,CEDARWOOD OIL HIMALAYAN,616-769-6,8000-27-9,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,299.0,H304:250;H410:136;H400:134;H411:113;H315:50;H317:8;Not classified:7;H373:1
17254,1-(4-Aminophenyl)-4-(4-methoxyphenyl)piperazine,616-146-9,74852-62-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;H332:1;H302:1;H312:1
17255,"5-amino-3-[[4-[[4-[[4-anilino-2-hydroxyphenyl]azo]phenyl]amino]-3-sulphophenyl]azo]-4-hydroxynaphthalene-2,7-disulphonic acid, sodium salt",286-386-3,85223-31-0,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,86.0,H412:85;H319:2;Not classified:1
17256,Trichlorohexylsilane,213-178-1,928-65-4,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,65.0,H331:38;H301:38;H314:65;H311:38;H318:5;H226:1;H290:1
17260,"2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[4-[[[4-[2-(2,4-diaminophenyl)diazenyl]phenyl]amino]sulfonyl]phenyl]diazenyl]-5-hydroxy-3-[2-(4-nitrophenyl)diazenyl]-, lithium salt (1:2)",619-161-9,95713-95-4,Not Classified,Notified C&L,83.0,Not classified:83
17263,"Diethyl [(α,α,α-trifluoro-m-toluidino)methylene]malonate",206-726-6,370-35-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
17270,ethyl 2-(4-hydroxyphenoxy)propanoate,615-275-8,71301-98-9,Not Classified,Notified C&L,1.0,Not classified:1
17272,"menadione nicotinamide bisulfite;1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)",277-543-7,73581-79-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H315:0;H319:0;H400:0
17278,"Oils, palm kernel, Me esters, glycerol-free",309-454-7,100299-00-1,Not Classified,Notified C&L,1.0,Not classified:1
17280,Sodium 4-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzenesulphonate,221-663-4,3179-84-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17282,O-methyl O-(4-methyl-2-nitrophenyl) isopropylthiophosphoramidate,252-829-4,36001-88-4,Acute Tox. 4,Notified C&L,40.0,H302:40
17288,"(R,S)-N-acetyl-(3,4-dimethoxyphenyl)-alanine, monohydrate",608-083-0,27313-65-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
17291,4-fluorophenyl isothiocyanate,216-280-4,1544-68-9,Skin Corr. 1B;Skin Sens. 1;Resp. Sens. 1,Notified C&L,45.0,H317:39;H334:39;H314:44;H332:4;H302:4;H312:4;H301:2;H311:1;H331:2;H319:1;H335:1;H315:1;H318:1
17295,"Amines, coco alkyl, acetates",263-147-1,61790-57-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,119.0,H302:68;H314:69;H400:68;H318:37;H315:50;H412:18;H319:18
17298,"Trisodium [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)][2-hydroxy-3-[(2-hydroxy-1-naphthyl)azo]-5-nitrobenzenesulphonato(3-)]chromate(3-)",274-230-7,69943-66-4,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,52.0,H317:5;H319:51;H412:6;H411:34;Not classified:1
17300,3-hydroxyphenethyl alcohol,236-485-2,13398-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17301,Propyl chloroacetate,226-411-7,5396-24-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H302:38;H315:38
17302,Isopentyl 2-methylcrotonate,255-423-5,41519-18-0,Not Classified,Notified C&L,88.0,Not classified:88
17304,Hexyl propionate,219-495-1,2445-76-3,Not Classified,REACH registration C&L,296.0,Not classified:296
17308,4-hexylbenzoic acid,244-490-6,21643-38-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17311,"phenol, (tetrapropenyl) derivatives",616-100-8,74499-35-7,Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H318:0;H410:0;H314:0;H400:0
17312,"(-)-1,2-Propanediol",610-038-5,4254-14-2,Eye Irrit. 2,Notified C&L,5.0,H319:3;Not classified:2
17313,"Wastes, lead battery reprocessing",305-445-7,94551-99-2,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14.0,H360:14;H332:14;H410:14;H351:13;H317:14;H372:13;H319:13;H302:14;H400:13;H350:1;H373:1
17316,reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene),406-325-8,,Acute Tox. 4;Aquatic Chronic 3,Harmonised C&L,0.0,H302:0;H412:0
17317,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-[2-[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-8-[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-",605-814-5,177964-38-4,Not Classified,Notified C&L,2.0,Not classified:2
17318,"Fatty acids, C18-unsatd., C16-18 and C18-unsatd. alkyl esters",294-311-0,91697-49-3,Not Classified,Notified C&L,56.0,Not classified:56
17320,"2-bromo-1,4-dichlorobenzene",215-859-9,1435-50-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H302:1;H332:1;H312:1
17323,Isonicotinaldehyde (4-pyridylmethylene)hydrazone,230-145-7,6957-22-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17326,"Disodium 4-[[2,4-dihydroxy-3-[(4-sulphonatophenyl)azo]phenyl]azo]naphthalene-1-sulphonate",227-446-0,5850-15-7,Eye Irrit. 2,Notified C&L,4.0,H319:3;Not classified:1;H332:1;H315:1
17330,"amporphous glass fibre formed from the melting and fiberisation of predominately slilcon dioxide, calcium oxide, magnesium oxide",610-130-5,436083-99-7,Not Classified,REACH registration C&L,33.0,Not classified:33;H351:1
17332,2-[(3-aminopropyl)amino]ethanol,224-718-0,4461-39-6,Skin Corr. 1B,Notified C&L,39.0,H314:39;H335:1
17334,"Aspartic acid, N,N'-(methylenedi-4,1-cyclohexanediyl)bis-, 1,1',4,4'-tetraethyl ester",603-946-8,136210-30-5,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,111.0,H317:111;H412:111
17336,DL-serine,206-130-6,302-84-1,Not Classified,REACH registration C&L,150.0,Not classified:150
17339,3-methoxy-4-methylaniline,240-500-8,16452-01-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H302:43;H315:39;H312:43;H319:39;H335:39;H341:5;H332:5
17340,1-ethyl-4-[(1-ethyl-4(1H)-quinolylidene)methyl]quinolinium iodide,225-223-2,4727-49-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38.0,H301:38;H311:38;H331:38;H319:38;H335:38;H315:38
17341,4-Fluorobenzohydrazide Hydrate,610-264-4,456-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
17342,"N,N'-[(methylimino)bis(trimethylene)]bis(stearamide)",236-793-7,13483-58-4,Not Classified,REACH registration C&L,4.0,Not classified:4
17344,"2-(2,7-dimethyl-5H-thiazolo[3',2':1,2]pyrimido[4,5-d]pyrimidin-8-yl)ethanol",202-149-9,92-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17347,Magnesium oxalate,208-932-1,547-66-0,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,9.0,H302:9;H312:9
17348,Ethyl [10-(3-chloropropanoyl)-10H-phenothiazin-2-yl]carbamate,609-026-2,34749-22-9,Skin Corr. 1B;Aquatic Chronic 4,REACH registration C&L,2.0,H313:2;H413:2;H314:2
17350,"(2,3-dihydroxypropyl)trimethylammonium chloride",251-783-2,34004-36-9,Not Classified,Notified C&L,150.0,Not classified:107;H315:43;H319:42;H301:20;H335:1;H318:1
17351,"2,6-dichlorophenylacetic acid",229-504-0,6575-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56.0,H335:55;H315:56;H319:56
17353,(carboxymethyl)dimethyl-3-[(1-oxooctadecyl)amino]propylammonium hydroxide,228-227-2,6179-44-8,Not Classified,Notified C&L,38.0,Not classified:31;H319:7
17354,sec-butylmagnesium chloride,239-403-3,15366-08-2,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,75.0,H314:75;H318:1;H225:26;H260:75;H250:48;H261:10
17356,"5-chloro-3-phenyl-2,1-benzisoxazole",211-950-2,719-64-2,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,43.0,H413:38;H302:38;H335:4;H315:5;H319:5
17358,"Cinnamomum burmanni, ext.",295-986-4,92201-56-4,Skin Irrit. 2;Skin Sens. 1;Carc. 1A,Notified C&L,75.0,H317:75;H315:75;H350:50;H312:50
17366,"4-(ethoxycarbonyl)-1,3-thiazolidin-3-ium chloride",613-908-2,66223-38-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H302:2;H315:2;H319:2
17367,Acemetacin,258-403-4,53164-05-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 1,Notified C&L,64.0,H330:38;H310:38;H300:64;H411:1;H336:1;H370:1;H372:1;H361:1
17371,"Fatty acids, tallow, hydrogenated, reaction products with diethylenetriamine, formaldehyde and urea",600-377-7,102979-89-5,Not Classified,Notified C&L,1.0,Not classified:1
17377,2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]ethyl benzoate hydrochloride,245-801-8,23642-66-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:1;H319:1;H301:1
17379,Potassium ethyl octylphosphonate,268-740-9,68134-28-1,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,77.0,H318:76;H315:76;H412:44;H411:32;H373:32;Not classified:1
17382,7-(trifluorophenyl)quinolin-4-ol,206-298-0,322-97-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
17383,"4,4'-diaminostilbene-2,2'-disulphonic acid",201-325-2,81-11-8,Aquatic Chronic 3,REACH registration C&L,218.0,H412:167;H302:38;H335:8;H315:9;H319:10;Not classified:2;H314:1
17384,"Fatty acids, C12-18, Me esters, sulfonated, sodium salts",604-693-6,149458-07-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,23.0,H302:21;H412:21;H400:20;H315:2;H319:1;Not classified:1;H318:1
17386,Octadecyl acrylate,225-383-3,4813-57-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,353.0,H411:316;H317:169;H315:318;H319:318;H335:316;Not classified:35
17389,Nonanoyl chloride,212-131-2,764-85-2,Skin Corr. 1B,Notified C&L,48.0,H314:48;H302:5;H335:5;H318:1;H290:2
17394,"2',3,4,5-Tetrafluor-4'''-propyl-1,1':4',1'':4'',1'''-quaterphenyl",617-983-2,872052-57-8,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
17397,2-(2-hydroxyethoxy)ethyl laurate,205-468-1,141-20-8,Not Classified,Notified C&L,16.0,Not classified:16
17400,"Carbonic acid, zinc salt, basic",257-467-0,51839-25-9,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,56.0,H411:23;H400:56
17402,"3,5-dichloroaniline",210-948-9,626-43-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,143.0,H301:142;H410:140;H373:140;H311:142;H331:142;H400:138;H411:1;H371:1;Not classified:2
17405,"Oils, citronella, reduced",614-785-8,68916-56-3,Not Classified,Notified C&L,36.0,Not classified:36
17406,Diphenyl p-tolyl phosphate,201-104-0,78-31-9,,Notified C&L,33.0,Not classified:33
17408,2-bromo-5-nitroanisole,278-669-5,77337-82-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H302:38;H315:46;H319:46
17409,N-(phenylsulphonyl)benzenesulphonamide,220-051-4,2618-96-4,Not Classified,REACH registration C&L,6.0,Not classified:3;H335:3;H315:3;H319:3;H302:1
17410,"2,2,4,4-tetramethylpentan-3-one",212-419-8,815-24-7,Flam. Liq. 3,Notified C&L,44.0,H226:44;H335:1;H315:1;H319:1
17411,Benzyl 2-ethylhexyl adipate,261-234-9,58394-64-2,,Notified C&L,33.0,Not classified:33
17413,"α-(2,4-dichlorophenyl)-1H-imidazole-1-ethanol",246-042-5,24155-42-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,118.0,H411:10;H319:22;H400:9;H302:108;H332:10;H371:9;H312:10;H335:9;H315:10;H361:1;H373:1
17414,"Toluene-2,4-disulphonic acid",204-446-9,121-04-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17418,2-(6-methoxy-2-naphthyl)propionic acid,245-969-2,23981-80-8,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H301:1;H315:2;H319:2;H371:1;H302:1
17420,"3,3'-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]imino]bispropiononitrile",267-758-4,67923-43-7,Skin Sens. 1B,REACH registration C&L,15.0,H317:10;Not classified:5
17423,Diethylammonium salicylate,224-586-4,4419-92-5,,Notified C&L,2.0,H335:1;H315:1;H319:2;H332:1;H302:1
17424,tributyl phosphate,204-800-2,126-73-8,Acute Tox. 4;Skin Irrit. 2;Carc. 2,Harmonised C&L,0.0,H302:0;H315:0;H351:0
17425,"Montmorillonite, calcined",274-991-5,70892-59-0,Not Classified,Notified C&L,2.0,Not classified:2
17426,"Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, sulfonated, sodium salts",614-896-1,69011-22-9,Not Classified,Notified C&L,132.0,Not classified:90;H335:39;H315:39;H319:41;H228:2;H318:1
17427,2-hydroxypropyl heptanoate,230-658-6,7249-54-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17435,(chloromethyl)ethoxydimethylsilane,236-835-4,13508-53-7,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H318:38;H332:38;H315:38;H226:38;H335:38;H302:38
17437,"Beet, red, ext.",289-611-3,89957-90-4,Not Classified,Notified C&L,25.0,Not classified:25
17440,Methylammonium iodide,239-037-4,14965-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H302:40;H315:41;H319:41
17443,"6-amino-5-formamido-1,3-dimethyluracil",231-501-4,7597-60-6,Acute Tox. 4,Notified C&L,40.0,H302:39;Not classified:1
17450,"Fatty acids, C18-unsatd., dimers, bis(2-ethylhexyl) esters",614-470-5,68424-40-8,,Notified C&L,571.0,Not classified:446;H413:125
17459,Yttrium oxide,215-233-5,1314-36-9,Not Classified,REACH registration C&L,456.0,Not classified:197;H335:238;H315:238;H319:200;H413:20
17460,"(2,2-difluoro-1,3-dioxaindan-5-yl)boronic acid",606-223-5,190903-71-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
17461,Hetacillin,222-512-5,3511-16-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39.0,H317:39;H334:39
17469,4-methoxybutyric acid,249-366-5,29006-02-8,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H335:1;H318:1;H315:1
17471,Fluocinolone acetonide,200-668-5,67-73-2,Repr. 2,Notified C&L,97.0,H361:58;H335:39;H315:39;H319:40;H372:3;H362:2;H373:2;H341:1
17475,"Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with (6R)-1,6-dihydro-N,N,6-trimethyl-1,3,5-triazine-2,4-diamine",616-469-5,775351-66-1,Not Classified,Notified C&L,1.0,Not classified:1
17477,"ethanol, 2,2'-iminobis-, N-(C13-15-branched and linear alkyl) derivs.",308-208-6,97925-95-6,Repr. 1B,Harmonised C&L,0.0,H360:0
17479,3-hydroxy-4H-pyran-4-one,207-823-6,496-63-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17486,"1,1,3-trimethylcyclohexane",221-347-6,3073-66-3,Not Classified,Notified C&L,4.0,Not classified:3;H225:1
17487,Octamethyltrisiloxane,203-497-4,107-51-7,Flam. Liq. 3,REACH registration C&L,304.0,H226:205;Not classified:99;H410:38;H413:16;H304:1;H335:1;H315:1;H319:1
17488,"Oat, ext.",281-672-4,84012-26-0,Not Classified,Notified C&L,96.0,Not classified:69;H317:24;H226:3;H319:1
17491,Diiron trioxide hydrate,215-166-1,1309-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,73.0,H335:39;H315:39;H319:39;Not classified:34
17492,2-ethoxy-1-methyl-2-oxoethyl butyrate,275-793-1,71662-27-6,Not Classified,Notified C&L,89.0,Not classified:89
17494,(1-methoxy-1-methylethyl)benzene,213-306-6,935-67-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38
17495,Methyl dihydrogen phosphate,212-379-1,812-00-0,Skin Corr. 1,REACH registration C&L,55.0,H314:54;H315:1;H319:1
17496,"Hydrocarbons, C",297-466-2,93572-36-2,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H304:0;H350:0
17500,4-(methylthio)butyraldehyde,256-001-3,42919-64-2,Flam. Liq. 4;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,Notified C&L,1.0,H318:1;H302:1;H332:1;H412:1;H227:1;H312:1;H335:1;H315:1
17507,hexan-2-one;methyl butyl ketone;butyl methyl ketone;methyl-n-butyl ketone,209-731-1,591-78-6,Flam. Liq. 3;STOT SE 3;STOT RE 1;Repr. 2,Harmonised C&L,0.0,H372:0;H336:0;H226:0;H361:0
17508,"endothal-sodium (ISO);disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate",204-959-8,129-67-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H301:0;H315:0;H312:0;H319:0;H335:0
17510,"4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol; bisphenol AF",216-036-7,1478-61-1,Eye Dam. 1;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,211.0,H360:76;H318:76;H410:158;H373:76;H372:20;H335:61;H315:133;H319:135;H400:83
17512,"1,2-bis(2-Nitrophenoxy)ethane",610-713-4,51661-19-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,43.0,H335:42;H315:43;H319:43;H400:38
17513,Tetraglycerol,310-131-8,56491-53-3,Not Classified,Notified C&L,54.0,Not classified:54
17518,2-bromo-p-cresol,229-595-7,6627-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H315:47;H319:47;H302:5;H312:5;H332:1
17519,2-(Trifluoromethyl)-3-ethoxydodecafluorohexane,608-415-4,297730-93-9,Aquatic Chronic 4,Notified C&L,4.0,H413:3;H335:1;H315:1;H319:1
17521,Methyl heptadecanoate,217-055-3,1731-92-6,Not Classified,Notified C&L,6.0,Not classified:6
17522,[2-(hexahydro-(2H)-azocin-1-yl)ethyl]guanidinium sulphate,211-442-0,645-43-2,Acute Tox. 4,Notified C&L,38.0,H302:38
17526,demeton-S (ISO);diethyl-S-2-ethylthioethyl phosphorothioate,204-801-8,126-75-0,Acute Tox. 2;Acute Tox. 1,Harmonised C&L,0.0,H310:0;H300:0
17530,"1,3-dichloro-3-methylbutane",210-873-1,624-96-4,Acute Tox. 4,Notified C&L,38.0,H302:38
17531,C.I. Acid Brown 290,602-516-7,12234-74-1,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,84.0,H412:83;H319:83;Not classified:1
17534,"potassium 3,6-dichloro-o-anisate",233-002-7,10007-85-9,Eye Irrit. 2;Aquatic Chronic 3,Harmonised C&L,0.0,H412:0;H319:0
17538,N-propylaniline,210-754-4,622-80-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 1;STOT RE 1,Notified C&L,1.0,H302:1;H332:1;H370:1;H372:1;H312:1;H319:1;H315:1
17540,"1,3-Difluoro-5-[trans-4-(trans-4-ethylcyclohexyl)-cyclohexyl]-benzene",607-681-9,252852-44-1,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
17542,"2,6-dichlorobenzoic acid",200-025-9,50-30-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H335:49;H315:50;H319:50;H400:1
17543,"Sodium 2-heptyl-2,3-dihydro-3-(2-hydroxyethyl)-1H-imidazole-1-propionate",271-928-3,68630-95-5,Skin Irrit. 2,REACH registration C&L,2.0,H315:2
17546,C.I. Acid Brown 360,612-461-0,61814-55-9,Not Classified,Notified C&L,1.0,Not classified:1
17548,1-({2-[4-(bromodifluoromethoxy)phenyl]-2-methylpropoxy}methyl)-3-phenoxybenzene,601-128-5,111872-58-3,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,128.0,H301:128;H410:128;H400:128
17555,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3,8-bis[2-[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]diazenyl]-, sodium salt (1:5)",618-252-0,891857-92-4,Not Classified,Notified C&L,13.0,Not classified:13
17557,"Trisodium [μ-[7-[[4'-[[6-anilino-1-hydroxy-3-sulpho-2-naphthyl]azo]-3,3'-dihydroxy[1,1'-biphenyl]-4-yl]azo]-8-hydroxynaphthalene-1,6-disulphonato(7-)]]dicuprate(3-)",229-687-7,6656-03-7,Not Classified,Notified C&L,2.0,Not classified:2
17558,Denatonium benzoate,223-095-2,3734-33-6,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,2393.0,H318:768;H332:2025;H302:2277;H330:112;H412:2067;H315:288;Not classified:116;H335:81;H319:83;H331:10;H312:1;H317:1
17561,"Soybean oil, mixed with soybean oil Me esters, sulfated, sodium salts",272-863-3,68918-44-5,Not Classified,Notified C&L,1.0,Not classified:1
17562,"Extracts (petroleum), deasphalted vacuum residue solvent",295-332-8,91995-70-9,Carc. 2,REACH registration C&L,8.0,H351:4;Not classified:4
17566,"Calcium 4,5-dichloro-2-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sulphonatophenyl)-1H-pyrazol-4-yl]azo]benzenesulphonate",265-634-4,65212-77-3,Not Classified,REACH registration C&L,251.0,Not classified:250;H412:1
17567,"2,2-dimethylsuccinic acid",209-899-6,597-43-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
17569,Zinc dioleate,209-154-5,557-07-3,Not Classified,Notified C&L,59.0,Not classified:58;H332:1;H302:1
17570,"Sodium 1,2-bis(tridecyloxycarbonyl)ethanesulphonate",220-219-7,2673-22-5,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,209.0,H411:118;H315:204;H319:167;H318:37;Not classified:5
17572,"2,2'-[[2-(oxiranylmethoxy)-1,3-phenylene]bis(methylene)]bisoxirane",236-951-5,13561-08-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2,Notified C&L,13.0,H341:13;H317:13;H315:13;H319:13
17573,Ferrous Oxalate,611-981-5,6047-25-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,45.0,H302:45;H312:45
17577,"Benzaldehyde, 4-(2-methylpropyl)-",609-787-0,40150-98-9,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,10.0,H317:10;H302:10;H410:10;H400:10
17585,Ammonium hexadecyl sulphate,225-162-1,4696-47-3,Not Classified,Notified C&L,38.0,Not classified:38
17588,"Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C",285-555-9,85117-03-9,Carc. 1B,Harmonised C&L,0.0,H350:0
17590,Tetramanganese nitride,234-785-8,12033-07-7,Not Classified,Notified C&L,8.0,Not classified:8
17594,1-ethylquinolinium iodide,211-206-7,634-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B,Notified C&L,42.0,H335:42;H360:38;H315:42;H319:42
17595,"1H-Indole-2-carboxylic acid, 2,3 dihydro [S]",616-741-3,79815-20-6,Skin Sens. 1;Repr. 2;STOT RE 2,Notified C&L,46.0,H317:45;H361:45;H373:45;H335:1;H315:1;H319:1
17598,Diethylmethylamine,210-480-5,616-39-7,Flam. Liq. 2;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 4,Notified C&L,45.0,H332:44;H301:40;H314:44;H225:43;H318:4;H302:4;H312:1;H311:1;H335:1;H330:1;H224:1;H300:1
17600,2-(Chloromethyl)-1-methyl-5-(methylsulfonyl)-1-H-benzimidazole,616-156-3,74878-53-8,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,31.0,H317:31;H318:31;H412:31
17602,N-propylethylenediamine,203-864-9,111-39-7,Flam. Liq. 3;Skin Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H226:42;H315:38;H314:4;H318:1
17603,tris(isopropenyloxy)phenyl silane,411-340-8,52301-18-5,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
17604,"2-hydroxy-1,3-propanediyl bismethacrylate",217-388-4,1830-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,62.0,H335:55;H315:56;H319:56;Not classified:6;H317:2
17612,(2-ethylhexanoato)phenylmercury,236-326-7,13302-00-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,1.0,H410:1;H330:1;H373:1;H300:1;H310:1;H400:1
17613,1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol,256-458-9,49744-28-7,Skin Sens. 1,REACH registration C&L,42.0,H317:2;Not classified:40
17615,Sodium N-(cyanomethyl)naphthalene-2-sulphonamidate,279-582-5,80866-78-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,38.0,H331:38;H301:38;H311:38
17616,"Formaldehyde, oligomeric reaction products with aniline, reaction products with butan-1-ol and 1-chloro-2,3-epoxypropane",500-725-7,162491-92-1,,Notified C&L,1.0,Not classified:1
17617,3-acetamidophthalic acid,239-404-9,15371-06-9,Skin Sens. 1;Muta. 2;Carc. 2;Repr. 2;Aquatic Chronic 4,Notified C&L,1.0,H351:1;H317:1;H413:1;H341:1;H361:1
17618,"(R*,S*)-(±)-α-[1-(methylamino)ethyl]benzyl alcohol hydrochloride",205-153-9,134-71-4,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,124.0,H317:84;H302:124;H412:83;H335:1;H315:1;H319:1
17621,p-methoxypropiophenone,204-512-7,121-97-1,Flam. Sol. 2,Notified C&L,2.0,H228:1;H302:1;H332:1;H315:1;H319:1;H335:1
17622,Diethyl (cyanomethyl)phosphonate,219-806-0,2537-48-6,Skin Irrit. 2,Notified C&L,64.0,H315:46;H302:22;H332:4;H312:6;H319:7;H290:2;H314:3;H301:1;H311:1;H331:4;H318:1
17623,"Polyphosphoric acids, esters with triethanolamine",268-624-8,68131-71-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,6.0,H318:4;H314:6;H302:1;H290:1
17629,2 palmitoyloxymethyl-5-palmitoyloxy-gamma-pyrone,616-725-6,79725-98-7,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,4.0,H332:3;H302:3;H315:3;Not classified:1
17632,"2',7'-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester",601-479-4,117464-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
17640,Elastase,232-670-7,9004-06-2,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,39.0,H335:39;H334:39;H315:39;H319:39
17646,"1,2-dichloro-4-fluorobenzene",215-858-3,1435-49-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H302:38;H315:44;H319:44
17650,"Butanoic acid, 3-oxo-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester",611-852-3,59557-05-0,Not Classified,Notified C&L,88.0,Not classified:88
17651,Manganese hydroxide oxide,234-707-2,12025-99-9,Not Classified,Notified C&L,1.0,Not classified:1
17657,1-ethyl-4-[3-(1-ethyl-4(1H)-quinolylidene)prop-1-enyl]quinolinium iodide,225-224-8,4727-50-8,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;H300:39
17658,4-chloro-3-hydroxybutyronitrile,203-287-2,105-33-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,55.0,H301:55;H317:55;H370:55;H311:55;H331:55;H319:55;H335:55;H315:55
17663,4-bromobenzylamine hydrochloride,247-503-3,26177-44-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,56.0,H335:55;H315:56;H319:56
17670,Disodium hexabromoplatinate,254-398-8,39277-13-9,,Notified C&L,5.0,H334:5;H317:5;H315:5;H319:5;H335:5
17672,Sodium 4-aminosalicylate,205-091-2,133-10-8,Not Classified,Notified C&L,11.0,Not classified:9;H335:4;H315:5;H319:5
17674,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with(chloromethyl)oxirane, 1,3-isobenzofurandione, 4,4'-(1-methylethylidene)bis[phenol] and 2-oxepanone",604-886-5,153128-88-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H315:1;H319:1
17675,"Benzene, 1-ethoxy-2,3-difluoro-4-(trans-4-propylcyclohexyl)-",606-627-1,207598-88-7,Not Classified,Notified C&L,1.0,Not classified:1
17677,(R)-(3-carboxy-2-hydroxypropyl)trimethylammonium chloride,229-663-6,6645-46-1,Not Classified,REACH registration C&L,55.0,Not classified:3;H335:51;H315:52;H319:52
17678,2-bromo-1-(4-hydroxyphenyl)ethan-1-one,219-655-0,2491-38-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,42.0,H302:40;H319:39;H314:3;H318:1;H290:1
17684,L-tryptophan monohydrochloride,228-179-2,6159-33-7,Not Classified,Notified C&L,1.0,Not classified:1
17686,"1,1'-[ethane-1,2-diylbis(sulphonyl)]bisbenzene",209-979-0,599-94-0,Eye Irrit. 2,Notified C&L,38.0,H319:38
17688,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valine,272-515-0,68858-20-8,Not Classified,Notified C&L,8.0,Not classified:5;H332:2;H302:2;H312:2;H335:1;H315:1;H319:1
17689,Piperidine-4-propanol,230-318-7,7037-49-2,Not Classified,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
17690,Phytosteryl Macadamiate,463-270-2,,Aquatic Chronic 4,REACH registration C&L,1.0,H413:1
17693,"Reaction mass of 3,7-Dimethyl-1,5-octadien-3-ol-7-hydroperoxid and 3,7-Dimethyl-1,7-octadien-3-ol-6-hydroperoxid",918-860-9,,Flam. Liq. 2;Org. Perox. B;Eye Irrit. 2,REACH registration C&L,2.0,H241:2;H225:2;H319:2
17696,"Glutens, enzyme-modified",615-058-8,70084-87-6,Not Classified,Notified C&L,1.0,Not classified:1
17698,"3-(4-aminophenyl)-1,2,4-oxadiazol-5(2H)-one",917-912-8,864680-71-7,Aquatic Chronic 2,REACH registration C&L,3.0,H411:3
17699,8-hydroxyquinoline-5-sulphonic acid,201-570-5,84-88-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:38;H315:38;H319:40;H302:1;H341:1;H318:1;H314:1
17702,5-[[4-(dimethylamino)phenyl]methylene]barbituric acid,217-140-5,1753-47-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
17705,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononan-1-ol",206-806-0,376-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17706,"Decanoic acid, ester with 1,2,3-propanetriol octanoate",265-724-3,65381-09-1,Not Classified,Notified C&L,265.0,Not classified:256;H412:9
17709,7-hydroxy-4-benzopyrone,261-973-7,59887-89-7,Acute Tox. 4,Notified C&L,38.0,H302:38
17714,"[3-methyl-5-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4-pentadienyl]triphenylphosphonium sulphate",212-028-2,751-83-7,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,84.0,H318:84;H302:84;H314:84;H410:84;H400:83
17717,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl derivs., chlorides, sodium salts",263-057-2,61789-39-7,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,22.0,H412:22;H319:22
17719,Isopropyl acetoacetate,208-798-4,542-08-5,Eye Irrit. 2,REACH registration C&L,95.0,H319:26;H315:46;Not classified:31;H335:7
17721,Cyclohexanediacetic acid,224-427-9,4355-11-7,Not Classified,REACH registration C&L,47.0,Not classified:2;H335:44;H315:45;H319:45
17724,p-menth-1-en-8-ol,202-680-6,98-55-5,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2240.0,H315:2232;H319:2216;H335:93;Not classified:8;H411:1;H412:1
17726,"2-hydroxy-3-[(2-hydroxy-1,1-dimethylethyl)amino]propanesulphonic acid",269-991-7,68399-79-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H335:1;H315:2;H319:2;H301:1;H332:1;H311:1;Not classified:1
17732,3-aminobenzenethiol,245-344-4,22948-02-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,45.0,H314:45;H332:39;H302:44;H312:39;H318:1
17733,N-1-methylheptyl-N'-phenyl-p-phenylenediamine,239-281-1,15233-47-3,Acute Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45.0,H317:44;H400:36;H410:41;H300:34;H302:4;H332:1;H312:1;H319:1;H315:1
17736,"Arabinofuranosidase, α-l-",232-957-7,9067-74-7,Resp. Sens. 1,REACH registration C&L,10.0,H334:10
17741,Sodium perfluorovalerate,220-299-3,2706-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17742,"5,5'-(1H-isoindole-1,3(2H)-diylidene)dibarbituric acid",253-256-2,36888-99-0,Not Classified,REACH registration C&L,435.0,Not classified:432;H314:2;H319:1
17743,"5,8-dihydroxy-1,4-naphthoquinone",207-495-4,475-38-7,,Notified C&L,6.0,H335:5;H315:6;H319:6;H302:2;H332:2;H312:2
17746,"N,N-dipropylaniline",218-705-9,2217-07-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17753,(iodomethyl)trimethylsilane,224-123-6,4206-67-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H226:43;H315:42;H319:42;H318:1;H314:1
17757,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl derivs., hydroxides, inner salts",263-058-8,61789-40-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1744.0,H317:7;H315:1246;H319:1448;H412:73;H400:526;H318:240;H335:38;Not classified:53;H302:31;H312:23;H411:8;H314:2;H300:1
17760,"tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-)",201-103-5,78-30-8,STOT SE 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H370:0
17761,Disodium 4-[2-[(1-oxooctadecadienyl)amino]ethyl] 2-sulphonatosuccinate,265-795-0,65504-99-6,Not Classified,Notified C&L,1.0,Not classified:1
17763,5-chloro-2-(trifluoromethyl)aniline,207-153-4,445-14-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
17767,"N2-[(1,1-dimethylethoxy)carbonyl]-L-lysine",237-303-4,13734-28-6,Not Classified,Notified C&L,3.0,Not classified:2;H335:1;H315:1;H319:1
17769,Pentyl isobutyrate,219-494-6,2445-72-9,Not Classified,Notified C&L,140.0,Not classified:135;H226:5
17770,"Fatty acids, tall-oil, compds. with N-tallow alkyltrimethylenediamines",263-146-6,61790-55-4,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,20.0,H318:18;H302:19;H315:18;H400:19;H314:1;Not classified:1
17776,"3',4',5'-trimethoxyacetophenone",214-501-9,1136-86-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
17780,Trisodium 2-phosphonatoacrylate,226-906-8,5541-93-5,Skin Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38
17783,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-tryptophan,252-706-5,35737-15-6,Not Classified,Notified C&L,1.0,Not classified:1
17788,"Ajowan, ext.",294-681-3,91745-13-0,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1350.0,H411:1349;H304:1323;H314:1323;H317:1322;H302:1323;H226:35;H318:2;Not classified:1;H335:1
17789,"Naphthalenedisulfonic acid, diisononyl-, compd. with 1,1'-iminobis[2-propanol] (1:2)",613-249-0,63568-35-4,,Notified C&L,1.0,Not classified:1
17791,Triethyl arsenate,605-040-8,15606-95-8,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,60.0,H301:60;H410:60;H350:60;H331:60;H400:60
17794,"Fatty acids, C8-10-branched, zirconium salts, basic",294-312-6,91697-50-6,Skin Irrit. 2,Notified C&L,1.0,H315:1
17796,"(ethyl 3-oxobutyrato-O1',O3)bis(propan-2-olato)aluminium",238-851-7,14782-75-3,Not Classified,REACH registration C&L,60.0,Not classified:23;H226:37;H315:5;H319:5;H335:1
17798,Chymopapain,232-580-8,9001-09-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,38.0,H334:38;H317:38;H315:38;H319:38;H335:38
17802,1-(10H-phenothiazin-2-yl)propan-1-one,202-148-3,92-33-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5.0,H335:4;H302:2;H315:3;H319:4;Not classified:1
17804,"Melissa officinalis, ext.",282-007-0,84082-61-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,387.0,H317:380;H318:296;H315:381;H412:186;H319:62;Not classified:5;H304:7;H411:4;H410:1;H226:4;H335:1;H413:1;H302:1
17805,N-methylhexylamine,252-410-6,35161-70-7,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,39.0,H226:39;H302:39;H314:39
17807,"2-(bromomethyl)-2-methylpropane-1,3-diol",218-636-4,2210-03-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17808,"N-(2,2-diethoxyethyl)pyridine-2-methylamine",230-144-1,6957-15-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
17812,Butylcyclopentane,218-040-4,2040-95-1,Flam. Liq. 3,Notified C&L,38.0,H226:38
17815,2-methylhexanoic acid,224-883-9,4536-23-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1923.0,H315:1728;H319:1287;H318:503;H314:190;Not classified:5;H290:1;H335:1
17817,"Disodium 3,3'-[iminobis(4,1-phenyleneazo)]bis[5-(benzoylamino)-4-hydroxynaphthalene-2,7-disulphonate]",286-385-8,85223-30-9,Not Classified,Notified C&L,83.0,Not classified:83
17819,"Nitriles, palm-oil",275-058-5,70955-38-3,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1.0,H315:1;H410:1;H400:1
17820,3-[[4-(benzoylethylamino)-2-methylphenyl]azo]-4-hydroxynaphthalene-1-sulphonic acid,246-824-6,25317-22-0,Not Classified,Notified C&L,2.0,Not classified:2
17821,"Disodium 4,4'-[(2,4-dihydroxy-1,3-phenylene)bis(azo)]bisnaphthalene-1-sulphonate",227-447-6,5850-16-8,Not Classified,REACH registration C&L,54.0,Not classified:9;H317:40;H319:5;H315:1
17826,2-chlorobut-2-ene,224-719-6,4461-41-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H225:39;H319:39
17827,"Osmanthus fragrans, ext.",296-209-1,92347-21-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1380.0,H411:1374;H315:1319;H319:1375;H317:90;H412:6;H318:1;H225:1
17828,1-methyl-4-(methylamino)piperidine,277-542-1,73579-08-5,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,4.0,H226:3;H314:4;H318:2
17829,Pentifylline,213-842-0,1028-33-7,,Notified C&L,5.0,H302:4;H335:1;H315:1;H319:1
17830,"Poly(oxy-1,2-ethanediyl), α-[2,4,6-tris(1-phenylethyl)phenyl]-ω-hydroxy-",619-457-8,99734-09-5,Aquatic Chronic 3,Notified C&L,632.0,H412:437;H411:179;Not classified:15;H413:1;H319:1
17831,"Oleic acid, compound with morpholine (1:1)",214-139-1,1095-66-5,Not Classified,Notified C&L,171.0,Not classified:124;H315:47;H319:47
17838,Calcium peroxoborate,259-263-7,54630-47-6,Not Classified,Notified C&L,7.0,Not classified:7
17839,Osalmid,208-385-9,526-18-1,Acute Tox. 4,Notified C&L,40.0,H302:39;Not classified:1
17847,"1,3-Benzenediamine, 4-methyl-2,6-bis(methylthio)-",676-681-9,102093-68-5,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,39.0,H411:33;H317:34;H302:34;Not classified:5;H410:1;H400:1
17850,"1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalene",229-724-7,6683-48-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
17852,Potassium octanoate,212-130-7,764-71-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,128.0,H315:101;H319:101;H335:40;Not classified:27
17854,"N,N'-dimethyl-N-[2-(methylamino)ethyl]ethylenediamine",203-337-3,105-84-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H302:38;H315:38;H319:38;H318:1;H314:1
17855,"9,10-Anthracenedione, 1,4-diamino-, N,N'-mixed 2-ethylhexyl and Me and pentyl derivs.",616-101-3,74499-36-8,Not Classified,Notified C&L,42.0,Not classified:42
17859,"2-dodecenylsuccinic acid, ester with 2,2'-oxydiethanol (2:1)",268-574-7,68128-23-4,,Notified C&L,1.0,Not classified:1
17860,"Alcohols, C10-14",283-066-5,84539-75-3,Not Classified,Notified C&L,31.0,Not classified:31
17861,Tetradecyl acrylate,244-491-1,21643-42-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,144.0,H411:142;H317:89;H315:127;H319:127;H335:142;Not classified:1
17864,"Bis(pentane-2,4-dionato-O,O')beryllium",233-513-5,10210-64-7,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 1B;STOT RE 1;Aquatic Chronic 2,Notified C&L,42.0,H411:42;H301:42;H330:42;H350:42;H317:42;H372:42;H319:42;H335:42;H315:42
17865,"cinerin I;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate",246-948-0,25402-06-6,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H400:0
17867,"Trans-2-Chloro-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthalenedione",604-936-6,153977-22-1,Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H317:1;H410:1;H319:1;H400:1;Not classified:1
17869,2-[1-(ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)]pyridinium phosphate,244-756-1,22059-60-5,Acute Tox. 4,Notified C&L,41.0,H302:41;H332:1;H312:1;H361:1
17872,"Fatty acids, coco, esters with sorbitan, ethoxylated",614-338-7,68154-33-6,Not Classified,Notified C&L,11.0,Not classified:11
17873,"p,α-dimethylbenzyl alcohol",208-637-8,536-50-5,Not Classified,Notified C&L,88.0,Not classified:88
17878,"β-d-Glucopyranose, 6-(dihydrogen phosphate), monosodium salt",282-721-2,84332-92-3,Not Classified,Notified C&L,3.0,Not classified:3
17879,"1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione",423-400-0,59653-74-6,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Acute Tox. 3;Muta. 1B;STOT RE 2,Harmonised C&L,0.0,H318:0;H373:0;H317:0;H331:0;H340:0;H302:0
17880,"Oils, Calophyllum inophyllum",607-323-1,241148-25-4,Not Classified,Notified C&L,23.0,Not classified:23
17881,"2-Fluoro-4,5-dimethoxybenzonitrile",601-606-3,119396-88-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H301:1;H315:1;H319:1
17884,"1,3,5-tri(tert-butyl)-2-nitrobenzene",223-789-5,4074-25-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
17885,"Disodium 1-amino-4-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]-2-methyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",276-374-6,72139-17-4,Resp. Sens. 1;Aquatic Chronic 1,REACH registration C&L,4.0,H334:4;H410:1;H317:3
17886,Alpha-methylene-γ-butyrolactone,208-931-6,547-65-9,Flam. Liq. 3;Skin Sens. 1,Notified C&L,40.0,H317:40;H226:40;H334:1;H319:1;H315:1;H412:1
17887,Resimal F-235,614-235-7,68038-41-5,Not Classified,Notified C&L,11.0,Not classified:6;H317:5;H319:5;H413:3
17891,"Copper, [29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32]-, [(2-hydroxyethyl)amino]sulfonyl derivs.",276-741-0,72623-97-3,Not Classified,Notified C&L,21.0,Not classified:21
17894,"Cedrus atlantica, ext.",295-985-9,92201-55-3,Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,1496.0,H411:1483;H317:32;H304:1486;H412:13;H401:1
17901,1-(2-chloroethyl)-4-methylpiperidinium chloride,260-405-5,56859-59-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
17902,"2,6-dimethylbenzonitrile",229-503-5,6575-13-9,,Notified C&L,5.0,H335:4;H302:5;H315:5;H319:5;H332:1;H312:1
17903,"Hexamethylene diisocyanate, trimers, reaction products with butanone oxime",500-727-8,162491-94-3,Not Classified,Notified C&L,36.0,Not classified:19;H317:17;H315:17;H373:1
17904,"tris(2-hydroxyethyl)ammonium 7-{}{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}}naphthalene-1,3-disulfonate",421-440-3,778583-04-3,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
17909,"1-(4-Aminobenzyl)-1,2,4-triazole",601-588-7,119192-10-8,Acute Tox. 4;Skin Sens. 1;STOT RE 1,Notified C&L,37.0,H372:35;H317:35;H302:36;H315:2;H319:2;H335:1
17911,"Fatty acids, C16-18, Me esters",287-824-6,85586-21-6,Not Classified,REACH registration C&L,93.0,Not classified:93
17918,"Beet, ext.",289-610-8,89957-89-1,Not Classified,Notified C&L,35.0,Not classified:35
17920,Bis(16-methylheptadecyl) malate,267-041-6,67763-18-2,Not Classified,REACH registration C&L,63.0,Not classified:63
17922,reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;N-(3-dimethylamino-2-methyl-phenyl)-benzamide;N-(3-dimethylamino-3-methyl-phenyl)-benzamide,420-600-1,,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H373:0
17923,Potassium cumenesulphonate,248-827-8,28085-69-0,Not Classified,Notified C&L,128.0,Not classified:49;H319:79;H335:39;H315:39
17924,(3-amino-3-carboxypropyl)dimethylsulphonium bromide,220-440-9,2766-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
17925,"(±)-3,7-dimethyloct-6-en-1-ol",247-737-6,26489-01-0,Skin Irrit. 2;Skin Sens. 1,Notified C&L,113.0,H317:113;H315:113;H319:18;H411:1
17934,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate, ethenylbenzene and N-(hydroxymethyl)-2-propenamide",610-706-6,51601-25-3,Not Classified,Notified C&L,37.0,Not classified:37
17935,Propanesulphonic acid,226-114-2,5284-66-2,Skin Corr. 1B,Notified C&L,40.0,H314:40;H318:1;H335:1
17938,"2,2-bis(hydroxymethyl)butyl oleate",225-384-9,4813-60-9,Not Classified,Notified C&L,5.0,Not classified:5
17941,2-fluoronaphthalene,206-299-6,323-09-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,42.0,H318:39;H302:39;Not classified:3
17946,"2,2'-iminodiethylamine;diethylenetriamine",203-865-4,111-40-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Harmonised C&L,0.0,H314:0;H302:0;H312:0;H317:0
17947,"Butane-2,3-diyl diacetate",214-219-6,1114-92-7,,Notified C&L,1.0,H335:1;H315:1;H319:1
17958,6-methyluracil,210-949-4,626-48-2,Repr. 2,Notified C&L,45.0,H361:45
17959,4-nitrotoluene-2-sulphonic acid,204-445-3,121-03-9,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,225.0,H317:184;H318:185;H302:184;H315:186;H314:37;H319:2;Not classified:2;H290:1
17966,"Melamine, reaction product with formaldehyde, methanol and diethylene glycol",925-933-9,,Not Classified,Notified C&L,31.0,Not classified:31
17967,Methylen Blue hydrate,602-909-3,122965-43-9,Acute Tox. 4,Notified C&L,48.0,H302:45;H315:1;H319:2;Not classified:1
17968,"Butanamide, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-, N,N'-bis(o-anisyl and 2,4-xylyl) derivs.",271-878-2,68610-86-6,Not Classified,Notified C&L,36.0,Not classified:36
17971,(R)-1-(4-bromophenyl)ethanamine hydrochloride,613-531-3,64265-77-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
17973,Z-77,482-260-9,,Not Classified,REACH registration C&L,443.0,Not classified:443
17979,16-methylheptadecanoic acid,220-336-3,2724-58-5,Not Classified,Notified C&L,11.0,Not classified:11
17984,"Fatty acids, tallow, hydrogenated, reaction products with diethylenetriamine and urea",600-376-1,102979-88-4,Not Classified,Notified C&L,1.0,Not classified:1
17985,Cyclobutylammonium chloride,228-540-4,6291-01-6,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,42.0,H314:38;H225:38;H335:4;H315:4;H319:4
17989,"1,1'-methylenebis[4-chlorobenzene]",202-973-9,101-76-8,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H302:38;H410:38;H400:38
17992,2-methyl-6-phenylpyridine,256-258-1,46181-30-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
17994,N-[2-[(2-hydroxyethyl)amino]ethyl]stearamide,205-469-7,141-21-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,10.0,H315:7;H319:7;Not classified:2;H360:1;H317:1
17995,POTASSIUM SUCCINATE,607-079-6,22445-04-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10.0,H335:10;H315:10;H319:10
17996,(Z)-hexadec-9-enal,260-064-2,56219-04-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,133.0,H335:127;H315:132;H319:127;H332:6;H400:5
17999,1-Fluor-3-(trans-4-propylcyclohexyl)-benzol,685-432-3,138679-81-9,Skin Irrit. 2;Aquatic Chronic 1,Notified C&L,1.0,H315:1;H410:1;Not classified:1
18001,6-nitroindazole,231-500-9,7597-18-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,45.0,H302:41;H332:41;H351:41;H312:41;H319:45;H335:44;H315:45;H341:4
18003,Diiron trioxide,215-168-2,1309-37-1,Not Classified,REACH registration C&L,3209.0,Not classified:1999;H319:625;H411:408;H335:268;H318:170;H315:350;H372:183;H370:72;H336:4;H332:3;H302:1;H373:2
18006,"Fatty acids, C16-18, reaction products with diethylenetriamine, acetates",282-956-0,84501-38-2,Not Classified,REACH registration C&L,14.0,Not classified:3;H315:11;H319:11
18008,"1-ethyl-2-(heptadecyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium ethyl sulphate",247-573-5,26266-76-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,19.0,H411:19;H318:19;H302:19;H315:19
18010,2-((3-(4-Hydroxyphenyl)propanoylamino)benzoic acid,470-130-4,,Not Classified,REACH registration C&L,1.0,Not classified:1
18011,"3,3-dimethylbutan-1-ol",210-872-6,624-95-3,Flam. Liq. 3,Notified C&L,133.0,H226:133
18013,1-(4-METHOXYPHENYL)-4-(4-NITROPHENYL)PIPERAZINE,616-145-3,74852-61-2,Not Classified,REACH registration C&L,1.0,Not classified:1
18014,"Triamcinolone 16-α,21-di(acetate)",200-669-0,67-78-7,Repr. 2,Notified C&L,4.0,H361:2;H360:2;H301:1;H332:1;H302:1;H312:1
18015,"monohydrochloride, (3S-(2(R*(R*)),3R*))-",601-514-3,118289-55-7,Aquatic Chronic 1,Notified C&L,29.0,H410:29
18016,"Disodium 2,2' - {4,4-(1,3-phenylenediamino) - 6,6'[bis(2-hydroxyethyl)amino] - di- 1,3,5-triazin-2,2' - diylamino}-diethanesulfonate",441-090-5,,Not Classified,REACH registration C&L,2.0,Not classified:2
18018,"Orthosiphon stamineus, ext.",281-674-5,84012-29-3,Flam. Liq. 3,Notified C&L,3.0,H226:2;Not classified:1
18019,3-phenylpropionyl chloride,211-443-6,645-45-4,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,49.0,H315:2;H412:2;H331:38;H314:47;H318:2;H332:3;H290:1;Not classified:1
18022,"2,3,5,6-tetrafluorobenzoic acid",416-800-1,652-18-6,Skin Irrit. 2;Eye Dam. 1,Harmonised C&L,0.0,H318:0;H315:0
18024,"Silane, dimethoxydioctyl-",619-063-6,947155-81-9,,Notified C&L,1.0,H335:1;H315:1;H319:1
18027,Dimethylammonium nitrate,250-337-4,30781-73-8,Not Classified,Notified C&L,1.0,Not classified:1
18030,"4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro-4,7-methano-1H-indene",223-096-8,3734-48-3,Acute Tox. 4;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,41.0,H331:38;H302:38;H311:38;H361:41;H312:3;H330:3
18034,"2,2,6-trimethylcyclohexanecarbaldehyde",236-094-7,13155-57-2,Not Classified,Notified C&L,10.0,Not classified:10
18037,"(R)-2,4-dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethylbutyramide",207-824-1,496-65-1,Acute Tox. 3,Notified C&L,38.0,H301:38
18041,"Sodium hydroxy[4-hydroxy-3-nitro-5-[(1,2,3,4-tetrahydro-2,4-dioxoquinolin-3-yl)azo]benzenesulphonato(3-)]chromate(1-)",229-686-1,6656-02-6,Not Classified,Notified C&L,5.0,Not classified:5
18042,"Rhododendron chrysanthum, ext.",290-242-5,90106-20-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1.0,H304:1;H410:1;H317:1;H226:1;H315:1
18046,5-nitropyrimidin-2-amine,221-348-1,3073-77-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
18047,3-oxoglutaric acid,208-797-9,542-05-2,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,15.0,H315:13;H319:13;H335:5;Not classified:2
18052,5-(2-aminoethyl)guaiacol hydrochloride,216-035-1,1477-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:41;H315:41;H319:41
18053,Bis[2-[(2-aminoethyl)amino]ethanolato][2-[(2-aminoethyl)amino]ethanolato-O](propan-2-olato)titanate,265-723-8,65380-84-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Repr. 1B,REACH registration C&L,3.0,H360:2;H317:2;H315:3;H319:3;H335:1
18054,Tungsten trioxide,215-231-4,1314-35-8,Not Classified,REACH registration C&L,704.0,Not classified:236;H335:460;H302:468;H315:460;H319:460;H332:1;H312:1
18057,"4,5α-epoxy-6α-hydroxy-3-methoxy-17-methylmorphinan hydrogen [R-(R*,R*)]-tartrate",227-747-7,5965-13-9,Acute Tox. 4,Notified C&L,10.0,H302:7;H335:3;H319:4;H332:2;H334:4;H317:3;H312:1;H301:3;H311:2;H331:2;H361:1;H315:1
18059,2-methylhexane,209-730-6,591-76-4,Flam. Liq. 2;Skin Irrit. 2;Asp. Tox. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H304:0;H410:0;H336:0;H225:0;H315:0;H400:0
18060,Ammonium octadecyl sulphate,225-161-6,4696-46-2,Not Classified,Notified C&L,37.0,Not classified:37
18062,"Reaction Mass of 3,3-diphenylhexamethyltrisiloxane and 3,3,5,5-tetraphenylhexamethyltetrasiloxane",451-620-7,352230-22-9,Not Classified,REACH registration C&L,2.0,Not classified:1;H413:1;H315:1;H319:1
18063,"Acetic acid ethenyl ester, polymer with ethenol and 1,1'-[methylenebis(oxy)]bis[ethene]",613-229-1,63450-15-7,Not Classified,Notified C&L,10.0,Not classified:10
18064,silver sodium zirconium hydrogenphosphate,422-570-3,265647-11-8,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
18065,Pyrite (FeS2),215-167-7,1309-36-0,,Notified C&L,46.0,Not classified:42;H335:4;H315:4;H319:4
18066,"Carbonic acid, polymer with 4,4'-(1-methylethylidene)bis[phenol]",607-501-9,25037-45-0,,Notified C&L,1.0,H400:1
18068,"1-chlorotricyclo[3.3.1.13,7]decane",213-305-0,935-56-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
18072,"N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide",423-250-6,130016-98-7,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
18073,Sennoside A,201-339-9,81-27-6,Acute Tox. 4,Notified C&L,5.0,H302:3;H317:2;H334:2
18078,"Euspongia officinalis, ext.",289-858-7,90028-65-2,Flam. Liq. 2,Notified C&L,1.0,H225:1
18079,sodium 2-(nonanoyloxy)benzenesulfonate,434-360-9,91125-43-8,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H317:0
18080,Di-μ-carbonyldecacarbonyl-triangulo-triiron,241-668-5,17685-52-8,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4,Notified C&L,44.0,H228:44;H332:39;H302:44;H371:6;H331:5;H312:6
18081,"Dimethyl, methyl (polyethylene oxide acetate-capped) siloxane",615-209-8,70914-12-4,Not Classified,Notified C&L,108.0,Not classified:106;H302:2;H319:2
18082,"Pyridine-2,5-diamine dihydrochloride",248-083-4,26878-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H301:4;H330:4
18083,4-(4-methoxyphenoxy)aniline,250-644-3,31465-36-8,Acute Tox. 4;Resp. Sens. 1,Notified C&L,39.0,H334:39;H302:39;H317:1
18086,1-(morpholin-4-ylmethyl)-2-naphthol,248-458-2,27438-39-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,38.0,H318:38;H302:38;H315:38;H335:38;H400:38
18087,"Castor oil, hydrogenated, acetylated",295-625-0,92113-20-7,Not Classified,Notified C&L,55.0,Not classified:55
18088,"1,2,3-trimethoxybenzene",211-207-2,634-36-6,Not Classified,Notified C&L,89.0,Not classified:88;H335:1;H315:1;H319:1
18090,"Fatty acids, C6-12, reaction products with ethanolamine, methacrylic acid and tetraethylenepentamine",600-427-8,1033746-64-3,Not Classified,Notified C&L,1.0,Not classified:1
18092,"DDT (ISO);clofenotane (INN);dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;dichlorodiphenyltrichloroethane",200-024-3,50-29-3,Acute Tox. 3;Carc. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H351:0;H372:0;H400:0
18098,"trans-1,2-dichlorocyclohexane",212-503-4,822-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18100,"Rose, Rosa canina, ext.",617-592-7,84603-93-0,Not Classified,Notified C&L,1.0,Not classified:1
18102,Sodium glyoxylate,220-298-8,2706-75-4,Eye Irrit. 2,REACH registration C&L,1.0,H319:1
18103,"Cajuput, ext.",287-316-4,85480-37-1,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1416.0,H411:1416;H304:1416;H317:1416;H226:1416;H319:23;H315:1411
18107,Tetradecamethylcycloheptasiloxane,203-496-9,107-50-6,Not Classified,Notified C&L,58.0,Not classified:57;H319:1
18109,Pentylcyclopentane,223-129-6,3741-00-2,Flam. Liq. 3,Notified C&L,1.0,H226:1
18112,"Soaps, stocks, soya",272-862-8,68918-42-3,Not Classified,Notified C&L,1.0,Not classified:1
18115,1-bromo-1-chloroethane,209-820-5,593-96-4,,Notified C&L,4.0,H302:4;H332:4;H312:4;H319:4;H335:4;H315:4
18120,"Hydrocarbons, C",297-465-7,93572-35-1,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H304:0;H350:0
18123,Isoflurane,247-897-7,26675-46-7,STOT SE 3,Notified C&L,101.0,H336:94;H373:41;Not classified:3;H360:2;H315:4;H319:6;H335:3;H361:2
18126,(2H4)methanol,212-378-6,811-98-3,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,87.0,H301:50;H370:51;H225:51;H311:50;H331:46;Not classified:37;H330:4;H360:1;H336:1;H372:1;H319:1;H335:1
18129,Methyl cyanoacetate,203-288-8,105-34-0,Eye Irrit. 2,REACH registration C&L,307.0,H319:255;Not classified:52;H335:15;H315:16
18132,Dexpanthenol,201-327-3,81-13-0,Not Classified,REACH registration C&L,302.0,Not classified:297;H319:5
18136,"4-(1-ethoxyvinyl)-3,3,5,5-tetramethylcyclohexanone",252-961-2,36306-87-3,Skin Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1609.0,H411:1342;H315:1343;Not classified:266
18137,Benzyltriphenylphosphonium bromide,215-908-4,1449-46-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H300:4
18138,"4-chloro-2,3-dimethylpyridine 1-oxide",611-910-8,59886-90-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H335:40;H318:39;H302:39;H315:41;Not classified:1;H319:2;H341:1
18139,"1,7,7-trimethylbicyclo[2.2.1]hept-2-yl propionate",243-673-8,20279-25-8,Not Classified,Notified C&L,88.0,Not classified:88
18140,(2-aminophenyl)acetonitrile,221-015-0,2973-50-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,39.0,H301:39;H311:39;H331:39;H319:39;H335:38;H315:39
18143,Methyl tridecanoate,217-054-8,1731-88-0,Not Classified,Notified C&L,7.0,Not classified:5;H318:2;H413:1
18145,β-D-galactose pentaacetate,224-008-0,4163-60-4,Not Classified,Notified C&L,3.0,Not classified:2;H335:1;H315:1;H319:1
18152,4-Pyridazinecarboxylic acid,610-561-9,50681-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:46;H315:48;H319:48;H302:1;H332:1;H312:1
18154,Sodium 4-amino-6-chlorotoluene-3-sulphonate,229-596-2,6627-59-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
18156,Potassium olivoyl hydrolyzed wheat protein,918-340-1,,,Notified C&L,1.0,Not classified:1
18158,"1-(3,5-Dihydroxyphenyl)-1-oxo-2-(N-1-(4-methoxyphenyl)isopropylamino)ethane Hydrobromide",928-779-0,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1.0,H318:1;H410:1;H317:1;H341:1;H302:1;H400:1
18160,"Fatty acids, C12-18, zinc salts",268-623-2,68131-61-3,Not Classified,Notified C&L,9.0,Not classified:7;H413:2
18163,"2,2,3-trimethylcyclopent-3-enylacetonitrile",239-405-4,15373-31-6,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,113.0,H315:11;H412:11;Not classified:102
18164,Methyl p-anisate,204-513-2,121-98-2,Not Classified,Notified C&L,169.0,Not classified:169
18168,"Benzene, 1-(trans-4-ethylcyclohexyl)-3,5-difluoro-",607-682-4,252852-45-2,Not Classified,Notified C&L,1.0,Not classified:1
18170,[2H3]acetyl chloride,242-925-4,19259-90-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,39.0,H314:39;H302:39;H225:39
18171,Dimethyl sulphite,210-481-0,616-42-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H226:39;H315:39;H319:39
18172,"[1,3(or 1,4)-phenylenebis(1-methylethylidene)]bis[tert-butyl] peroxide",246-678-3,25155-25-3,Org. Perox. D;Aquatic Chronic 4,REACH registration C&L,233.0,H413:199;H242:228;Not classified:5;H319:7
18173,"Bis[[R-(R*,S*)]-β-hydroxy-α-methylphenethyl)methylammonium] sulphate",205-154-4,134-72-5,Acute Tox. 3;Skin Sens. 1,REACH registration C&L,124.0,H301:84;H317:84;H302:40
18174,Tetramethylammonium perchlorate,219-805-5,2537-36-2,Ox. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65.0,H335:43;H272:64;H315:65;H319:65;H411:21;H300:21;H373:21;H370:21;H311:21;H271:1
18180,"N2,N6-dibenzyloxycarbonyl-L-lysine",206-971-9,405-39-0,Not Classified,Notified C&L,1.0,Not classified:1
18181,"2,9-dimethylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone",226-866-1,5521-31-3,Not Classified,REACH registration C&L,269.0,Not classified:228;H335:40;H315:41;H319:41
18182,"(S)-7-amino-6,7-dihydro-10-hydroxy-1,2,3-trimethoxybenzo[a]heptalen-9(5H)-one",222-464-5,3482-37-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38.0,H332:38;H302:38;H312:38
18183,"[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol",604-360-5,14347-78-5,Not Classified,Notified C&L,4.0,Not classified:2;H302:1;H335:1;H227:1;H315:1;H319:1
18184,chymotrypsin,232-671-2,9004-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Resp. Sens. 1,Harmonised C&L,0.0,H335:0;H334:0;H315:0;H319:0
18195,3-nitrobenzylammonium hydrochloride,247-502-8,26177-43-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
18197,2-(octylthio)ethanol;2-hydroxyethyl octyl sulphide,222-598-4,3547-33-9,Eye Dam. 1,Harmonised C&L,0.0,H318:0
18200,"(2S,3R,4R,6R)-3-Methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one",613-127-7,62996-74-1,Muta. 1B;Carc. 1B,Notified C&L,7.0,H340:3;H350:4;H351:1;H410:2;H300:1;H228:1;H310:1;H400:1;H373:1;H302:1;H361:1
18201,"Alpha,2-dichloro-6-fluorotoluene",259-487-5,55117-15-2,Skin Corr. 1A;Aquatic Chronic 2,Notified C&L,203.0,H411:158;H314:203;H318:1;H290:1
18202,"2,6-dimethyloct-7-ene-2,6-diol",249-511-2,29210-77-3,Not Classified,REACH registration C&L,2.0,Not classified:2
18204,"3-(3-Chloropropyl)-1,3-dihydro-7,8-dimethoxy-2H-3-benzazepin-2-on",617-684-7,85175-59-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,4.0,H332:1;H302:3;H312:1;H335:2;H315:2;H319:2;H341:2;H317:2;H351:2;H413:1;H361:1
18205,"2,6,10-trimethyldodeca-2,6,9,11-tetraene",207-948-6,502-61-4,Asp. Tox. 1,Notified C&L,1479.0,H304:1433;Not classified:46
18206,"1,8-naphthylenediamine",207-529-8,479-27-6,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,66.0,H317:65;H302:65;H410:17;H400:10;H351:53;H315:6;H319:6;H412:1;H335:5;H411:1;H341:1
18207,ME2N,417-320-5,56131-48-7,Skin Sens. 1,Notified C&L,1.0,H317:1;Not classified:1
18210,"Benzly (S)-N-(1-oxopentyl)-N-((2'-(1H-tetrazole-5-yl)-1, 1'-biphenyl-4-yl)methyl)-L-valinate",428-430-8,,Acute Tox. 4;Aquatic Acute 3,Notified C&L,2.0,H302:2;H402:1;H412:1
18213,"4-chloro-α,α,α-trifluorotoluene",202-681-1,98-56-6,Flam. Liq. 3;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1199.0,H411:318;H317:71;H226:1128;H315:974;H412:41;H319:974;H335:964;Not classified:70;H351:32;H373:32;H410:9;H350:3;H336:2;H302:2
18215,"6-amino-1,3-dimethyluracil",229-662-0,6642-31-5,Not Classified,REACH registration C&L,145.0,Not classified:143;H332:2;H302:2;H312:2
18217,2-[[]2-(octadecyloxy)ethoxy]ethan-1-ol,605-213-8,16057-43-5,Eye Dam. 1,Notified C&L,13.0,H318:13
18218,4-nitroazobenzene,219-656-6,2491-52-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Carc. 2,Notified C&L,38.0,H302:38;H332:38;H351:38;H312:38;H319:38;H335:38;H315:38
18219,lithium methanolate;lithium methoxide,212-737-7,865-34-9,Self-heat. 1;Skin Corr. 1B,Harmonised C&L,0.0,H314:0;H251:0
18221,8-(2-aminoethylamino)naphthalene-1-sulphonic acid,256-576-0,50402-57-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38.0,H318:38;H314:38
18225,Benzyl acetate,205-399-7,140-11-4,Aquatic Chronic 3,REACH registration C&L,2170.0,H412:1280;Not classified:779;H335:104;H411:40;H315:110;H319:110;H372:2;H370:2;H302:1
18226,Propyl toluene-4-sulphonate,209-978-5,599-91-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4.0,H315:4;H319:4;H335:3;H302:1
18230,methyl 2-fluoro-4-methoxybenzoate,603-265-6,128272-26-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
18233,5-(hydroxymethyl)uracil,224-636-5,4433-40-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:1;H315:1;H319:1;Not classified:1
18234,"1,1'-diheptyl-4,4'-bipyridinium dibromide",228-178-7,6159-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:39
18237,4-HYDRAZINO-N-METHYL BENZENE METHANE SULFONAMIDE HCl,618-222-7,88933-16-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
18240,3-methyl-5-phenylpentan-1-al,433-900-0,55066-49-4,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0;H302:0;H315:0
18242,5-aminonaphthalene-1-sulphonic acid,201-571-0,84-89-9,Not Classified,REACH registration C&L,86.0,Not classified:40;H314:40;H332:40;H312:40;H335:5;H315:6;H319:6
18243,Methyl 4-chlorophenylacetate,257-927-0,52449-43-1,Acute Tox. 4,Notified C&L,194.0,H302:194
18245,Pent-4-enal,218-265-8,2100-17-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,1379.0,H332:1379;H315:1375;H302:1379;H312:1379;H225:93;H319:1;H335:1
18246,N-(4-Methyl-3-nitro-phenyl)-4-(4-methyl-piperazin-1-ylmethyl)-benzamide,611-622-2,581076-60-0,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H317:1;H410:1;H400:1
18250,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 2-methyloxirane",608-344-9,29316-47-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60.0,H315:59;H319:60
18251,"4,6-Dimethoxy-2-[(phenoxycarbonyl)amino]pyrimidine",618-270-9,89392-03-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1;H411:1;H317:1
18253,"Trisodium pyrene-1,3,6-trisulphonate",285-897-9,85154-17-2,,Notified C&L,33.0,Not classified:33
18255,Tetradecyl palmitate,224-884-4,4536-26-9,Not Classified,Notified C&L,8.0,Not classified:8
18261,Germanium telluride,234-706-7,12025-39-7,Acute Tox. 4,Notified C&L,56.0,H302:56
18263,3-ethylhexahydro-1-methyl-2H-azepin-2-one,261-974-2,59891-41-7,Not Classified,Notified C&L,1.0,Not classified:1
18267,"Spiro[3H-2,1-benzoxathiole-3,9'-[9H]xanthene]-3',4',5',6'-tetrol 1,1-dioxide",251-134-3,32638-88-3,Not Classified,Notified C&L,1.0,Not classified:1
18274,(Z)-dihydro-5-(2-octenyl)furan-2(3H)-one,242-497-9,18679-18-0,Not Classified,Notified C&L,89.0,Not classified:88;H335:1;H315:1;H319:1
18276,2-chloroethyl thiocyanate,213-177-6,928-57-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 3;STOT SE 3,Notified C&L,1.0,H301:1;H311:1;H331:1;H319:1;H335:1;H315:1
18277,"Silica, [(ethenyldimethylsilyl)oxy]- and [(trimethylsilyl)oxy]- modified",614-874-1,68988-89-6,Not Classified,Notified C&L,9.0,Not classified:6;H319:3
18278,Potassium 4-aminosalicylate,205-090-7,133-09-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18279,"Potassium O-(octahydro-4,7-methano-1H-inden-5-yl) dithiocarbonate",280-379-9,83373-60-8,Acute Tox. 4,Notified C&L,38.0,H302:38
18287,1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride,420-950-3,163831-67-2,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H410:0;H400:0
18288,"α-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate",268-450-2,68085-85-8,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40.0,H301:39;H410:39;H330:39;H317:38;H319:39;H315:38;H400:39;H332:1;H225:1;H312:1;H302:1
18289,β-hydroxy-4-(2-hydroxyethyl)piperazine-1-propanesulphonic acid,269-990-1,68399-78-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:41;H301:38;H315:41;H319:41
18293,Oct-3-yne,239-280-6,15232-76-5,Flam. Liq. 2,Notified C&L,43.0,H225:38;H226:5;H304:5
18295,Latschenkiefernöl,616-768-0,8000-26-8,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,4.0,H304:3;H410:3;H317:3;H226:3;H315:4;H319:1;H400:1
18299,"Carboxylase, phosphopyruvate (phosphate)",232-958-2,9067-77-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H315:40;H319:40;H334:1
18301,"(N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate",422-200-0,178277-55-9,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0;H314:0
18303,Oxacycloheptadec-10-en-2-one,249-120-7,28645-51-4,Not Classified,REACH registration C&L,1613.0,Not classified:1578;H410:35;H400:35
18306,"2,6-di-tert-butylphenol",204-884-0,128-39-2,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1176.0,H315:909;H410:750;H400:692;Not classified:228;H335:161;H319:295;H411:37;H305:12;H372:12;H320:12;H333:12;H302:5;H401:2
18309,"Phosphine, bis(1,1-dimethylethyl)(2'-methyl[1,1'-biphenyl]-2-yl)-",607-748-2,255837-19-5,,Notified C&L,4.0,H335:4;H315:4;H319:4
18313,Corn oil,232-281-2,8001-30-7,Not Classified,Notified C&L,166.0,Not classified:166
18322,2-(2-hydroxypropyl)-1-methylethyl salicylate,272-070-2,68683-31-8,Not Classified,Notified C&L,442.0,Not classified:441;H302:1;H319:1
18323,"Lysozyme, hydrochloride",232-954-0,9066-59-5,Resp. Sens. 1,REACH registration C&L,4.0,H334:4
18324,Cholanthrene,207-528-2,479-23-2,Not Classified,Notified C&L,3.0,Not classified:3
18328,4-isopropoxy-N-phenylaniline,202-970-2,101-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,38.0,H335:38;H413:38;H315:38;H319:38
18332,Zuclopenthixol,258-758-5,53772-83-1,Acute Tox. 4,REACH registration C&L,2.0,H302:2
18338,(C10-C12) Alkylethoxylate phosphate,614-762-2,68908-64-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,452.0,H318:452;H315:452
18345,[2-[3(or4)-(chloromethyl)phenyl]ethyl]trimethoxysilane,268-575-2,68128-25-6,,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
18347,"N,N-bis(3-aminopropyl)methylamine",203-336-8,105-83-9,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Harmonised C&L,0.0,H331:0;H302:0;H314:0;H311:0
18350,"10-benzoyl-3,7-bis(dimethylamino)phenothiazine",215-005-5,1249-97-4,Not Classified,Notified C&L,1.0,Not classified:1
18353,Citronella Ceylon,616-771-7,8000-29-1,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,193.0,H411:110;H318:123;H335:40;H334:38;H315:95;H412:38;H350:36;H304:16;H317:19;Not classified:5;H361:1;H351:1
18356,"Fatty acids, C14-22 and C16-22-unsatd., potassium salts",286-079-4,85186-93-2,Not Classified,Notified C&L,12.0,Not classified:6;H319:6
18358,1-methylbutyl acetate,210-946-8,626-38-0,Flam. Liq. 3,Harmonised C&L,0.0,H226:0
18360,4-cyclodecen-1-one,247-957-2,26749-90-6,Eye Irrit. 2,Notified C&L,38.0,H319:38
18364,3-(2-furyl)-acrylonitrile,230-550-9,7187-01-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H312:38;H319:38;H335:38;H315:38
18369,"ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate",414-820-5,125630-94-6,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
18372,2-(2-oxopyrrolidin-1-yl)butyramide,446-650-2,,Not Classified,Notified C&L,1.0,Not classified:1
18375,"2,2'-[[3-methyl-4-[(4-nitrophenyl)azo]phenyl]imino]bisethanol",221-665-5,3179-89-3,Acute Tox. 4,Notified C&L,112.0,H302:49;H411:58;H373:37;H317:3;Not classified:3
18376,2-[(trimethylsilyl)oxy]ethyl methacrylate,241-432-1,17407-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
18381,Methyl 3-(p-methoxyphenyl)oxirane-2-carboxylate,255-735-1,42245-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18387,"Poly(oxy-1,2-ethanediyl), a-(nonylphenyl)-[?]-hydroxy-, phosphate, ammonium salt",614-540-5,68511-21-7,Not Classified,Notified C&L,5.0,Not classified:5
18389,Ethylguanidinium sulphate (2:1),222-467-1,3482-86-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
18390,reaction mass of: Ca salicylates (branched C,415-930-6,,Skin Sens. 1;Repr. 2,Harmonised C&L,0.0,H317:0;H361:0
18391,"Naphthenic acids, compds. with N-tallow alkyltrimethylenediamines",263-145-0,61790-54-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,60.0,H315:59;H319:59;Not classified:1
18394,Zirconium dichloride oxide,603-909-6,13520-92-8,Skin Corr. 1B,Notified C&L,67.0,H314:67;H341:5;H302:6;H318:2;H290:1
18395,Hydroxylammonium perchlorate,239-650-7,15588-62-2,Unst. Expl.;Ox. Liq. 1;Skin Corr. 1A;Skin Sens. 1;Aquatic Acute 1,Notified C&L,1.0,H271:1;H314:1;H317:1;H200:1;H400:1
18398,(3-chloropropyl)ethoxydimethylsilane,236-837-5,13508-63-9,,Notified C&L,2.0,H318:2;H302:2;H315:2;H226:2;H335:2
18401,cyclohexadecanone,438-930-8,2550-52-9,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
18407,"4,4'-dinitrostilbene-2,2'-disulphonic acid",204-885-6,128-42-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,13.0,H315:8;H319:8;Not classified:5
18412,3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde,253-151-1,36663-00-0,Aquatic Chronic 4,Notified C&L,38.0,H413:38
18419,"2,6-bis(4-azidobenzylidene)-4-methylcyclohexan-1-one",226-117-9,5284-79-7,Flam. Sol. 1,Notified C&L,40.0,H228:40
18420,Aluminium hydroxide,244-492-7,21645-51-2,Not Classified,REACH registration C&L,2177.0,Not classified:1674;H335:450;H315:446;H319:477;H410:6;H400:6;H336:1;H222:1;H229:1
18421,3-(4-CHLOROPHENYL)GLUTARIC ACID MONOAMIDE,917-377-0,,Not Classified,Notified C&L,1.0,Not classified:1
18422,tetrahydrophthalic anhydride,247-570-9,26266-63-7,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H318:0;H334:0;H412:0;H317:0
18423,"trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II)",413-590-3,164058-22-4,Carc. 1B,Harmonised C&L,0.0,H350:0
18426,"3,6-bis(dimethylamino)xanthylium chloride",202-147-8,92-32-0,Muta. 2,Notified C&L,1.0,H341:1
18429,2-(pyridin-4-yl)ethan-1-amine,625-467-3,13258-63-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:40;H315:40;H319:40;H314:6;H318:1
18430,Didodecyl maleate,220-834-0,2915-52-8,Not Classified,Notified C&L,2.0,Not classified:2
18435,N-methylpropyn-2-ylamine,252-411-1,35161-71-8,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,40.0,H314:40;H225:40;H318:1
18438,"N,N-dimethylbenzene-1,4-diammonium sulphate",208-636-2,536-47-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,45.0,H301:45;H311:41;H331:45;H319:43;H335:43;H315:43;H310:4
18439,"parathion (ISO);O,O-diethyl O-4-nitrophenyl phosphorothioate",200-271-7,56-38-2,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H330:0;H300:0;H311:0;H372:0;H400:0
18441,"2-(3,4-dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene",207-710-1,490-46-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
18446,Propylene distearate,228-229-3,6182-11-2,Not Classified,Notified C&L,17.0,Not classified:17
18448,"Benzenesulfonic acid, propenated, calcium salt, overbased",271-877-7,68610-84-4,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,12.0,H317:7;H413:7;Not classified:5
18449,Chlorocyclohexylmagnesium,213-237-1,931-51-1,Flam. Liq. 2;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,72.0,H314:72;H318:40;H225:31
18451,Lobeline hydrochloride,205-150-2,134-63-4,Acute Tox. 3;Acute Tox. 3,Notified C&L,42.0,H331:40;H301:42;H311:1
18453,methyl lactate,208-930-0,547-64-8,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H226:0;H335:0;H319:0
18457,"Fatty acids, C16-18, reaction products with 2-[(2-aminoethyl)amino]ethanol",287-825-1,85586-22-7,Not Classified,Notified C&L,65.0,Not classified:34;H411:28;H318:28;H315:2;H319:3
18460,Cholic acid,201-337-8,81-25-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,14.0,H315:11;H319:10;H317:6;H312:6;Not classified:3;H412:1
18461,"1,4-bis(4-methyl-5-phenyloxazol-2-yl)benzene",221-349-7,3073-87-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
18463,"Trisodium 4,5-dihydroxy-3-(4-sulphonatophenylazo)naphthalene-2,7-disulphonate",245-803-9,23647-14-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,82.0,H335:44;H315:45;H319:45;Not classified:37
18466,"Perhydroimidazo[4,5-d]imidazole-2,5-dione",207-821-5,496-46-8,Not Classified,REACH registration C&L,78.0,Not classified:38;H302:40
18470,1-naphtol,201-969-4,90-15-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Harmonised C&L,0.0,H318:0;H302:0;H315:0;H312:0;H335:0
18472,2-(4-hydroxy-3-phenylbenzoyl)benzoic acid,617-597-4,84627-04-3,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,3.0,H302:3;H412:2;H319:1
18475,"Arnica chamissonis, ext.",307-460-4,97659-55-7,Flam. Liq. 3,Notified C&L,1.0,H226:1
18477,D-alanine,206-418-1,338-69-2,Not Classified,Notified C&L,4.0,Not classified:4
18478,"1,1'-[oxybis(ethyleneoxy)]diethylene",212-133-3,764-99-8,Not Classified,REACH registration C&L,181.0,Not classified:120;H312:56;H315:4;H319:5
18480,"1,2-Benzenedicarboxylic acid, 1-heptyl 2-undecyl ester, branched and linear",601-083-1,111381-90-9,Not Classified,Notified C&L,23.0,Not classified:23
18481,Bromo(hexahydro-2H-azepin-2-onato-N)magnesium,241-158-2,17091-31-5,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,REACH registration C&L,1.0,H335:1;H332:1;H315:1;H319:1
18483,C.I. Solvent Red 168,615-553-9,71832-19-4,Not Classified,Notified C&L,1.0,Not classified:1
18484,"Meso-2,3-dibromosuccinic acid",452-290-7,608-36-6,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2.0,H318:1;H290:1;H314:2
18486,"1-hydroxy-1H-pyrrole-2,5-dione",225-385-4,4814-74-8,Skin Corr. 1B,Notified C&L,38.0,H314:38
18493,"Disodium 5-acetylamino-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonate",223-098-9,3734-67-6,Not Classified,REACH registration C&L,2139.0,Not classified:2129;H317:7;H315:3;H319:3
18494,(2-aminoethyl)phosphonic acid,218-043-0,2041-14-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39.0,H315:39;H319:39
18496,Pyrazin-1-ylethan-1-one,244-753-5,22047-25-2,Not Classified,Notified C&L,279.0,Not classified:152;H335:126;H315:127;H319:127;H302:1;H332:1;H312:1
18497,nickel (II) sulfide,240-841-2,16812-54-7,Skin Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H410:0;H350:0;H317:0;H372:0;H341:0;H400:0
18500,dimethyl disulphide,210-871-0,624-92-0,Flam. Liq. 2;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;STOT SE 3;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H317:0;H336:0;H370:0;H225:0;H331:0;H319:0;H400:0
18501,"18-methylnonadecyl 2,2-dimethylpropanoate",424-370-1,125496-22-2,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H317:0;H413:0;H315:0
18502,"Papaya, ext.",281-675-0,84012-30-6,Not Classified,Notified C&L,172.0,Not classified:172
18506,"N-(4,4'-dinitro[1,1'-biphenyl]-2-yl)benzamide",283-596-7,84682-33-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18510,3-trimethoxysilylpropane-1-thiol,224-588-5,4420-74-0,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,434.0,H411:297;H317:310;H302:405;H312:59;H319:38;Not classified:22;H315:4;H335:5;H301:1
18512,"[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl3-(2,2-dichlor-oethenyl)-2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate (alpha-Cypermethrin)",614-054-3,67375-30-8,Acute Tox. 3;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,272.0,H301:272;H410:272;H373:272;H335:272;H400:271;H332:85;H411:1
18513,"4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo) diethyl ester",605-256-2,16150-45-1,Not Classified,REACH registration C&L,7.0,Not classified:6;H332:1;H302:1;H312:1
18514,4-nitrotoluene-2-sulphonyl chloride,204-444-8,121-02-8,Skin Corr. 1B,Notified C&L,45.0,H314:45;H318:1;H290:1
18519,Dilead chromate oxide,242-339-9,18454-12-1,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21.0,H360:16;H332:16;H410:16;H373:16;H302:16;H400:16;Not classified:5
18520,Hexyl acetoacetate,236-953-6,13562-84-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
18522,Naphthalenesulphonic acid,246-676-2,25155-19-5,Not Classified,Notified C&L,247.0,Not classified:155;H318:91;H302:86;H314:92
18527,"4-fluoro-N,N,N-trimethyl-3-nitroanilinium iodide",254-478-2,39508-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18528,"Phenol, 2,6-dimethyl-, homopolymer",607-561-6,25134-01-4,Not Classified,Notified C&L,42.0,Not classified:41;H360:1
18536,N-methyl-L-tryptophan,208-388-5,526-31-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39.0,H332:39;H302:39;H312:39
18537,Dodecyl hydrogen maleate,219-360-7,2424-61-5,Skin Irrit. 2;Eye Irrit. 2A,REACH registration C&L,6.0,H315:3;H319:3;Not classified:3
18542,Cobalt(II) isooctanoate,282-602-5,84255-51-6,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1.0,H317:1;H410:1;H400:1
18547,2-methylbutyl 2-methylbutyrate,219-497-2,2445-78-5,Aquatic Chronic 2,Notified C&L,164.0,H411:154;Not classified:10
18549,Methyl nonanoate,217-052-7,1731-84-6,Not Classified,Notified C&L,96.0,Not classified:96
18551,[R-(Z)]-12-hydroxy-9-octadecenamide,252-703-9,35732-94-6,Not Classified,Notified C&L,1.0,Not classified:1
18553,"N,N-bis(2-hydroxyethyl)isonicotinamide",274-993-6,70892-82-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18556,Rare earth oxides,269-164-0,68188-83-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,125.0,H410:85;H319:85;H400:85;Not classified:35;H413:4;H411:1;H317:1;H318:1
18560,"Fatty acids, C16-18, reaction products with 2-amino-2-(hydroxymethyl)-1,3-propanediol",282-955-5,84501-37-1,Not Classified,Notified C&L,1.0,Not classified:1
18561,"2,4-di-tert-butylcyclohexanone",405-340-7,13019-04-0,Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H315:0
18569,Orange lead,215-235-6,1314-41-6,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,179.0,H360:174;H362:42;H332:174;H410:174;H351:116;H372:116;H302:174;H400:170;H272:39;H341:32;H373:58;Not classified:5
18570,"Fatty acids, animal, unsatd., iso-Bu esters",287-319-0,85480-39-3,Not Classified,Notified C&L,1.0,Not classified:1
18575,"sodium 3-α,12-α-dihydroxy-5-β-cholan-24-oate",206-132-7,302-95-4,Acute Tox. 4;STOT SE 3,Notified C&L,96.0,H335:46;H302:59;Not classified:37;H315:7;H319:7;H412:1
18576,Dichromium nitride,235-002-2,12053-27-9,Not Classified,REACH registration C&L,53.0,Not classified:11;H317:42;H302:42;H334:4
18577,2-Chloro-4-fluoroiodobenzene,600-191-6,101335-11-9,,Notified C&L,6.0,H335:5;H315:6;H319:6;H302:1;H332:1;H312:1
18582,TEPP (ISO);tetraethyl pyrophosphate,203-495-3,107-49-3,Acute Tox. 2;Acute Tox. 1;Aquatic Acute 1,Harmonised C&L,0.0,H400:0;H310:0;H300:0
18586,2-nitrophenylacetic acid,223-128-0,3740-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45;H341:4
18589,"Distillates (petroleum), C",309-862-5,101316-56-7,Asp. Tox. 1;Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H304:0;H350:0
18590,"3,4,5-trimethoxyphenol",211-387-2,642-71-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:43;H315:43;H319:43
18591,2-methylpropyl isothiocyanate,209-733-2,591-82-2,,Notified C&L,7.0,H332:5;H314:4;H226:6;H312:5;H302:5;H319:3;H315:3;H335:1;H301:1
18595,2-ethoxybenzoyl chloride,256-003-4,42926-52-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,44.0,H302:39;H314:44;H318:1;H290:1
18597,"3-methyl-4-(2,2-dimethyl-6-methylenecyclohexyl)-3-buten-2-one",230-969-7,7388-22-9,Aquatic Chronic 3,Notified C&L,36.0,H412:36
18600,"cis-1,2,3,6-tetrahydrophthalic anhydride",213-308-7,935-79-5,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H318:0;H334:0;H412:0;H317:0
18601,"Vitex agnus-castus, ext.",294-446-5,91722-47-3,Not Classified,Notified C&L,31.0,Not classified:27;H304:2;H410:1;H317:2;H226:4;H315:2;H319:1;H411:1
18602,2-methyl-4-nitro-1-(4-trifluoromethylsulfanyl-phenoxy)-benzene,929-785-6,,Acute Tox. 4,REACH registration C&L,3.0,H302:3
18603,Didysprosium trioxide,215-164-0,1308-87-8,Not Classified,REACH registration C&L,31.0,Not classified:30;H335:1;H315:1;H319:1
18604,"2,5-dihydro-2,5-dimethoxyfuran",206-367-5,332-77-4,Flam. Liq. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,153.0,H332:85;H226:153;H302:90;H319:85
18609,RUBINOL GA 1469,404-850-7,,Not Classified,REACH registration C&L,40.0,Not classified:40
18611,"1,3-bis(3-(2,3-epoxypropoxy)propyl)-1,1,3,3-tetramethyldisiloxane",204-803-9,126-80-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,55.0,H317:1;H315:55;H319:55;H335:54;H302:2;H332:2;H312:2
18613,C.I. Solvent Yellow 14;1-phenylazo-2-naphthol,212-668-2,842-07-9,Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 4,Harmonised C&L,0.0,H341:0;H317:0;H413:0;H351:0
18621,Methyl undecanoate,217-053-2,1731-86-8,Not Classified,Notified C&L,8.0,Not classified:7;H318:1
18623,"Dibenzylbenzene, ar-methyl derivative",258-649-2,53585-53-8,Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,38.0,H413:34;H304:38;H360:4;H410:4
18626,Benzylphenethylammonium acetate,281-069-6,83846-89-3,Not Classified,Notified C&L,1.0,Not classified:1
18627,3-benzyl-1-p-tolyltriazene,241-665-9,17683-09-9,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H228:1;H332:1;H302:1;H312:1
18630,Methyl methylcarbamate,229-661-5,6642-30-4,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H302:1;H315:1;H226:1;H319:1;H335:1
18631,Tris(methacrylato-O)(propan-2-olato)titanium,262-788-4,61436-48-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
18632,Barium bis(dinonylnaphthalenesulphonate),247-132-7,25619-56-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1374.0,H332:1339;H317:951;H315:1061;H319:1015;H302:1318;H301:20;Not classified:6;H318:7;H335:1;H312:1
18634,"Oxobis(pentane-2,4-dionato-O,O')vanadium",221-590-8,3153-26-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,292.0,H335:287;H302:282;H315:286;H319:288;H301:6;H411:3;H332:4;H312:2;Not classified:1
18635,4-fluorophenylacetic acid,206-972-4,405-50-5,Skin Irrit. 2,Notified C&L,51.0,H315:50;H335:7;H319:9;Not classified:1
18637,"2H-Tetrazole, 5-(3-bromophenyl)-",608-985-4,3440-99-1,,Notified C&L,4.0,H335:4;H315:4;H319:4
18638,"(17ß)-3-Hydroxyestra-1,3,5(10)-trien-17-yl acetate",605-722-5,1743-60-8,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2B;Acute Tox. 4;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,41.0,H360:41;H332:2;H410:2;H317:2;H319:2;H302:2;H400:2
18639,Bis(2-butoxyethyl) adipate,205-466-0,141-18-4,Acute Tox. 4,REACH registration C&L,3.0,H302:2;Not classified:1
18640,trixylyl phosphate,246-677-8,25155-23-1,Repr. 1B,Harmonised C&L,0.0,H360:0
18642,"Butanedioic acid, mono-C12-18-alkenyl derivs., 4-[2-(2-hydroxyethoxy)ethyl] esters, monosodium salts",287-949-6,85631-02-3,Acute Tox. 4,Notified C&L,1.0,H302:1
18643,"trans-1,2-dimethylcyclopentane",212-500-8,822-50-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,42.0,H318:38;H302:38;H225:4
18646,"Silk, powd.",618-451-2,9009-99-8,Not Classified,Notified C&L,54.0,Not classified:54
18648,"4-Thiazolecarboxylic acid, 4,5-dihydro-2-(6-hydroxy-2-benzothiazolyl)-, sodium salt (1:1), (4S)-",600-430-4,103404-75-7,Not Classified,Notified C&L,1.0,Not classified:1
18650,"1-methyl-6-nitro-2H-3,1-benzoxazine-2,4(1H)-dione",225-150-6,4693-01-0,Acute Tox. 3;Eye Irrit. 2,Notified C&L,39.0,H301:39;H319:39;H335:1;H315:1
18651,"Soaps, stocks, C16-18 and C18-unsatd. alkyl, acidulated",272-861-2,68918-41-2,Not Classified,Notified C&L,1.0,Not classified:1
18653,2-(tert-butylamino)-1-(3-chloro-4-hydroxy-5-chloromethylphenyl)ethanone hydrochloride,930-857-4,,Not Classified,REACH registration C&L,1.0,Not classified:1
18659,Methyl perfluorooctanoate,206-808-1,376-27-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
18663,Piretanide,259-852-9,55837-27-9,Aquatic Chronic 3,Notified C&L,3.0,H412:2;Not classified:1
18665,"6-methyl-1,3,5-triazine-2,4-diyldiamine",208-796-3,542-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:43;H315:44;H319:44;Not classified:3
18666,4-(Trifluoromethyl)phenylhydrazine,609-305-9,368-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:46;H315:46;H319:46;H302:7;H332:6;H312:6;H301:1;H311:1;H331:1
18667,N-(4-chlorophenyl)-2-cyanoacetamide,241-720-7,17722-17-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H312:38;H319:38;H335:38;H315:38
18669,"bis(Acetato-O)[9,10-difluoro-2,3-dihydro-3-methyl-7-dihydro-7Hpyrido[1,2,3-de][1,4]benzoxazine-6-carboxilato-O6,O7]boron",619-289-5,97746-91-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
18671,"7(S),18(R)-dihydroxy-16(S),18-dimethyl-10-phenyl[11]cytochalasa-6(12),13(E),19(E)-triene-1,17-dione 21(R)-acetate",244-804-1,22144-77-0,Acute Tox. 2;Repr. 2,Notified C&L,40.0,H361:40;H300:40
18672,7-[2-(2-aminothiazol-4-yl)-2-(methylcarbonyloxyimino)acetamido]-3-vinyl-cephem-4-carboxylic acid,610-178-7,443874-49-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,1.0,H317:1;H334:1;H315:1;H319:1
18674,4-(o-tolyloxy)aniline,260-349-1,56705-83-0,,Notified C&L,5.0,H335:5;H315:5;H319:5
18678,4-boronobenzoic acid,604-189-6,14047-29-1,,Notified C&L,17.0,H335:14;H315:15;H319:15;H332:2;H302:4;H312:2
18679,1-ethylbenz[cd]indol-2(1H)-one,217-386-3,1830-56-4,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,33.0,H411:33;H302:33
18683,"Phenol, isopropylated, phosphate (3:1)",273-066-3,68937-41-7,Repr. 2;Repr. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1241.0,H361:1205;H410:115;H373:1065;H413:13;H317:933;H411:525;Not classified:11;H400:7
18688,Methyl 4-amino-3-hydroxybenzoate,919-647-3,63435-16-5,,Notified C&L,4.0,H335:4;H315:4;H319:4
18689,"ε-Caprolactone, oligomers, esters with acrylic acid",500-280-9,97387-29-6,,Notified C&L,1.0,H317:1;H312:1;H319:1
18691,2-chloro-6-nitroanisole,279-580-4,80866-77-9,Acute Tox. 4,Notified C&L,39.0,H302:39
18693,Cyclohexyl isocyanide,213-238-7,931-53-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39.0,H331:39;H301:39;H311:39;H319:1;H315:1
18694,p-nitrophenyl 3-amino-4-methoxybenzenesulphonate,303-928-7,94232-04-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,33.0,H335:33;H318:33;H315:33
18699,Iron titanium trioxide,234-667-6,12022-71-8,Not Classified,REACH registration C&L,42.0,Not classified:4;H302:38;H332:38;H351:38;H312:38;H319:38;H335:38;H315:38
18700,1-benzylpiperidin-4-ol,225-226-9,4727-72-4,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H301:38;H315:47;H319:47;H302:1;H332:1;H312:1
18702,"1,1'-[1,1'-biphenyl]-4,4'-diylbis[2-bromoethan-1-one]",223-785-3,4072-67-7,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,39.0,H302:38;H314:38;H400:38;H317:1;H252:1;H413:1;H335:1
18703,"Isobutyric acid, ester with 2,2,4-trimethylpentane-1,3-diol benzoate",252-412-7,35164-39-7,Not Classified,Notified C&L,5.0,Not classified:5
18705,Germanium disulphide,234-705-1,12025-34-2,Not Classified,Notified C&L,1.0,Not classified:1
18707,2-[(2-hydroxy-1-methylethyl)methylamino]propan-2-ol,285-898-4,85154-18-3,,Notified C&L,33.0,Not classified:33
18708,"4,8-dicyclohexyl-6-hydroxy-2,10-dimethyl-12H-dibenzo[d,g][1,3,2]dioxaphosphocin",277-633-6,73912-21-7,Aquatic Chronic 4,REACH registration C&L,3.0,H413:2;Not classified:1
18710,Insulin,232-672-8,9004-10-8,Not Classified,Notified C&L,117.0,Not classified:116;H334:1
18712,"2,4,6-Tris(1-phenylethyl) polyoxyethylenated phosphates",618-446-5,90093-37-1,Eye Irrit. 2,Notified C&L,345.0,H319:345;H315:10
18713,"1,5,9-trimethylcyclododeca-1,5,9-triene",244-190-5,21064-19-7,Skin Corr. 1B;Aquatic Chronic 4,Notified C&L,38.0,H413:38;H314:38
18714,"N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",258-110-1,52697-38-8,Skin Sens. 1B,REACH registration C&L,87.0,H317:29;Not classified:58;H412:6
18716,5-(Aminomethyl)-2-chloropyridine,619-497-6,97004-04-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,44.0,H301:39;H318:39;H317:39;H315:39;H335:39;H314:5
18717,Cadmium sulfoselenide orange,235-758-3,12656-57-4,Not Classified,Notified C&L,39.0,Not classified:39
18719,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-henicosafluorododecanol",212-748-7,865-86-1,,Notified C&L,2.0,H335:1;H315:1;H319:1;H226:1
18720,"4-amino-2,5-dichloro-N,N-dimethylbenzenesulphonamide",247-501-2,26175-68-8,Aquatic Chronic 2,Notified C&L,190.0,H411:188;H401:32;Not classified:2
18722,"Tetrasodium [μ-[7-benzamido-3-[[3,3'-dihydroxy-4'-[(1-hydroxy-4,8-disulpho-2-naphthyl)azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxynaphthalene-1,5-disulphonato(8-)]]dicuprate(4-)",280-157-1,83027-55-8,Not Classified,Notified C&L,9.0,Not classified:9
18723,"Carbamic acid, (3-isocyanatomethylphenyl)-, isotridecyl ester",611-014-7,53564-52-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 1;Resp. Sens. 1;STOT SE 3;Carc. 2;Aquatic Chronic 3,REACH registration C&L,3.0,H334:3;H330:3;H351:3;H317:3;H412:3;H319:3;H335:3;H315:3
18725,2-fluoroacetophenone,207-156-0,445-27-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,49.0,H335:48;H315:49;H319:49;H302:3;H332:3;H312:3
18729,2-methylpentan-1-ol,203-285-1,105-30-6,Flam. Liq. 3;Acute Tox. 4,Notified C&L,73.0,H226:39;H302:53;H335:20;H315:20;H319:20;H318:14
18733,"4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)",420-530-1,,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H317:0;H413:0;H334:0
18738,"1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-azido-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-",606-551-9,204255-06-1,Not Classified,Notified C&L,3.0,Not classified:3
18740,Sodium 4'-aminoazobenzene-4-sulphonate,219-657-1,2491-71-6,,Notified C&L,7.0,H335:6;H315:6;H319:6;Not classified:1
18741,"Evening primrose, Oenothera biennis, ext.",289-859-2,90028-66-3,Not Classified,Notified C&L,112.0,Not classified:112
18743,"1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one",426-110-2,98377-35-6,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H317:0;H412:0
18744,1-ethoxypropene,213-176-0,928-55-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:43;H225:44;H319:44
18746,"1,3-bis(4-chloro-α,α,α-trifluoro-m-tolyl)urea",206-728-7,370-50-3,Acute Tox. 4,Notified C&L,3.0,H302:3
18748,potassium methanolate;potassium methoxide,212-736-1,865-33-8,Self-heat. 1;Skin Corr. 1B,Harmonised C&L,0.0,H314:0;H251:0
18749,1-(2-naphthyl)-2-thiourea,222-242-8,3394-04-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H301:1;H315:1;H319:1
18750,N-[2-(diethylamino)ethyl]-2-methoxy-5-(methylsulphonyl)benzamide monohydrochloride,256-908-4,51012-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,2.0,H335:1;H315:1;H319:1;H361:1;Not classified:1
18752,1-methyldecylamine,236-173-6,13205-56-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 4,Notified C&L,38.0,H318:38;H302:38;H413:38;H315:38;H335:38
18756,Dodecylbis(2-hydroxyethyl)methylammonium chloride,244-921-8,22340-01-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,32.0,H302:32;H314:32;H412:32
18757,hymexazol (ISO);hymexazol (ISO); 3-hydroxy-5-methylisoxazole,233-000-6,10004-44-1,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0.0,H411:0;H318:0;H317:0;H302:0;H361:0
18758,Phenyl propyl ether,210-756-5,622-85-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
18761,"3',6'-bis(ethylamino)-2',7'-dimethylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",255-345-1,41382-37-0,Not Classified,Notified C&L,83.0,Not classified:83
18763,"Sodium (Z,Z)-1,4-dioctadec-9-enyl sulphonatosuccinate",262-937-3,61732-58-9,Not Classified,Notified C&L,1.0,Not classified:1
18767,"6-methoxypyridine-2,3-diamine dihydrochloride",303-358-9,94166-62-8,,Notified C&L,5.0,H335:5;H302:4;H315:5;H319:5
18768,1-chloro-4-(2-chloroethoxy)benzene,235-833-0,13001-28-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156.0,H410:156;H400:156
18771,"N-[(1,1-dimethylethoxy)carbonyl]sarcosine",237-306-0,13734-36-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4.0,H335:4;H315:4;H319:4
18774,"Butanedioic acid, (tetrapropenyl)-, dipotassium salt",611-478-0,57195-19-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
18775,"1,1-diiodoethane",209-821-0,594-02-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
18776,4-tert-butylcyclohexyl chloroformate,255-670-9,42125-46-2,Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,88.0,H318:88;H314:88;H290:5;H412:5;H331:88
18777,"17-hydroxy-6-methylenepregn-4-ene-3,20-dione 17-acetate",251-133-8,32634-95-0,Aquatic Chronic 4,REACH registration C&L,4.0,H413:3;H360:2;H362:1;H351:1
18778,"Naphthenic acids, calcium salts",263-055-1,61789-36-4,Eye Dam. 1,Notified C&L,264.0,H318:125;Not classified:82;H315:57
18780,Methyl 5-methylisoxazole-3-carboxylate,243-311-9,19788-35-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
18781,"2-[(4-amino-2,5-dimethoxyphenyl)sulphonyl]ethyl hydrogen sulphate",247-896-1,26672-24-2,Eye Dam. 1;STOT SE 3,Notified C&L,11.0,H318:9;H335:9;Not classified:2
18782,"Oils, palm, Me esters, glycerol-free",309-456-8,100299-02-3,Not Classified,Notified C&L,1.0,Not classified:1
18787,"Hexanedioic acid oligomeric reaction products with 2,2'-oxybis[ethanol]",618-460-1,9010-89-3,Not Classified,REACH registration C&L,183.0,Not classified:183
18792,cyclomaltodextrin glucanotransferase,618-522-8,9030-09-5,Resp. Sens. 1,REACH registration C&L,4.0,H334:4
18795,5-(2-aminoethylamino)naphthalene-1-sulphonic acid,256-575-5,50402-56-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H302:38;H317:38;H315:38;H319:38;H335:38
18796,Propyl methacrylate,218-639-0,2210-28-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H226:42;H315:42;H319:42
18799,"Diethyl (methylenedi-4,1-phenylene)dicarbamate",233-230-7,10097-16-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H400:38
18801,cis-4-hydroxy-D-proline,219-963-5,2584-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5.0,H335:3;H315:3;H319:3;Not classified:1;H302:1
18802,5-bromovanillin,221-016-6,2973-76-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
18804,Isohexadecanol,252-964-9,36311-34-9,Eye Irrit. 2,Notified C&L,36.0,H319:20;Not classified:16
18805,Methyl 2-amino-3-thenoate,225-084-8,4651-81-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:41;H315:41;H319:41
18807,1-chloro-4-(methylsulphonyl)benzene,202-682-7,98-57-7,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,49.0,H302:49;H315:48;H335:6;H319:6;H332:1
18808,Phendimetrazine,211-204-6,634-03-7,Acute Tox. 4,REACH registration C&L,2.0,H302:2
18809,Manganese ditelluride,234-783-7,12032-89-2,,Notified C&L,4.0,H302:4
18810,2-isopropyl-3-methoxypyrazine,247-256-1,25773-40-4,Acute Tox. 4,Notified C&L,1448.0,H302:1287;Not classified:96;H335:40;H315:41;H319:41;H226:24
18815,Ethyl 3-phenylprop-2-ynoate,218-703-8,2216-94-6,,Notified C&L,5.0,H315:5;H319:5
18816,"Amides, coco alkyl, N-(hydroxyethyl), ethoxylated",500-211-2,68425-44-5,Eye Dam. 1,Notified C&L,106.0,H318:94;Not classified:12;H315:1
18821,"1,4,5,6-tetrahydro-1,2-dimethylpyrimidine",224-262-2,4271-96-9,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,105.0,H318:103;H302:105;H314:104;H312:55;H311:33
18822,"amines, polyethylenepoly-;HEPA",268-626-9,68131-73-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H314:0;H317:0;H312:0;H302:0;H400:0
18823,"6-(dibutylamino)-1,3,5-triazine-2,4(1H,3H)-dithione",249-682-3,29529-99-5,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,6.0,H317:2;H318:2;H412:2;Not classified:4
18824,"3a,4,5,6,7,7a-hexahydromethoxy-4,7-methano-1H-indene",248-247-5,27135-90-6,Eye Irrit. 2,Notified C&L,1450.0,H319:1450
18827,[No public or meaningful name is available],479-710-1,,Repr. 1B;STOT RE 2;Aquatic Chronic 4,Notified C&L,1.0,H360:1;H413:1;H373:1
18830,"N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine",605-520-7,16858-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,195.0,H335:194;H315:195;H319:195
18831,2-[(3-aminophenyl)sulphonyl]ethanol,226-046-3,5246-57-1,Not Classified,REACH registration C&L,11.0,Not classified:1;H411:9;H315:1;H319:1
18832,"Trisodium 4-hydroxy-5-[[4-(methylamino)-6-[[3-[(2,5,6-trichloro-4-pyrimidinyl)amino]phenyl]amino]-1,3,5-triazin-2-yl]amino]-3-[(2-sulphonatophenyl)azo]naphthalene-2,7-disulphonate",276-372-5,72139-15-2,Eye Irrit. 2,Notified C&L,31.0,H319:31
18834,Fluoromethyl methyl carbonate,606-635-5,207804-61-3,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H315:1;H226:1;H319:1;H302:1
18837,2-hydroxyisopropyl 2-hydroxypropyl bicarbamate,286-815-4,85391-60-2,Eye Irrit. 2,Notified C&L,25.0,H319:25
18843,4-(4-((((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-N-METHYL-2-PYRIDINECARBOXAMIDE,608-209-4,284461-73-0,Repr. 1B;Lact.;STOT RE 1;Aquatic Chronic 1,Notified C&L,2.0,H360:1;H362:1;H410:1;H372:1;H361:1;H351:1;H402:1
18845,2-amino-6-chlorobenzonitrile,229-501-4,6575-11-7,Skin Sens. 1,Notified C&L,46.0,H317:39;H301:6;H332:5;H312:5;H319:6;H335:6;H315:6;H331:1;H311:1
18846,4-(p-chlorophenyl)piperidin-4-ol,254-479-8,39512-49-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,55.0,H318:3;H317:3;H315:52;H412:3;H302:14;H335:48;H319:49;H411:1
18853,Clonidine hydrochloride,224-121-5,4205-91-8,Acute Tox. 3;Acute Tox. 1,Notified C&L,48.0,H301:48;H330:45;H410:1;H370:1;H311:1;H331:1
18857,"L-Aspartic acid, magnesium salt, hydrate (2:1:4)",615-078-7,7018-07-7,Not Classified,Notified C&L,2.0,Not classified:2
18861,"4,4-dimethyloxazolidine",257-048-2,51200-87-4,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 3,REACH registration C&L,1405.0,H318:1369;H315:1229;H311:2;H331:122;H226:1346;H302:1374;H332:1231;H312:244;H335:185;H330:55;H317:40;Not classified:29;H412:22;H319:1
18866,2-methylbutyl isovalerate,219-496-7,2445-77-4,Not Classified,Notified C&L,134.0,Not classified:134
18868,Collagenase,232-582-9,9001-12-1,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,124.0,H335:124;H334:124;H315:124;H319:124;H317:3
18869,Benzyltriethylammonium chloride,200-270-1,56-37-1,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,324.0,H317:176;H302:193;H412:175;Not classified:59;H335:83;H315:89;H319:87;H312:9;H332:6;H318:1;H314:1;H225:1;H371:1;H336:1;H228:2
18871,"4'-chloro-2',5'-dimethoxyacetoacetanilide",224-638-6,4433-79-8,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,67.0,H302:59;H412:51;Not classified:8;H332:8;H312:8;H373:8
18874,4-(2-dimethylaminoethyl)phenol,208-710-4,539-15-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,40.0,H317:38;H302:38;H319:40;H315:2;H335:1
18876,Mesna,243-285-9,19767-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:45;H315:46;H319:46;Not classified:1
18880,"7-hydroxy-8-[[4-(phenylazo)phenyl]azo]naphthalene-1,3-disulphonic acid",246-826-7,25317-39-9,,Notified C&L,1.0,H315:1;H319:1
18882,Aluminium sulfate octadecahydrate,616-524-3,7784-31-8,Eye Dam. 1,Notified C&L,122.0,H318:121;H290:21;H412:21;H411:1;H302:1;H315:3;H335:3;H319:1
18883,Titanium tetraisobutanolate,231-061-3,7425-80-1,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,5.0,H318:4;H336:4;H315:4;H226:5;H335:4
18886,Benzoyl isocyanate,224-717-5,4461-33-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:42;H332:42;H312:38;H319:42;H335:42;H315:42;H334:4
18887,"Benzene, 1-chloro-2-fluoro-4-methyl-",611-246-9,5527-94-6,,Notified C&L,5.0,H335:5;H226:4;H315:5;H319:5
18890,"Sodium 4-[[2,4-dihydroxy-3-(phenylazo)phenyl]azo]benzenesulphonate",227-445-5,5850-13-5,,Notified C&L,2.0,H319:1;Not classified:1
18892,"1,3,5-tribromobenzene",210-947-3,626-39-1,Aquatic Chronic 4,Notified C&L,51.0,H413:39;H335:7;H315:8;H319:8;H332:4;H302:4;H312:4
18894,3-[2-(diethylamino)ethyl]-7-hydroxy-4-methyl-2H-1-benzopyran-2-one hydrochloride,239-872-4,15776-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:40;H315:40;H319:40
18896,3-chloropropyl(diethyl)amine hydrochloride,224-881-8,4535-85-7,Acute Tox. 4;Skin Corr. 1C;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H302:2;H314:1;H319:2;H315:1
18900,"3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one",617-868-7,86499-96-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3.0,H302:1;H332:1;H312:1;H319:3;H335:2;H315:3;H303:1
18901,N-isopropylacrylamide,218-638-5,2210-25-5,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,51.0,H318:4;H302:51;H319:46;H335:2;H315:3;H332:1;H312:1
18908,"Sodium (R)-α-[(3-methoxy-1-methyl-3-oxo-1-propenyl)amino]cyclohexa-1,4-diene-1-acetate",248-000-1,26774-89-0,,REACH registration C&L,13.0,Not classified:2;H335:11;H315:11;H319:11
18910,"1,1,3,3-tetrabutyl-1,3-dichlorodistannoxane",233-904-0,10428-19-0,Skin Corr. 1B,Notified C&L,38.0,H314:38
18916,Triphenyl borate,214-137-0,1095-03-0,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3,Notified C&L,39.0,H331:38;H301:39;H318:39;H311:38
18918,"2-Amino-3,4-dimethylbenzoic Acid",610-529-4,50419-58-4,,Notified C&L,6.0,H335:5;H315:6;H319:6
18919,"dimethyl 5-methylpyridine-2,3-dicarboxylate",601-161-5,112110-16-4,Eye Irrit. 2,Notified C&L,1.0,H319:1
18920,Dodecenylsuccinic acid,249-757-0,29658-97-7,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1040.0,H318:971;H412:971;Not classified:61;H315:5;H319:5
18922,Tetrahydro-6-nonyl-2H-pyran-2-one,220-334-2,2721-22-4,Not Classified,Notified C&L,126.0,Not classified:122;H335:4;H315:4;H319:4
18923,5-fluoro-1-(tetrahydro-2-furyl)uracil,241-846-2,17902-23-7,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,41.0,H331:39;H301:39;H311:39;H360:2;H373:2;H300:1;H371:1;H372:1;H302:1
18926,(Z)-hex-3-enyl isobutyrate,255-424-0,41519-23-7,Not Classified,REACH registration C&L,1511.0,Not classified:1472;H315:39
18929,Chlorodiethylphosphine,211-689-4,686-69-1,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B;STOT SE 3,Notified C&L,43.0,H314:43;H335:38;H225:43;H260:38;H252:4;H250:4;H318:1
18932,"acequinocyl (ISO);3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate",611-595-7,57960-19-7,Skin Sens. 1;STOT SE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H373:0;H317:0;H370:0;H400:0
18934,Sulfachlorpyridazine,201-269-9,80-32-0,Skin Sens. 1,Notified C&L,44.0,H317:42;Not classified:2;H334:1;H302:1
18940,"(S)-N,N'-dibutyl-2-[(1-oxododecyl)amino]glutaramide",264-391-1,63663-21-8,Not Classified,REACH registration C&L,2.0,Not classified:2
18942,"9H-Thioxanthen-9-one, (1-methylethyl)-",616-186-7,75081-21-9,Not Classified,Notified C&L,9.0,Not classified:9
18946,"Alcohols, C16-20",283-068-6,84539-77-5,Not Classified,Notified C&L,6.0,Not classified:6
18947,"4,4'-methylenebis(aniline), compound with sodium chloride (3:1)",244-493-2,21646-20-8,Acute Tox. 4,Notified C&L,62.0,H302:62
18948,2-ethylhexenal,247-571-4,26266-68-2,Flam. Liq. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H317:2;H315:2;H226:2;H319:2;H335:2;H350:1
18950,Methyl 3-[(dimethoxyphosphinyl)oxy]isocrotonate,206-417-6,338-45-4,Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39.0,H400:39;H410:39;H310:39;H300:39;H330:1;H370:1;H372:1
18951,"1,2-benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt",204-886-1,128-44-9,Not Classified,REACH registration C&L,299.0,Not classified:284;H302:10;H350:3;H361:1;H335:2;H351:2;H332:1;H312:1;H315:1;H319:1
18952,"Fatty acids, C18-unsatd., dimers, mixed esters with oleic acid and trimethylolpropane",604-580-1,147256-33-5,Not Classified,Notified C&L,83.0,Not classified:83
18955,"2,2',4,4',6,6'-hexamethylbenzophenone",227-052-9,5623-45-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
18957,"Tall oil, compd. with diethanolamine",268-452-3,68092-28-4,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,4.0,H412:1;H315:1;H319:1;H373:1;Not classified:3
18959,[No public or meaningful name is available],682-135-0,76144-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:41;H315:41;H319:41
18960,"Fatty acids, C14-18, ethoxylated propoxylated",614-336-6,68154-31-4,Not Classified,Notified C&L,1.0,Not classified:1
18961,Lavender oil (Natural oil),616-770-1,8000-28-0,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,279.0,H317:250;H304:251;H315:252;H412:250;Not classified:25;H319:18;H335:1
18962,"N,N-dimethylbenzene-1,4-diamine dihydrochloride",208-635-7,536-46-9,Acute Tox. 2;Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3,Notified C&L,48.0,H331:41;H319:47;H311:46;H300:45;H330:6;H335:4;H315:5;H301:1;H314:1;H332:1;H302:1;H312:1;H310:1
18963,2-ethylhexyl stearate,244-754-0,22047-49-0,Not Classified,REACH registration C&L,722.0,Not classified:720;H319:2
18977,Sodium 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl sulphate,236-091-0,13150-00-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,71.0,H315:70;H319:57;H318:13;H302:10
18982,"Tetrasodium hydrogen bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]chromate(5-)",274-870-7,70776-54-4,Not Classified,Notified C&L,69.0,Not classified:55;H317:14
18984,"Lolium perenne, ext.",290-022-9,90063-63-1,Skin Sens. 1,Notified C&L,1410.0,H317:1410
18985,"Gymnema silvestre, ext.",289-908-8,90045-47-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H312:1
18990,"4,4'-isopropylidenebis(2-(2,6-dibromophenoxy)ethanol)",224-005-4,4162-45-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:42;H315:43;H319:43;Not classified:1
18991,"7-methyl-2H-1,3-benzoxazine-2,4(3H)-dione",445-680-3,24088-77-5,Acute Tox. 4,REACH registration C&L,2.0,H302:2
18994,2-ethylhexyl (6-isocyanatohexyl)-carbamate,247-735-5,26488-60-8,Skin Sens. 1B;Acute Tox. 3;Resp. Sens. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,25.0,H334:25;H317:25;H412:25;H331:25;H335:25
18995,"Pentaerythritol tetraesters of n-C5, n-C7, n-C8, i-C9 and n-C10 fatty acids",451-190-0,156558-98-4,Not Classified,REACH registration C&L,3.0,Not classified:3
18996,1-[2-amino-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride,603-392-7,130198-05-9,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,59.0,H302:57;H315:3;H411:53;H362:54;H332:53;H319:55;Not classified:1;H301:1
18999,2'-Chloro-4'-hydroxyacetophenone,614-402-4,68301-59-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
19010,"2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione",454-720-9,161596-47-0,Skin Sens. 1;Eye Dam. 1;Muta. 2,REACH registration C&L,16.0,H341:16;H317:16;H318:16
19011,"Fatty acids, animal, unsatd., 1-methyl-1,2-ethanediyl esters",287-318-5,85480-38-2,Not Classified,Notified C&L,1.0,Not classified:1
19012,"Grease, sulfated, sodium salt",269-163-5,68188-82-9,Not Classified,Notified C&L,1.0,Not classified:1
19015,"2,3-Epoxypropyl neodecanoate, oligomeric reaction products with toluene-4-sulfonic acid",500-281-4,98362-33-5,Skin Sens. 1B;Muta. 2;Aquatic Chronic 3,REACH registration C&L,2.0,H341:1;H317:1;H412:1;Not classified:1
19016,2-amino-N-ethylbenzenesulphonanilide,201-324-7,81-10-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19023,Propylcyclopentane,218-042-5,2040-96-2,Flam. Liq. 2;Asp. Tox. 1,Notified C&L,42.0,H304:38;H225:42
19028,Tolonium chloride,202-146-2,92-31-9,Not Classified,Notified C&L,7.0,Not classified:6;H302:1
19029,"cyanthoate (ISO);S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate",223-099-4,3734-95-0,Acute Tox. 2;Acute Tox. 3,Harmonised C&L,0.0,H311:0;H300:0
19032,"Hexanedioic acid, di-C8-10-branched alkyl esters, C9-rich",291-426-8,90411-51-1,Not Classified,Notified C&L,1.0,Not classified:1
19033,"2,3-dichlorohexafluorobut-2-ene",206-133-2,303-04-8,Skin Corr. 1B;Acute Tox. 1,Notified C&L,40.0,H314:39;H330:39;H335:1;H315:1;H319:1;H301:1;H311:1
19038,2-(2-aminoethylamino)ethanol;(AEEA),203-867-5,111-41-1,Skin Corr. 1B;Skin Sens. 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H317:0;H314:0
19039,Threoninium dihydrogen phosphate,214-217-5,1114-81-4,Skin Corr. 1;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1
19043,Methylbenzethonium chloride,246-675-7,25155-18-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H318:40;H302:40;H332:40;H312:40;H335:40;H315:40
19045,2-ethylhexyl (3-isocyanatomethylphenyl)-carbamate,259-265-8,54634-94-5,Acute Tox. 4;Resp. Sens. 1;Aquatic Chronic 4,REACH registration C&L,86.0,H413:3;H334:86;H332:86
19048,"1,2,3,4-Butanetetracarboxylic acid, tetramethyl ester, reaction products with 1,2,2,6,6-pentamethyl-4-piperidinol and β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol",287-947-5,85631-00-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,3.0,H317:2;H413:2;H302:3;H319:2
19049,2-hydroxypropyl laurate,205-542-3,142-55-2,Not Classified,Notified C&L,36.0,Not classified:36
19050,4-hydroxy-3-methoxybenzonitrile,224-589-0,4421-08-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H302:43;H332:43;H312:43;H319:44;H335:43;H315:44;H301:1;H311:1;H331:1
19054,4-fluorophenoxyacetic acid,206-974-5,405-79-8,,Notified C&L,6.0,H335:6;H315:6;H319:6;H302:1
19056,"trans-4-(trans-4-Pentylcyclohexyl)-cyclohexancarbonicacid-(3,4,5-trifluorphenyl)ester",605-762-3,175859-25-3,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
19057,"4-nitro-α,α,α-trifluoro-o-toluidine",204-443-2,121-01-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H332:6;H311:4;H302:6;H312:2
19059,Lobeline sulphate,205-151-8,134-64-5,,Notified C&L,6.0,H301:6
19060,"Butanedioic acid, sulfo-, C-C16-18-alkyl esters, disodium salt",294-268-8,91697-07-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,89.0,H318:84;H302:84;Not classified:5
19063,"(1R)-1,2,3,4,5,6-hexahydro-1,5-methano-8H-pyrido[1,2-a][1,5]diazocin-8-one",207-643-8,486-86-2,Acute Tox. 4,Notified C&L,40.0,H302:40;H332:2;H312:2
19070,4-morpholinophenol,228-542-5,6291-23-2,Acute Tox. 4,Notified C&L,38.0,H302:38
19074,"Extracts (petroleum), hydrotreated light paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C",295-335-4,91995-73-2,Carc. 1B,Harmonised C&L,0.0,H350:0
19079,Ytterbium (III) oxide,215-234-0,1314-37-0,Not Classified,REACH registration C&L,126.0,Not classified:78;H335:48;H315:48;H319:48
19083,Dec-1-yne,212-132-8,764-93-2,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46.0,H318:39;H410:39;H315:40;H226:46;H335:39;H400:39;H411:1;H319:1
19084,m-phenylenebis(methylamine),216-032-5,1477-55-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,1105.0,H318:185;H332:362;H314:1099;H317:993;H412:956;H302:1025;H331:475;H330:184;H312:209;H315:48;Not classified:6;H373:2;H370:5;H311:2;H351:1;H335:1;H319:1;H371:1
19086,"1,1-dipropoxyethane",203-335-2,105-82-8,Flam. Liq. 3,REACH registration C&L,1374.0,H226:1297;H335:77;H315:87;H225:77;H319:87
19087,N-ethyl-N-methylpiperidinium iodide,407-780-5,4186-71-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
19088,3-(4-hydroxyphenyl)propan-1-ol,233-511-4,10210-17-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19093,DL-2-benzamido-5-guanidino-N-2-naphthylvaleramide hydrochloride,213-015-4,913-04-2,Carc. 1A,Notified C&L,1.0,H350:1
19095,Bis(2-butoxyethyl) sebacate,205-467-6,141-19-5,Not Classified,Notified C&L,1.0,Not classified:1
19097,Dichromium tritelluride,235-003-8,12053-39-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:42;H332:42;H312:38;H319:38;H335:38;H315:38;H317:4;H350:4
19101,"1,2,3-Propanetricarboxylic acid, 2-(1-oxobutoxy)-, trihexyl ester",619-746-9,82469-79-2,Aquatic Chronic 1,Notified C&L,2.0,H410:2;H400:1
19103,1-(4-hydrazinophenyl)sulfonyl-2-methyl-propane-2-sulfonic acid,619-707-6,58370-36-8,Aquatic Chronic 3,REACH registration C&L,38.0,H412:38
19104,"Butan-2-one O,O'-(dimethylsilanediyl)dioxime",253-689-7,37843-26-8,Skin Sens. 1;Eye Irrit. 2;STOT RE 2,Notified C&L,23.0,H317:23;H319:23;H373:22;H315:1;H312:1
19105,"ethametsulfuron-methyl (ISO); methyl 2-[(4-ethoxy-6-methylamino-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoate",619-290-0,97780-06-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,131.0,H410:128;H400:128;Not classified:3;H319:1
19107,"Benzenesulfonic acid, mono-C10-13-alkyl derivs., sodium salts",290-656-6,90194-45-9,Not Classified,Notified C&L,469.0,Not classified:143;H318:203;H315:319;H302:159;H312:47;H319:116;H400:44;H411:33;H412:8;H311:1;H410:1
19115,1-nitropyrene,226-868-2,5522-43-0,Carc. 2,Notified C&L,56.0,H351:55;H341:13;H413:1;H350:1;H315:1;H319:1;H340:1;H335:1
19117,"α,α,α-trifluoro-3-nitro-o-xylene",229-688-2,6656-49-1,,Notified C&L,6.0,H301:4;H319:5;H315:5;H311:4;H332:2;H302:2;H312:2;H335:1
19122,"Disodium 4,5-dichloro-2-[[4,5-dihydro-3-methyl-5-oxo-1-(3-sulphonatophenyl)-1H-pyrazol-4-yl]azo]benzenesulphonate",265-633-9,65212-76-2,,Notified C&L,83.0,Not classified:83
19123,Reaction mass of (Z)-3-Methylhex-2-enyl acetate and (E)-3-Methylhex-2-enyl acetate,439-080-0,341017-24-1,Aquatic Acute 1,Notified C&L,25.0,H400:25
19124,6-(phthalimido)peroxyhexanoic acid,410-850-8,128275-31-0,Org. Perox. D;Eye Dam. 1;Aquatic Acute 1,Harmonised C&L,0.0,H318:0;H242:0;H400:0
19126,Nonan-5-one,207-946-5,502-56-7,Flam. Liq. 3,Notified C&L,3.0,H226:1;H372:1;H336:1;H335:1;H319:1;Not classified:1
19127,Pent-4-enoic acid,209-732-7,591-80-0,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1547.0,H318:1354;H302:1547;H314:1547;H290:1
19131,"3,5-dinitrosalicylohydrazide",213-471-4,955-07-7,,Notified C&L,2.0,H302:2;H332:1;H312:1;H319:1;H335:1;H315:1
19134,Ketobemidone hydrochloride,227-749-8,5965-49-1,Acute Tox. 3;Acute Tox. 3,Notified C&L,3.0,H331:1;H301:2;H302:1;Not classified:1;H335:1;H315:1;H319:1
19135,Lead hydroxide,243-310-3,19783-14-3,Acute Tox. 4;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,1.0,H360:1;H332:1;H410:1;H351:1;H373:1;H302:1
19136,"Phenol, heptyl derivs.",276-743-1,72624-02-3,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,448.0,H318:448;H410:448;H314:448;H317:448;H302:448;H400:448
19137,"N,N'-octamethylenebis(dichloroacetamide)",216-033-0,1477-57-2,Acute Tox. 4;Acute Tox. 4;Carc. 2,Notified C&L,38.0,H332:38;H312:38;H351:38
19139,Europium(III) oxide,215-165-6,1308-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,71.0,H335:48;H315:48;H319:48;Not classified:23
19141,3-methylcyclopentadecan-1-one,208-795-8,541-91-3,Not Classified,REACH registration C&L,1563.0,Not classified:1560;H315:3;H319:3;H335:1
19143,1-aminocyclopentane-1-carbonitrile,610-484-0,49830-37-7,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1.0,H302:1;H314:1
19151,4-bromobenzenesulphonyl chloride,202-683-2,98-58-8,Skin Corr. 1B,Notified C&L,46.0,H314:46;H318:1;H290:1
19153,1-ethyl-2-[(1-ethyl-4(1H)-quinolylidene)methyl]quinolinium iodide,211-205-1,634-21-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,38.0,H301:38;H311:38;H331:38;H319:38;H335:38;H315:38
19156,Dibutyl sulphide,208-870-5,544-40-1,Not Classified,Notified C&L,324.0,Not classified:238;H335:68;H315:86;H319:86;H301:10;H305:10;H303:10;H336:18;H331:18;H227:10
19157,Cymbopogon martini oil,616-947-3,8014-19-5,Skin Irrit. 2,Notified C&L,112.0,H315:112;H317:48;H318:47;H412:33;H411:1;H226:1
19158,"Hexasodium hydrogen bis[2-[[6-[[4-chloro-6-[[4-[2-(4-nitro-2-sulphophenyl)vinyl]-3-sulphophenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3-sulpho-2-naphthyl]azo]benzoato(5-)]chromate(7-)",274-995-7,70892-94-3,Not Classified,Notified C&L,54.0,Not classified:54
19161,"N,N-diethylbutane-1,4-diamine",248-456-1,27431-62-5,,Notified C&L,5.0,H314:5
19163,butyl methylphosphinate,612-366-4,6172-80-1,Skin Corr. 1C;Aquatic Chronic 3,Notified C&L,1.0,H314:1;H412:1
19165,Triethyltin bromide,220-443-5,2767-54-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,42.0,H410:42;H330:42;H300:42;H310:42;H400:42
19166,"Reaction mass of 1-butyl-5-[(9,10-dioxo-9,10-dihydroanthracen-1-yl)diazenyl]-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile and 5-[(9,10-dioxo-9,10-dihydroanthracen-1-yl)diazenyl]-1-hexyl-6-hydroxy-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile and 5-[(9,10-dioxo-9,10-dihydroanthracen-1-yl)diazenyl]-6-hydroxy-4-methyl-2-oxo-1-propyl-1,2-dihydropyridine-3-carbonitrile",457-500-0,,Aquatic Chronic 4,Notified C&L,1.0,H413:1
19169,Cyclohex-2-ene-1-ol,212-501-3,822-67-3,Flam. Liq. 3,Notified C&L,41.0,H226:41
19170,Dodecylphenoxybenzene,247-133-2,25619-63-0,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H315:1
19172,"1,2,3,4-Butanetetracarboxylic acid, tetramethyl ester, reaction products with 2,2,6,6-tetramethyl-4-piperidinol and β,β,β',β'-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol",287-948-0,85631-01-2,Acute Tox. 4,Notified C&L,1.0,H302:1
19173,C.I. DIRECT BLUE 273,400-780-6,,Not Classified,Notified C&L,39.0,Not classified:39
19174,C.I. Acid Red 362,612-464-7,61814-58-2,Not Classified,Notified C&L,1.0,Not classified:1
19177,"2,3,6-TBA (ISO);2,3,6-trichlorobenzoic acid",200-026-4,50-31-7,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
19179,"1,5-Naphthalenedisulfonic acid, 2-[2-[8-[[4-chloro6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-,sodium salt (1:5)",402-420-3,,Not Classified,REACH registration C&L,45.0,Not classified:45
19180,1-iodonaphthalene,201-968-9,90-14-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
19181,reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane),401-530-9,,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 1,Harmonised C&L,0.0,H332:0;H370:0;H228:0;H312:0;H302:0
19184,"Soaps, stocks, C14-18 and C16-18-unsatd. alkyl, acidulated",272-860-7,68918-40-1,Not Classified,Notified C&L,1.0,Not classified:1
19188,"6-nitro-2H-3,1-benzoxazine-2,4(1H)-dione",225-151-1,4693-02-1,Acute Tox. 3;Eye Irrit. 2,Notified C&L,39.0,H301:38;H319:39;H335:1;H315:1
19194,"1-bromo-4,5-dimethoxy-2-methylbenzene",610-900-0,52806-46-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
19198,"1,3-Benzodioxole-5-carboxylic acid, 2,2-diethyl-3a,6,7,7a-tetrahydro-7-[(methylsulfonyl)oxy]-, ethyl ester, (3aR,7R,7aR)-",606-549-8,204254-90-0,Aquatic Chronic 3,Notified C&L,1.0,H412:1
19199,Benethamine penicillin,212-029-8,751-84-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,115.0,H317:115;H334:106;H373:9
19200,Isopentadecanoic acid,256-870-9,50973-09-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1.0,H335:1;H413:1;H315:1;H319:1
19202,Triisopentylamine,211-441-5,645-41-0,Skin Corr. 1B,Notified C&L,40.0,H314:40;H317:1;H318:1
19203,"Fatty acids, C8-10, tetraesters with pentaerythritol",287-827-2,85586-24-9,Not Classified,REACH registration C&L,13.0,Not classified:13
19204,Amphotericin B,215-742-2,1397-89-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,260.0,H335:259;H315:258;H319:256;H318:1;H302:2;H332:3;H312:3;H334:1;H317:2;H372:1
19207,5-chloro-2-nitroanisole,229-594-1,6627-53-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
19208,Dimethyl 3-oxoglutarate,217-385-8,1830-54-2,Not Classified,REACH registration C&L,98.0,Not classified:5;H317:94;H319:1
19210,"7(S),18-dihydroxy-16(S),18(R)-dimethyl-10-phenyl[11]cytochalasa-5,13(E),19(E)-triene-1,17-dione 21(R)-acetate",244-803-6,22144-76-9,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Repr. 2,Notified C&L,38.0,H361:38;H330:38;H310:38;H300:38
19214,(R)-9-(2-Hydroxypropyl)adenine,604-188-0,14047-28-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
19218,"Eucalyptus, ext.",296-357-7,92502-70-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,81.0,H411:53;H304:55;H317:56;H226:55;H315:78;H410:3;H400:3;H319:1
19220,"Potassium hydrogen 7-aminonaphthalene-1,3-disulphonate",212-669-8,842-15-9,Not Classified,Notified C&L,7.0,Not classified:6;H335:1;H315:1;H319:1
19221,Tris(dioctyl phosphato-O'')(propan-2-olato)titanium,262-787-9,61436-47-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H335:1;H315:1;H319:1
19224,Phenyl isocyanide,213-239-2,931-54-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1.0,H331:1;H301:1;H311:1
19227,"Phenol, isobutylenated, phosphate (3:1)",273-065-8,68937-40-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,34.0,H410:25;H400:23;Not classified:7;H412:1;H411:1
19228,"1,2-Benzenedicarboxylic acid, 1-nonyl 2-undecyl ester, branched and linear",601-084-7,111381-91-0,,Notified C&L,1.0,Not classified:1
19230,"Disodium [[N,N'-ethylenebis[N-(carboxymethyl)glycinato]](4-)-N,N',O,O',ON,ON']manganate(2-)",239-407-5,15375-84-5,Not Classified,REACH registration C&L,189.0,Not classified:186;H319:3
19234,"(4aS, 6R, 8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef] [2] benzazepine-6-ol",927-076-6,,Not Classified,Notified C&L,1.0,Not classified:1
19237,"1,4-bis(bromomethyl)-2,5-dimethylbenzene",252-413-2,35168-62-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1
19238,Poly(hexamethylenbiguanid)-hydrochlorid,618-745-0,91403-50-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,47.0,H410:47;H317:47;H319:47;H315:47;H400:47
19240,"Resin acids and Rosin acids, sodium salts",263-144-5,61790-51-0,Eye Irrit. 2,REACH registration C&L,346.0,H319:178;Not classified:119;H412:33;H317:16;H334:16;H315:1
19244,N-(tert-butoxycarbonyl)-L-phenylalanine,237-305-5,13734-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8.0,H335:3;H315:3;H319:6;Not classified:2;H302:2
19246,"1,3-dimethyl-2-[[4-(methylamino)phenyl]azo]-1H-imidazolium chloride",289-543-4,89923-52-4,Not Classified,Notified C&L,1.0,Not classified:1
19247,"4,4'-methylenebis(2,6-xylidine)",223-786-9,4073-98-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,125.0,H411:2;H302:125;H332:125;H351:84;H317:85;H401:1;H312:125;H319:124;H335:125;H315:125;H410:83;H400:83
19249,"2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline, disulpho derivative, disodium salt",258-111-7,52698-84-7,Not Classified,Notified C&L,1.0,Not classified:1
19253,Tributylethylammonium ethyl sulphate,268-329-4,68052-51-7,Aquatic Chronic 3,REACH registration C&L,104.0,H412:1;Not classified:84;H314:18;H318:18;H302:18;H312:18;H315:1;H319:1
19254,2-fluoro-α-methylbenzyl alcohol,207-155-5,445-26-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:41;H315:41;H319:41
19255,(R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone,226-908-9,5543-58-8,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1;STOT RE 1;Aquatic Chronic 2;Repr. 1A,Harmonised C&L,0.0,H411:0;H360:0;H330:0;H300:0;H372:0;H310:0
19256,Tetraethyl pyrophosphite,244-494-8,21646-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19257,"lead chromate molybdate sulfate red;C.I. Pigment Red 104;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.]",235-759-9,12656-85-8,Carc. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1A,Harmonised C&L,0.0,H360:0;H410:0;H373:0;H350:0;H400:0
19259,"1,3-(dihexyl)thiourea",244-191-0,21071-28-3,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,38.0,H413:38;H302:38
19260,"potassium 6-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide",449-880-1,,Flam. Sol. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;STOT SE 1;Aquatic Chronic 3,REACH registration C&L,2.0,H314:2;H317:2;H370:2;H412:2;H228:2;H302:2
19263,"Alcohols, C16 and C18-unsatd.",283-069-1,84539-78-6,Not Classified,Notified C&L,2.0,Not classified:2
19268,"1,4-dihydroxy-5,8-bis[(2-hydroxyethyl)amino]anthraquinone",221-666-0,3179-90-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,61.0,H335:45;H302:45;H315:45;H319:45;Not classified:16
19270,"Formaldehyde, polymer with nonylphenol, reaction products with diethanolamine and propylene oxide",614-668-1,68610-97-9,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,10.0,H411:3;H317:3;H315:8;H319:3;H318:5;H302:5;Not classified:2
19274,5-chloro-2-methyl-2H-isothiazol-3-one,247-500-7,26172-55-4,Acute Tox. 2;Acute Tox. 2;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1,Notified C&L,2390.0,H318:1525;H314:2352;H330:839;H300:479;H317:2354;H310:664;H400:2260;H301:1753;H311:1564;H335:700;H302:219;H410:915;H331:538;H226:83;H334:120;H370:80;H413:90;H312:42;Not classified:31;H412:20;H332:3;H319:2;H315:2
19275,2-chloro-3-trifluoromethylpyridine,424-520-6,65753-47-1,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Chronic 3,Harmonised C&L,0.0,H301:0;H314:0;H311:0;H412:0;H372:0
19276,"Benzenesulfonic acid, hydroxy-, polymer with formaldehyde and urea",618-545-3,9041-04-7,Not Classified,Notified C&L,11.0,Not classified:8;H412:3
19277,Benzyl hydrogen phenylmalonate,247-257-7,25774-02-1,,Notified C&L,5.0,H335:4;H315:5;H319:5
19279,"Glycerides, tallow di-, hydrogenated",271-389-4,68553-09-3,Not Classified,Notified C&L,2.0,Not classified:2
19280,Aluminium methanolate,212-735-6,865-31-6,Flam. Sol. 1;Skin Corr. 1B,Notified C&L,26.0,H228:26;H314:26
19283,Ethyl (E)-4-decenoate,278-509-4,76649-16-6,Not Classified,Notified C&L,88.0,Not classified:88
19285,"(±)-2,3-dihydro-1H-pyrrole-2-carboxylic acid",222-243-3,3395-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
19286,"N,N-oxalylbis(cyclohexanone hydrazone)",206-729-2,370-81-0,,Notified C&L,7.0,H335:5;H315:6;H319:6;H302:1;H312:1
19289,N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-iodoquinazolin-4-amine,458-180-5,,Aquatic Chronic 4,Notified C&L,1.0,H413:1
19290,β-chlorophenetole,210-757-0,622-86-6,Acute Tox. 4;Eye Irrit. 2,REACH registration C&L,49.0,H302:4;H319:49;H335:40;H315:45
19294,Lead oxide,215-626-1,1335-25-7,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Chronic 1,Notified C&L,286.0,H360:286;H332:286;H410:286;H373:286;H302:286;H400:286
19296,Dipotassium silicate,233-001-1,10006-28-7,,Notified C&L,39.0,H335:39;H314:39
19299,C.I. Disperse Orange 93,615-960-1,73299-31-7,,Notified C&L,8.0,H412:8
19303,1-(o-tolyl)cyclohexan-1-ol,230-142-0,6957-09-1,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H335:39;H318:39;H315:39
19310,4'-Iodoacetanilide,612-973-4,622-50-4,Skin Irrit. 2,Notified C&L,40.0,H315:40;H319:2;H335:1
19312,Cottonseed oil,232-280-7,8001-29-4,Not Classified,Notified C&L,272.0,Not classified:272
19315,"Trisodium bis[2-hydroxy-5-[[4-[(4-nitro-2-sulphophenyl)amino]phenyl]azo]benzoato(3-)-O1,O2]chromate(3-)",280-158-7,83027-56-9,Eye Irrit. 2,Notified C&L,36.0,H319:35;Not classified:1
19318,"Fatty acids, tall-oil, diesters with polyethylene glycol",612-390-5,61791-01-3,Not Classified,Notified C&L,45.0,Not classified:45
19320,7-amino-4-hydroxy-3-[(4-methoxy-2-sulphophenyl)azo]naphthalene-2-sulphonic acid,240-502-9,16452-06-5,Not Classified,REACH registration C&L,2.0,Not classified:2
19322,"2,4-dichloro-5-(chlorosulphonyl)benzoic acid",223-127-5,3740-18-9,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1
19325,2-[(4-amino-3-methoxyphenyl)sulphonyl]ethyl hydrogen sulphate,247-895-6,26672-22-0,Not Classified,REACH registration C&L,2.0,Not classified:2
19326,Zinc distearate,209-151-9,557-05-1,Not Classified,REACH registration C&L,2003.0,Not classified:1195;H413:475;H335:597;H400:651;H319:77;H302:57;H412:15;H320:1;H315:2;H301:1
19327,"[S(R*,R*)]-2,3-bis[(4-methylbenzoyl)oxy]succinic acid",251-132-2,32634-68-7,Not Classified,REACH registration C&L,54.0,Not classified:44;H317:4;H319:10;H412:4;H315:5;H335:3
19329,"{(S)-1-[2-(2,3- Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-diphenyl-acetonitrile",607-657-8,252317-48-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H317:1;H410:1;H400:1
19333,"(2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate",408-050-9,76855-69-1,Eye Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0;H319:0
19336,Hex-1-yn-3-ol,203-286-7,105-31-7,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Eye Dam. 1,Notified C&L,44.0,H301:44;H318:39;H226:44;H310:43;H330:1;H311:1;H315:1
19338,"4,7-Methanoisobenzofuran-1,3-dione, 4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro-, polymer with 1,2-ethanediol and 2,5-furandione",814-277-8,31471-93-9,Carc. 2,Notified C&L,1.0,H351:1
19342,"3,5-dibromo-4-hydroxybenzaldehyde",221-017-1,2973-77-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
19345,"Fatty acids, C14-18 and C16-18-unsatd., mixed esters with neopentyl glycol and trimethylolpropane",286-078-9,85186-92-1,Not Classified,Notified C&L,1.0,Not classified:1
19348,3-α-hydroxy-7-oxo-5-β-cholan-24-oic acid,225-083-2,4651-67-6,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,13.0,H315:8;H319:8;Not classified:3;H302:2;H228:1;H335:1;H332:1
19349,4-chlorobutan-1-ol,213-175-5,928-51-8,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H302:46;H315:45;H226:43;H319:45;H335:45;Not classified:1;H351:2;H290:2;H314:1
19350,Undecanolactone,254-399-3,39282-36-5,Not Classified,REACH registration C&L,4.0,Not classified:4
19351,"Antimony, compound with manganese (1:2)",234-784-2,12032-97-2,,Notified C&L,4.0,H411:4;H332:4;H302:4
19354,"Cashew, nutshell liq., oligomeric reaction products with 1-chloro-2,3-epoxypropane",500-210-7,68413-24-1,Skin Sens. 1B;STOT RE 2,REACH registration C&L,252.0,H317:229;H373:5;Not classified:23;H411:10;H315:10;H319:10
19358,"2-(heptadecenyl)-4,5-dihydro-1H-imidazole-1-ethanol",248-248-0,27136-73-8,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1170.0,H318:578;H410:1123;H314:1067;H317:1017;H302:1132;H400:1122;H315:65;H319:94;H373:15;H411:9;H334:1;H420:1;H340:1
19359,"Benzo[h]benz[5,6]acridino[2,1,9,8-klmna]acridine-8,16-dione",207-498-0,475-71-8,Not Classified,Notified C&L,128.0,Not classified:90;H319:38
19361,1-phenylpentan-2-one,229-726-8,6683-92-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38.0,H302:38;H319:38
19363,2-[(p-aminophenyl)sulphonyl]ethanol,226-047-9,5246-58-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39;H303:1;H333:1
19365,"Polyphosphoric acids, esters with triethanolamine, sodium salts",268-625-3,68131-72-6,Met. Corr. 1,REACH registration C&L,52.0,H290:29;Not classified:18;H315:5;H319:5
19366,"2-bromo-4,6-difluoroaniline",429-430-0,444-14-4,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
19368,"Phosphoric acid, C12-14-branched and linear alkyl esters, sodium salts",306-974-6,97468-22-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,2.0,H318:2;H315:2
19369,Tofisopam,244-922-3,22345-47-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,40.0,H302:40;H400:39;H335:1;H315:1;H319:1;H410:1
19370,"(±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile",419-290-9,,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H317:0;H413:0
19371,Tris(2-pyridylmethyl)amine,605-519-1,16858-01-8,Acute Tox. 4,Notified C&L,39.0,H302:38;H315:1;H319:1
19374,Monosodium phosphate monohydrate,600-102-0,10049-21-5,Not Classified,Notified C&L,46.0,Not classified:36;H335:9;H315:9;H319:9;H332:1;H302:1;H312:1
19375,"3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile",236-325-1,13301-61-6,Skin Sens. 1,Notified C&L,46.0,H317:41;Not classified:5
19379,"Esterification reaction of fatty acids, linseed-oil and neodecanoic acid, oxiranylmethyl ester",920-782-5,,Not Classified,Notified C&L,71.0,Not classified:71
19380,2-ethyl-3-methoxypyrazine,247-184-0,25680-58-4,Acute Tox. 4,Notified C&L,1416.0,H302:1414;H335:40;H318:39;H315:41;H319:2
19381,"2,2-diphenylvaleric acid",212-665-6,841-32-7,Acute Tox. 4,Notified C&L,38.0,H302:38
19383,"2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine hydrochloride",617-892-8,86604-75-3,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,11.0,H317:1;H413:1;H315:2;H319:3;H335:1;H314:7;H302:3;H316:1;Not classified:1
19384,Dipotassium methanedisulphonate,228-543-0,6291-65-2,Not Classified,REACH registration C&L,47.0,Not classified:3;H335:44;H315:44;H319:44
19385,Harman,207-642-2,486-84-0,Not Classified,Notified C&L,1.0,Not classified:1
19390,4-(4-chlorophenoxy)aniline,202-976-5,101-79-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,134.0,H318:129;H302:130;H317:129;H315:133;H335:133;H351:5;H319:4;H332:1;H312:1
19394,"Bentonite, sodian",285-199-4,85049-30-5,Not Classified,Notified C&L,1.0,Not classified:1
19396,Isobutyl 2-(methylamino)benzoate,265-798-7,65505-24-0,Not Classified,Notified C&L,89.0,Not classified:88;H335:1;H302:1;H315:1;H319:1
19398,o-(1-piperazinyl)phenol dihydrobromide,261-190-0,58260-69-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
19399,Potassium selenite,233-909-8,10431-47-7,,Notified C&L,4.0,H301:4;H410:4;H373:4;H331:4;H400:4
19400,2-(1-methyl-2-pyrrolidine)ethanol,266-538-5,67004-64-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,42.0,H318:42;H302:42;H315:42
19401,"Butanedioic acid, sulfo-, C-C14-18-alkyl esters, disodium salts",294-267-2,91697-06-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4.0,H318:4;H315:3
19403,"4-hydroxymethyl-1,3-dioxolan-2-one",213-235-0,931-40-8,Not Classified,REACH registration C&L,16.0,Not classified:16
19404,"4-bromo-α,α,α-trifluoro-o-toluidine",207-150-8,445-02-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,46.0,H302:45;H332:45;H312:41;H319:46;H335:40;H315:46;H311:4
19407,"Petasites japonicus, ext.",295-215-1,91845-41-9,Not Classified,Notified C&L,2.0,Not classified:2
19411,Propyl 2-butenoate,233-768-2,10352-87-1,,Notified C&L,1.0,H226:1;H319:1
19412,DCF-pyrimidine,446-560-3,,Acute Tox. 2;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4;STOT RE 2;Aquatic Chronic 1,Notified C&L,1.0,H332:1;H410:1;H314:1;H300:1;H373:1;H317:1;H311:1
19413,3-[(trifluoromethyl)thio]aniline,206-722-4,369-68-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H302:42;H332:42;H312:38;H319:44;H335:40;H315:44;H311:6;H301:2;H331:2
19414,Cesium acetate,222-248-0,3396-11-0,Acute Tox. 4;Eye Irrit. 2;Repr. 2;STOT RE 2,REACH registration C&L,51.0,H373:2;H302:3;H319:2;H361:3;Not classified:47;H336:1
19415,"2,5-dichloro-4-nitroaniline",229-591-5,6627-34-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,43.0,H411:38;H330:38;H373:38;H300:38;H310:38;H335:4;H315:5;H319:5
19420,p-propylphenol,211-446-2,645-56-7,Skin Corr. 1B,Notified C&L,1444.0,H314:1316;H332:127;H302:133;H312:127;H319:48;H335:48;H315:48;H412:10;Not classified:1;H318:1
19421,"methyl 3-amino-4,6-dibromo-2-methyl-benzoate",425-190-6,119916-05-1,STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H373:0
19423,2-chloroquinoxaline,215-905-8,1448-87-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:40;H301:39;H315:41;H319:41;H332:2;H302:2;H312:2
19424,2-bromobenzonitrile,218-045-1,2042-37-7,Acute Tox. 4,Notified C&L,49.0,H302:45;H301:4;H332:8;H412:6;H312:10;H319:9;H335:6;H315:7
19425,tert-butyl peroxyneodecanoate,247-955-1,26748-41-4,Org. Perox. D;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,111.0,H410:23;H242:26;H317:111;H315:111;H400:23;H412:3
19429,Magnesium bis(hydrogen carbonate),218-240-1,2090-64-4,Not Classified,Notified C&L,1.0,Not classified:1
19430,Tetrapotassium ethylenediaminetetraacetate,227-743-5,5964-35-2,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT RE 2,REACH registration C&L,132.0,H318:7;H332:4;H302:55;H373:4;H319:127;Not classified:1;H335:1;H315:1
19431,"2,4-dihydro-4-[(2-hydroxyphenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-one",233-006-9,10010-74-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,38.0,H301:38;H315:38;H319:38;H335:38;H400:38
19434,"3H-1,4-Benzodiazepine-2-acetic acid, 7-chloro-5-(2-fluorophenyl)-α-(hydroxyimino)-, ethyl ester",616-438-6,77132-89-9,Not Classified,REACH registration C&L,2.0,Not classified:2
19435,2-bromo-N-(2-hydroxy-5-nitrophenyl)acetamide,223-539-5,3947-58-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19438,1-allyl-3-(2-hydroxyethyl)thiourea,203-334-7,105-81-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
19439,"tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate",403-660-1,107246-80-0,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
19442,5-methylheptan-3-one,208-793-7,541-85-5,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Harmonised C&L,0.0,H226:0;H335:0;H319:0
19449,Phenylbutazone,200-029-0,50-33-9,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2,Notified C&L,137.0,H301:128;H332:93;H334:56;H351:89;H317:57;H312:93;H319:133;H335:99;H315:100;H361:33;H302:8;H360:1;H362:1;H350:1;H373:1;H400:1
19451,2-chloro-N-methyl-3-oxobutyramide,223-907-5,4116-10-3,Acute Tox. 4;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H318:38;H317:38;H315:38;H311:38;H335:38;H302:38
19453,4-[2-[(cyclohexylcarbonimidoyl)amino]ethyl]-4-methylmorpholinium toluene-p-sulphonate,219-650-3,2491-17-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
19457,"fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide",607-285-6,239110-15-7,Aquatic Acute 1,Notified C&L,128.0,H400:128;H410:1
19458,(triethylammonium) maleate,213-960-2,1069-58-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1,Notified C&L,71.0,H318:71;H302:71;H314:71;H317:71;H312:71;H315:71
19460,"3-hydroxy-2,2-dimethylpropionaldehyde",209-895-4,597-31-9,Eye Irrit. 2,Notified C&L,40.0,H319:40;H315:2;H335:1
19462,2-methylpent-2-en-1-ol,216-549-6,1610-29-3,Flam. Liq. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,38.0,H317:38;H318:38;H226:38
19463,"α,α,α-trifluoro-p-tolyl isocyanate",216-284-6,1548-13-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3,Notified C&L,45.0,H302:39;H332:38;H334:44;H312:38;H319:45;H335:44;H315:45;H330:6;H301:1;H311:1;H331:1;H227:1
19466,N-[4-bromo-2-(2-pyridylcarbonyl)phenyl]-2-chloroacetamide,255-427-7,41526-21-0,Not Classified,REACH registration C&L,4.0,Not classified:2;H335:1;H302:2;H315:1;H319:1
19467,N-(4-butoxyphenyl)acetamide,245-739-1,23563-26-0,Skin Sens. 1,Notified C&L,38.0,H317:38
19470,Triethylmethylammonium Tetrafluoroborate,614-970-3,69444-47-9,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2.0,H318:1;H302:1;H314:1;Not classified:1
19473,"3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-(2-cyanoethyl) 5-methyl ester",616-188-8,75130-24-4,Eye Irrit. 2;STOT SE 3,REACH registration C&L,1.0,H335:1;H319:1
19474,Calcium dilaurate,225-166-3,4696-56-4,Not Classified,Notified C&L,96.0,Not classified:95;H319:1
19476,4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid,223-701-5,4027-18-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,7.0,H301:7;H410:7;H331:7;H372:7;H312:7;H319:7;H315:7;H400:7
19480,"1,8-dibenzoylnaphthalene",242-929-6,19274-72-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H410:38;H400:38
19481,6-methylbenzothiazol-2-ylamine,219-801-3,2536-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
19483,Cymene,246-674-1,25155-15-1,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,17.0,H411:17;H226:17;H304:17
19488,"1-chloro-2,3-dimethylbenzene",480-880-4,608-23-1,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H317:1
19491,"2,2'-iminodiethanol;diethanolamine",203-868-0,111-42-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT RE 2,Harmonised C&L,0.0,H318:0;H302:0;H315:0;H373:0
19495,"2,4-dichlorostyrene",218-337-9,2123-27-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,91.0,H332:91;H302:91
19499,"2,2-dipropylvaleronitrile",226-279-0,5340-48-7,,Notified C&L,1.0,H301:1
19501,2-(chloromethyl)pyridinium chloride,230-149-9,6959-47-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,88.0,H302:87;H314:88;H312:5;H317:6;H318:4;H332:1;H330:1;H311:3;H335:1
19504,4-heptylbenzoyl chloride,256-648-1,50606-96-7,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,43.0,H318:39;H335:38;H314:43;H290:1
19505,"2,6-dihydroxybenzoic acid",206-134-8,303-07-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H315:47;H319:47
19507,"2-Benzyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine",605-122-3,157995-00-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1.0,H332:1;H225:1;H312:1;H302:1;H361:1
19508,Chlorotrioctylstannane,219-969-8,2587-76-0,Skin Sens. 1;Acute Tox. 2;Repr. 2;STOT RE 1;Aquatic Chronic 1,REACH registration C&L,64.0,H410:1;H330:3;H317:2;H372:3;H361:3;H335:60;H413:60;H315:60;H319:60;Not classified:3
19510,"Coconut oil, Et ester",292-754-4,90989-95-0,Not Classified,Notified C&L,88.0,Not classified:88
19511,"D-Glucitol, propoxylated",500-118-7,52625-13-5,Not Classified,REACH registration C&L,184.0,Not classified:184
19512,(hexadecylamidopropyl)trimethylammonium chloride,257-104-6,51277-96-4,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,17.0,H318:14;H410:1;H412:1;H400:4;H302:3;H314:3
19513,Methyl 4-cyanobenzoate,214-443-4,1129-35-7,,Notified C&L,8.0,H302:7;H332:7;H312:7;H319:5;H335:5;H315:5;H331:1;H301:1;H311:1
19515,"Sorbitan, diisooctadecanoate",269-410-7,68238-87-9,Not Classified,Notified C&L,8.0,Not classified:8
19518,"reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane",428-110-8,,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
19523,"1,2,3,4,5,6,7,8-octahydro-5,5-dimethylnaphthalene-2-carbaldehyde",273-660-2,68991-96-8,Not Classified,Notified C&L,233.0,Not classified:223;H411:10;H317:10
19524,bleached shellac,924-777-9,,Not Classified,Notified C&L,1.0,Not classified:1
19525,Acetoxyacetic acid,237-541-9,13831-30-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,40.0,H318:39;H314:40
19527,"1H-Pyrrolizine-1-carboxylic acid, 2,3-dihydro-, methyl ester",616-384-3,76786-65-7,Acute Tox. 3,Notified C&L,1.0,H301:1
19531,Hexadecyldimethylamine,203-997-2,112-69-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,773.0,H302:682;H314:767;H410:191;H400:682;H318:207;Not classified:4;H315:2
19532,"1,3-bis(4-nitrophenyl)urea",209-607-7,587-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19533,"2-Propenoic acid, 2-methyl-, C12-15-branched and linear alkyl esters",292-122-8,90552-02-6,Not Classified,REACH registration C&L,106.0,Not classified:22;H315:84;H319:84;H335:1
19536,"5-chloro-1,2,3-thiadiazole",609-892-1,4113-57-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H302:2;H332:2;H312:2;H319:2;H335:2;H315:2
19541,"4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride",425-030-5,159939-85-2,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0.0,H411:0;H314:0;H317:0;H302:0;H361:0
19544,"Silicic acid, aluminum salt",215-628-2,1335-30-4,Eye Dam. 1,REACH registration C&L,263.0,H318:207;Not classified:56
19548,4-heptylbenzoic acid,253-894-1,38350-87-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
19556,3-(9-anthryl)acrylaldehyde,254-235-0,38982-12-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2.0,H411:1;H317:1;H315:2;H319:2;H302:1
19557,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, phenyl ether",618-547-4,9041-09-2,Not Classified,Notified C&L,1.0,Not classified:1
19559,"(2,6-xylyloxy) acetic acid",430-910-7,13335-71-2,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H318:0;H302:0;H412:0
19560,Ethyl nitroacetate,210-944-7,626-35-7,,Notified C&L,9.0,H315:9;H319:7;H335:2
19564,Dihydralazine sulphate,230-808-0,7327-87-9,Acute Tox. 4,Notified C&L,5.0,H302:5;H335:2;H315:2;H319:2
19566,Diisodecyl sebacate,249-047-0,28473-19-0,Not Classified,REACH registration C&L,271.0,Not classified:271
19567,Bis(2-hexyldecyl)dodecanedioate,439-900-7,,Not Classified,Notified C&L,1.0,Not classified:1
19570,Yellow HAS 2-1232/6-RW,479-120-4,943914-64-5,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,37.0,H411:37;H317:37;H318:37;H302:37
19571,"2-[7-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)hepta-1,3,5-trienyl]-1,3,3-trimethyl-3H-indolium iodide",243-282-2,19764-96-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;Not classified:1
19572,Diethyl(3H-1-ethoxy-3-phenoxazinylidene)ammonium chloride,220-516-1,2787-91-9,,Notified C&L,11.0,H318:10;H302:8;H301:2;H410:2;H400:2;Not classified:1
19580,"1-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl]pyridinium hydrogen sulphate",264-665-0,64086-81-3,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,2.0,H411:2;H302:2;H319:2
19583,"Pyrido[3,2-b]pyrazine",206-294-9,322-46-3,,Notified C&L,6.0,H335:6;H315:6;H319:6
19584,"Ethyl 2-amino-4,5-dimethyl3-thenoate",225-387-5,4815-24-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,5.0,H335:4;H315:5;H319:5;H302:2;H332:2;H312:2
19585,chromium pentanitrate hydroxide solution,612-078-9,610803-21-9,Skin Corr. 1A,Notified C&L,1.0,H314:1
19587,"2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide]",225-822-9,5102-83-0,Not Classified,REACH registration C&L,521.0,Not classified:520;H413:1
19589,"2,6-dimethyl-1-piperidylamine",254-310-8,39135-39-2,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38.0,H302:38;H332:38;H226:38;H312:38;H319:38;H335:38;H315:38
19592,"2-amino-6-ethoxy-4-methylamino-1,3,5-triazine",403-580-7,62096-63-3,Acute Tox. 4,Harmonised C&L,0.0,H302:0
19594,"benzhydryl (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-trityloxyiminoacetyl]amino]-3-formyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",609-462-3,376653-37-1,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1.0,H317:1;H334:1;H302:1
19595,Indium triiodide,236-839-6,13510-35-5,Skin Sens. 1;Repr. 2,Notified C&L,45.0,H317:41;H361:40;H314:4;H334:2;H302:1;H315:1;H319:1;H335:1
19599,Etofamide,246-790-2,25287-60-9,Not Classified,Notified C&L,30.0,Not classified:30
19601,N-cyclohexyltoluene-4-sulphonamide,201-268-3,80-30-8,Eye Irrit. 2,Notified C&L,38.0,H319:38
19604,2-tert-butyl-4-methoxyphenol,204-442-7,121-00-6,Not Classified,Notified C&L,153.0,Not classified:146;H351:2;H302:3;H319:6;H410:1;H315:4;H400:1;H317:1;H335:2
19605,"Thiazolidine-2,4-dione",218-941-2,2295-31-0,Not Classified,REACH registration C&L,14.0,Not classified:4;H302:7;H335:3;H315:3;H319:3;H332:1;H312:1
19608,"Chromate(3-), bis[3-[2-[5-(aminosulfonyl)-2-(hydroxy-κO)phenyl]diazenyl-κN1]-4-(hydroxy-κO)-7-[2-[2-oxo-1-[(phenylamino)carbonyl]propyl]diazenyl]-2-naphthalenesulfonato(3-)]-, sodium (1:3)",601-622-0,119535-63-6,,Notified C&L,1.0,H318:1
19611,"Carbon black, hydroxy- and 4-sulfophenyl-modified, sodium salts",610-410-7,481066-70-0,Not Classified,Notified C&L,1.0,Not classified:1
19612,Hexanoyl chloride,205-549-1,142-61-0,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,62.0,H318:5;H226:53;H314:62;H335:10;H302:16;H332:6;H312:2;H290:1
19613,Spiperone,212-024-0,749-02-0,Acute Tox. 4;Repr. 2,Notified C&L,128.0,H302:127;H361:128
19616,"1,4,10,13-tetraoxa-7,16-diazacyclooctadecane",245-965-0,23978-55-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:44;H315:45;H319:45;H318:1;H314:1;Not classified:1
19619,Bis(2-ethylhexyl) succinate,220-836-1,2915-57-3,Not Classified,Notified C&L,110.0,Not classified:110
19622,Dimethyl sulfoxide,200-664-3,67-68-5,Not Classified,REACH registration C&L,795.0,Not classified:477;H315:298;H319:309;H335:127;H332:5;H373:4;H302:1;H312:1;H341:1;H318:1;H412:1;H226:1;H351:1
19623,9-Hexadecenoic acid,606-666-4,2091-29-4,Not Classified,Notified C&L,588.0,Not classified:537;H410:51;H400:51
19626,"[1S-(1α,3aβ,4α,8aβ)]-decahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene",207-491-2,475-20-7,Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1536.0,H317:1501;H304:1501;H410:1501;H400:1533;Not classified:2;H315:2;H411:1;H412:1
19627,"Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).]",309-749-0,100801-66-9,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
19631,Noscapine hydrochloride,213-014-9,912-60-7,Acute Tox. 4,Notified C&L,48.0,H302:47;H341:1;H317:1;H334:1;H331:1;H301:1;H340:1;H311:1
19636,5-(dimethylamino)naphthalene-1-sulphonic acid,224-268-5,4272-77-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
19639,"sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid",604-228-7,141250-43-3,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1.0,H318:1;H412:1
19640,"1,2-dichloro-4-methoxybenzene",609-241-1,36404-30-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2.0,H302:1;H332:1;H315:1;H319:1;H335:1;Not classified:1
19642,5-(methylthio)-2-[(methylthio)methyl]pent-2-enal,261-978-4,59902-01-1,Acute Tox. 4,Notified C&L,1373.0,H302:1363;H335:87
19644,2-Bromo-5-(methylsulphonyl)pyridine,608-970-2,343262-51-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
19645,"[2,2,3,3,4,4,5,5,6,6,7,7,8,9,9,9-hexadecafluoro-8-(trifluoromethyl)nonyl]oxirane",255-587-8,41925-33-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
19646,C.I. Acid Red 361,612-738-6,61931-22-4,Not Classified,Notified C&L,8.0,Not classified:8
19653,"Disodium 2,2'-[(1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-2,17-divinyl-21H-biline-8,12-diyl)bis[(1-oxopropane-3,1-diyl)imino]]bis[ethane-1-sulphonate]",272-072-3,68683-34-1,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H317:1;H302:1;H319:1
19654,Mefenamic acid potassium salt,917-750-8,,Not Classified,Notified C&L,1.0,Not classified:1
19655,Disodium 8-(phenylamino)-5-[[4-[(5-sulphonatonaphthyl)azo]naphthyl]azo]naphthalenesulphonate,221-343-4,3071-73-6,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,78.0,H317:16;H319:66;H412:54;Not classified:8;H302:8
19658,"Disodium [2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-5-sulphobenzoato(3-)]chromate(2-)",280-159-2,83027-57-0,Not Classified,Notified C&L,40.0,Not classified:37;H412:3
19662,Allyl methyl trisulphide,251-843-8,34135-85-8,Eye Irrit. 2;STOT SE 3,Notified C&L,1374.0,H335:1374;H319:1374;H315:10
19670,"Distillates (petroleum), hydrodesulfurized full-range middle coker;Kerosine - unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-864-6,101316-58-9,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
19674,p-anisylamine,219-247-2,2393-23-9,Acute Tox. 4;Skin Corr. 1B,REACH registration C&L,142.0,H302:137;H314:141;H317:2;H318:87;H412:83;H312:84;H335:84;Not classified:2;H332:1
19675,Methaqualone,200-780-4,72-44-6,Acute Tox. 3;Aquatic Chronic 4,Notified C&L,194.0,H301:194;H413:194
19676,Hydroxyl-2-pyridone,212-506-0,822-89-9,Acute Tox. 4;Eye Dam. 1;STOT RE 2,REACH registration C&L,5.0,H318:4;H302:4;H373:2;H335:2;H315:1;H319:1;H371:2
19678,Bis(hydroxyethyl)methyloleylammonium chloride,242-332-0,18448-65-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,35.0,H318:5;H315:4;H319:4;H302:34;H400:35;H314:31
19681,N-(2-ethoxyphenyl)-N'-(4-isododecylphenyl)oxamide,279-979-3,82493-14-9,Not Classified,REACH registration C&L,42.0,Not classified:40;H332:2;H226:2;H315:2;H312:2
19682,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with biphenyl-4-ol",500-655-7,161308-15-2,Not Classified,Notified C&L,2.0,Not classified:2
19684,"disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide",419-990-4,,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H400:0
19686,1-(tert-Butyl)-4-iodobenzene,609-176-9,35779-04-5,Eye Irrit. 2,Notified C&L,45.0,H319:45;H335:1;H315:1
19690,"1H-Imidazoledipropanoic acid, 4,5-dihydro-1-(2-hydroxyethyl)-, 2-norcoco alkyl derivs., disodium salts",275-119-6,71010-80-5,Not Classified,Notified C&L,1.0,Not classified:1
19697,"1,2-Difluoro-4,5-dimethoxybenzene",606-514-7,203059-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:42;H315:43;H319:43
19698,Pyrimidine-4-carboxylic acid,250-641-7,31462-59-6,Eye Irrit. 2,Notified C&L,39.0,H319:39;H335:1;H315:1
19700,"2,4-dimethylpentan-2-ol",210-877-3,625-06-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,42.0,H335:38;H318:38;H302:38;H315:38;H226:4
19711,Dimethyl suberate,217-059-5,1732-09-8,Not Classified,Notified C&L,1.0,Not classified:1
19717,"2-Propenoic acid, 3-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-, methyl ester",608-318-7,29122-72-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,REACH registration C&L,2.0,H332:2;H302:2;H312:2
19721,"6-(chloromethyl)pteridine-2,4-diamine monohydrochloride",280-027-4,82778-08-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2,REACH registration C&L,2.0,H332:2;H302:2;H312:2;H351:2
19724,2-methylamino-1-phenylpropan-1-ol,206-293-3,321-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
19730,"9-fluoro-11β,16α,17,21-tetrahydroxypregn-4-ene-3,20-dione",206-411-3,337-02-0,,Notified C&L,1.0,H302:1;H373:1
19732,"D-Ribonic acid, 2,3-O-(1-methylethylidene)-",608-517-9,30725-00-9,Not Classified,Notified C&L,1.0,Not classified:1
19734,2-methylheptan-4-one,210-943-1,626-33-5,Flam. Liq. 3,Notified C&L,1.0,H226:1
19735,Holmium trihydroxide,235-009-0,12054-57-8,Not Classified,Notified C&L,2.0,Not classified:2
19736,Trimethylphosphine,209-823-1,594-09-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51.0,H335:46;H315:47;H225:51;H319:47;H314:4;H252:4;H250:4;H302:1;H332:1;H312:1
19737,L-serine,200-274-3,56-45-1,Not Classified,REACH registration C&L,72.0,Not classified:71;H335:1;H315:1;H319:1
19740,"2,2'-[[2-[(2-hydroxyethyl)amino]ethyl]imino]bisethanol",262-258-2,60487-26-5,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8.0,H318:8;H315:8
19743,2-[4-[2-[4-(benzoxazol-2-yl)phenyl]vinyl]phenyl]-5-methylbenzoxazole,226-044-2,5242-49-9,Not Classified,Notified C&L,52.0,Not classified:51;H413:1
19744,"Phosphoric acid, mono- and bis(C6-10-branched and linear alkyl) esters",306-975-1,97468-23-0,Not Classified,Notified C&L,10.0,Not classified:10
19745,3'-methoxypropiophenone,253-729-3,37951-49-8,Not Classified,REACH registration C&L,10.0,Not classified:8;H302:2;H332:1;H315:1;H319:1;H335:1
19757,4-isopropylbenzaldehyde,204-516-9,122-03-2,Acute Tox. 4,REACH registration C&L,1756.0,H302:1755;H317:298;H335:45;H315:47;H319:46;H226:2;H411:1;H304:1
19758,"Fatty acids, C16-18, Bu esters",287-039-9,85408-76-0,Not Classified,REACH registration C&L,26.0,Not classified:23;H335:3;H315:3;H319:3
19763,Magnesium peroxide,215-627-7,1335-26-8,Ox. Sol. 2,Notified C&L,99.0,H272:99
19764,"(6R,7R,14S)-7-acetyl-7,8-dihydro-3,6-O-dimethyl-6,14-ethenomorphine",928-666-6,,Not Classified,Notified C&L,1.0,Not classified:1
19765,Prolintane hydrochloride,214-917-0,1211-28-5,,Notified C&L,1.0,H302:1
19767,Pentafluoropyridine,211-839-9,700-16-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,49.0,H332:42;H226:48;H302:42;H312:42;H314:5;H315:3;H319:3;H225:1;H335:1
19775,"Fatty acids, C8-10, triesters with trimethylolpropane",293-036-3,91050-89-4,Not Classified,REACH registration C&L,122.0,Not classified:122
19777,Azintamide,217-384-2,1830-32-6,Acute Tox. 4,Notified C&L,1.0,H302:1
19778,"2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, mixed esters with C12-13-alcs. and phosphoric acid",283-752-4,84712-62-9,,Notified C&L,1.0,H318:1;H314:1
19783,Silicon monoxide,233-232-8,10097-28-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,222.0,H335:215;H315:215;H319:215;H373:4;Not classified:3
19784,Eulava SM,606-187-0,18972-56-0,,Notified C&L,9.0,H301:8;H302:1;H314:1;H318:1;H332:1;H412:1;H331:1;H311:1
19785,"2',5'-dihydroxyacetophenone",207-716-4,490-78-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,49.0,H335:48;H315:49;H319:49
19786,"1-Ethyl-14-diethoxycarbonyl-1,2,3,4,5,6,12,12b-octahydro-indolo[2,3-a]tetrahydro-pyranyl[2,3-c]quinolyzine",603-893-0,135099-82-0,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H332:2;H410:2;H373:2;H317:2;H302:2;H400:2
19788,3-bromo-5-(trifluoromethyl)aniline,259-412-6,54962-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,48.0,H335:43;H315:48;H319:48;H332:8;H311:4;H302:8;H312:4
19792,Ethylenediammonium dichloride,206-369-6,333-18-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3,Notified C&L,61.0,H334:52;H317:56;H315:55;H319:55;H335:52;H302:57;H361:4;H373:4
19793,"Perfluoro Compunds, (primary Compounds with 12 Carbons)",617-869-2,86508-42-1,Aquatic Chronic 4,Notified C&L,190.0,H413:185;Not classified:3;H315:2;H319:2
19794,Methyl 3-oxo-2-pentylcyclopentaneacetate,246-495-9,24851-98-7,Not Classified,REACH registration C&L,1798.0,Not classified:1798
19795,3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione,402-540-6,105254-85-1,Skin Corr. 1B;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H410:0;H314:0;H400:0
19800,"3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane",410-730-5,90498-90-1,Acute Tox. 4,Harmonised C&L,0.0,H312:0
19801,"Benzene, 1-ethoxy-2,3-difluoro-4-[(trans,trans)-4'-propyl[1,1'-bicyclohexyl]-4-yl]-",606-626-6,207598-84-3,Not Classified,Notified C&L,1.0,Not classified:1
19804,"trans,trans-1,3-Difluor-2-[(R)-(1-methylheptyl)oxy]-5-(4-propyl[1,1-bicyclohexyl]-4-yl)-benzene",605-172-6,159077-75-5,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
19805,Sodium bis[1-[(2-hydroxy-4-nitrophenyl)azo]naphthalen-2-olato(2-)]cobaltate(1-),264-965-1,64611-71-8,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,86.0,H318:83;H412:83;Not classified:2;H335:1;H315:1;H319:1
19807,"Disodium [2,2'-bi-1H-indole]-3,3'-diolate",212-974-6,894-86-0,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,5.0,H318:4;H314:4;Not classified:1
19808,Ethyl trimethylsilylacetate,223-783-2,4071-88-9,Flam. Liq. 3,Notified C&L,43.0,H226:43
19810,1-chloronaphthalene,201-967-3,90-13-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,52.0,H302:52;H315:46;H319:46;H335:45;H400:42;Not classified:2;H410:4;H411:1;H371:1;H373:1;H332:1;H341:1
19812,"Hexahydro-2H-azepin-2-one, sodium salt",218-336-3,2123-24-2,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,2.0,H318:2;H332:2;H314:2;H290:2;H302:2
19815,Cerium zirconium tetraoxide,258-407-6,53169-24-7,Not Classified,Notified C&L,1.0,Not classified:1
19816,Cellulose,232-674-9,9004-34-6,Not Classified,Notified C&L,3130.0,Not classified:3070;H335:57;H332:3;H302:2;H312:2;H319:2;H315:2;H301:1;H314:1;H412:1
19819,"2,2',2'',2'''-ethylenedinitrilotetraethanol",205-396-0,140-07-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,14.0,H318:13;H315:13;H302:2;H314:1;H317:1
19820,"Undecane-1,11-diol",212-135-4,765-04-8,Not Classified,Notified C&L,1.0,Not classified:1
19825,"1H,2H,3H,4H,6H,7H,11bH-pyrazino[2,1-a]isoquinolin-4-one",612-098-8,61196-37-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H335:1;H318:1;H302:1;H315:1
19829,Methyl 4-chlorobutyrate,221-592-9,3153-37-5,Flam. Liq. 3,Notified C&L,45.0,H226:45;H335:6;H315:6;H319:6
19830,4-[2-[4-(2-benzoxazoleyl)phenyl]vinyl]benzoic acid,225-303-7,4763-79-5,Aquatic Chronic 4,REACH registration C&L,32.0,H413:1;Not classified:31
19833,"5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, hydrochloride (2:1), [6R-[6α,7β(Z)]]-",278-299-4,75738-58-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1.0,H317:1;H334:1
19840,Methyl L-methionate hydrochloride,219-651-9,2491-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
19841,2-(p-chlorobenzyl)isothiouronium chloride,208-871-0,544-47-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19843,2-oxooctanoic acid,206-331-9,328-51-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
19853,"2,6-dichloro-4,8-dipiperidinopyrimido[5,4-d]pyrimidine",230-437-4,7139-02-8,Not Classified,REACH registration C&L,3.0,Not classified:3
19854,4-methylanisole,203-253-7,104-93-8,Acute Tox. 4;Skin Irrit. 2;Repr. 2,REACH registration C&L,1823.0,H302:1822;H315:1819;H361:1555;H412:1748;H226:1577;H319:211;H331:1
19856,"Poly(oxy-1,2-ethanediyl), a-butyl-w-hydroxy-, mixed ethers with 2-ethyl-1-hexanol and 2,2´-thiobis[ethanol]",615-238-6,71010-88-3,Aquatic Chronic 3,Notified C&L,37.0,H412:37
19857,"2,4-diethyl-1,5-pentanediol",429-310-8,57987-55-0,Eye Dam. 1,Harmonised C&L,0.0,H318:0
19859,"Fatty acids, rape-oil, Me esters",287-828-8,85586-25-0,Not Classified,REACH registration C&L,132.0,Not classified:109;H315:23;H319:23
19862,Chloroacetic anhydride,208-794-2,541-88-8,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Aquatic Acute 1,REACH registration C&L,48.0,H301:48;H314:48;H311:5;H331:5;H400:5;H317:38;H318:1
19867,"1,2-(methylenedioxy)-4-nitrobenzene",220-055-6,2620-44-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,43.0,H332:43;H302:43;H312:43
19871,HIVERNAL,437-470-5,,Acute Tox. 4;Skin Sens. 1B,Notified C&L,74.0,H317:74;H302:74
19873,Trimethyl[(1-phenylvinyl)oxy]silane,237-308-1,13735-81-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
19874,"2,6-dimethylheptan-4-one;di-isobutyl ketone",203-620-1,108-83-8,Flam. Liq. 3;STOT SE 3,Harmonised C&L,0.0,H226:0;H335:0
19876,"Propanedioic acid, 1,3-bis(2-ethylhexyl) ester",606-387-8,19824-16-9,Not Classified,Notified C&L,1.0,Not classified:1
19877,Pentyl decanoate,227-682-4,5933-87-9,Not Classified,Notified C&L,89.0,Not classified:89
19880,2-amino-3-methylpentan-1-ol,246-371-4,24629-25-2,Not Classified,Notified C&L,5.0,Not classified:3;H335:1;H315:2;H319:2
19881,"1,5-dideoxy-1,5-[(2-hydroxyethyl)imino]-D-glucitol",276-661-6,72432-03-2,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,1.0,H315:1;H314:1;H319:1;H361:1
19884,(S)-pyrrolidine-2-carboxamide monohydrochloride,255-818-2,42429-27-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
19887,"2,5-difluorobenzoyl chloride",252-701-8,35730-09-7,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,48.0,H226:43;H314:48;H335:1;H319:1;H318:1;H290:1
19889,"1,1,3,3,3-pentafluoropropene",211-717-5,690-27-7,Flam. Gas 1;Press. Gas (Liq.);Acute Tox. 3;Muta. 2,Notified C&L,2.0,H220:2;H341:2;H331:2;H280:2
19893,Rare earth fluorides,269-166-1,68188-85-2,Not Classified,Notified C&L,29.0,Not classified:27;H302:2;H332:2;H312:2;H319:2;H335:2;H315:2
19896,Diisopropyl tartrate,218-709-0,2217-15-4,Not Classified,Notified C&L,2.0,Not classified:2
19901,2-hydroxyethyl benzoate,202-323-4,94-33-7,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
19906,"2-Propenoic acid, polymer with 2-propenal",613-603-4,64476-57-9,Met. Corr. 1;Eye Dam. 1,Notified C&L,1.0,H318:1;H290:1
19907,Linalyl butyrate,201-109-8,78-36-4,Not Classified,Notified C&L,312.0,Not classified:273;H411:38;H315:1;H319:1
19910,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tri-C8-10-alkyl esters",292-007-2,90529-73-0,Not Classified,Notified C&L,3.0,Not classified:3
19912,"hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide",412-240-7,89797-03-5,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
19918,"1-Butanone, 1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-",614-249-3,68047-07-4,,Notified C&L,2.0,H302:2
19931,"Benzonitrile, 3,3'-(2,3,5,6-tetrahydro-3,6-dioxopyrrolo[3,4-c]pyrrole-1,4-diyl)bis-",617-600-9,84632-50-8,Not Classified,Notified C&L,3.0,Not classified:3
19933,"N-dodecylpropane-1,3-diamine",226-902-6,5538-95-4,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,68.0,H314:35;H317:1;H319:1;H302:22;H400:35;Not classified:33;H301:13;H318:13;H410:13;H372:13
19937,Melizitose,209-894-9,597-12-6,Not Classified,Notified C&L,2.0,Not classified:2
19941,[4-(benzyloxy)phenyl]hydrazine monohydrochloride,257-636-9,52068-30-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H335:3;H315:3;H319:3;H302:2;H332:2;H312:2
19944,Octadecyl hydrogen maleate,219-361-2,2424-62-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,5.0,H315:4;H319:4;Not classified:1;H335:2;H332:2
19945,"2,2,3,3,4,4,5,5,6,6,7,7-dodecafluoroheptanoic acid",216-283-0,1546-95-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,42.0,H302:41;H314:42;H332:1;H312:1
19950,Barium octanoate,225-165-8,4696-54-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,4.0,H332:3;H302:3;Not classified:1
19951,"Isooctanoic acid, lead(2+) salt, basic",293-985-3,91671-83-9,Not Classified,Notified C&L,1.0,Not classified:1
19952,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ester with 1,2,3-propanetriol monooctadecanoate",259-855-5,55840-13-6,Not Classified,Notified C&L,17.0,Not classified:17
19953,"reaction mass of 2,2,3,3,5,5,6,6-octafluoro-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)morpholine and 2,2,3,3,5,5,6,6-octafluoro-4-(heptafluoropropyl)morpholine",473-390-7,,,Notified C&L,2.0,Not classified:1;H319:1;H302:1;H311:1
19955,3-(diethoxymethylsilyl)propylamine,221-660-8,3179-76-8,Skin Corr. 1B,REACH registration C&L,183.0,H314:158;H412:20;Not classified:5;H318:1
19957,1-[2-cyano-1-(cyanoimino)ethyl]piperidine,260-219-4,56488-00-7,Not Classified,Notified C&L,1.0,Not classified:1
19964,"2,3,6-trimethyl-p-benzoquinone",213-309-2,935-92-2,Acute Tox. 3;Acute Tox. 1;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,85.0,H301:84;H318:83;H410:83;H314:83;H317:83;H310:83;H400:83;H335:1;H315:2;H319:2;H311:1
19965,2-methoxypyridine,216-623-8,1628-89-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:42;H226:44;H315:44;H319:44
19966,Substance P,251-545-8,33507-63-0,,Notified C&L,1.0,H332:1;H302:1;H312:1
19967,2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide,405-190-2,122371-93-1,Skin Sens. 1;Aquatic Chronic 4,Harmonised C&L,0.0,H317:0;H413:0
19969,"dioxathion (ISO);1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate)",201-107-7,78-34-2,Acute Tox. 2;Acute Tox. 3;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H330:0;H300:0;H311:0;H400:0
19970,"2-Propenoic acid, 3-[6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl]-, (2E)-",618-080-6,87848-99-5,Not Classified,Notified C&L,1.0,Not classified:1
19974,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium hydrogen sulphate",281-439-7,83949-79-5,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H301:2;H410:2;H319:2;H400:2
19975,3-nitro-p-cresol,218-044-6,2042-14-0,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,135.0,H412:91;H315:135;H319:135;H335:45;H332:4;H311:4;H302:5
19976,"Alcohols, C11-13-branched",600-353-6,102782-46-7,Not Classified,Notified C&L,4.0,Not classified:4
19978,Ethoxylated monoethanolamide of fatty acids of coconut oil,612-392-6,61791-08-0,Not Classified,Notified C&L,150.0,Not classified:63;H319:57;H315:34;H318:30;H225:1
19982,"1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxyisoquinoline",230-148-3,6957-27-3,Acute Tox. 4,REACH registration C&L,1.0,H302:1
19985,aclonifen (ISO);2-chloro-6-nitro-3-phenoxyaniline,277-704-1,74070-46-5,Skin Sens. 1A;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H410:0;H351:0;H400:0
19987,4-bromo-3-hydroxy-2-naphthoic acid,218-632-2,2208-15-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
19990,1-methyl-1-phenylethyl peroxyneodecanoate,247-956-7,26748-47-0,Org. Perox. D,REACH registration C&L,8.0,H242:8;H226:2;H304:2;H315:4
19991,"Fatty acids, C18-unsatd., dimers, compds. with C18-unsatd. fatty acid trimers and N-tallow alkyltrimethylenediamines",616-474-2,77536-81-3,Not Classified,Notified C&L,2.0,Not classified:2
19993,N-(6-ethoxybenzothiazol-2-yl)acetoacetamide,224-269-0,4273-88-5,Eye Irrit. 2,Notified C&L,38.0,H319:38
19994,"L-aspartic acid, sodium salt",241-155-6,17090-93-6,Not Classified,Notified C&L,1.0,Not classified:1
19995,"1,3-dichlorbenzene",208-792-1,541-73-1,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
19996,"5-benzoyl-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid",616-049-1,74103-06-3,Acute Tox. 3,REACH registration C&L,6.0,H301:6;H335:1;H315:1;H319:1
19998,Dodecylethyldimethylammonium bromide,269-249-2,68207-00-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
19999,"Anthra[1,9-cd]pyrazol-6(2H)-one",204-955-6,129-56-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
20003,"Rare earth metals, hydroxides",269-165-6,68188-84-1,Not Classified,Notified C&L,2.0,Not classified:2
20004,benzo[a]pyrene;benzo[def]chrysene,200-028-5,50-32-8,Skin Sens. 1;Muta. 1B;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 1B,Harmonised C&L,0.0,H360:0;H410:0;H350:0;H317:0;H340:0;H400:0
20005,(p-tolylsulphonyl)acetone,226-353-2,5366-49-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2
20006,Cyclohexapentylose,233-007-4,10016-20-3,Not Classified,REACH registration C&L,76.0,Not classified:73;H319:4
20007,ACID YELLOW 194,612-458-4,61814-52-6,Eye Irrit. 2,Notified C&L,8.0,H319:4;Not classified:4
20010,p-phenylenediacetonitrile,210-751-8,622-75-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H302:39;H332:38;H312:39;H319:40;H335:39;H315:40;H331:5;H301:5;H311:5
20015,"4,12,12-trimethyl-9-methylene-5-oxatricyclo[8.2.0.04,6]dodecane",241-609-3,17627-43-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,10.0,H335:10;H315:10;H319:10
20018,Prometon,216-548-0,1610-18-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,197.0,H411:156;H302:196;H315:194;H319:194;H335:194;Not classified:1
20020,"2,3,4-trichloroanisole",258-990-7,54135-80-7,Aquatic Chronic 4,Notified C&L,42.0,H413:38;Not classified:4
20021,2-chloro-2-oxoethyl acetate,237-542-4,13831-31-7,Skin Corr. 1B;STOT SE 3,Notified C&L,50.0,H335:44;H314:50;H318:2;H290:1;H332:1;H413:1;H312:1;H302:1
20022,"2,2'-[vinylenebis[(3-sulpho-4,1-phenylene)imino(6-chloro-1,3,5-triazine-4,2-diyl)(methylimino)(1-hydroxy-3-sulphonaphthalene-6,2-diyl)azo]]bis(naphthalene-1,5-disulphonic) acid",300-617-8,93942-63-3,Not Classified,Notified C&L,1.0,Not classified:1
20030,dinitrobenzene,246-673-6,25154-54-5,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H330:0;H373:0;H300:0;H310:0;H400:0
20032,"Sodium 1-amino-4-[[3-[[(chloroacetyl)amino]methyl]-2,4,6-trimethylphenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate",274-393-4,70209-96-0,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,96.0,H317:17;H412:59;Not classified:37
20033,"Butanedioic acid, sulfo-, C-C12-14-alkyl esters, disodium salts",294-266-7,91697-05-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,447.0,H315:441;H319:441;H318:5;Not classified:1
20034,Ethynylcyclohexane,213-236-6,931-48-6,Flam. Liq. 2,Notified C&L,44.0,H225:44;H335:1;H315:1;H319:1
20035,5-(hydroxymethyl)resorcinol,249-751-8,29654-55-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H315:45;H319:45
20039,"2,4-dimethyl-4-methyl-3H-1,2,4-triazole-3-thione",246-496-4,24854-43-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
20040,Ammonium myristate,240-599-8,16530-71-5,Not Classified,REACH registration C&L,3.0,Not classified:3
20044,"2',5-dichloro-2-(methylamino)benzophenone",227-050-8,5621-86-3,Flam. Sol. 2;Aquatic Chronic 4,Notified C&L,1.0,H228:1;H413:1
20045,"6,7-dimethyl-2,3-di-2-pyridylquinoxaline",229-592-0,6627-38-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20046,"[R-(R*,R*)]-N,N'-[dithiobis[ethyleneimino(3-oxopropane-3,1-diyl)]]bis[2,4-dihydroxy-3,3-dimethylbutyramide]",240-842-8,16816-67-4,Aquatic Acute 1,Notified C&L,1.0,H400:1
20049,2-oxoglutaric acid,206-330-3,328-50-7,Eye Dam. 1,REACH registration C&L,175.0,H318:165;H335:93;H315:94;H319:9;H314:1;Not classified:1
20052,"Disodium 4-amino-3-[{4-[({4-[(2,4-diaminophenyl)diazenyl]phenyl}sulfonyl)amino]phenyl}diazenyl]-5-hydroxy-6-[phenyldiazenyl]naphthalene-2,7-disulfonate",605-104-5,157577-99-6,Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,40.0,H318:32;H412:32;Not classified:7;H315:1;H319:1
20053,"Potassium phosphate, tribasic, monohydrate",608-057-9,27176-10-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,44.0,H318:40;H315:43;H319:4;H314:1
20054,Potassium O-butyl dithiocarbonate,212-808-2,871-58-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H332:1;H302:1;H315:1;H319:1
20057,Magnesium dibutanolate,240-060-7,15921-15-0,Flam. Sol. 1;Eye Irrit. 2,Notified C&L,2.0,H228:2;H319:2
20058,4-methylpiperazine-1-carbonyl chloride monohydrochloride,259-482-8,55112-42-0,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,143.0,H315:4;H319:4;H331:83;H301:83;H314:139;H311:83;Not classified:1
20059,Vetiverol,268-578-9,68129-81-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,307.0,H317:306;H315:307;H319:307
20061,"N,N-diethyl-N-methylethanaminium chloride",600-107-8,10052-47-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44
20063,"4,4'-Methylenediphenyl diisocyanate, oligomeric reaction products with [(methylethylene)bis (oxy)]dipropanol",500-119-2,52747-01-0,Resp. Sens. 1,Notified C&L,78.0,H334:63;Not classified:15;H332:8;H351:8;H373:8;H317:8;H319:8;H335:8;H315:8
20067,Dodec-1-yne,212-134-9,765-03-7,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,39.0,H318:38;H413:38;H335:1;H315:1;H319:1
20069,2-Butyrylfuran,609-987-8,4208-57-5,Skin Sens. 1;Eye Dam. 1,Notified C&L,43.0,H317:38;H318:38;H335:4;H315:4;H319:4;Not classified:1
20071,Methyl propyl ether,209-158-7,557-17-5,Flam. Liq. 1,Notified C&L,39.0,H224:38;H336:1;H225:1
20073,"Pyridine-2,6-diacetyl",214-442-9,1129-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:43;H315:45;H319:45
20074,"Fatty acids, C12-18 and C18-unsatd., C12-18-alkyl esters",305-957-0,95370-91-5,Not Classified,Notified C&L,1.0,Not classified:1
20075,1H-imidazole-4-carbodithioic acid,284-227-2,84824-76-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20080,"1,1'-isopropylidenebis(ethylferrocene)",310-202-3,37206-42-1,Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,9.0,H360:2;H302:4;H410:2;H373:2;Not classified:5;H312:1;H317:1
20081,Tridecan-1-ol,203-998-8,112-70-9,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2391.0,H412:5;H315:163;H319:147;H400:1584;H410:1404;H318:477;Not classified:157;H335:140;H413:16
20082,"(R*,R*)-1,4-dimercaptobutane-2,3-diol",222-468-7,3483-12-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,243.0,H318:2;H302:243;H315:243;H335:233;H319:241;H332:2;H317:2;H312:2;H341:1;Not classified:1;H412:1
20084,"(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-[(triphenylmethoxy)imino]acethyl]amino]-3-(hydroxymethyl)-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylic acid diphenylmethyl ester",609-461-8,376653-36-0,Acute Tox. 4;Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1.0,H317:1;H334:1;H302:1
20089,"1,4,7,13,16-pentaoxa-10,19-diazacyclohenicosane",245-964-5,23978-10-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20092,Diphenylmercury,209-606-1,587-85-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,45.0,H410:45;H330:45;H373:45;H300:45;H310:45;H400:45
20095,[(p-nonylphenoxy)methyl]oxirane,228-224-6,6178-32-1,Not Classified,Notified C&L,93.0,Not classified:55;H317:38;H315:38;H351:38
20096,"2,2'-(Z)-octadec-9-en-1-ylimino)bisethanol N-oxide",300-699-5,93962-62-0,Skin Corr. 1C;Aquatic Acute 1,Notified C&L,1.0,H314:1;H400:1
20097,Flopropione,218-942-8,2295-58-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
20099,"[S-(R*,S*)]-α-[2-(dimethylamino)-1-methylethyl]-α-phenylphenethyl alcohol",253-893-6,38345-66-3,Acute Tox. 4,Notified C&L,1.0,H302:1
20100,dimercury dicyanide oxide;mercuric oxycyanide,215-629-8,1335-31-5,Expl. 1.1;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H373:0;H311:0;H331:0;H201:0;H400:0
20101,"Octanoic acid, compound with tributylamine (1:1)",260-409-7,56863-01-5,Not Classified,Notified C&L,18.0,Not classified:18
20102,Chlorflurenol,219-800-8,2536-31-4,Not Classified,Notified C&L,3.0,Not classified:3
20104,Erythro-5-hydroxy-L-lysine monohydrochloride,300-180-3,93923-90-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
20109,Glycine,200-272-2,56-40-6,Not Classified,REACH registration C&L,605.0,Not classified:584;H319:17;H373:4;H315:6;H335:2
20110,"trans-4-ethyl-4'-(4-propylcyclohexyl)-1,1'-biphenyl",283-130-2,84540-37-4,Not Classified,REACH registration C&L,4.0,Not classified:4
20112,"Acetic acid, 2-hydroxy-, ammonium salt (1:1)",609-106-7,35249-89-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2
20113,"Siloxanes and Silicones, hexyl Me, Me 2-phenylpropyl",614-838-5,68952-01-2,Not Classified,Notified C&L,5.0,Not classified:5
20114,Dioctyl maleate,220-835-6,2915-53-9,Not Classified,Notified C&L,48.0,Not classified:46;H335:2;H302:2
20115,Isooctyl 2-(4-chloro-2-methylphenoxy)propionate,249-046-5,28473-03-2,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1,Notified C&L,38.0,H317:38;H302:38;H400:38
20118,dipropyl ether,203-869-6,111-43-3,Flam. Liq. 2;STOT SE 3,Harmonised C&L,0.0,H336:0;H225:0
20119,Ethyl (aminocarbonyl)carbamate,210-945-2,626-36-8,Eye Irrit. 2,Notified C&L,39.0,H319:39;H335:1;H315:1
20121,"2H-Indol-2-one, 1,3-dihydro-1-phenyl-",608-864-6,3335-98-6,,Notified C&L,1.0,H411:1
20124,O-benzyl-L-serine,225-220-6,4726-96-9,,Notified C&L,2.0,Not classified:1;H335:1;H315:1;H319:1
20127,"5-(1,3-benzodioxol-5-yl)penta-2,4-dienoic acid",226-118-4,5285-18-7,Acute Tox. 3,Notified C&L,38.0,H301:38
20131,Sodium N-(2-carboxyethyl)-N-dodecyl-β-alaninate,239-032-7,14960-06-6,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,580.0,H318:241;H315:276;Not classified:218;H319:121;H402:1
20132,Sodium 2-ethylhexanoate,243-283-8,19766-89-3,Repr. 2,REACH registration C&L,277.0,H361:88;H318:83;H315:135;H319:134;Not classified:54;H335:44
20133,2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate,410-900-9,83056-32-0,Flam. Liq. 3;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 2,Harmonised C&L,0.0,H318:0;H332:0;H334:0;H373:0;H226:0;H341:0
20134,"2,2'-dihydroxy-2,2'-biindan-1,1',3,3'-tetraone",225-823-4,5103-42-4,Acute Tox. 4;Eye Dam. 1,Notified C&L,38.0,H318:38;H302:38
20142,"Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate",225-388-0,4815-30-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
20144,ethyl 2-(2-chloroethoxy)acetate,605-630-5,17229-14-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
20152,"2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate",415-490-5,141773-73-1,Aquatic Chronic 2,Harmonised C&L,0.0,H411:0
20156,"3-[(4-amino-o-tolyl)azo]naphthalene-1,5-disulphonic acid",201-575-2,84-94-6,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,157.0,H302:157;H412:157
20157,N-(o-tolyl)-p-toluenesulphonamide,201-267-8,80-28-4,Acute Tox. 4,Notified C&L,38.0,H302:38
20158,3-aminopropylmethylamine,228-544-6,6291-84-5,Flam. Liq. 3;Skin Corr. 1;Eye Dam. 1,REACH registration C&L,501.0,H318:454;H226:501;H314:501;H332:445;H312:46;H302:489;H330:44;H301:4
20159,λ-Carrageenan,232-953-5,9064-57-7,Not Classified,Notified C&L,3.0,Not classified:3
20160,"4-(2-(Dipropylamino)ethyl)-1,3-Dihydro-2H-indol-2-one-hydrochloride",618-737-7,91374-21-9,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1.0,H302:1;H412:1
20162,3-(p-aminophenyl)propionic acid,219-245-1,2393-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:44;H315:44;H319:44
20163,"4-trans-Propyl-[1,1-bicyclohexyl]-4-trans-carbonic acid-(4-pentylphenyl)ester",617-528-8,84078-44-4,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
20171,(1R)-1-Naphthylethylamine Hydrochloride,617-358-4,82572-04-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,44.0,H335:44;H302:41;H315:44;H319:44;H400:38
20173,α-[4-[2-(dimethylamino)ethoxy]phenyl]-β-ethyl-α-phenylphenethyl alcohol,212-023-5,748-97-0,Not Classified,REACH registration C&L,11.0,Not classified:3;H350:5;H360:4;H410:3;H302:5;H400:3;H228:1;H351:1
20176,"2-Propenoic acid, 2-methyl-, methyl ester, polymer with ethyl 2-propenoate",618-459-6,9010-88-2,Not Classified,Notified C&L,217.0,Not classified:179;H332:38;H302:38
20178,Octyl propionate,205-548-6,142-60-9,Not Classified,Notified C&L,89.0,Not classified:89
20180,3-phenylpropiononitrile,211-447-8,645-59-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,55.0,H331:49;H301:45;H311:49;H315:10;H319:10;H335:10;H302:10
20184,Dimethyl sulphone,200-665-9,67-71-0,Not Classified,REACH registration C&L,154.0,Not classified:98;H319:56;H315:1
20187,Methyl 4-oxo-2-butenoate,230-809-6,7327-99-3,Not Classified,Notified C&L,31.0,Not classified:31
20189,"Bis(2,4-dichlorobenzoyl) peroxide",205-094-9,133-14-2,Org. Perox. D;Skin Sens. 1;Repr. 1B,REACH registration C&L,104.0,H360:20;H317:23;H242:77;H241:27;H315:6
20193,Aminopyralid,604-721-7,150114-71-9,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,252.0,H318:213;H410:213;H412:156;H400:55;H319:39;H335:1;H315:1
20194,"Cyanamide, reaction products with carbon dioxide, ethylene oxide and 1-octadecanamine",274-761-4,70693-20-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,104.0,H410:97;H315:97;H319:97;H400:97;Not classified:7
20195,"Chrysanthemum cinerariaefolium, ext.",289-699-3,89997-63-7,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,94.0,H332:91;H410:93;H317:64;H302:91;H400:93;H312:13;H304:3;H226:1
20196,"1,2-Ethanediamine, N1-(2-aminoethyl)-, polymer with 2-(chloromethyl)oxirane",607-530-7,25085-17-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,59.0,H315:59;H319:59
20198,"Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).]",309-748-5,100801-65-8,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
20199,"6a,7-dihydro-3,4,6a,10-tetrahydroxybenz[b]indeno[1,2-d]pyran-9(6H)-one",207-492-8,475-25-2,Not Classified,Notified C&L,1.0,Not classified:1
20200,"Fatty acids, C12-16 and C18-unsatd., reaction products with diethanolamine",282-952-9,84501-35-9,Not Classified,Notified C&L,1.0,Not classified:1
20201,"N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)",443-010-4,53641-10-4,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
20203,17β-hydroxyestr-4-en-3-one 17-(3-cyclohexylpropionate),213-013-3,912-57-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1B,Notified C&L,16.0,H360:16;H332:16;H351:16;H312:16;H302:16
20207,"(9bR)-2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-(2H,9bH)-dibenzofuran-1,3-dione",231-456-0,7562-61-0,Acute Tox. 4,Notified C&L,42.0,H302:42
20215,"Chlorodimethyl(3,3,3-trifluoropropyl)silane",216-039-3,1481-41-0,Flam. Liq. 2;Skin Corr. 1B,Notified C&L,43.0,H314:43;H225:43
20216,"Benzenesulfonic acid, 3-[(1,3-dioxobutyl)amino]-4-methoxy-",613-367-2,6375-00-4,Not Classified,Notified C&L,31.0,Not classified:31
20217,gamma Oryzanol,600-960-6,11042-64-1,Acute Tox. 2,Notified C&L,55.0,H310:55
20218,"4-(chloromethyl)-3,5-dimethylisoxazole",243-312-4,19788-37-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,45.0,H302:39;H332:39;H312:39;H319:44;H335:43;H315:44;Not classified:1
20219,Allyl acetate,209-734-8,591-87-7,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 2,Notified C&L,46.0,H301:46;H330:40;H225:46;H312:46;H319:41;H331:1
20229,"1,3-dimethyl-5-[(1-methyl-2-pyrrolidinylidene)ethylidene]-2-thioxoimidazolidine-4-one",219-490-4,2445-60-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:38;H319:38;Not classified:1
20235,N-[(tert-butoxy)carbonyl]-L-valine,237-307-6,13734-41-3,Not Classified,REACH registration C&L,16.0,Not classified:15;H335:1;H315:1;H319:1
20236,"Potassium 2,5-dihydroxybenzenesulphonate",244-584-7,21799-87-1,Aquatic Chronic 3,REACH registration C&L,123.0,H412:17;H317:74;H302:69;H319:118;H335:48;H315:49;Not classified:1
20237,"Gooseberry, ext.",289-902-5,90045-41-3,Not Classified,Notified C&L,10.0,Not classified:10
20238,5-amino-2-methoxybenzenesulphonic acid,229-291-4,6470-17-3,Skin Irrit. 2,REACH registration C&L,41.0,H315:3;H314:38;H319:1
20240,"bis[2,2,6,6-tetramethyl-1-(octyloxy)piperidin-4-yl] decanedioate",687-535-9,122586-52-1,Aquatic Chronic 4,Notified C&L,1.0,H413:1
20241,"Distillates (petroleum), hydrodesulfurized full-range middle;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C",309-863-0,101316-57-8,Carc. 1B,Harmonised C&L,0.0,H350:0
20248,"2-[(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)METHOXY]ETHYL N-(BENZYLOXYCARBONYL)-L-VALINATE",603-016-1,124832-31-1,Muta. 2;Carc. 2;Repr. 2,Notified C&L,2.0,H261:1;H341:1;H361:1;H351:1;H335:1;H317:1;H315:1;H319:1
20252,Hypersol Synergist L 4722,410-510-9,,Not Classified,REACH registration C&L,41.0,Not classified:41
20254,"1,2-Dichloro-4-fluoro-5-nitrobenzene",607-228-5,2339-78-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40.0,H302:40;H332:39;H312:39;H319:39;H335:39;H315:39
20255,"N,N-diethyl-α-methyl-10H-phenothiazine-10-ethylamine monohydrochloride",214-134-4,1094-08-2,Acute Tox. 4,Notified C&L,39.0,H302:39;H317:1;H315:1;H319:1;H335:1
20264,Orange oil,616-946-8,8014-17-3,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,259.0,H411:233;H318:117;H304:232;H317:234;H315:234;H226:102;Not classified:25;H412:1;H319:1
20268,Potassium O-hexyl dithiocarbonate,220-331-6,2720-76-5,Not Classified,Notified C&L,2.0,Not classified:2
20269,2'-(3-bromobenzoyl)-2-naphthohydrazide,282-686-3,84282-41-7,,Notified C&L,38.0,Not classified:38
20272,"Fatty acids, C6-18, triesters with trimethylolpropane",293-035-8,91050-88-3,Not Classified,Notified C&L,2.0,Not classified:2
20277,6-amino-4-hydroxy-5-[[2-(phenylsulphonyl)phenyl]azo]naphthalene-2-sulphonic acid,246-820-4,25317-07-1,Not Classified,Notified C&L,2.0,Not classified:2
20280,1-acetyl-1H-indole-3-carbaldehyde,245-347-0,22948-94-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42.0,H335:42;H315:42;H319:42
20282,4-chloroindoline,255-586-2,41910-64-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
20286,"Waste solids, lead silver anode",305-449-9,94552-05-3,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6.0,H360:6;H332:6;H410:6;H351:6;H373:6;H372:6;H302:6;H400:6
20293,Hyoscine hydrobromide,204-050-6,114-49-8,Acute Tox. 4,Notified C&L,3.0,H302:2;H330:1;H310:1;H300:1;H361:1
20294,Heptafluorobutyric anhydride,206-410-8,336-59-4,Skin Corr. 1B,Notified C&L,51.0,H314:51;H318:2;H290:1;H332:1;H302:1;H312:1
20297,"Pyridine-2,6-dicarbonyl dichloride",223-125-4,3739-94-4,Skin Corr. 1B,Notified C&L,43.0,H314:43
20298,"Benzenecarboximidamide, N-hydroxy-4-nitro-",605-253-6,1613-86-1,,Notified C&L,5.0,H335:5;H315:5;H319:5
20301,Trimethylstibine,209-824-7,594-10-5,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,108.0,H411:108;H332:108;H302:108;H314:53;H260:52;H225:52;H250:53;H318:14;H312:1
20305,L-alanine,200-273-8,56-41-7,Not Classified,REACH registration C&L,320.0,Not classified:318;H335:2;H315:2;H319:2
20312,"Phosphoric acid, mono- and bis(C8-10-branched and linear alkyl) esters",306-976-7,97468-24-1,Skin Corr. 1B,Notified C&L,72.0,H314:39;H315:33;H319:1
20313,"trans-4-(5-propyl-1,3-dioxan-2-yl)benzonitrile",277-786-9,74240-64-5,Aquatic Chronic 4,Notified C&L,1.0,H413:1;Not classified:1
20316,"reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate",426-470-0,,Skin Sens. 1,Harmonised C&L,0.0,H317:0
20319,6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene,405-410-7,41201-60-9,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H318:0;H315:0;H317:0
20320,4-nitrobenzoyl chloride,204-517-4,122-04-3,Skin Corr. 1C,REACH registration C&L,134.0,H314:134;H302:7;H318:2;H290:2
20322,"2,2'-ethylenedithiodiethanol",226-045-8,5244-34-8,Eye Irrit. 2B;Aquatic Chronic 2,REACH registration C&L,8.0,H411:6;H320:6;H319:7;H312:1;H317:1
20323,Hexadecyltrimethylammonium methyl sulphate,265-352-1,65060-02-8,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,94.0,H318:33;H410:2;H314:2;H311:2;H302:33;H400:2;Not classified:61;H315:31
20324,Diphenylammonium hydrogen sulphate,209-605-6,587-84-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H315:1
20325,MGE561-19A,430-240-5,,Not Classified,Notified C&L,83.0,Not classified:83
20326,3-(dodecylamino)propiononitrile,225-302-1,4763-40-0,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,34.0,H410:33;H314:33;H400:2;H335:1;H315:1;H319:1
20331,Cobalt zinc aluminate blue spinel,269-049-5,68186-87-8,Not Classified,REACH registration C&L,123.0,Not classified:123
20332,4-bromo-α-propylbenzyl alcohol,244-801-5,22135-53-1,Acute Tox. 4,Notified C&L,38.0,H302:38
20333,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide,214-916-5,1210-83-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
20334,"2,3,5-trimethylhydroquinone",211-838-3,700-13-0,Skin Irrit. 2;Eye Dam. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H332:0;H410:0;H317:0;H315:0;H335:0;H400:0
20337,Manganese telluride,234-782-1,12032-88-1,,Notified C&L,4.0,H332:4;H302:4
20340,"(E)-2,2'-vinylenebis[5-methylbenzoxazole]",241-271-7,17233-65-7,Not Classified,Notified C&L,31.0,Not classified:31
20341,Zinc acrylate,238-692-3,14643-87-9,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,223.0,H318:207;H410:63;H314:35;H317:48;H302:101;H400:101;H335:137;H315:137;H311:38;H412:13;H319:16
20342,4-bromoanisole,203-252-1,104-92-7,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,97.0,H302:7;H315:10;H412:83;H373:83;Not classified:4;H319:2
20343,Acrylated polysiloxanes,603-069-0,125455-51-8,Skin Sens. 1,Notified C&L,27.0,H317:27
20349,Triethylsulphonium iodide,217-383-7,1829-92-1,,Notified C&L,6.0,H335:6;H315:6;H319:6
20353,4-carboxyphenyl 4-(hexyloxy)benzoate,258-246-1,52899-68-0,,Notified C&L,1.0,H335:1;H315:1;H319:1
20358,Hexadecyl chloroformate,247-578-2,26272-90-2,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,159.0,H317:124;H290:42;H315:125;Not classified:33;H335:1;H319:1;H318:1;H314:1;H330:1;H300:1;H310:1
20359,"1,5-Naphthalenedisulfonic acid, 2-[2-[8-[[4-chloro-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]diazenyl]-, sodium salt (1:5)",618-246-8,89157-03-9,Not Classified,Notified C&L,1.0,Not classified:1
20362,"amines, N-tallow alkyltrimethylenedi-, reaction products with formaldehyde, ethoxylated, chloromethanequaternized",614-638-8,68603-77-0,Skin Corr. 1B;Aquatic Chronic 1,Notified C&L,27.0,H410:27;H314:27;H400:4
20363,"2,5,6-triaminopyrimidin-4(1H)-one sulphate",254-393-0,39267-74-8,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,39.0,H317:38;H302:38;H319:39;H335:1;H315:1
20365,Oxaceprol,251-780-6,33996-33-7,Eye Dam. 1,REACH registration C&L,48.0,H318:46;H335:5;H315:5;H319:2
20375,IM 0391,446-270-7,,Not Classified,Notified C&L,1.0,Not classified:1
20376,N-(2-chloroethyl)perhydroazepine hydrochloride,247-733-4,26487-67-2,,Notified C&L,5.0,H302:5;H332:5;H315:5;H319:5;H335:4
20379,"mono-, di-, tri- tetra- and penta esters of (2,4-dihydroxyphenyl)(2,3,4-trihydroxyphenyl)methanone and 6-diazo-5-oxo-5,6-dihydronaphthalene-1-sulfonic acid",433-680-6,,Flam. Sol. 1;Aquatic Chronic 4,Notified C&L,1.0,H228:1;H413:1
20380,Nortriptyline hydrochloride,212-973-0,894-71-3,Acute Tox. 4,Notified C&L,44.0,H302:41;H301:2;H370:2;H361:2;Not classified:1;H341:1
20382,"reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione",401-970-1,,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H410:0;H400:0
20386,Dextrin,232-675-4,9004-53-9,Not Classified,Notified C&L,233.0,Not classified:233
20389,"1,3-dimethylbutyl acetate",203-621-7,108-84-9,Flam. Liq. 3,Notified C&L,127.0,H226:127;H335:38;H315:39;H319:39;H336:1
20394,2-morpholinoethanesulphonic acid,224-632-3,4432-31-9,Not Classified,REACH registration C&L,281.0,Not classified:275;H335:4;H315:5;H319:5;H302:1
20399,"Disodium [2-[[4,5-dihydro-3-methyl-5-oxo-1-(4-sulpho-o-tolyl)-1H-pyrazol-4-yl]azo]-4-sulphobenzoato(4-)]hydroxychromate(2-)",233-355-7,10127-05-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Carc. 2,Notified C&L,38.0,H301:38;H351:38;H311:38;H331:38;H319:38;H335:38;H315:38
20400,"26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24- octaoxahexacosan -1-ol",604-395-6,14409-72-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,32.0,H411:32;H302:32;H315:32;H319:32
20402,"tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate)",400-010-9,81898-60-4,Skin Sens. 1,Harmonised C&L,0.0,H317:0
20413,Heptacosanoic acid,230-436-9,7138-40-1,Not Classified,Notified C&L,1.0,Not classified:1
20414,"Ethanone, 1-[4-(4-methylcyclohexyl)phenyl]-, trans-",613-132-4,63007-34-1,Not Classified,Notified C&L,1.0,Not classified:1
20416,Methyl L-alaninate hydrochloride,219-652-4,2491-20-5,Not Classified,REACH registration C&L,3.0,Not classified:1;H335:2;H315:2;H319:2
20419,"tricarbonyl[(1,2,3,4,5,6-η)cyclohepta-1,3,5-triene]molybdenum",235-197-4,12125-77-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,42.0,H302:38;H332:38;H312:38;H319:42;H335:42;H315:42;H301:4
20423,N-[3-(dimethylamino)propyl]dodecanamide N-oxide,263-218-7,61792-31-2,Met. Corr. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,47.0,H318:44;H290:2;H315:46;H412:2;H302:45;H400:3;H373:3;Not classified:1;H319:2;H361:1
20426,Polyvinylpyrrolidone iodine,607-771-8,25655-41-8,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,157.0,H411:90;H318:90;H315:98;Not classified:58;H317:8;H319:10;H335:8;H361:8
20428,"Propylidynetrimethanol, reaction products with 2-propenoic acid and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",918-107-4,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H315:1;H319:1
20433,"(2,4-dihydroxybenzoato-O1,O2)hydroxycopper",274-171-7,69868-09-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1.0,H410:1;H400:1
20435,"2-methylenepropane-1,3-diol",222-516-7,3513-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H315:41;H319:41
20437,"3,4,5-trifluorophenol",436-120-9,99627-05-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3.0,H411:3;H302:2;H315:1;H319:1;H301:1;H314:2;H318:1;H332:1;H312:1
20440,5-methylnicotinic acid,608-720-2,3222-49-9,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,51.0,H315:50;H319:49;H335:46;Not classified:1
20442,1-methylnaphthalene,201-966-8,90-12-0,Acute Tox. 4;Asp. Tox. 1,Notified C&L,1854.0,H304:1647;H302:1754;Not classified:82;H411:123;H334:38;H315:46;H319:47;H335:42;H336:1;H401:1
20446,Methyl (2-chlorophenyl)acetate,260-764-8,57486-68-7,,Notified C&L,1.0,H335:1;H315:1;H319:1
20447,"4,4'-oxydianiline and its salts;p-aminophenyl ether",202-977-0,101-80-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 1B;Carc. 1B;Aquatic Chronic 2;Repr. 2,Harmonised C&L,0.0,H411:0;H301:0;H350:0;H311:0;H331:0;H340:0;H361:0
20450,"Benzenesulfonic acid, mono-C15-36-branched alkyl derivs., barium salts",290-659-2,90194-48-2,Acute Tox. 4;Acute Tox. 4,Notified C&L,33.0,H332:33;H302:33
20455,4-hydroxy-7-(methylamino)naphthalene-2-sulphonic acid,244-924-4,22346-43-6,Not Classified,REACH registration C&L,1.0,Not classified:1
20456,"Starch, acetate",618-556-3,9045-28-7,Not Classified,Notified C&L,52.0,Not classified:52
20457,Cocarboxylase,205-836-1,154-87-0,Not Classified,Notified C&L,4.0,Not classified:4
20460,1-(2-ethylphenyl)piperazine,254-847-8,40224-10-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
20465,"Diethyl (2,2-diethoxyethyl)phosphonate",231-504-0,7598-61-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H335:38;H315:43;H319:43
20468,"1,5-dimethyl-1-vinylhex-4-enyl isobutyrate",201-108-2,78-35-3,Aquatic Chronic 2,REACH registration C&L,1601.0,H411:1325;Not classified:276
20470,Ethyl 4-chlorobutyrate,221-591-3,3153-36-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,55.0,H335:54;H302:38;H315:55;H319:55;H226:2
20471,1-benzhydrylpiperazine,212-667-7,841-77-0,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Repr. 2;STOT SE 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,51.0,H411:1;H301:2;H318:2;H317:2;H370:1;H372:1;H361:1;H302:48;H332:6;H315:7;H319:7;H335:6;Not classified:1
20484,Quinoline-4-carboxylic acid,207-640-1,486-74-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
20485,"2-(3,4-Epoxycyclohexyl)ethyl-triethoxysilan",600-284-1,10217-34-2,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,10.0,H317:10;H412:10;Not classified:1
20486,DMO ALKYNE,609-267-3,36602-31-0,Flam. Liq. 3,Notified C&L,10.0,H226:10
20488,"[N,N,N',N',N'',N''-hexaethyl-29H,31H-phthalocyaninetrimethylaminato(2-)-N29,N30,N31,N32]copper tris(dodecylbenzenesulphonate)",278-150-3,75247-18-6,Not Classified,REACH registration C&L,291.0,Not classified:261;H412:30;H319:30
20497,"(aS)-methyl alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate 2-propyl sulfate",614-478-9,684269-94-1,STOT SE 2;Aquatic Chronic 2,Notified C&L,1.0,H411:1;H371:1
20498,Lussatite (SiO2),606-473-5,20243-18-9,Not Classified,Notified C&L,149.0,Not classified:149
20502,"4,4'-diaminodiphenylmethane;4,4'-methylenedianiline",202-974-4,101-77-9,Skin Sens. 1;Muta. 2;Carc. 1B;STOT SE 1;STOT RE 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H373:0;H350:0;H317:0;H370:0;H341:0
20506,"Fatty acids, soya, ethoxylated",612-391-0,61791-07-9,Not Classified,Notified C&L,1.0,Not classified:1
20507,N-(dichlorofluoromethylthio)phthalimide;N-(fluorodichloromethylthio)phthalimide,211-952-3,719-96-0,Skin Irrit. 2,Harmonised C&L,0.0,H315:0
20513,1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone,411-500-7,116256-11-2,Acute Tox. 4;Eye Dam. 1;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H318:0;H302:0;H317:0
20519,Sulbactam,269-878-2,68373-14-8,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,51.0,H317:10;H334:10;H302:39;Not classified:1;H335:2;H315:2;H319:2
20520,o-fluorophenyl isothiocyanate,254-237-1,38985-64-7,Skin Corr. 1B;STOT SE 3,Notified C&L,46.0,H335:41;H314:46;H332:4;H302:4;H312:4;H301:2;H330:1;H311:1;H319:1;H331:1;H318:1
20522,"S-(2,5-dimethyl-3-furyl) thio-3-furoate",265-796-6,65505-16-0,Not Classified,Notified C&L,88.0,Not classified:88
20524,Orange ext,614-649-8,68606-94-0,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,201.0,H411:136;H304:200;H317:137;H226:198;H315:137;H410:40;H319:2;H400:1
20527,"2,4-dioxo-1,3-diazetidine-1,3-bis(methyl-m-phenylene) diisocyanate",247-953-0,26747-90-0,Skin Sens. 1A;STOT SE 3,REACH registration C&L,104.0,H317:45;H335:45;Not classified:59;H334:2;H315:2;H412:2;H319:2
20529,1-phenylthiosemicarbazide,211-444-1,645-48-7,Acute Tox. 3,Notified C&L,39.0,H301:39
20530,Allylurea,209-157-1,557-11-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40.0,H332:40;H302:40;H312:40;H335:2;H319:1;H315:1
20533,C.I. Acid Yellow 204,612-460-5,61814-53-7,Not Classified,Notified C&L,5.0,Not classified:5
20534,"Methyl 4,5-dimethoxyanthranilate",247-967-7,26759-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H315:46;H319:46
20535,Dimethyl (dimethoxyphosphinyl)succinate,220-518-2,2788-26-3,Flam. Liq. 4,REACH registration C&L,1.0,H227:1
20536,"Benzene-1,3-diammonium sulphate",208-791-6,541-70-8,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,8.0,H411:6;H301:7;H332:7;H317:7;H312:7;H319:6;H302:1;H331:1;H311:1
20537,Magnetite,215-169-8,1309-38-2,Not Classified,Notified C&L,156.0,Not classified:142;H302:8;H373:4;H335:2;H315:2;H319:2
20538,5-phenylthiazol-2-amine,254-312-9,39136-63-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
20539,Isobutyl hexanoate,203-332-6,105-79-3,Not Classified,Notified C&L,186.0,Not classified:146;H315:39;H319:40
20540,Methyl pivaloylacetate,259-481-2,55107-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,43.0,H335:42;H315:43;H319:43
20541,"Lard, stearins",297-469-9,93572-39-5,Not Classified,Notified C&L,1.0,Not classified:1
20544,"5-Brom-1,3-difluor-2-trifluormethoxybenzene",601-363-3,115467-07-7,Not Classified,REACH registration C&L,5.0,Not classified:2;H317:2;H334:2;H314:2;H412:2;H315:1;H319:1
20546,"N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide",416-260-7,147613-95-4,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
20550,"Amines, hydrogenated tallow alkyl, acetates",263-149-2,61790-59-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,74.0,H318:70;H315:71;H400:31;Not classified:2;H319:1;H314:1;H410:1;H373:1
20551,"2,2-bis(hydroxymethyl)propane-1,3-diyl bisheptanoate",267-042-1,67763-19-3,,Notified C&L,1.0,Not classified:1
20552,"Poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy-, phosphate, potassium salt",611-641-6,58318-92-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4.0,H318:2;H315:4;H319:2
20553,"1,1,2-trimethyl-1H-benz[e]indole",255-429-8,41532-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48.0,H335:48;H315:48;H319:48
20554,1-(trifluoroacetyl)-1H-imidazole,216-282-5,1546-79-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:44;H226:45;H315:45;H319:45
20555,"heptenophos (ISO);7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate",245-737-0,23560-59-0,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H400:0
20557,Di-tert-butylcarbodiimide,211-719-6,691-24-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41.0,H335:40;H226:41;H315:41;H319:41
20560,reaction product of wheat aminoacids and lauryl chloride,927-837-2,,Eye Dam. 1,REACH registration C&L,2.0,H318:2
20563,2-methyl-3-butenenitrile,240-596-1,16529-56-9,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,REACH registration C&L,42.0,H331:4;H301:4;H226:2;H311:4;H332:38;H302:38;H225:40;H350:1;H340:1
20564,POLYOXYETHYLENE TRIDECYL ETHER PHOSPHATE AMMONIUM SALT,614-905-9,69029-43-2,,Notified C&L,592.0,Not classified:446;H318:146;H315:145;H411:23;H302:1;H412:1
20567,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, mixed Bu and hexyl triesters",292-004-6,90529-70-7,Not Classified,Notified C&L,2.0,Not classified:2
20568,6-methoxynaphthalene-2-acetic acid,245-967-1,23981-47-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H302:40;H315:39;H319:39
20572,N-[3-(dimethylamino)propyl]dodecanamide,221-661-3,3179-80-4,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,547.0,H411:1;H318:444;H314:66;H317:443;H302:63;H400:12;H315:480;H335:38;H319:39;Not classified:1
20574,"(3β,18α,20β)-3-hydroxy-11-oxoolean-12-en-29-oic acid",215-907-9,1449-05-4,Acute Tox. 4,Notified C&L,40.0,H302:40
20576,"Fatty acids, C18-unsatd.",289-450-9,88895-93-6,Not Classified,REACH registration C&L,180.0,Not classified:163;H315:17;H319:17
20578,"1,1'-sulphonylbis-1H-imidazole",230-554-0,7189-69-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40.0,H335:39;H315:40;H319:40
20579,Tris(p-tert-butylphenyl) phosphate,201-106-1,78-33-1,Not Classified,Notified C&L,77.0,Not classified:76;H330:1;H317:1;H315:1;H319:1;H335:1
20581,"hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel",417-250-5,151436-99-6,Eye Dam. 1;Skin Sens. 1,Harmonised C&L,0.0,H318:0;H317:0
20585,"3-hexadecyl-1,1-bis(2-hydroxyethyl)urea",286-149-4,85187-62-8,Not Classified,Notified C&L,1.0,Not classified:1
20588,1-benzyl-3-piperidone hydrochloride hydrate,256-646-0,50606-58-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3.0,H335:3;H302:3;H315:3;H319:3
20589,Hexachloroethane,200-666-4,67-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,21.0,H410:12;H351:13;H315:10;H319:11;H335:9;H400:8;H411:4;H350:4;Not classified:2;H373:2;H332:1;H303:1;H312:1;H320:1
20591,"2-[2-(2,3-dihydro-2-methyl-1H-indol-1-yl)vinyl]-1,3,3-trimethyl-3H-indolium acetate",281-438-1,83949-78-4,Acute Tox. 3;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2.0,H301:2;H410:2;H319:2;H400:2
20599,"1,3-diamino-7-(diethylamino)-8-methylphenoxazin-5-ium chloride",233-358-3,10127-36-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20602,Triethylammonium closo-dodecahydrododecaborate,603-077-4,12551-42-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
20605,"(3R,5aS,6R,8aS,9R,12S,12aR)-3,6,9-trimethyloctahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10(3H)-one",700-290-5,63968-64-9,Org. Perox. E;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,163.0,H410:161;H242:161;H400:160;Not classified:1;H335:1;H315:1;H319:1
20608,"Calcium 1,4-bis(2-ethylhexyl) bis(2-sulphosuccinate)",204-889-8,128-49-4,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,75.0,H315:70;H319:70;Not classified:5
20610,"Siloxanes and Silicones, di-Me, Me hydrogen, reaction products with polyethylene-polypropylene glycol monoacetate allyl ether",614-224-7,68037-64-9,,Notified C&L,125.0,H319:69;Not classified:56
20613,"2,2,2-Trifluoroethyl Methanesulfonate",607-659-9,25236-64-0,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,131.0,H317:89;H332:89;H302:89;H314:42;H318:1;H290:1
20616,3-ethoxypropylamine,228-545-1,6291-85-6,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,47.0,H226:47;H302:41;H314:47;H318:3;H317:1
20621,Illite ([Al1.75(Fe0-1Mg0-1)0.25]K0.75(Si3.5Al0.5)[(OH)0.5-1F0-0.5]2O10),601-803-4,12173-60-3,Not Classified,Notified C&L,38.0,Not classified:38
20622,5-methylquinolin-8-ol,226-905-2,5541-67-3,Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H319:2
20625,N-(methoxycarbonyl)-L-valine,616-135-9,74761-42-5,Eye Dam. 1,REACH registration C&L,9.0,H318:7;H335:1;H315:1;H319:1;Not classified:1;H228:1
20627,"Fatty acids, tall-oil, compds. with (Z)-N-9-octadecenyl-1,3-propanediamine (2:1)",295-184-4,91845-13-5,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,4.0,H411:1;H317:1;Not classified:1;H302:1;H314:1;H400:1;H318:1;H315:1;H412:1
20629,1-bromotetradecane,203-999-3,112-71-0,Not Classified,REACH registration C&L,44.0,Not classified:2;H335:41;H315:42;H319:42
20636,"1,2-dichloropentane",605-481-6,1674-33-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H318:1;H302:1;H315:1;H226:1;H335:1
20647,Methenamine allyloiodide,253-259-9,36895-62-2,Skin Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38
20648,"Benzenesulfonic acid, methyl-, mono-C20-24-branched alkyl derivs., calcium salt",682-816-2,722503-68-6,,Notified C&L,490.0,Not classified:446;H317:44;H413:23
20649,"1,4-dichlorobenzene;p-dichlorobenzene",203-400-5,106-46-7,Eye Irrit. 2;Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H351:0;H319:0;H400:0
20653,1-benzylpiperidine-4-carbaldehyde,244-757-7,22065-85-6,Acute Tox. 3;Eye Dam. 1,Notified C&L,44.0,H301:39;H318:39;H315:5;H319:5
20659,Diethyl ethylmalonate,205-093-3,133-13-1,Flam. Liq. 4,REACH registration C&L,11.0,H227:6;Not classified:5
20660,N-(7-hydroxy-1-naphthyl)acetamide,229-293-5,6470-18-4,Not Classified,REACH registration C&L,2.0,Not classified:2
20665,Tetramethoxyethane,607-582-0,2517-44-4,Flam. Liq. 3,Notified C&L,189.0,H226:189
20670,"3,4'-dichloropropiophenone",223-537-4,3946-29-0,Skin Corr. 1B;Eye Dam. 1;STOT SE 3,Notified C&L,76.0,H318:71;H335:43;H314:40;H410:31;H317:31;H315:35;H400:31;H319:4;H252:1;H272:1;H260:1;H225:1;H201:1;H240:1
20672,(2-hydroxypropyl)trimethylammonium,231-457-6,7562-87-0,Not Classified,Notified C&L,4.0,Not classified:4
20673,(4-methylphenyl)boronic acid,611-480-1,5720-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,50.0,H335:48;H315:49;H319:49;H302:2;H332:1;H312:1
20676,"Benzoic acid, 2-iodo-5-methyl-, methyl ester",600-437-2,103440-52-4,,Notified C&L,4.0,H335:4;H315:4;H319:4
20678,"17,21-dihydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione",236-177-8,13209-41-1,,Notified C&L,2.0,Not classified:1;H302:1
20681,"Bis(1,1,1,5,5,5-hexafluoropentane-2,4-dionato-O,O')copper",238-850-1,14781-45-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,3.0,H332:1;H302:1;H315:2;H319:2;H335:1
20684,2-methylbutyl isobutyrate,219-493-0,2445-69-4,,Notified C&L,1.0,H226:1
20685,Caesium fluoride,236-487-3,13400-13-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Repr. 2;STOT RE 2,REACH registration C&L,85.0,H318:67;H373:2;H315:66;H302:2;H361:40;H301:82;H311:82;H331:78;H314:19;H330:4
20686,N-(n-octyl)-2-pyrrolidone,403-700-8,2687-94-7,Skin Corr. 1B;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H314:0
20689,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with D-glucitol (6:1), (9Z)-9-octadecenoate",611-887-4,59800-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20691,"Cumin, ext.",616-945-2,8014-13-9,Aquatic Chronic 2,Notified C&L,217.0,H411:154;H317:130;H226:115;H304:128;H319:39;H335:39;H315:53;H412:15;Not classified:10;H302:9
20692,2-bromoethyldiethylammonium bromide,213-962-3,1069-72-3,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39.0,H335:38;H318:38;H315:39;H300:38;H302:1;H332:1;H312:1;H319:1
20693,"xylylcarb (ISO);3,4-dimethylphenyl N-methylcarbamate;3,4-xylyl methylcarbamate;MPMC",219-364-9,2425-10-7,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H400:0
20698,Silafluofen,600-629-6,105024-66-6,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H360:38;H410:38;H400:38
20703,"Spirosta-5,25(27)-diene-1β,3β-diol",241-660-1,17676-33-4,Acute Tox. 4,Notified C&L,1.0,H302:1
20706,5'-chloro-3-hydroxy-2'-methoxy-2-naphthanilide,205-300-7,137-52-0,Not Classified,Notified C&L,41.0,Not classified:41
20711,Diclofenamide,204-440-6,120-97-8,Repr. 2,Notified C&L,1.0,H361:1
20712,"Fatty acids, C9-11-branched, compds. with triethanolamine",287-036-2,85408-73-7,Not Classified,Notified C&L,1.0,Not classified:1
20714,"nabam (ISO);disodium ethylenebis(N,N'-dithiocarbamate)",205-547-0,142-59-6,Acute Tox. 4;Skin Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H302:0;H410:0;H317:0;H335:0;H400:0
20715,nonylphenol,246-672-0,25154-52-3,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H302:0;H410:0;H314:0;H361:0;H400:0
20716,"pregn-5-ene-3,20-dione bis(ethylene ketal)",407-450-0,7093-55-2,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
20718,"1,3-Butadiene, 2-methyl-, polymer with 2-methyl-1-propene",618-457-5,9010-85-9,Not Classified,Notified C&L,69.0,Not classified:69
20723,"Benzene, diethenyl-, polymer with ethenylbenzene and ethenylethylbenzene, sulfonated",614-895-6,69011-20-7,Eye Dam. 1,Notified C&L,347.0,H318:165;H335:156;H315:157;H319:181;H228:1;Not classified:2
20724,"Lard, chlorosulfurized",263-059-3,61789-43-3,Skin Sens. 1,Notified C&L,1.0,H317:1
20729,1-chloro-2-naphthol,211-200-4,633-99-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3.0,H315:3;H319:3
20737,"2,3-Dihydro-thieno[3,4-b][1,4]dioxin-5,7-dicarboxylic acid",605-999-2,18361-03-0,Aquatic Chronic 3,REACH registration C&L,2.0,H412:1;H302:1;H332:1;H312:1;H319:1;H315:1
20739,Hept-3-yne,219-967-7,2586-89-2,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H225:39;H319:39;H304:1
20741,"3,4,4a,5,6,7,8,8a-octahydro-6-isopropylnaphthalene-2(1H)-one",251-840-1,34131-98-1,Skin Irrit. 2,Notified C&L,1044.0,H315:958;Not classified:86
20742,"Extract residues (coal), light oil alk., acid ext., indene fraction;Light Oil Extract Residues, intermediate boiling",309-867-2,101316-62-5,Muta. 1B;Carc. 1B,Harmonised C&L,0.0,H340:0;H350:0
20746,Bis (Borondifluoro Diphenylglyoximato) Cobaltate,617-044-7,80290-99-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:1;H319:1;Not classified:1
20748,"9β,11β-epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione 21-acetate",213-012-8,912-38-9,STOT RE 2,REACH registration C&L,2.0,H373:2
20750,Transesterification products of epoxidized soybean oil with 2-ethylhexan-1-ol,614-268-7,68082-34-8,Not Classified,Notified C&L,1.0,Not classified:1
20751,exo-(+/-)-1-Methyl-4-(1-methylethyl)-2[(2-methylphenyl)methoxy]-7-oxabicyclo[2.2.1]heptane,618-074-3,87818-31-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,39.0,H411:39;H332:39
20753,Benzoylnaphthalene,211-382-5,642-29-5,,Notified C&L,5.0,H335:5;H315:5;H319:5;H302:1
20757,(S)-N-[5-amino-1-(chloroacetyl)pentyl]-p-toluenesulphonamide monohydrochloride,224-266-4,4272-74-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
20763,2-fluorosulphonylbenzenesulphonyl chloride,250-277-9,30672-70-9,Skin Corr. 1B,Notified C&L,38.0,H314:38
20764,Bisguanidinium sulphate,209-826-8,594-14-9,Not Classified,Notified C&L,24.0,Not classified:23;H302:1;H315:1;H319:1
20769,Dipotassium hexafluorotitanate,240-969-9,16919-27-0,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,137.0,H318:121;H302:105;H317:97;H301:29;H335:70;H332:9;H315:13;H319:11;H314:2;Not classified:1
20777,Copper divanadium hexaoxide,239-030-6,14958-34-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,42.0,H315:38;H319:38;H332:4;H302:4
20779,"3-(piperazin-1-yl)-1,2-benzothiazole",618-048-1,87691-87-0,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,47.0,H400:4;H410:4;H317:4;H316:4;H319:46;H302:4;H361:4;H301:40;H315:42;Not classified:1
20783,Anthracene-9-carbaldehyde,211-383-0,642-31-9,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,REACH registration C&L,7.0,H332:2;H302:2;H312:2;H319:7;H335:4;H315:5
20785,"Penta-1,2-diene",209-737-4,591-95-7,Flam. Liq. 2,Notified C&L,23.0,H225:23
20787,(Z)-5-hex-3-enyldihydro-5-methylfuran-2(3H)-one,274-942-8,70851-61-5,Not Classified,Notified C&L,124.0,Not classified:123;H335:1;H315:1;H319:1
20789,"Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 °C to 250 °C (212 °F to 482 °F.]",309-866-7,101316-61-4,Asp. Tox. 1,Harmonised C&L,0.0,H304:0
20791,"1-iodo-2,3,5,6-tetramethylbenzene",218-266-3,2100-25-6,Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38.0,H413:38;H319:38
20793,"O,O-dibutyl hydrogen thiophosphate, compound with (Z)-octadec-9-en-1-amine (1:1)",295-900-5,92130-55-7,Skin Sens. 1;Eye Dam. 1,Notified C&L,468.0,H317:468;H318:468
20802,Diisodecyl azelate,249-044-4,28472-97-1,Not Classified,REACH registration C&L,4.0,Not classified:4
20803,"N2,N2-dimethylpropane-1,2-diamine",243-280-1,19764-58-0,Skin Corr. 1B,Notified C&L,1.0,H314:1
20807,"2,2'-(1,4-phenylene)bis[4,5-dihydrooxazole]",231-066-0,7426-75-7,Not Classified,Notified C&L,1.0,Not classified:1
20811,"Octanoic acid, compound with morpholine (1:1)",253-891-5,38344-72-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,27.0,H335:25;H315:25;H319:27;H317:2
20813,2-(nitropropylamino)ethyl nitrate,279-977-2,82486-83-7,Expl. 1.3;Acute Tox. 4,Notified C&L,2.0,H302:2;H203:2
20815,Danazol,241-270-1,17230-88-5,Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,60.0,H332:57;H361:41;H312:57;H360:19;H351:16
20817,Terconazole,267-751-6,67915-31-5,Acute Tox. 4,Notified C&L,94.0,H302:56;H335:40;H413:38;H315:40;H319:40
20818,"2,4,6-tripropyl-1,3,5-trioxane",219-249-3,2396-43-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 1;STOT RE 1,Notified C&L,1.0,H370:1;H315:1;H372:1;H226:1;H319:1;H302:1
20819,Hexyltriphenylphosphonium bromide,225-301-6,4762-26-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,44.0,H335:43;H315:44;H319:44;H302:5
20820,"1,2-dihydroxyanthraquinone",200-782-5,72-48-0,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,72.0,H317:1;H318:1;H410:1;H302:40;H315:19;H319:25;Not classified:8
20822,Gellan gum,275-117-5,71010-52-1,,Notified C&L,52.0,Not classified:51;H335:1;H315:1;H319:1
20824,dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate,262-784-2,61432-55-1,Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0
20827,Disodium [3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]naphthalene-1-sulphonato(3-)][1-[[2-hydroxy-5-[(2-methoxyphenyl)azo]phenyl]azo]-2-naphtholato(2-)]chromate(2-),248-453-5,27425-58-7,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,3.0,H411:2;H317:2;H319:2;Not classified:1
20829,Ammonium oleate,208-873-1,544-60-5,Aquatic Chronic 3,Notified C&L,223.0,H412:85;Not classified:58;H335:39;H315:39;H319:81
20830,4-methyl-N-phenyl-6-(prop-1-yn-1-yl)pyrimidin-2-amine,432-140-7,110235-47-7,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13.0,H410:13;H351:13;H400:13
20834,"4-amino-6-[[4-[[[4-[(2,4-diaminophenyl)azo]phenyl]amino]sulphonyl]phenyl]azo]-5-hydroxy-3-[(4-nitrophenyl)azo]naphthalene-2,7-disulphonic acid, potassium salt",286-384-2,85223-29-6,Not Classified,Notified C&L,233.0,Not classified:191;H318:33;H412:33;H319:8;H335:1;H315:1;H317:2;H334:2;H302:1
20838,Dimethyl heptanedioate,217-057-4,1732-08-7,Not Classified,REACH registration C&L,2.0,Not classified:2
20839,4-nitrosophenol,203-251-6,104-91-6,Acute Tox. 4;Eye Dam. 1;Muta. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H341:0;H318:0;H302:0;H411:0
20840,"2,3-dihydro-1,4-benzodioxin-6-methanol",254-396-7,39270-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2.0,H335:2;H315:2;H319:2;H302:1;H412:1
20844,"Silane, trichloro(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl)-",616-629-4,78560-44-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,49.0,H318:40;H314:49;H290:2
20847,Quinine benzoate,212-026-1,750-88-9,,Notified C&L,1.0,H317:1;H302:1
20850,"Psi,psi-carotene",207-949-1,502-65-8,Not Classified,Notified C&L,181.0,Not classified:181
20852,"Naphthenic acids, reaction products with diethylenetriamine, benzyl chloride-quaternized",277-250-4,73049-47-5,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,58.0,H411:33;H314:58
20855,3-methylcholanthrene,200-276-4,56-49-5,Carc. 1B;Aquatic Chronic 4,Notified C&L,41.0,H413:38;H350:38;H301:2;H330:2;H311:2;H373:2;Not classified:1
20857,Allyl chloroacetate,220-839-8,2916-14-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,44.0,H302:43;H332:43;H312:43;H319:44;H335:43;H315:44;H227:1
20859,p-menth-1-en-8-yl propionate,201-266-2,80-27-3,Not Classified,Notified C&L,92.0,Not classified:91;H411:1;H315:1;H319:1
20860,Myristic anhydride,210-941-0,626-29-9,Skin Corr. 1B,Notified C&L,3.0,H314:1;Not classified:1;H315:1;H319:1
20861,Ethyl 5-hydroxy-2-methylindole-3-carboxylate,231-507-7,7598-91-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
20865,4'-methylacetophenone,204-514-8,122-00-9,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,1736.0,H302:1735;H315:1430;H332:2;H319:2;H335:2;H314:1;H311:1;H412:1;Not classified:1
20866,Potassium polysulfide,677-755-3,39365-88-3,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,7.0,H317:1;H318:2;H302:1;H315:1;H228:4;H314:6;H400:2
20867,"2,5-Furandione, C18-24-alkenyl derivs., reaction products with tetraethylenepentamine",287-552-8,85536-67-0,,Notified C&L,1.0,Not classified:1
20868,"1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-5-[(2-nitrophenyl)azo]-2-oxonicotinonitrile",256-456-8,49744-25-4,Not Classified,REACH registration C&L,34.0,Not classified:34
20870,Clostebol,214-133-9,1093-58-9,Carc. 2,Notified C&L,39.0,H351:39
20871,Labetalol,253-258-3,36894-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Chronic 2,REACH registration C&L,3.0,H411:2;H315:3;H319:3;H335:3;H361:3
20873,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,12,12,12-icosafluoro-11-(trifluoromethyl)dodecyl methacrylate",277-789-5,74256-14-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20875,Cesium vanadium trioxide,238-693-9,14644-55-4,,Notified C&L,4.0,H370:4;H332:4;H302:4
20877,3-cyclohexylaminopropylamine,222-001-7,3312-60-5,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,204.0,H318:144;H290:2;H314:199;H301:1;H311:1;H412:102;H317:105;H302:139;Not classified:5
20878,Diethyl aminomalonate hydrochloride,236-556-8,13433-00-6,Not Classified,REACH registration C&L,52.0,Not classified:5;H335:46;H315:47;H319:47
20879,Methoxytriphenylsilane,217-382-1,1829-41-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
20881,4-(triphenylmethyl)aniline,245-346-5,22948-06-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20882,"Benzamide, 4-(1,1-dimethylethyl)-N,N-bis(2-hydroxyethyl)-",614-428-6,68368-33-2,Not Classified,Notified C&L,1.0,Not classified:1
20885,Pentamethylbenzene,211-837-8,700-12-9,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H228:44;H335:42;H315:43;H319:43
20892,"8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride",204-957-7,129-64-6,Eye Dam. 1;Skin Sens. 1;Resp. Sens. 1,Harmonised C&L,0.0,H318:0;H334:0;H317:0
20895,Methyl 5-chloro-2-nitrobenzoate,257-107-2,51282-49-6,Acute Tox. 4,Notified C&L,42.0,H302:38;H335:4;H315:4;H319:4
20898,(Isocyanatomethyl)(dimethoxy)methylsilane,453-230-2,,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1;STOT RE 1,Notified C&L,1.0,H301:1;H318:1;H334:1;H330:1;H317:1;H372:1
20902,"musk ketone;3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;4'-tert-butyl-2',6'-dimethyl-3',5'-dinitroacetophenone",201-328-9,81-14-1,Carc. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H410:0;H351:0;H400:0
20904,"Fatty acids, animal, Me esters, sulfurized",304-817-6,94279-72-8,Not Classified,Notified C&L,1.0,Not classified:1
20907,"2,6-dimethylpyridin-4-amine",222-515-1,3512-80-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2.0,H302:2;H332:2;H312:2;H319:2;H315:2;H335:1
20908,"Marjoram, pot, ext.",281-670-3,84012-24-8,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,192.0,H304:163;H317:161;H413:119;H315:185;H302:162;H311:36;H412:35;H226:25;H319:38;H411:11;H312:4;H314:6;H318:1
20912,Glyceryl undecylenate,918-906-8,,Skin Sens. 1A,REACH registration C&L,2.0,H317:2
20914,"Fats and Glyceridic oils, pumpkin seed",616-982-4,8016-49-7,Not Classified,Notified C&L,52.0,Not classified:52
20917,4-Butylcyclohexane carbaldehyde,924-667-0,,Not Classified,Notified C&L,1.0,Not classified:1
20922,4-acetamido-5-(ethylsulphonyl)-2-methoxybenzoic acid,302-772-7,94134-06-2,Not Classified,REACH registration C&L,1.0,Not classified:1
20924,1-bromonaphthalene,201-965-2,90-11-9,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,52.0,H410:1;H319:49;H400:1;H302:51;Not classified:1
20926,Sodium octadecyl fumarate,223-781-1,4070-80-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,148.0,H315:78;H319:78;Not classified:70;H335:2
20930,"2-(2-chlorophenyl)-1-[2-(2-chlorophenyl)-4,5-diphenyl-2H-imidazol-2-yl]-4,5-diphenyl-1H-imidazole",230-555-6,7189-82-4,Not Classified,REACH registration C&L,122.0,Not classified:73;H413:48;H335:1;H315:1;H319:1
20932,Benzamide oxime,210-361-8,613-92-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,48.0,H335:46;H301:40;H315:47;H319:47;Not classified:1;H302:6;H332:2;H312:2
20933,(E)-2-Ethoxy-N-(2-methyl-1-phenylpropylidene)ethylamine,604-106-3,139007-06-0,Not Classified,REACH registration C&L,1.0,Not classified:1
20937,trans-cinnamic acid,205-398-1,140-10-3,Not Classified,REACH registration C&L,376.0,Not classified:291;H319:85;H335:64;H315:70
20938,1-butynylbenzene,210-752-3,622-76-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
20939,Dihydro-5-methylenefuran-2(3H)-one,233-004-8,10008-73-8,Skin Sens. 1;Resp. Sens. 1,Notified C&L,39.0,H317:38;H334:38;H315:1;H319:1
20940,1-(vinyloxy)decane,212-137-5,765-05-9,Not Classified,Notified C&L,88.0,Not classified:88
20949,Prop-2-ynyltriphenylphosphonium bromide,218-242-2,2091-46-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,43.0,H302:42;H332:38;H312:38;H319:43;H335:42;H315:43
20950,"N-[3-(dodecyloxy)propyl]propane-1,3-diamine",258-243-5,52898-18-7,,Notified C&L,39.0,H335:39;H317:39;H302:39;H314:39
20952,"4H-Benzo[4,5]cyclohepta[1,2-b]thiophen-4-one, 9,10-dihydro-",605-282-4,1622-55-5,Not Classified,Notified C&L,1.0,Not classified:1
20955,Anhydro-D-glucitol tripalmitate,258-994-9,54140-20-4,Not Classified,Notified C&L,12.0,Not classified:12
20960,"Amylase, α-, Aspergillus oryzae",232-588-1,9001-19-8,Resp. Sens. 1,Notified C&L,1353.0,H334:1353
20961,3-methylbenzothiazol-2(3H)-one hydrazone,214-440-8,1128-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
20962,phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex,413-650-9,93971-95-0,Aquatic Chronic 3,Harmonised C&L,0.0,H412:0
20964,"Poly[oxy(methyl-1,2-ethanediyl)], .alpha.-[(9Z)-(1-oxo-9-octadecenyl)]-.omega.-hydroxy-",608-614-6,31394-71-5,Not Classified,Notified C&L,114.0,Not classified:56;H319:38;H315:20
20965,2-chloro-N-methyl-N-phenylacetamide,220-053-5,2620-05-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H302:38;H315:38;H319:38
20966,Divanadium trioxide,215-230-9,1314-34-7,Eye Irrit. 2,REACH registration C&L,74.0,H319:72;H332:63;H335:25;H315:21;H301:4;H310:4;H411:2;Not classified:2
20968,[8-[(4-amino-3-nitrophenyl)azo]-7-hydroxy-2-naphthyl]trimethylammonium chloride,269-944-0,68391-32-2,Aquatic Chronic 2,REACH registration C&L,43.0,H411:4;Not classified:37;H317:2
20971,"[(2S,3R,5S)-3-acetoxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl]methyl acetate",610-122-1,433733-94-9,Skin Sens. 1B,REACH registration C&L,1.0,H317:1
20972,Cyclohex-3-ene-1-carbaldehyde,202-858-3,100-50-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,50.0,H314:4;H318:5;H226:50;H312:50;H315:42;H319:45;H335:45;H332:1
20973,Hex-3-enal,224-659-0,4440-65-7,Flam. Liq. 3;Acute Tox. 4,Notified C&L,137.0,H226:137;H302:137
20974,Zinc dioctanoate,209-156-6,557-09-5,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,211.0,H411:3;H319:183;H400:181;H302:178;H332:178;H410:179;H312:178;H315:180;Not classified:28;H335:1
20975,Isooctadecyl lactate,255-674-0,42131-28-2,Not Classified,Notified C&L,18.0,Not classified:18
20980,Sodium 3-hydroxy-4-[(1-hydroxy-2-naphthyl)azo]naphthalene-1-sulphonate,222-639-6,3564-14-5,Eye Irrit. 2,Notified C&L,41.0,H319:41;Not classified:1;H315:1
20983,6-methoxy-N-methyl-3-nitropyridin-2-amine,303-354-7,94166-58-2,Eye Irrit. 2,Notified C&L,1.0,H319:1
20986,2-benzylcyclohexylamine,276-663-7,72436-51-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1.0,H335:1;H318:1;H302:1;H315:1
20987,6-methylpyridine-2-thioamide,227-680-3,5933-30-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H302:38;H315:38
20990,Bromocyclohexane,203-622-2,108-85-0,Not Classified,REACH registration C&L,7.0,Not classified:2;H335:5;H315:5;H319:5;H411:1
20992,4-methoxybenzhydryl alcohol,211-953-9,720-44-5,Aquatic Acute 1,Notified C&L,38.0,H400:38
20995,"ioxynil (ISO);4-hydroxy-3,5-diiodobenzonitrile",216-881-1,1689-83-4,Acute Tox. 3;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1;Repr. 2,Harmonised C&L,0.0,H301:0;H410:0;H373:0;H331:0;H312:0;H319:0;H361:0;H400:0
20999,2-aminoanthraquinone,204-208-4,117-79-3,Carc. 2,Notified C&L,47.0,H351:43;Not classified:3;H341:2;H332:2;H302:2;H312:2;H412:1;H319:1;H335:1;H315:1
21000,p-[(2-chloroethyl)methylamino]benzaldehyde,202-321-3,94-31-5,Not Classified,Notified C&L,1.0,Not classified:1
21001,"1,1,3,3-tetramethylbutyl isocyanate",238-577-8,14542-93-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40.0,H332:40;H226:40;H302:40;H312:40;H319:1;H335:1;H315:1
21002,"4-amino-3-[[4-[[[4-[(2,4-diaminophenyl)azo]phenyl]amino]carbonyl]phenyl]azo]-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulphonic acid",253-493-1,37405-95-1,Not Classified,Notified C&L,1.0,Not classified:1
21006,"Rape oil, sodium salt",269-168-2,68188-93-2,Not Classified,Notified C&L,1.0,Not classified:1
21007,"1,2,3-Thiadiazole-5-carboxylic acid, 4-methyl-, methyl ester",605-990-3,183298-93-3,,Notified C&L,33.0,Not classified:33
21011,1-[(trifluoromethyl)sulphonyl]-1H-imidazole,249-686-5,29540-81-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,40.0,H332:38;H302:38;H312:38;H335:1;H315:2;H319:2
21013,S-phenyl benzenethiosulphonate,214-919-1,1212-08-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H335:1;H315:1
21014,"(2E)-3-(4-AMINO-3,5-DIMETHYLPHENYL)PROP-2-ENENITRILE",610-496-6,500292-86-4,Skin Sens. 1;Eye Dam. 1;Muta. 2,REACH registration C&L,2.0,H341:2;H317:2;H318:2
21015,Trimethylsilyl chlorosulphate,224-425-8,4353-77-9,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,38.0,H226:38;H314:38
21017,"Tallow, sulfated",274-998-3,70900-12-8,Not Classified,Notified C&L,1.0,Not classified:1
21022,Acrylated Polydimethylsiloxane,603-070-6,125455-52-9,Skin Sens. 1,Notified C&L,523.0,H317:511;Not classified:13
21023,(Z)-dodec-8-enyl acetate,248-823-6,28079-04-1,Not Classified,Notified C&L,90.0,Not classified:89;H413:1
21024,"1-ethoxy-4-(1-ethoxyvinyl)-3,3,5,5-tetramethylcyclohexene",252-960-7,36306-86-2,Not Classified,Notified C&L,113.0,Not classified:113
21026,"2(1H)-Naphthalenone, octahydro-5,5,8a-trimethyl-, (4aR,8aS)-",601-270-8,113667-25-7,,Notified C&L,1.0,H304:1;H373:1;H336:1;H226:1;H315:1;H361:1
21027,1-chloro-4-(dibromomethyl)benzene,263-381-4,62037-06-3,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1.0,H318:1;H314:1
21028,Cyclizine hydrochloride,206-136-9,303-25-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 1;Repr. 2,Notified C&L,39.0,H301:39;H361:39;H330:39;H311:39;H411:1;H317:1;H228:1;H319:1
21031,1-chloro-3-(dodecyloxy)propan-2-ol,241-661-7,17677-15-5,Not Classified,Notified C&L,1.0,Not classified:1
21032,Sodium valproate,213-961-8,1069-66-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1A,Notified C&L,103.0,H360:63;H302:103;H315:60;H319:55;H335:55;H318:5;H332:1;H372:1;H341:1;H371:1
21034,"captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide",219-363-3,2425-06-1,Skin Sens. 1;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H317:0;H400:0;H410:0;H350:0
21039,"Bergamot, ext.",289-612-9,89957-91-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1705.0,H304:1617;H317:1642;H412:103;H226:1570;H319:130;H315:1618;H410:1511;H400:1505;Not classified:61;H411:27;H225:24;H318:1;H314:1
21040,(1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol,601-329-8,114798-26-4,Repr. 2,REACH registration C&L,78.0,H361:1;H335:39;H413:38;H315:39;H319:40;H360:37;H317:36;H362:36;H302:2
21042,bromobenzene,203-623-8,108-86-1,Flam. Liq. 3;Skin Irrit. 2;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H226:0;H315:0
21044,"Condensation products of m-phenylenebis(methylamine) with condensation products of 4-methyl-m-phenylene diisocyanate with alcohols, C10-14 (even numbered)",428-710-1,207574-76-3,Not Classified,Notified C&L,1.0,Not classified:1
21046,Methoprotryne,212-664-0,841-06-5,Acute Tox. 2,Notified C&L,41.0,H310:38;Not classified:3
21048,Enzymatic Digest of Casein and Yeast,921-186-8,,Not Classified,Notified C&L,1.0,Not classified:1
21051,Barium dilaurate,225-167-9,4696-57-5,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,48.0,H332:48;H302:48
21053,"tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-)",201-105-6,78-32-0,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H302:0;H312:0
21059,Methyl phenothiazin-10-yl ketone,216-621-7,1628-29-1,Not Classified,Notified C&L,1.0,Not classified:1
21063,Ethyl diphenylphosphinite,211-951-8,719-80-2,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,127.0,H302:84;H412:84;H335:42;H315:43;H319:43
21064,2-methyl-3-(methyldithio)furan,265-797-1,65505-17-1,Acute Tox. 3,Notified C&L,1588.0,H301:1588
21070,tert-butyl peroxyneoheptanoate,247-954-6,26748-38-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,6.0,H315:6;H319:6;H242:2
21071,"2-(3,4-DIMETHYLPHENYL)-5--METHYL-2,4-DIHYDROPYRAZOL-3-ONE",605-898-3,18048-64-1,Not Classified,Notified C&L,12.0,Not classified:11;H317:1;H410:1;H400:1
21073,"Zeolite, cuboidal, crystalline, synthetic, non-fibrous",930-915-9,,Not Classified,Notified C&L,84.0,Not classified:84
21080,"1,3,3-trimethyl-2-[(methylphenylhydrazono)methyl]-3H-indolium acetate",281-437-6,83949-77-3,Acute Tox. 4;Eye Dam. 1,Notified C&L,2.0,H318:2;H302:2
21083,Tetradecamethylhexasiloxane,203-499-5,107-52-8,Not Classified,REACH registration C&L,32.0,Not classified:31;H335:1;H315:1;H319:1
21084,"Lard, oleins",297-468-3,93572-38-4,Not Classified,Notified C&L,1.0,Not classified:1
21088,Ethyl 2-acetyloctanoate,249-518-0,29214-60-6,Not Classified,Notified C&L,1521.0,Not classified:1521
21093,"Goldenrod, Solidago virgaurea, ext.",285-559-0,85117-06-2,Flam. Liq. 3,Notified C&L,3.0,H226:3
21094,m-phenylenediamine dihydrochloride,208-790-0,541-69-5,Acute Tox. 3;Acute Tox. 3;Eye Irrit. 2;Skin Sens. 1;Acute Tox. 3;Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H317:0;H311:0;H331:0;H319:0;H341:0;H400:0
21100,Cinnamyl 2-methylcrotonate,263-215-0,61792-12-9,Not Classified,Notified C&L,233.0,Not classified:233
21102,Ethyl 4-(6-guanidinohexanoyloxy)benzoate methanesulphonate,611-438-2,56974-61-9,Not Classified,Notified C&L,13.0,Not classified:12;H373:1
21103,(4S)-4-(phenylthio)-L-proline,617-252-8,81653-77-2,Not Classified,REACH registration C&L,13.0,Not classified:4;H360:9;H302:9;H350:9;H315:9;H319:9;H340:9;H335:9
21107,"2,4,4-trimethylcyclopentan-1-one",225-155-3,4694-12-6,Flam. Liq. 3,Notified C&L,43.0,H226:43
21108,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with ethenylbenzene",607-649-4,25213-39-2,Not Classified,Notified C&L,22.0,Not classified:22
21109,3-isopropyl-(1H)-pyrazin-2-one,247-185-6,25680-59-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
21111,2-methoxyethyl phenyl ether,255-428-2,41532-81-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38.0,H335:38;H318:38;H315:38
21112,Zinc didocosanoate,240-597-7,16529-65-0,Not Classified,REACH registration C&L,9.0,Not classified:9
21113,"2,2,4-Trimethyl-4-phenylbutane- nitrile",801-874-3,75490-39-0,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,24.0,H411:24;H302:24
21115,"Sulfonic acids, C20-24-alkane hydroxy and C20-24-alkene, sodium salts",307-905-2,97766-43-3,,Notified C&L,1.0,H301:1;H318:1
21118,"2-Propenoic acid, 2-methyl-, 3,5-dihydroxytricyclo[3.3.1.13,7]dec-1-yl ester, polymer with hexahydro-2-oxo-3,5-methano-2H-cyclopenta[b]furan-6-yl 2-propenoate and 1-methyl-1-tricyclo[3.3.1.13,7]dec-1-ylethyl-2-methyl-2-propenoate",473-380-2,,Flam. Sol. 2,Notified C&L,2.0,H228:2
21120,1-(dimethylamino)acetone,239-402-8,15364-56-4,Flam. Liq. 3;Skin Irrit. 2,Notified C&L,38.0,H226:38;H315:38
21121,"6-hydroxy-5-[(4-methoxy-2-nitrophenyl)diazenyl]-1,4-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile",452-590-8,75511-89-6,Aquatic Chronic 4,Notified C&L,1.0,H413:1
21124,Calcium magnesium dihydroxide oxide,261-235-4,58398-71-3,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,68.0,H335:67;H318:68;H315:68
21126,2-ethyl-4-methylimidazole,213-234-5,931-36-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,452.0,H317:146;H318:423;H302:445;H315:261;H314:7;H351:5;H400:22;Not classified:7;H335:7;H412:2;H319:1;H311:1;H331:1
21128,2-methylpropyl isocyanide,230-553-5,7188-38-7,Flam. Liq. 2;Acute Tox. 2,Notified C&L,44.0,H225:44;H330:39;H331:1
21129,N-butylphosphorothioic triamide,435-740-7,94317-64-3,Eye Dam. 1;Repr. 2,REACH registration C&L,161.0,H318:161;H361:157;H317:6;H335:1;H315:1
21131,"tert-Butylammonium-(3R,5R)-3,5-dihydroxy-7-[(1'S,2'S,8'S,8a'R) -2'-methyl-8'-[(2""S)-2""-methyl-butoxy]-1',2',3',7',8',8a'-hexahydro-napht-1-yl] heptanoate",451-580-0,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1.0,H317:1;H319:1
21134,"1-amino-4-[[3-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-sulphophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",240-844-9,16823-51-1,Not Classified,Notified C&L,1.0,Not classified:1
21137,N-carbamoyl-2-cyanoacetamide,215-906-3,1448-98-2,,Notified C&L,5.0,H335:4;H302:4;H315:5;H319:5;H301:1
21138,(carboxymethyl)dimethyloleylammonium hydroxide,212-806-1,871-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,443.0,H302:442;H315:442;H319:442;H318:1
21139,(S)-2-amino-4-methyl-N-2-naphthylvaleramide monohydrochloride,212-970-4,893-36-7,Carc. 1A,Notified C&L,1.0,H350:1
21140,"Benzene, diethenyl-, polymer with ethenylbenzene, sulfonated, sodium salts",614-499-3,68441-33-8,Eye Irrit. 2,Notified C&L,71.0,H319:38;Not classified:33
21143,cis-stilbene,211-445-7,645-49-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,43.0,H315:38;H319:43
21145,4-trans-(4-trans-Pentylcyclohexyl)-cyclohexancarbonic acid,613-783-4,65355-33-1,Aquatic Chronic 1,Notified C&L,3.0,H410:1;Not classified:1;H315:2;H319:2;H335:1
21148,4-hexylbenzoyl chloride,256-647-6,50606-95-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,42.0,H318:38;H314:42
21149,"Disodium 2,2'-(9,10-dioxoanthracene-1,4-diyldiimino)bis(5-butylbenzenesulphonate",229-061-3,6408-57-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,84.0,H315:57;H319:58;Not classified:16;H412:8;H317:2
21152,"[2-[1-(4-chlorophenyl)-1-phenylethoxy]propyl]dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate",227-744-0,5964-37-4,Acute Tox. 4,Notified C&L,38.0,H302:38
21156,"2,3-dichlorotetrahydrofuran",222-513-0,3511-19-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H315:1;H319:1
21159,Ammonium isovalerate,231-458-1,7563-33-9,Not Classified,Notified C&L,90.0,Not classified:90
21160,Chlorohydrotris(triphenylphosphine)ruthenium,259-480-7,55102-19-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39.0,H302:38;H332:38;H312:38;H319:39;H335:39;H315:39
21165,"Amines, di-C14-18-alkylmethyl, [29H,31H-phthalocyaninedisulfonato(4-)-N29,N30,N31,N32]cuprate(2-) (2:1)",285-198-9,85049-29-2,Not Classified,Notified C&L,7.0,Not classified:7
21166,"Fatty acids, C14-22-conjugated unsatd.",305-959-1,95370-93-7,Not Classified,Notified C&L,7.0,Not classified:7
21169,"Grapefruit, ext.",289-904-6,90045-43-5,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2031.0,H411:325;H304:1991;H317:1991;H226:1991;H315:1992;H410:1477;H400:1444;Not classified:39;H335:1;H319:1
21176,"3,3'-(3,6-dioxo-2,3,5,6-tetrahydropyrrolo[3,4-c]pyrrole-1,4-diyl)dibenzonitrile",412-640-1,,Not Classified,REACH registration C&L,85.0,Not classified:85
21180,2-(diethylamino)ethyl stearate,221-662-9,3179-81-5,Not Classified,Notified C&L,1.0,Not classified:1
21182,"4-chloro-α,α,α-trifluoro-o-toluidine",207-151-3,445-03-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,49.0,H302:47;H332:44;H373:39;H312:44;H319:48;H335:42;H315:49;H411:2;H301:1;H330:1;H311:1;H318:1
21183,4-isopropenylcyclohex-1-en-1-ylmethanol,208-639-9,536-59-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1571.0,H317:1286;H315:1571;H319:1563;H335:2
21189,4-chloroaniline,203-401-0,106-47-8,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Carc. 1B;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H350:0;H317:0;H311:0;H331:0;H400:0
21192,(R)-6-methoxy-α-methylnaphthalene-1-acetic acid,245-966-6,23979-41-1,Acute Tox. 4,Notified C&L,40.0,H302:39;H331:1;H301:1;H311:1
21193,Sodium 3-(p-anilinophenylazo)benzenesulphonate,209-608-2,587-98-4,Skin Sens. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,427.0,H411:164;H317:108;H361:14;H318:190;Not classified:79;H332:54;H302:51;H312:54;H319:51;H412:44;H335:1;H315:2;H351:1;H341:1
21194,Dichlorodipropylsilane,218-940-7,2295-24-1,,Notified C&L,4.0,H226:4;H314:4
21197,"Amines, bis(hydrogenated tallow alkyl), 2-[[bis(hydrogenated tallow alkyl)amino]carbonyl]benzoates",294-705-2,91745-35-6,Not Classified,REACH registration C&L,32.0,Not classified:32
21199,Pholedrine,206-725-0,370-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
21205,"4-ethoxy-2,3-difluoro-4'-(trans-4-propylcyclohexyl)-1,1'-biphenyl",921-136-5,,Not Classified,REACH registration C&L,2.0,Not classified:2
21208,Sodium salts of heparin,618-546-9,9041-08-1,Not Classified,Notified C&L,229.0,Not classified:150;H317:66;H334:23;H319:11;H302:5;H312:1;H332:1;H315:1;H373:1
21212,Dodecyl benzoate,220-837-7,2915-72-2,Not Classified,Notified C&L,1.0,Not classified:1
21213,"Palmitic acid, monoester with propane-1,2-diol",249-369-1,29013-28-3,Not Classified,Notified C&L,19.0,Not classified:19
21214,Pyridine-2-carbaldehyde (2-pyridylmethylene)hydrazone,230-146-2,6957-24-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
21215,4-fluoro-4'-hydroxybenzophenone,247-340-8,25913-05-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2.0,H315:2;H319:2;H335:1
21216,Iodine trichloride,212-739-8,865-44-1,Ox. Sol. 2;Skin Corr. 1B,Notified C&L,41.0,H272:38;H314:41;H290:2;H335:3;Not classified:2;H318:1
21218,"Paraffin waxes and Hydrocarbon waxes, chloro, sulfonated, sodium salts",297-889-2,93763-67-8,Not Classified,Notified C&L,49.0,Not classified:40;H302:9;H315:9;H319:9
21219,Proscillaridin,207-370-4,466-06-8,Acute Tox. 3,Notified C&L,40.0,H301:40;H335:1;H315:1;H319:1
21220,"3-acetoxy-α,α,α-trifluoro-p-toluic acid",206-297-5,322-79-2,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,43.0,H302:43;H317:39;H315:41;H319:43;H335:39;H413:1;H361:1;H312:1
21221,"CELLULOSE, ETHER WITH α-[2-HYDROXY-3-(TRIMETHYLAMMONIO)PROPYL]-ω-HYDROXYPOLY(OXY-1,2-ETHANEDIYL), CHLORIDE",614-667-6,68610-92-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,569.0,H315:489;H319:490;H412:51;H335:46;H411:26;Not classified:2
21222,"Disodium 4,4'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[3,5-diethyltoluene-2-sulphonate]",276-816-8,72749-79-2,Not Classified,Notified C&L,5.0,Not classified:4;H412:1
21223,"4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane, reaction products with butan-1-ol and 3-aminomethyl-3,5,5-trimethylcyclohexylamine",500-652-0,161308-12-9,Not Classified,Notified C&L,9.0,Not classified:9
21224,(2-methoxyphenyl)boranediol,611-481-7,5720-06-9,,Notified C&L,12.0,H335:10;H315:11;H319:11;H302:2;H332:2;H312:2
21226,"2-(diphenylacetyl)-1H-indene-1,3(2H)-dione 1-hydrazone",225-821-3,5102-79-4,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38.0,H301:38;H410:38;H400:38
21228,Neopentyl glycol dimethylsulfate,611-011-0,53555-41-2,Eye Dam. 1,Notified C&L,38.0,H318:38
21229,"3-Pyridinecarbonitrile, 5-[2-(4-chloro-2-nitrophenyl)diazenyl]-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-",617-927-7,86836-02-4,Not Classified,Notified C&L,19.0,Not classified:19
21230,"N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea",445-760-8,,Eye Dam. 1;Resp. Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H318:0;H334:0;H410:0;H400:0
21231,"(S)-(+)-1,2-Propanediol",610-039-0,4254-15-3,Not Classified,Notified C&L,3.0,Not classified:2;H319:1
21235,"α,α,α',α'-tetrabromo-o-xylene",236-176-2,13209-15-9,Skin Corr. 1B;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,45.0,H318:40;H335:42;H314:45;H400:38;H317:4;H302:3;H312:3;H332:2;H410:1
21237,Trichlorodecylsilane,237-540-3,13829-21-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,43.0,H318:39;H314:43;H290:1
21240,tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-),405-110-6,88377-66-6,STOT RE 2;Aquatic Chronic 4,Harmonised C&L,0.0,H413:0;H373:0
21241,"7-nitronaphth[1,2-d][1,2,3]oxadiazole-5-sulphonic acid",201-573-1,84-91-3,Not Classified,Notified C&L,85.0,Not classified:85
21243,"(2,5-dimethyl-2,3-dihydro-1H-inden-2-yl)methanol",437-760-1,,Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,6.0,H336:6;H319:6;H412:6
21246,"4,4'-isopropylidenebis[(allyloxy)benzene]",223-123-3,3739-67-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,32.0,H315:29;H319:29;H317:15;H413:1;H226:2;H314:1
21250,"2,3-dihydrobenzo[b]thiophen-3-amine 1,1-dioxide",281-115-5,83863-51-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
21252,3-(1H-benzimidazol-2-yl)-7-(diethylamino)-2-benzopyrone,248-451-4,27425-55-4,Not Classified,REACH registration C&L,213.0,Not classified:51;H317:123;H335:38;H315:39;H319:39
21255,N-(2-hydroxyethyl)myristamide,205-546-5,142-58-5,Not Classified,Notified C&L,3.0,Not classified:1;H318:2
21256,"4,4'-dihydroxy-7,7'-iminodi(naphthalene-2-sulphonic acid)",201-719-4,87-03-6,Not Classified,REACH registration C&L,2.0,Not classified:2
21257,[[(2-chloroethyl)sulphonyl]methyl]benzene,266-535-9,66998-67-2,Acute Tox. 3;Eye Dam. 1,Notified C&L,38.0,H301:38;H318:38
21259,"2,2-dimethylthiazolidine-4-carboxylic acid hydrochloride",254-236-6,38984-68-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H302:1;H315:1;H319:1
21260,poly[ethene-co-(ethyl 2-propenoate)],618-458-0,9010-86-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,78.0,H335:38;H315:38;H319:38;Not classified:37;H317:3;H412:3
21264,disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate,402-360-8,92511-22-3,Eye Dam. 1,Harmonised C&L,0.0,H318:0
21268,Bis-O-(benzylidene)-D-glucitol,251-136-4,32647-67-9,Not Classified,REACH registration C&L,114.0,Not classified:114
21272,1-butyl-5-oxopyrrolidine-3-carboxylic acid,256-084-6,43094-86-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1.0,H302:1;H332:1;H312:1;H319:1;H315:1
21273,Manganese silicide,234-780-0,12032-85-8,Not Classified,Notified C&L,3.0,Not classified:3
21274,"1-[difluoro(trifluoromethoxy)methoxy]-1,2,2-trifluoroethylene",615-064-0,700874-87-9,Flam. Gas 1;Flam. Liq. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2.0,H220:2;H410:2;H224:2;H400:2
21277,6-methylheptan-2-one,213-179-7,928-68-7,Eye Irrit. 2,Notified C&L,43.0,H319:39;Not classified:3;H226:2;H335:1;H315:1
21280,1-bromo-2-methylnaphthalene,219-966-1,2586-62-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:39;H315:39;H319:39
21281,"Disodium 4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4'-[(2-hydroxy-1-naphthyl)azo][1,1'-biphenyl]-2,2'-disulphonate",229-294-0,6470-20-8,,Notified C&L,44.0,Not classified:37;H412:3;H318:3;H315:1;H319:1
21282,"Reaction product of Polymethylene Polyphenyl Polyisocyanate (CAS 9016-87-9) and amines, coco alkyl (EC 262-977-1)",927-693-0,,,Notified C&L,1.0,H413:1
21283,TDE,200-783-0,72-54-8,Acute Tox. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9.0,H301:8;H410:6;H312:8;H400:6;H351:2;Not classified:1
21286,alkali fluorosilicates(NH4),240-968-3,16919-19-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Harmonised C&L,0.0,H331:0;H301:0;H311:0
21287,"Lithium acetylide, ethylenediamine complex",229-967-9,6867-30-7,Water-react. 1;Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,70.0,H318:3;H302:27;H314:70;H260:27;H261:43
21295,4-fluorosulphonylbenzenesulphonyl chloride,250-278-4,30672-72-1,Skin Corr. 1B,Notified C&L,1.0,H314:1
21296,"Pentaerythritol tetrakis(3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate)",229-722-6,6683-19-8,Not Classified,REACH registration C&L,2939.0,Not classified:2696;H413:157;H412:68;H350:11;H331:5;H332:2;H302:1;H312:1
21297,5-methylhept-2-en-4-ol,920-434-2,,Not Classified,REACH registration C&L,1.0,Not classified:1
21298,"1,2-Benzenedicarboxylic acid, mixed decyl and lauryl and octyl diesters",274-763-5,70693-30-0,Not Classified,Notified C&L,3.0,Not classified:3
21299,"Betaines, (C12-16 branched and linear alkyl)dimethyl",282-950-8,84501-33-7,Not Classified,Notified C&L,1.0,Not classified:1
21302,"2-Pyrrolidinone, 1-ethenyl-, homopolymer",607-660-4,25249-54-1,,Notified C&L,41.0,Not classified:41
21304,"Decanoic acid, mixed esters with neopentyl glycol and octanoic acid",274-764-0,70693-32-2,Not Classified,REACH registration C&L,35.0,Not classified:35
21311,sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate,416-370-5,156738-27-1,Skin Sens. 1;Aquatic Chronic 3,Harmonised C&L,0.0,H317:0;H412:0
21312,"Penta-1,4-diene",209-736-9,591-93-5,Flam. Liq. 1;Asp. Tox. 1,Notified C&L,44.0,H304:40;H224:44
21313,"Pyrrolidinium, 1-[[(6R,7R)-7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-, chloride",600-395-5,103121-85-3,Skin Sens. 1B;Resp. Sens. 1,Notified C&L,1.0,H317:1;H334:1
21314,"3,7,11,15-hexadeca-6,10,14-trien-3-ol",274-941-2,70851-60-4,Not Classified,Notified C&L,233.0,Not classified:233
21316,Ethyl 2-mercaptopropionate,243-314-5,19788-49-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1444.0,H302:1393;H332:1393;H315:1390;H319:1390;H335:1389;H226:148;Not classified:10;H312:4
21318,"N,N'-ethane-1,2-diylbishexadecan-1-amide",226-864-0,5518-18-3,Not Classified,Notified C&L,198.0,Not classified:193;H413:5
21319,1-methyl-5-oxo-DL-proline,276-664-2,72442-37-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
21320,"Distillates (petroleum), hydrodesulfurized middle coker;Cracked gasoil;[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C",309-865-1,101316-59-0,Carc. 1B,Harmonised C&L,0.0,H350:0
21321,nickel dihydroxide,235-008-5,12054-48-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Muta. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A;Repr. 1B,Harmonised C&L,0.0,H360:0;H334:0;H332:0;H410:0;H350:0;H317:0;H315:0;H372:0;H341:0;H302:0;H400:0
21327,Isobutyl 2-methylbutyrate,219-492-5,2445-67-2,Flam. Liq. 3,Notified C&L,1378.0,H226:1378
21330,2-chlorocyclohexanone,212-505-5,822-87-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,47.0,H335:46;H317:46;H315:47;H319:47
21332,"coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid",425-400-6,179986-09-5,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
21334,"Magnesium silicon oxide (Mg2Si3O8), hydrate",609-658-9,39365-87-2,Not Classified,Notified C&L,1.0,Not classified:1
21337,"Schinopsis lorentzii, ext., bisulfited",309-213-6,100085-70-9,Not Classified,Notified C&L,1.0,Not classified:1
21338,"4-Fluoro-1,3-dioxolan-2-one",483-360-5,114435-02-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT RE 1,REACH registration C&L,26.0,H317:10;H315:11;H372:6;H319:11;H302:11;Not classified:14
21341,p-[4-isopropyl-1-piperazinyl]phenol,267-750-0,67914-97-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
21342,"6,10-dimethylundec-9-en-2-one",224-634-4,4433-36-7,Skin Sens. 1,Notified C&L,260.0,H317:258;Not classified:1;H335:1;H315:1;H319:1
21345,"Disodium [(9,10-dihydro-9,10-dioxo-1,4-anthrylene)bis[imino(3-methylpropane-1,3-diyl)]]bis(benzenesulphonate)",274-999-9,70900-27-5,Aquatic Chronic 3,REACH registration C&L,7.0,H412:6;Not classified:1
21346,"2,4,5-trimethoxybenzoic acid",207-715-9,490-64-2,,Notified C&L,6.0,H335:5;H315:6;H319:6;H302:1
21353,Dimethyl 4-aminophthalate,257-460-2,51832-31-6,Acute Tox. 4,Notified C&L,38.0,H302:38
21355,"Estrogens, conjugates",235-199-5,12126-59-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 1B;Repr. 1B,Notified C&L,43.0,H360:43;H350:43;H315:42;H319:42;H335:42;H372:1
21356,"Fatty acids, C16-18, triesters with trimethylolpropane",293-037-9,91050-90-7,Not Classified,Notified C&L,1.0,Not classified:1
21361,Batilol,208-874-7,544-62-7,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3.0,H410:2;H400:2;Not classified:1
21366,di(C,428-870-0,,Aquatic Chronic 4,Harmonised C&L,0.0,H413:0
21368,4-methyl-8-methylenetricyclo[3.3.1.1,406-560-6,122760-85-4,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Harmonised C&L,0.0,H411:0;H317:0;H315:0
21376,Desoxycortone acetate,200-275-9,56-47-3,Repr. 1A;STOT RE 2,Notified C&L,25.0,H360:24;H373:24;H335:1;H315:1;H319:1;H361:1
21379,cobalt lithium nickel oxide,442-750-5,,Skin Sens. 1;Acute Tox. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1;Carc. 1A,Harmonised C&L,0.0,H410:0;H330:0;H350:0;H317:0;H372:0;H400:0
21381,N-methyldidodecylamine,220-838-2,2915-90-4,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,6.0,H318:4;H315:5;H400:5;H302:1;H319:1
21384,Ketoprofen,244-759-8,22071-15-4,Acute Tox. 3,REACH registration C&L,637.0,H301:635;H335:148;H315:147;H319:147;H311:27;H331:44;H341:9;H361:12;H412:12;H302:1;H332:1;H330:2;H372:1;H317:3;Not classified:1;H413:2;H410:2;H362:1;H400:1
21385,p-menth-1-en-8-yl acetate,201-265-7,80-26-2,Aquatic Chronic 2,REACH registration C&L,1806.0,H411:1639;Not classified:110;H315:55;H319:53;H335:4;H412:3;H301:1
21389,"1-chloro-2,5-dimethoxybenzene",218-267-9,2100-42-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,36.0,H302:31;H412:29;H335:5;H315:7;H319:5
21391,guaiacol,201-964-7,90-05-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Harmonised C&L,0.0,H302:0;H315:0;H319:0
21395,[No public or meaningful name is available],453-010-6,,Not Classified,Notified C&L,1.0,Not classified:1
21396,"Extract residues (coal tar), high-temperature, naphthalene oil alkaline, distn. overheads",310-256-8,140362-65-8,Not Classified,REACH registration C&L,1.0,Not classified:1
21397,4-chlorobenzoyl chloride,204-515-3,122-01-0,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,154.0,H317:4;H315:4;H319:16;H318:90;H314:150;H335:52;H290:1
21399,"α-phenyl[1,1'-biphenyl]-4-methanol",231-506-1,7598-80-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,63.0,H410:62;H400:62;H302:1
21401,"2-(2-methoxyethoxy)ethyl 4-[(5-cyano-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridin-3-yl)azo]benzoate",256-457-3,49744-26-5,Not Classified,REACH registration C&L,13.0,Not classified:6;H412:7
21402,Potassium perfluorooctanoate,219-248-8,2395-00-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1.0,H302:1;H332:1;H315:1;H319:1;H335:1
21403,"Decanoic acid, mixed esters with heptanoic acid, octanoic acid, pentaerythritol and valeric acid",275-118-0,71010-76-9,Not Classified,REACH registration C&L,5.0,Not classified:5
21406,Hexaphenyldisiloxane,217-381-6,1829-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39.0,H335:38;H315:39;H319:39
21407,"Alcohols, C10-14, reaction products with phosphorus oxide (P2O5)",292-437-0,90622-36-9,Not Classified,Notified C&L,9.0,Not classified:9
21408,1-D-alanyl-L-proline,262-783-7,61430-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
21410,"Starch, hydrogen phosphate, 2-hydroxypropyl ether",610-966-0,53124-00-8,Not Classified,Notified C&L,2.0,Not classified:2
21412,Fenamisal,205-092-8,133-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
21414,Zirconium sulphate,238-694-4,14644-61-2,Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,126.0,H318:57;H314:90;H302:44;H335:31;H315:24;H319:24;Not classified:2;H411:1;H332:1
21417,5-ethyl-2-methylpyridine,203-250-0,104-90-5,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1B;Acute Tox. 3;Aquatic Chronic 3,REACH registration C&L,1844.0,H314:1662;H317:1470;H311:1838;H412:1553;H331:1656;H302:1843;H319:182;H315:182;H318:136;H332:6;H312:5;H301:1
21419,3-hydroxymethylindole,211-836-2,700-06-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,45.0,H315:44;H319:45;H335:2
21420,"Amines, N-coco alkyltrimethylenedi-, adipates",268-960-5,68155-42-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1.0,H318:1;H315:1
21424,2-(2-methylpropoxy)ethanol,224-658-5,4439-24-1,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;STOT RE 2,REACH registration C&L,46.0,H318:3;H314:3;H373:4;H311:46;H302:46;H226:42;H319:2;H371:1
21428,Sodium o-chloro-α-hydroxytoluene-α-sulphonate,269-945-6,68391-33-3,Not Classified,Notified C&L,1.0,Not classified:1
21430,Isotridecyl isononanoate,255-673-5,42131-27-1,Not Classified,REACH registration C&L,30.0,Not classified:30
21431,triethyl arsenate,427-700-2,15606-95-8,Acute Tox. 3;Acute Tox. 3;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0.0,H301:0;H410:0;H350:0;H331:0;H400:0
21432,No IUPAC name,614-637-2,68603-75-8,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,35.0,H317:23;H302:35;H314:35;H410:30;H318:12;H400:12
21438,"S-(4,5-dihydro-2-methyl-3-furyl) ethanethioate",247-731-3,26486-14-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1375.0,H332:1375;H302:1375;H312:1375
21441,"1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-, hydrate (1:1)",611-861-2,5967-84-0,,Notified C&L,5.0,H301:5;H330:1;H311:1
21443,4-bromobenzohydrazide,227-681-9,5933-32-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,45.0,H335:43;H315:44;H319:44;H332:1;H302:1;H312:1
21445,Dextran,232-677-5,9004-54-0,Not Classified,Notified C&L,79.0,Not classified:79
21447,"2,2'-[(1-methylethylidene)bis[(2,6-dibromo-4,1-phenylene)oxymethylene]]bisoxirane",221-346-0,3072-84-2,Not Classified,REACH registration C&L,40.0,Not classified:37;H317:3
21450,Tetrairon octasodium pentakis(pyrophosphate),252-700-2,35725-46-3,Not Classified,Notified C&L,1.0,Not classified:1
21451,"2-(4-Fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(trimethylsilyl)-2-propanol",604-694-1,149508-90-7,Acute Tox. 4,Notified C&L,194.0,H302:194
21464,"Tetrasodium 2-[[8-[[4-chloro-6-[[4-(6-methyl-7-sulphonatobenzothiazol-2-yl)phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulphonato-2-naphthyl]azo]benzoate",274-390-8,70209-93-7,Not Classified,Notified C&L,1.0,Not classified:1
21467,"Sodium [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]hydroxychromate(1-)",233-357-8,10127-27-2,Not Classified,Notified C&L,1342.0,Not classified:1305;H412:33;H315:3;H319:3;H317:1;H318:1
21468,"21-Acetoxy-6alpha-fluoro-11ß-hydroxy-16alpha-methyl-4-pregnene-3,20-dione",601-489-9,1176-81-4,Repr. 1A;STOT RE 1,Notified C&L,1.0,H360:1;H372:1
21470,Benzyl isothiocyanate,210-753-9,622-78-6,Eye Irrit. 2;STOT SE 3,Notified C&L,1423.0,H335:1417;H319:1419;H302:137;H332:127;H334:73;H312:125;H315:69;H311:10;H331:10;H314:4;H351:4;H317:6;H400:2
21472,Tris(2-chloroethyl) phosphite,205-397-6,140-08-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Muta. 1B;Carc. 1B,Notified C&L,98.0,H301:93;H330:38;H350:39;H311:72;H319:59;H335:58;H340:39;H315:58;H312:20;Not classified:5;H331:1
21474,"Sodium hydrogen piperazine-1,4-diethanesulphonate",233-005-3,10010-67-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1.0,H335:1;H315:1;H319:1
21475,"Coca, Erythroxylum coca, ext.",283-877-4,84775-48-4,Flam. Liq. 2,Notified C&L,1374.0,H225:1374
21477,(2-methoxyphenyl)thiourea,604-809-5,1516-37-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,46.0,H332:38;H302:38;H312:38;H301:7;H335:2;H315:2;H319:2;H331:1;H311:1
21479,Rare earth chlorides,269-167-7,68188-88-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,91.0,H411:85;H318:85;H315:84;Not classified:6;H317:1;H290:1
21483,Methyl 3-bromopropionate,222-247-5,3395-91-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,46.0,H335:45;H302:46;H315:46;H319:46;H227:1
21485,"2,5-bis([1,1'-biphenyl]-4-yl)-1,3,4-oxadiazole",218-046-7,2043-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38.0,H335:38;H315:38;H319:38
21486,"Castor oil, mixed esters with adipic acid, diethylene glycol and tall oil",295-627-1,92113-22-9,Not Classified,Notified C&L,1.0,Not classified:1
